



























































Burkholderia	 cenocepacia,	 is	 a	 Gram-negative	 bacterial	 species	 belonging	 to	
the	Burkholderia	 cepacia	 complex	 (Bcc),	 a	 group	 of	 closely	 related	 species	 found	
ubiquitously	 in	 the	environment	 that	 are	 also	opportunistic	 human	pathogens.	B.	
cenocepacia	 is	 predicted	 to	 be	 able	 to	 secrete	 proteins	 through	 the	 type	 six	
secretion	 system	 (T6SS).	 Characterised	 in	 other	 bacteria,	 this	 secretory-apparatus	
can	perforate	the	cellular	membrane	in	pro-	and/or	eukaryotic	targets,	to	deliver	an	
arsenal	 of	 effector	 proteins.	 A	 cognate	 immunity	 protein	 is	 required	 to	 provide	
protection	against	these	effectors.	Identifying	and	characterising	the	T6SS-secreted	
effectors,	 their	 cognate	 immunity	 proteins	 and	 their	 molecular	 targets	 is	 key	 to	
understanding	the	role	 the	T6SS	plays	 in	 the	 interactions	between	B.	cenocepacia	
and	 its	 target	 organism(s).	 Here,	 this	 study	 defines	 a	 functional	 role	 for	 the	 B.	
cenocepacia	 T6SS	 in	bacterial	 competition.	Moreover,	 this	 is	partly	dependent	on	
the	phospholipase	A1	activity	of	 a	novel	 evolved	TssI,	 TssI0667.	 The	 involvement	of	
the	B.	cenocepacia	T6SS	in	pathogenicity	in	two	models	of	innate	immune	infection	
were	 assessed,	 but	 these	 studies	 did	 not	 demonstrate	 a	 contribution	 from	 this	
system	 to	 overall	 virulence.	 	 A	 further	 putative	 T6SS-dependent	 effector,	 TanBH,	
was	characterised	as	having	nuclease	activity	but	the	role	of	this	candidate	effector	
in	 vivo	 remains	 unclear.	 The	 cognate	 immunity	 protein	 for	 each	 effector	 was	
identified	 as	 Tli6	 and	 TaaB1H,	 respectively,	 and	 demonstrated	 to	 form	 a	 direct	
complex	with	 its	 effector	 that	 inhibited	 the	 toxic	 activity	 of	 the	 latter.	 Therefore,	
this	 work	 has	 begun	 to	 uncover	 mechanisms	 used	 by	 Bcc	 bacteria,	 such	 as	 B.	
cenocepacia,	 that	 may	 contribute	 towards	 their	 survival	 in	 their	 natural	
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Protein	 secretion,	defined	as	 the	process	of	 translocating	protein	molecules	
from	an	 intracellular	 to	an	extracellular	 location,	 is	an	 important	 feature	 for	both	
prokaryotic	 and	 eukaryotic	 cells.	 For	 bacteria,	 it	 is	 of	 particular	 importance	 for	
proper	 functioning	 and	 survival	 of	 the	 microorganism	 within	 its	 growth	
environment.	 Several	 bacterial	 secretion	 systems	 have	 been	 discerned,	 including	
the	type	VI	secretion	system	(T6SS).		This	is	a	multi-subunit,	membrane-embedded,	
protein	 translocation	 complex,	 which	 is	 widespread	 in	 the	 genomes	 of	 Gram-
negative	 bacteria.	 These	 include	 pathogenic	 bacteria	 such	 as	 Vibrio	 cholerae,	
Pseudomonas	 aeruginosa	 and	 the	 Burkholderia	 species	 (Pukatzki	 et	 al.,	 2006;	
Mougous	 et	 al.,	 2006;	 Schell	 et	 al.,	 2007;	 Shalom	 et	 al.,	 2007).	 This	 includes	
Burkholderia	 cenocepacia,	 a	 soil-dwelling	 organism	 found	 ubiquitously	 in	 the	
environment.		
The	T6SS	allows	the	translocation	of	specific	proteins	(effectors)	through	the	





the	 Burkholderia	 cepacia	 complex	 (Bcc).	 Unfortunately,	 many	 Bcc	 bacteria	 are	
opportunistic	pathogens.	Notably,	Bcc	infections	pose	a	significant	risk	to	immuno-
compromised	people,	specifically	patients	with	lung	dysfunction,	such	as	those	with	
cystic	 fibrosis	 (CF)	 (Isles	et	al.,	1984).	When	Bcc	colonization	occurs	 in	the	 lungs	 it	
can	 lead	 to	 serious	 life-threatening	 complications,	 including	 pneumonia,	 chronic	








Interestingly,	 it	 was	 found	 that	 some	 T6SSs	 are	 virulence	 determinants	 in	
bacterial	 pathogens	 including	 P.	 aeruginosa	 V.	 cholerae	 and	 highly	 pathogenic	
Burkholderia	species	(Pukatzki	et	al.,	2006;	Mougous	et	al.,	2006;	Schell	et	al.,	2007;	
Burtnick	et	al.,	2011).	However,	the	main	role	of	the	T6SS	appears	to	be	in	providing	
the	 bacteria	 with	 a	 fitness	 advantage	 over	 other	 competing	 bacteria	 within	 its	
environment.	As	a	relatively	new	addition	to	the	bacterial	protein	secretion	scene,	
the	fundamentals	of	the	T6SS	are	only	just	beginning	to	be	uncovered.		
Despite	 this,	 significant	discoveries	have	been	made,	particularly	 in	 the	past	
four	 years,	 regarding	 the	 identification	 and	 characterisation	 of	 effector	 proteins	
that	are	secreted	by	the	T6SS.	A	variety	of	effectors,	that	have	a	range	of	molecular	
targets,	 have	 been	 discovered	 in	 well-characterised	 T6SS-containing	 bacteria,	
including	phospholipases,	peptidoglycan	hydrolases	and	nucleases,	many	of	which	
show	toxicity	towards	other	bacteria,	and	several	towards	eukaryotes.	Yet,	there	is	
still	 a	 distinct	 lack	 of	 published	 experimental	 evidence	 regarding	 the	 role	 of	 the	




















bulbs	 (Burkholder,	 1950).	 It	 was	 initially	 thought	 to	 belong	 to	 the	 Pseudomonas	
genus	(Pseudomonas	cepacia).	But	due	to	advances	in	taxonomic	identification	over	
the	 years,	 in	 particular,	 the	 use	 of	 DNA-DNA	 hybridization	 and	 16S	 rRNA	 gene	
sequence	analysis,	it	was	reclassified	from	the	Pseudomonas	genus	to	a	new	genus	
Burkholderia,	 within	 the	 β-proteobacteria	 class	 (Yabuuchi	 et	 al.,	 1992).	
Furthermore,	 strains	 of	 Burkholderia	 cepacia	were	 then	 found	 to	 be	 genetically	
diverse	 leading	 to	 division	 of	 the	 genus	 into	 several	 phylogenetically	 different	
species,	 known	 as	 genomovars,	 which	 were	 later	 assigned	 species	 designations	
bases	 on	 phenotypic	 and	 biochemical	 tests	 (Vandamme	 et	 al.,	 1997).	 These	 Bcc	
species	 include	 B.	 cepacia	 (genomovar	 I),	 B.	 multivorans	 (genomovar	 II),	 B.	
cenocepacia	 (genomovar	 III),	 B.	 stabilis	 (genomovar	 IV)	 and	 B.	 vietnamiensis	
(genomovar	 V).	 Each	 of	 these	 are	 phenotypically	 similar,	 having	 a	 rod-shaped	
flagella	bearing	structure,	but	genetically	different.	These	species	live	in	a	range	of	
habitats,	including	soil,	water	and	the	rhizosphere	of	some	plants.	It	is	now	thought	








are	 generally	 organised	 into	 multiple	 large	 replicons.	 This	 feature	 was	 first	
recognised	in	B.	multivorans	ATCC	17616,	with	3	large	circular	replicons	of	varying	
size	(Cheng	and	Lessie,	1994).	Advances	in	nucleotide	sequencing	technology	have	
meant	 various	 Bcc	 species	 have	 now	 had	 their	 complete	 genome	 sequenced,	





































an	opportunistic	pathogen	 in	humans	 (Isles	et	al.,	1984).	Sequencing	of	 the	 J2315	
multi-drug	 resistant	 variant	of	B.	 cenocepacia,	 an	epidemic	 lineage	 strain	 isolated	
from	 a	 CF-patient	 (Edinburgh-Toronto-12,	 ET12),	 identified	 just	 over	 8	 Mbps	 of	
genetic	 sequence	making	up	 its	genome,	organised	 in	3	circular	chromosomes,	of	
sizes	3.87	Mbp	(known	as	BCAL),	3.22	Mbp	(BCAM)	and	0.87	Mbp	(BCAS),	with	an	
additional	 93	 kbp	 plasmid,	 having	 an	 average	 G-C	 content	 of	 approximately	 67%	
(Holden	et	 al.,	 2009).	 The	 genome	 is	 estimated	 to	 contain	 7,365	 genes,	 encoding	
approximately	7,116	predicted	proteins	(Holden	et	al.,	2009).		
Unexpectedly,	 the	 J2315	 genome	 study	 highlighted	 two	 key	 genomic	
features,	the	first	being	a	relatively	large	number	of	insertion	sequences	(Holden	et	
al.,	 2009).	 These	 are	 small	 DNA	 sequences	 that	 can	 move	 within	 the	 genome	
autonomously,	 that	 only	 encode	 genes	 required	 for	 insertional	 events	 (Mahillon	
and	Chandler,	1998).	The	second	feature	was	a	high	prevalence	of	genomic	islands,	
which	 are	 large	 sequences	 of	 genomic	 DNA	 that	 have	 a	 foreign	 origin,	 probably	
acquired	by	horizontal	gene	transfer	during	the	evolution	of	 the	species	relatively	




cenocepacia	 island	 (cci)	 and	 encodes	 virulence	 and	metabolism-associated	 genes	
(Baldwin	 et	 al.,	 2004).	 The	 cci	 also	 encodes	 a	 B.	 cepacia	 epidemic	 strain	marker	
(BCESM),	 historically	 used	 as	 a	 epidemiology	 marker	 for	 virulent	 B.	 cenocepacia	
strains	 isolated	 from	 CF-patients	 (Baldwin	 et	 al.,	 2004).	 The	 BCESM	 marker	 is	
present	in	many	but	not	all	CF-isolated	B.	cenocepacia	strains	and	is	also	present	in	










as	 the	cause	of	sour	skin	 in	onions	 (Burkholder,	1950),	many	members	of	 the	Bcc	
have	 now	 been	 shown	 to	 have	 a	 positive	 impact	 on	 the	 flora	 present	 in	 its	
ecosystem	(Parke	and	Gurian-Sherman,	2001).	For	example,	Bcc	species	have	been	
discovered	 living	 harmoniously	 as	 plant	 commensals	 in	 the	 rhizospheric	 soil	 of	





seedlings	 during	 their	 development	 period.	 Bcc	 is	 postulated	 to	 do	 this	 by	
producing	anti-microbial	agents,	such	as	antibiotics	like	phenylpyrroles	(Yoshihisa	et	
al.,	 1989)	 or	 lipopeptides	 (Kang	 et	 al.,	 1998),	 that	 can	 directly	 target	 these	
pathogenic	fungi.	Another	environmental	benefit	the	Bcc	is	thought	to	bring	to	its	
habitat	 is	 its	 ability	 to	 remove	pollutants	 from	 the	 soil,	 as	Bcc	bacteria	 can	use	 a	
variety	of	complex	carbon	sources	as	an	energy	supply.	For	example,	some	strains	




In	 stark	 contrast	 to	 the	 predominantly	 positive	 impact	 the	 Bcc	 has	 on	 its	
natural	 environment,	 the	 Bcc	 can	 have	 significantly	 different	 consequences	 on	 a	
human	host.	 Fortunately,	 the	Bcc	does	not	 generally	 colonise	healthy	 individuals.	
However,	 those	 with	 certain	 underlying	 health-problems	 and	 weakened	 immune	
systems	 are	 susceptible	 to	 Bcc	 infections,	 with	 cystic	 fibrosis	 patients	 being	 the	
most	at	risk.	The	thick,	sticky	and	nutrient-rich	secretions	produced	by	the	alveolar	
epithelium	 of	 CF-patients	 creates	 a	 breeding	 ground	 for	 infectious	 bacteria.	 The	
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prevalence	of	Bcc	 infections	 in	CF	patients	was	 first	 recognised	 in	 the	mid-1980’s,	
with	a	Canadian	CF	clinic	recognising	up	to	a	20%	Bcc	infection	rate	in	patients	(Isles	
et	 al.,	 1984).	 The	 clinical	 outcome	 of	 these	 infections	 were	 often	 varied,	 some	
patients	 carried	 the	 bacteria	 with	 no	 detrimental	 effect	 on	 their	 health,	 while	
others	became	chronically	 infected,	 resulting	 in	a	gradual	decline	 in	 lung	 function	
(Isles	 et	 al.,	 1984).	 A	 rare	 sub-population	 of	 Bcc	 infected	 individuals	 reacted	
adversely	 to	 the	 infection,	 leading	 to	 rapid	 decline	 in	 lung	 function,	 septicaemia,	





In	 particular,	 B.	 cenocepacia	 and	 B.	 multivorans	 are	 the	 most	 common	
causative	 agent	 of	 Bcc	 infections	 in	 CF-patients	 in	 the	 USA,	 Canada	 and	 the	 UK	
(Drevinek	and	Mahenthiralingam,	2010;	De	Soyza	et	al.,	2010),	and	B.	contaminans	
has	 been	 identified	 as	 commonest	 recovered	 species	 in	 some	 CF	 centres	 in	
Argentina	 and	 Spain	 (Martina	 et	 al.,	 2013;	Medina-Pascual	 et	 al.,	 2015).	A	 recent	
publication	of	a	long	term	epidemiological	study	of	Bcc	Infections	in	CF	patients	in	
British	 Columbia,	 Canada,	 indicated	 a	 higher	 incidence	 of	 new	 infections	 being	
caused	by	B.	multivorans	(Zlosnik	et	al.,	2015),	yet	infection	with	B.	cenocepacia	still	




makes	 Bcc	 and	B.	 cenocepacia	 a	 perturbing	 pathogen	 for	 CF	 and	 other	 immuno-
comprised	 patients.	 These	 bacteria	 appear	 to	 have	 evolved	 a	 variety	 of	 features	









as	 virulence	 determinants/factors.	 Virulence	 factors	 aim	 to	 collectively	 allow	 the	
bacteria	 to	 colonize	 a	 host	 efficiently,	 obtaining	 sufficient	 energy	 and	 nutrients	
from	it,	whilst	evading	and	supressing	the	host’s	immune	system	at	the	same	time.	
Some	 of	 the	 potential	 virulence	 determinants	 of	 Bcc	 species	 include	 haemolysin	
production,	cell	invasion,	intracellular	survival,	iron	acquisition,	biofilm	generation,	
and	protein	secretion,	including	secretion	by	the	type	II,	type	IV	and	pertinently	the	
type	VI	 secretion	systems	 (Figure	1.2).	Some	of	 these	virulence	 factors	have	been	
shown	 to	 be	 coordinated	 by	 quorum	 sensing	 regulatory	 systems,	 including	 acyl-
homoserine	 lactone	 (AHL)-dependent	 systems	 governed	 by	 CepIR	 (Sokol	 et	 al.,	
2003)	 and	 CciIR	 (Baldwin	 et	 al.,	 2004)	 and	 an	 AHL-independent	 orphan	 LuxR	
homologue	CepR2	(Malott	et	al.,	2009).	A	number	of	these	factors	will	be	explored.	





to	 target	 their	 host.	 Both	 clinical	 and	 environmental	 isolates	 of	 Bcc	 strains	 have	
haemolytic	 abilities,	 including	 B.	 cenocepacia	 (Nakazawa	 et	 al.	 1987;	 Vasil	 et	 al.	
1990).	B.	 cenocepacia	 J2315	was	 shown	 to	 secrete	 a	 haemolytic	 lipopeptide	 that	
induces	 the	 destruction	 of	mammalian	 neutrophils	 and	macrophages	 by	 inducing	






































The	 immune	 system	 plays	 a	 vital	 role	 in	 combating	 infections	 by	 foreign	
bodies.	However,	 tight	 control	over	 it	 is	 required	 to	prevent	unnecessarily	 severe	
immune	responses	from	occurring,	such	as	those	observed	in	some	Bcc	infected	CF-
patients.	 A	 trait	 of	 the	 Bcc	 that	 may	 aid	 in	 virulence	 is	 an	 ability	 to	 invade	 and	
survive	intracellularly	in	a	variety	of	cells,	evading	detection	by	the	immune	system.	
Invasion	of	mammalian	cells	by	Bcc	bacteria	has	been	demonstrated	 in	many	cell	
types.	 This	 includes	epithelial	 cell	 invasion	by	B.	cenocepacia	 (Burns	et	 al.,	 1996).	
Here,	 B.	 cenocepacia	 were	 able	 to	 invade,	 survive	 and	 replicate	 intracellularly	
within	A549	human	alveolar	 epithelial	 cells	 in	 in	 vitro	 tissue	 culture	 experiments.	
This	 cell	 line	 was	 then	 further	 tested	 with	 a	 range	 of	 Bcc	 bacteria	 to	 identify	
particularly	 invasive	 strains,	 it	 showed	 that	 over	 70%	 of	 B.	 cenocepacia	 strains	
tested	were	invasive	in	A549	cells	(Cieri	et	al.,	2002).		
Interestingly,	 a	 study	 observed	 different	 invasion	 routes	 can	 be	 used	 by	
different	 species	 of	 the	 Bcc	 to	 infiltrate	 the	 human	 airway	 epithelium	 in	 vitro	
(Schwab	et	al.,	2002).	For	example,	B.	cenocepacia	formed	biofilms	at	the	epithelial	
cell	 surface,	 which	 the	 bacteria	 then	 invaded	 and	 destroyed	 by	 causing	 actin	




include	 the	 demonstration	 of	 the	 invasive	 capabilities	 of	 B.	 cenocepacia	 and	 B.	
multivorans	 into	 non-CF-phenotype	 and	 CF-phenotype	 lung	 epithelial	 cell	 lines,	
where	the	bacterial	invasion	observed	was	facilitated	by	a	direct	interaction	of	the	
invading	 bacteria	 with	 glycosphingolipid	 receptors	 on	 the	 epithelial	 cell	 surface	
(Mullen	et	al.,	2010).	This	again	suggests	an	importance	of	surface	glycoproteins	on	
the	 host	 cell	 for	 invasion.	 Interestingly,	 a	 tyrosine	 kinase	 and	 paired	
phosphotyrosine	 phosphatase	 in	 the	 Bcc	 bacteria	 B.	 contaminans,	 of	 which	
homologues	 are	 found	 in	 other	Bcc	bacteria,	 has	 been	 shown	 to	be	 important	 in	






macrophages	 and	 monocytes	 (Martin	 and	 Mohr,	 2000;	 McKeon	 et	 al.,	 2010;	
Gavrilin	 et	 al.,	 2012),	 surviving	within	 bacteria-containing	membrane	 vacuoles	 (B.	
cenocepacia-containing	 vacuoles,	 BcCVs).	 BcCVs	 are	 similar	 in	 structure	 to	
autophagosomes,	 but	 are	 delayed	 in	 their	 maturation	 (Lamothe	 et	 al.,	 2007),	
preventing	 the	 bacteria	 from	 lysosomal	 destruction.	 Infected	macrophages	 show	
disrupted	actin	cytoskeletons	and	BcCV	membranes	surrounding	the	bacteria	have	
delayed	 NADPH	 oxidase	 complex	 formation	 (Rosales-Reyes	 et	 al.,	 2012b).	 This	
results	in	a	delayed	production	of	superoxide	anions	and	thus	a	delayed	production	
of	 reaction	 oxygen	 species	 (ROS)	 (Keith	 et	 al.,	 2009).	 ROS	 production	 is	 a	 key	
bactericidal	mechanism	 for	 damaging	 intracellular	 bacteria	 in	 the	 innate	 immune	
response	(Lambeth,	2004).		
Intracellular	 sensing	 of	 B.	 cenocepacia-infected	 phagocytes	 results	 in	
caspase-1	 activation	 and	 production	 of	 pro-inflammatory	 cytokines	 such	 as	 IL-1β	
from	the	 infected	cell	eliciting	an	 inflammatory	 response	 in	 the	host	 (Kotrange	et	
al.,	2011).	This	sensing	acts	via	pyrin	inflammasome	activation	(Gavrilin	et	al.,	2012;	
Xu	 et	 al.,	 2014).	 Interestingly,	 the	 T6SS	 has	 been	 linked	 to	 some	 of	 the	
characteristics	 of	 the	 BcCVs	 in	 infected	 macrophages,	 details	 of	 which	 will	 be	
discussed	in	Section	1.2.5.5.		
1.2.5.3 Biofilms	
Biofilms	 are	 an	 aggregated	 complex	 of	microorganisms	 that	 develop	 on	 a	
solid	 surface.	 This	 adherent	 microbial	 micro-community	 is	 predominantly	 bound	
together	through	the	production	of	extracellular	molecules,	 including	extracellular	
proteins,	 polysaccharides	 and	 DNA	 (reviewed	 in	 O’Toole	 et	 al.	 (2000)).	 This	
aggregated	 complex	 is	 thought	 to	 protect	 the	 bacteria	 from	 its	 external	
environment.	 Interestingly,	 the	 two	commonest	 species	 found	 in	CF-patients	with	
Bcc	 infections,	 B.	 cenocepacia	 and	 B.	 multivorans,	 have	 demonstrated	 a	 greater	
ability	 to	 form	 biofilms	 than	 other	 Bcc	 bacteria	 in	 vitro	 (Conway	 et	 al.,	 2002),	
indicating	 biofilm	 formation	may	 play	 a	 role	 in	 virulence	 in	 some	way,	 either	 by	









	 A	 biological	 role	 for	 flagellin	 glycosylation	 in	 host	 interactions	 has	 been	
suggest	 in	 several	 pathogenic	 Gram-negative	 bacterial	 species,	 including	
Campylobacter	 jejuni	 (Guerry	et	al.,	2006),	P.	aeruginosa	 (Arora	et	al.,	2005),	and	
some	Aeromonas	 species	 (Gavín	 et	 al.,	 2002;	 Tabei	 et	 al.,	 2009;	Wilhelms	 et	 al.,	
2012).	An	O-glycosylation	flagellin	system	was	recently	discovered	in	B.	cenocepacia	
and	implicated	in	virulence	(Hanuszkiewicz	et	al.,	2014;	Khodai-Kalaki	et	al.,	2015).	
Specifically,	 it	 was	 shown	 that	 epithelial	 cells	 exposed	 to	 purified	 glycosylated	
flagellin	 showed	 a	 reduced	 inflammatory	 response	 through	 the	 TLR5-mediated	
pathway	 in	 comparison	 to	 non-glycosylated	 flagellin	 (Hanuszkiewicz	 et	 al.,	 2014).	
However,	contradictory	findings	were	seen	in	an	Arabidopsis	thaliana	plant	model	
where	 purified	 glycosylated	 flagellin	 still	 elicited	 an	 innate	 immune	 response,	
demonstrated	by	production	of	 reactive	oxygen	 species	 (ROS)	 and	activation	of	 a	




component	 of	 the	 B.	 cenocepacia	 lipopolysaccharide	 layer	 (Khodai-Kalaki	 et	 al.,	
2015).	This	LPS	modification	has	been	demonstrated	to	be	important	for	resistance	
to	 anti-microbial	 peptides	 such	 as	 polymyxin	 B,	 where	 it	 was	 first	 described	 in	
Escherichia	coli	and	Salmonella	typhimurium	and	later	in	B.	cenocepacia	(Nummila	






Zinc	metalloproteases	 ZmpA	 and	 ZmpB	 (positively	 regulated	 by	 the	 CepIR	
quorum	sensing	system	(Sokol	et	al.	2003)),	are	two	proteins	known	to	be	secreted	
by	 the	 type	 II	 secretion	 system	 (T2SS)	 in	 B.	 cenocepacia	 (McKevitt	 et	 al.,	 1989;	
Corbett	 et	 al.,	 2003;	 Kooi	 et	 al.,	 2006).	 Both	 of	 which	 have	 been	 implicated	 as	
virulence	factors	in	particular	B.	cenocepacia	strains,	such	as	K56-2	(Corbett	et	al.,	
2003).	ZmpA	and	ZmpB	are	zinc-dependent	M4	 family	metallopeptidases	 that	are	
expressed	 as	 larger	 prepropenzymes	 before	 under-going	 autoproteolysis	 to	
generate	 mature	 ZmpA	 and	 ZmpB.	 B.	 cenocepacia	 mutants	 deficient	 in	 these	
metalloproteases	 show	 reduced	 extracellular	 protease	 activity,	 as	 determine	 by	
casein	degradation	and	are	less	virulent	in	a	rat	lung	infection	model	(Corbett	et	al.,	
2003;	 Kooi	 et	 al.,	 2006).	 It	 has	 been	 postulated	 that	metalloproteases	 like	 these	
may	be	responsible	for	degrading	proteinaceous	host	tissues,	such	as	collagen	and	
fibronectin,	 allowing	greater	dissemination	within	 the	host	 and/or	degradation	of	
proteinous	 immune	 system	 molecules	 such	 as	 immunoglobulins	 (Corbett	 et	 al.,	
2003;	Kooi	et	al.,	2005).	Bcc	bacteria	can	also	produce	lipases	in	a	T2SS-dependent	
manner,	 which	 may	 also	 contribute	 to	 virulence.	 For	 example,	 a	 lipase	 from	 B.	
cenocepacia	has	been	shown	to	contribute	to	epithelial	cell	invasion	(Mullen	et	al.,	
2007).	
There	 is	 evidence	 to	 suggest	 that	 a	 Sec-dependent,	 low	molecular	weight,	
non-functional	tyrosine	kinase	(Dmp),	encoded	by	BCAM028,	is	involved	in	delaying	
maturation	 of	 B.	 cenocepacia	 when	 infected	 with	 ET12	 lineage	 strains	 of	 B.	
cenocepacia	(Andrade	and	Valvano,	2014).	 It	 is	also	secreted	into	the	extracellular	
medium	 from	 the	 periplasm	 by	 an	 undefined	 mechanism.	 Secretion	 systems	
responsible	 for	 the	 translocation	 of	 Sec-dependent	 proteins	 over	 the	 outer	
membrane	in	the	final	step	of	their	secretion	include	the	T2SS	and	T5SS.		
1.2.5.5.2 T5SS-dependent	effectors	
T5SS-dependent	 cell	 surface	 proteins,	 termed	 trimeric	 autotransporter	
adhesins	 (TAAs),	 have	 been	 implicated	 in	 virulence	 in	 pathogenic	 Gram-negative	




those	 encoded	 by	 BCAM0224	 and	 BCAM0223	 (Mil-Homens	 et	 al.,	 2010;	 Mil-
Homens	and	Fialho,	2011).	These	cell	surface	TAAs	were	observed	to	contribute	to	
adherence	of	 the	bacteria	 to	epithelial	 cells	 in	 vitro,	 protecting	 the	bacteria	 from	







al.,	 2011).	 The	 T6SS-5	 in	 the	 related	 Burkholderia	 species	 B.	 mallei	 and	 B.	
thailandensis	 were	 required	 for	 virulence	 in	 similar	 models	 (Schell	 et	 al.,	 2007;	
Schwarz	et	al.,	2010).	This	virulence	is	in	part	due	to	T6SS-5	dependent	intracellular	















involves	 the	 T6SS	 puncturing	 the	 membrane	 of	 these	 vesicles	 within	 the	





Further	 evidence	 that	 links	 the	 T6SS	with	 intracellular	 pathogenicity	 of	B.	
cenocepacia	 includes	 findings	 that	 suggested	 the	 T6SS	 is	 responsible	 for	
manipulating	the	actin	cytoskeleton	of	macrophages	upon	infection.	It	is	thought	to	
do	 this	 by	 reducing	 the	 amount	 of	 the	 active	GTP-bound	Rho	GTPases,	 Rac1	 and	
Cdc42,	 whilst	 increasing	 the	 amount	 of	 active	 GTP-bound	 RhoA,	 which	 impairs	
normal	 functioning	of	 the	microtubule	network,	actin	polymerisation	 in	particular	
(Rosales-Reyes	 et	 al.,	 2012b).	 It	 was	 later	 found	 that	 the	 T6SS	 in	B.	 cenocepacia	
specifically	induces	the	deamination	of	RhoA,	which	actually	leads	to	the	activation	
of	 innate	 immune	 defences,	 such	 as	 programmed	 cell	 death	 and	 release	 of	 pro-
inflammatory	cytokines,	via	activation	of	the	pyrin	 inflammasome	and	subsequent	



















Gram-negative,	 or	 diderm,	 bacteria,	 have	 fundamentally	 different	
architectures	 to	 their	 cell	 envelope	 than	 Gram-positive,	 or	 monoderm,	 bacteria.	
Both	 contain	 a	 cytoplasmic	 membrane,	 but	 Gram-negative	 bacteria	 have	 an	
additional	 lipid	 bilayer	 designated	 as	 the	 outer	 membrane.	 There	 is	 an	 inter-
membrane	region	between	the	inner	and	outer	membrane	known	as	the	periplasm.	
Protein	trafficking	is	important	for	both	Gram-negative	and	Gram-positive	bacteria	
and	 generally	 refers	 to	 the	 translocation	 of	 proteins	 across	 a	 membrane	 and/or	
insertion	 of	 a	 protein	 into	 the	membrane.	 In	Gram-negative	 bacteria	 secretion	 is	
thought	 of	 as	 the	 translocation	 of	 proteins	 from	 the	 cytoplasm	 across	 the	 inner	




the	periplasm	 in	Gram-negative	bacteria.	 But	 in	Gram-positive	bacteria,	 secretion	




Sec,	 Tat	 and	 holin	 systems	 in	 Gram-negative	 bacteria	 allow	 the	 export	 of	
proteins	from	the	cytoplasm	into	the	periplasmic	space.	Whilst	not	strictly	a	bona	
fide	 secretion	 system	 in	 Gram-negative	 bacteria,	 exported	 proteins	 can	 then	 be	
further	translocated	across	the	outer	membrane	using	additional	secretion	systems,	
such	as	the	T2SS.		
Briefly,	 the	 Sec	 export	 system	 in	 Gram-negative	 bacteria	 functions	 by	
transporting	 proteins	 in	 a	 unfolded	 state	 into	 the	 periplasm,	 either	 in	 a	 co-
















Figure	 1.3	 Structural	 overview	 of	 secretion	 systems	 present	 in	Gram-negative	 bacteria.	
There	 are	 nine	 described	 protein	 secretion	 systems	 in	 Gram-negative	 bacteria,	 eight	 are	
depicted	in	this	illustration.	(A)	Illustration	of	the	secretion	systems	that	span	the	inner	and	
outer	membrane.	T1SS,	T3SS,	T4SS	and	T6SS	do	not	generally	require	participation	of	 the	
Sec	or	Tat	 systems.	 (B)	 Secretion	 systems	 that	are	 located	 in	 the	outer	membrane,	T5SS,	
chaperone-usher	system	(T7SS)	and	curli	biogenesis	system	(T8SS).	The	Sec	export	system	










al.,	 1990).	 SecA	 is	 associated	with	 a	membrane-embedded	 channel	 complex,	 the	
SecYEG	 translocon	 (Brundage	 et	 al.,	 1990;	Nishiyama	 et	 al.,	 1994;	 Douville	 et	 al.,	
1994).	 In	an	active	process	 requiring	ATP	and	 the	proton	motif	 force	 (PMF),	SecA	
facilitates	 the	 threading	 of	 the	 unfolded	 presecretion	 protein	 through	 a	 channel	
created	by	the	SecYEG	complex	into	the	periplasm.	The	N-terminal	signal	peptide	is	
cleaved	by	a	signal	peptidase,	such	as	LepB	 in	E.	coli	 (Dalbey	and	Wickner,	1985).	
Periplasmic	 chaperone	 proteins	 such	 as	 DsbA	 facilitate	 further	 folding	 into	 the	
mature	 protein	 by	 disulphide	 bond	 formation	 in	 the	 oxidative	 periplasmic	
environment	(Bardwell	et	al.,	1991).	
Rather	 than	 exporting	 proteins	 in	 an	 unfolded	 state,	 the	 Twin	 arginine	
transport	 system	 (Tat)	 functions	 to	 translocate	 folded	 proteins	 across	 the	 inner	
membrane	into	the	periplasm	in	Gram-negative	bacteria	(Settles,	1997;	Sargent	et	
al.,	 1998),	using	energy	derived	 from	 the	PMF	 (review	 in	Palmer	&	Berks	 (2012)).	
Proteins	 exported	 by	 this	 system	 have	 a	 typical	 N-terminal	 signal	 sequence	 that	
contains	an	RRxFxK	motif	(the	twin	arginine	motif)	preceding	a	hydrophobic	stretch	
of	 amino	 acids,	which	 targets	 the	 folded	 substrate	 protein	 to	 the	 Tat	 translocase	
complex	 spanning	 the	 cytoplasmic	 membrane.	 The	 Tat	 translocase	 in	
proteobacteria	is	comprised	of	TatABC	membrane	embedded	subunits.	TatBC	form	
a	 complex	 that	 is	 subsequently	 bound	 by	 the	 N-terminal	 portion	 of	 the	 Tat	
substrate	though	a	recognition	site	in	TatC,	which	causes	a	conformational	change	
in	 the	 TatBC	 complex	 (Bolhuis	 et	 al.,	 2001;	 Alami	 et	 al.,	 2003).	 This	 results	 in	
association	 of	 the	 TatBC-substrate	 complex	 with	 TatA	 subunits	 within	 the	
membrane,	causing	PMF-dependent	polymerisation	of	TatA,	that	creating	a	channel	
allowing	 the	 export	 of	 the	main	 body	 of	 folded	 substrate	 though	 the	membrane	
(Mori	 and	 Cline,	 2002;	 Dabney-Smith	 et	 al.,	 2006;	 Leake	 et	 al.,	 2008).	 The	 N-
terminal	signal	sequence	remains	affix	to	the	TatBC	complex.	The	signal	peptide	is	






The	 Type	 I	 secretion	 system	 (T1SS)	 is	 a	 one-step	 protein	 translocation	
mechanism	used	by	Gram-negative	 bacteria.	 It	 contains	 three	 essential	 structural	





this	 active	 process.	 This	 is	 in-complex	 with	 an	 inner	 membrane	 anchored	 fusion	
protein	 (MFP)	 that	 acts	 as	 platform	 linking	 the	 inner	 membrane	 ABC	 protein	




A	 well	 characterised	 substrate	 of	 the	 T1SS	 is	 the	 E.	 coli	 haemolysin	 HlyA,	
which	requires	the	ABC	transporter	HlyB,	MFP	HlyD	and	the	OMP	TolC	 (Nicaud	et	
al.,	 1985;	 Mackman	 et	 al.,	 1985;	 Mackman	 et	 al.,	 1986;	 Wandersman	 and	
Delepelaire,	 1990).	 Unfolded	 substrates	 have	 a	 C-	 terminal	 recognition	 sequence	
that	is	recognised	by	the	cytoplasmic	portion	of	the	MFP	(Balakrishnan	et	al.,	2001;	
Delepelaire,	2004).	This	interaction	and/or	an	interaction	of	the	unfold	protein	with	
the	 ABC	 transporter	 results	 in	 complex	 formation	 with	 the	 OMP,	 and	 triggers	
opening	 of	 the	 helical	 channel	 in	 the	 OMP,	 allowing	 the	 unfolded	 protein	 to	 be	
threaded	 through	 the	 entire	 channel	 structure	 (Bakkes	 et	 al.,	 2010).	 Once	 in	 the	
exterior,	the	protein	folds	into	its	mature	confirmation.	Most	T1SS	substrates	have	
specific	ABC	and	MFS	proteins,	but	some	share	a	common	OMP,	as	 in	the	case	of	





translocation	 of	 folded	 periplasmic	 proteins	 across	 the	 outer	membrane	 into	 the	
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extracellular	 surroundings	 in	Gram-negative	bacteria.	 It	 is	a	 two-step	process	 that	
first	 requires	either	 translocation	of	 folded	proteins	 into	 the	periplasm	by	 the	Tat	
export	 system	 (Voulhoux	 et	 al.,	 2001)	 or	 unfolded	 proteins	 by	 the	 Sec	 system.	
Subsequent	 translocation	across	 the	outer-membrane	 then	occurs	using	 the	T2SS	
(also	known	as	 the	 secreton)	 (reviewed	 in	Korotkov	et	al.	 (2012)).	 Several	human	
pathogens	have	been	shown	 to	use	 the	T2SS	 for	 secretion	of	proteins	 that	act	as	
virulence	 determinants,	 such	 as	 P.	 aeruginosa	 and	 its	 T2SS	 substrates	 ToxA	 and	
LasB	 (elastase)	 (Woods	 et	 al.,	 1982;	Wretlind	 et	 al.,	 1987;	 Bally	 et	 al.,	 1992),	 V.	
cholerae	 with	 AB5	 cholera	 toxin	 (Sandkvist	 et	 al.,	 1997)	 and	B.	 cenocepacia	 with	
ZmpA	(Corbett	et	al.,	2003).		
Using	 the	 Gsp	 nomenclature,	 the	 T2SS	 requires	 at	 least	 twelve	 different	
subunits	arrange	into	four	subassemblies:	an	outer	membrane	complex	containing	
at	least	GspD	(secretin)	and	GspS,	the	pseudopilus	containing	GspG,	-H,	-I,	-J	and	-K,	
an	 inner-membrane	 complex	 containing	 GspC,	 -F,	 -L	 and	 -M,	 and	 a	 cytoplasmic	
ATPase	(GspE)	associated	with	cytoplasmic	regions	of	the	inner-membrane	complex	
(Korotkov	 et	 al.,	 2012).	 The	 mode	 of	 secretion	 by	 this	 system	 is	 not	 well	
understood.	 The	 current	 accepted	 model	 involves	 association	 of	 the	 folded	
periplasmic	 protein	 substrate	with	 either	 the	 periplasmic	 portion	 of	 GspC	 and/or	
the	 tip	 region	of	 the	pseudopilus.	 The	 substrate	 is	 then	 forced	 through	 the	outer	
membrane	secretin	channel,	by	extension	of	the	pseudopilus	structure	towards	the	





The	 type	 III	 (T3SS),	 also	 known	 as	 the	 injectisome,	 is	 a	 complex	 protein	
secretion	 system	 that	 features	 in	many	pathogenic	bacteria	 (reviewed	 in	Cornelis	
(2006)).	 This	 includes	 B.	 pseudomallei,	 and	 its	 T3SS	 effector	 BopA	 that	 aids	 in	
preventing	 clearance	 of	 the	 bacteria	 by	 autophagosomal	 action	 (Cullinane	 et	 al.,	
2008).	 The	 T3SS	 complex	 uses	 a	 hollow	 needle	 structure	 to	 thread	 unfolded	
effector	proteins	 (containing	poorly	defined	signal	sequences	generally	 residing	 in	
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the	N-terminus)	 through	 the	needle	 into	 a	 eukaryotic	 target	 cell,	 either	 in	 to	 the	
cytosol	or	insertion	into	the	cytoplasmic	membrane.	It	does	this	by	using	chaperone	
proteins	 that	 unfold	 and	 direct	 the	 effector	 to	 the	 T3SS	 complex,	 which	 is	 then	
thread	through	the	basal	body,	through	the	inner	rod	and	then	through	the	needle	
in	an	uninterrupted	conduit,	 in	an	ATP-dependent	process	 (Marlovits	et	al.,	2004;	
Radics	 et	 al.,	 2014).	 It	 is	 then	 translocated	 through	 to	 the	 host	 cell	 membrane	
(Hueck,	1998;	Akeda	and	Galán,	2005).		
Contact	with	the	host	cell	through	the	needle	is	the	main	trigger	for	protein	
secretion	 (Mota	et	al.,	2005).	This	contacts	 results	 in	 the	 formation	of	a	~	2.3	nm	
pore	 in	 the	membrane	 of	 the	 target	 cell	 (Mueller	 et	 al.,	 2008).	 Three	 additional	













define	 the	T4SS.	One	 type	 is	used	 for	 the	 transfer	of	DNA	 from	cell-to-cell,	 in	 the	
form	 of	 an	 ssDNA-protein	 conjugative	 intermediate,	which	 is	 also	 known	 as	 DNA	
conjugation.	 This	 type	 of	 system	 includes	 the	 T4SSs	 encoded	 on	 the	 R388	 and	
pKM101	 conjugative	 plasmids	 of	 E.	 coli	 (Winans	 and	 Walker,	 1983;	 Llosa	 et	 al.,	
1994).	 Another	 type	 is	 used	 for	 the	 translocation	 of	 effector	 proteins	 into	
eukaryotes,	 such	 as	 the	 T4SS	 in	 Bordetella	 pertussis	 that	 translocates	 the	 A/B	
pertussis	toxin,	and	the	third	type	is	responsible	for	the	release	and	uptake	of	DNA	





the	 current	 model	 postulates	 the	 structure	 is	 arranged	 into	 an	 inner	 membrane	
core	complex	formed	by	association	of	VirB8,	VirB3	and	VirB6	subunits	with	ATPase	




space.	 The	 exact	 mechanism	 for	 the	 secretion	 of	 unfolded	 protein	 substrates	 or	
conjugative	DNA	intermediates	after	pilus	assembly	is	unknown,	but	it	is	thought	it	





The	 Type	 V	 secretion	 system	 (T5SS),	 is	 a	 two-step	 protein	 secretion	
mechanism	 that	 allows	 the	 translocation	 of	 a	 Sec-dependent	 periplasmic	 protein	
across	the	outer	membrane	through	an	outer	membrane	pore	structure	(reviewed	
in	Henderson	 et	 al.	 (2004);	 Costa	 et	 al.	 (2015)).	 Several	 classes	 of	 the	 T5SS	 exist,	
termed	 T5SSa	 to	 T5SSe,	 none	 of	 which	 require	 NTPase	 activity	 or	 the	 PMF	 for	
translocation	 of	 their	 substrates.	 The	 T5SSa,	 also	 known	 as	 the	 autotransporter	
system,	 includes	the	well	characterised	IgA1	protease	from	Neisseria	gonorrhoeae	




terminal	 signal	peptide	using	 the	Sec	export	 system.	Periplasmic	 chaperones	may	









unfolded	 protease	 ‘passenger’	 domain	 out	 through	 the	 outer	 membrane	 pore	
structure	 into	 the	exterior	of	 the	cell	 (Wu	et	al.,	2005;	 Ieva	and	Bernstein,	2009).	
This	 is	 thought	 to	 occur	 by	 the	 passenger	 domain	 interacting	 with	 periplasmic	
POTRA	 (polypeptide	 transport-associated)	 domains	 on	 BamA	 to	 aid	 in	 transfer	 of	
the	passenger	domain	though	the	β-barrel	channel	(Pavlova	et	al.,	2013;	Noinaj	et	
al.,	 2013).	 It	 has	 recently	 been	 suggested	 that	 passenger	 domain	 translocation	 is	
not	 solely	 through	 the	 β-barrel	 structure,	 but	 may	 involve	 larger	 membrane	
assemblies	that	 include	Bam	and	TAM	complexes	(an	alternative	outer	membrane	
translocation	module)	(Selkrig	et	al.,	2012;	Pavlova	et	al.,	2013;	Gruss	et	al.,	2013).	
Upon	 release	 into	 the	 extracellular	 milieu	 the	 protein	 undergoes	 maturation	 to	
form	its	fully	active	protein	(Pohlner	et	al.,	1987).	The	T5SSb	(TPS)	differs	from	the	











The	 Gram-negative	 type	 VII	 secretion,	 also	 termed	 the	 chaperone-usher	
system,	 is	 a	 further	 two-step	 secretory	mechanism	 used	 for	 the	 assembly	 of	 pili,	
fimbriae	 or	 other	 polymeric	 adhesin	 structures	 on	 the	 surface	 of	 Gram-negative	
bacteria.	 A	 relatively	 well	 understood	 pilus	 structure,	 termed	 the	 type	 I	 pilus,	
common	 to	 the	Enterobacteriaceae	 family	 (Jones	 et	 al.,	 1995),	 contributes	 to	 the	
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pathogenicity	 of	 uropathogenic	 E.	 coli	 (UPEC),	 by	 direct	 interaction	 between	 the	
bacterium	 and	 host	 epithelial	 cells	 in	 the	 bladder	 via	 mannose-containing	
glycoproteins	 (Abraham	 et	 al.,	 1988;	 Mulvey	 et	 al.,	 1998).	 This	 structure	 is	
assembled	 by	 a	 chaperone-usher	 system	 that	 utilises	 pilin	 subunits	 that	 are	
exported	 into	 the	 periplasm	 via	 the	 Sec	 pathway.	 It	 specifically	 uses	 subunits	 of	
FimD,	 known	as	 the	usher,	 to	 create	 a	 pore	 in	 the	outer	membrane	 (Klemm	and	
Christiansen,	 1990;	 Thanassi	 et	 al.,	 1998),	 and	 a	 periplasmic	 chaperone	 protein,	
FimC	(Lindberg	et	al.,	1989).	This	chaperone	protein	associates	with	the	major	and	
minor	 pilus	 subunits,	 FimA,	 and	 FimF,	 -G,	 and	 -H,	 respectively,	 to	 facilitate	 their	
folding	 and	 transport	 through	 the	 periplasm,	 docking	 with	 the	 outer	 membrane	
usher	 FimD,	 where	 pilus	 assembly	 occurs	 extending	 outwards	 from	 the	 outer	
membrane	 to	 the	 exterior.	 The	 role	 of	 the	 chaperone	 is	 three-fold,	 it	 prevents	
misfolding	 of	 the	 pilin	 subunits,	 prevents	 premature	 assembly	 of	 the	 pilus	 in	 the	
periplasm	 and	 stabilises	 the	 pilus	 against	 proteolysis	 (Lillington	 et	 al.,	 2014).	 The	
minor	 pilin	 tip	 region	 is	 assembled	 first,	 with	 FimH	 at	 the	 very	 tip,	 preceded	 by	
FimG	 and	 then	 FimF,	 and	 then	 extensive	major	 pilin	 structure	made	 up	 of	 FimA	
subunits.			
Note,	 the	 Gram-positive	 ESX	 secretion	 system	 present	 in	 mycobacterium,	





The	 type	 VIII	 secretion	 system	 (T8SS),	 also	 termed	 the	 extracellular	
nucleation-precipitation	 secretion	 pathway	 (Desvaux	 et	 al.,	 2009)	 has	 a	 similar	
purpose	 as	 the	 T7SS,	 to	 function	 to	 append	 surface	 adhesins	 on	 Gram-negative	
bacteria.	But	rather	than	pilin	structures,	the	T8SS	is	involved	in	the	appendage	of	






The	 common	nomenclature	 used	 to	 designate	 the	 subunit	 components	 of	




CsgG	 lipoprotein	 subunits	 that	 contain	 a	 hollow	 periplasmic	 region,	 which	
associates	with	the	periplasmic	CsgE	subunit	(Nenninger	et	al.,	2011).	This	acts	as	a	
stopper,	 forming	 a	 structure	 likened	 to	 a	 vestibule/chamber	 (Goyal	 et	 al.,	 2014).	
The	 major	 curli	 subunit,	 CsgA,	 and	 an	 additional	 minor	 curli	 subunit,	 CsgB,	 are	
translocated	 in	 an	unfolded	 state	 through	 the	narrow	 channel	 in	CsgG.	A	 current	
model	 suggests	 polypeptides	 of	 CsgA	 become	 trapped	 within	 the	 CsgG-CsgE	






The	 final	 known	 Gram-negative	 secretion	 system	 is	 the	 type	 IX	 secretion	 system	
(T9SS),	 also	 known	 as	 the	 Por	 secretion	 system.	 This	 is	 a	 recently	 discovered	
secretion	 system	 restricted	 to	 species	 of	 the	 Bacteroidetes	 phylum	 (review	 in	
Nakayama	 (2015)).	 It	 is	 required	 for	 Flavobacterium	 johnsoniae	 gliding	 motility	
across	a	surface	(Nelson	et	al.,	2007;	Sato	et	al.,	2010;	Shrivastava	et	al.,	2013)	and	
has	 been	 implicate	 in	 the	 secretion	 of	 virulence	 factors,	 such	 as	 extracellular	







been	observed	that	PorK,	 -N	and	 -P	associate	with	 the	outer	membrane	and	PorL	
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The	 type	 VI	 secretion	 system	 (T6SS)	 has	 multiple	 subunits	 making	 up	 its	
large	and	complex	 structure,	 thought	 to	be	organised	 into	a	needle-like	 structure	
containing	two	distinct	 interacting	subassemblies,	a	phage	tail-like	structure	and	a	
channel/chamber	 structure	 that	 spans	 the	 inner	 membrane,	 periplasm	 and	 the	
outer	membrane.		It	is	proposed	to	require	the	products	of	approximately	thirteen	
genes	 (tssA	 through	 to	 tssM)	 organised	 into	 a	 T6SS	 gene	 cluster	 (Shalom	 et	 al.,	
2007;	Cascales,	2008;	Aschtgen	et	al.,	2008).	These	protein	products	either	act	as	
structural	proteins	and/or	secreted	products	(Zheng	and	Leung,	2007;	Bingle	et	al.,	
2008).	 Some	 systems	 require	 an	 additional	 protein	 (TagL,	 TagN,	 TagP	 or	 TagW,	
dependent	on	the	system)	containing	a	peptidoglycan-binding	domain	that	anchors	
the	 T6SS	 to	 the	 cell	 envelope	 (Aschtgen	et	 al.,	 2010b).	 These	occur	 in	 systems	 in	
which	 the	 TssL	 subunit	 lacks	 such	 a	 domain.	 The	 consensus	 idea	 is	 that	 the	 T6SS	
forms	 a	 needle-like	 structure	 extending	 from	 the	 cytoplasm,	 which	 uses	 a	





in	 a	manner	 similar	 to	 that	 of	 bacteriophage	 T4,	 which	 punctures	 and	 injects	 its	
DNA	into	a	susceptible	bacterium.		Several	subunits	of	the	T6SS	share	homology	to	
proteins	 that	 make	 up	 the	 T4	 bacteriophage	 contractile	 tail.	 Firstly,	 a	 trimeric	
secreted	 protein,	 TssI	 (also	 referred	 to	 as	 VgrG),	 has	 structural	 similarities	 to	 the	
phage	 tail	 T4	 spike	 proteins	 gp5	 and	 gp27,	 which	 similarly	 form	 a	 (gp5-gp27)3	
complex	responsible	for	puncturing	the	bacterial	outer	membrane	(Pukatzki	et	al.,	
2007;	Leiman	et	al.,	2009).		
Recent	 work	 has	 suggested	 the	 TssI	 spike	 may	 be	 further	 sharpened	 by	


































the	 tip	 of	 TssI.	 The	 system	 contains	 a	 baseplate	 complex	 of	 unknown	 composition,	 but	
probably	includes	TssE,	TssF,	TssG	and	TssA.	The	TssD	tail	tube	is	surrounded	by	a	sheath	
of	TssB	and	TssC	units,	which	 in	an	extended	state	readies	the	tube	complex	to	be	fired	
through	 the	 cell	 envelope	 (IM,	 PG,	 and	 OM)	 into	 the	 host	 cell	 membrane.	 TssH	





system	(Shneider	et	al.,	2013).	The	PAAR	protein	 is	 similar	 to	 the	apex	domain	of	
phage	 spike	 proteins	 gpV	 and	 gp138	 in	 bacteriophages	 P2	 and	 ϕ92.	 All	 show	 a	
tapered	structure	containing	a	co-ordinated	metal	 iron	 for	stability,	an	 iron	 ion	 in	
gpV	and	gp138	and	a	zinc	ion	in	PAAR	(Browning	et	al.,	2012;	Shneider	et	al.,	2013).	
Bacteriophages	 P2	 gpV	 and	 ϕ92	 gp138	 are	 also	 homologous	 to	 the	 gp5	 spike	
protein	 of	 bacteriophage	 T4.	 Although,	 gp5	 does	 not	 contain	 an	 apex	 domain	
(Kanamaru	et	al.,	2002),	but	instead	it	 is	thought	it	uses	a	PAAR-like	protein	gp5.4	
to	 sharpen	 its	 tip	 in	 a	 similar	manner	 (Kostyuchenko	et	 al.,	 2003;	 Shneider	et	 al.,	
2013).	
Accordingly,	 the	 TssI-PAAR	 complex	 is	 proposed	 to	 act	 as	 a	 spike	 protein	
sitting	at	the	top	of	a	long	syringe-like	structure	with	an	inner	tube	structure	made	
from	 the	 stacking	 of	 hollow	 rings	 of	 a	 small	 T6SS	 protein	 known	 as	 TssD	 (Hcp)	
(Mougous	et	al.,	2006;	Leiman	et	al.,	2009;	Pell	et	al.,	2009),	which	has	structural	
similarities	 to	 the	 T4	 bacteriophage	 tail	 protein	 gp19	 (Leiman	 et	 al.,	 2009)	 and	 λ	
phage	tail	protein	gpV	(Pell	et	al.,	2009).	Six	TssD	monomers	come	together	to	form	
the	ring	structure	that	measures	80-90	Å	in	diameter,	with	an	internal	diameter	of	
35-40	 Å	 (Mougous	 et	 al.,	 2006),	 proposed	 to	 be	 wide	 enough	 to	 allow	 the	




which	 also	 controls	 the	 TssD	 polymerisation	 process	 (Brunet	 et	 al.,	 2014).	 	 This	
syringe-like	 spike	 complex	 penetrates	 the	 target	 cell	membrane	 allowing	 effector	
molecules	to	be	transported	into	the	target	cell	(Leiman	et	al.,	2009).	
The	force	used	to	push	out	the	TssD	tube	structure	is	likely	to	be	generated	
by	 the	 contraction	 of	 a	 tail	 sheath-like	 structure	 comprised	 of	 polymerized	 TssB	












ATP	hydrolysis,	 is	able	to	 interact	with	and	disassemble	the	TssBC	units	 that	 form	
the	sheath	structure	around	the	inner	TssD	tube	(Bönemann	et	al.,	2009).	In	certain	
systems	 TssH	 mutants	 still	 retain	 some	 T6SS	 activity,	 but	 are	 significantly	 less	
efficient	(Zheng	et	al.,	2011;	Basler	et	al.,	2012).	This	led	to	the	idea	that	the	ATP-
dependent	 activity	 of	 TssH	 is	 required	 for	 the	 removal	 of	 the	 contracted	 TssBC	
subunits	by	disassembly	of	the	components,	which	are	then	recycled,	increasing	the	
efficiency	of	the	system	(Basler	et	al.,	2012;	Basler	and	Mekalanos,	2012;	Zoued	et	
al.,	 2014).	 TssB	 and	 TssC	 are	 also	 prevented	 from	 forming	 aggregates	within	 the	
cytoplasm	by	TssH,	thus	preventing	the	cell	 from	being	overladen	with	contracted	
sheaths	 (Kapitein	 et	 al.,	 2013).	 The	 interaction	 between	 TssH	 and	 the	 contracted	
sheath	is	facilitated	through	a	specific	region	located	at	the	N-terminus	of	TssH	that	





membrane	 recognition	 and	 attachment,	 but	 more	 importantly	 it	 undergoes	
structural	changes	that	lead	to	contraction	of	the	tail	sheath,	to	propel	the	tail	tube	
forward	through	the	centre	of	the	baseplate	(Kostyuchenko	et	al.,	2003).	During	tail	
tube	 injection	 the	 bacteriophage	 T4	 baseplate	 undergoes	 goes	 a	 conformational	
change	 from	 a	 hexagon	 shape	 to	 a	 6-pointed	 star	 (Kostyuchenko	 et	 al.,	 2003).	 A	
similar	 mechanism	 is	 envisaged	 for	 the	 T6SS	 complex,	 where	 contraction	 of	 the	
TssBC	 sheath,	 and	 thus	 propulsion	 of	 the	 TssD	 tail	 tube,	 is	 caused	 by	 a	
conformational	change	in	the	T6SS	baseplate	(Basler	et	al.,	2012).		
The	components	of	the	T6SS	baseplate	are	not	yet	established.	TssE,	which	





all	 of	 which	 are	 essential	 for	 T6SS	 activity.	 A	 further	 uncharacterised	 essential	
cytoplasmic	 subunit,	 TssA,	has	also	been	 suggested	 to	 form	part	of	 the	baseplate	
complex	(Zoued	et	al.,	2013;	English	et	al.,	2014).		
1.4.1.2 Transmembrane	sub-complex	
A	 cell	 envelope-embedded	 sub-complex	 is	 needed	 to	 hold	 the	 phage-like	
subassembly	 of	 the	 T6SS	 in	 place,	 comprised	 of	 TssJ,	 TssL	 and	 TssM	 (Zheng	 and	
Leung,	2007;	Ma	et	al.,	2009b;	Aschtgen	et	al.,	2010a;	Durand	et	al.,	2012;	Durand	
et	 al.,	 2015).	 TssK	 is	 also	 thought	 to	 facilitate	 a	 link	 between	 these	 two	 sub-
complexes	 (Zoued	 et	 al.,	 2013).	 	 TssM	 and	 TssL	 make	 up	 an	 inner	 membrane-
embedded	complex	(Ma	et	al.,	2009b;	Durand	et	al.,	2012),	which	is	then	connected	
to	 the	outer	membrane	via	 the	C-terminal	periplasmic	 region	of	 TssM	 interacting		
with	 the	 outer	 membrane-anchored	 lipoprotein	 TssJ,	 forming	 a	 transenvelope	
chamber	 (Aschtgen	 et	 al.,	 2008;	 Felisberto-Rodrigues	 et	 al.,	 2011;	 Durand	 et	 al.,	




thought	 to	 stabilize	 the	 T6SS	 complex	 in	 the	 cell	 envelope,	 and/or	 provide	 a	
mechanism	of	targeting	the	T6SS	to	particular	locations	in	the	membrane	(Aschtgen	


















When	 first	 discovered,	 the	 major	 role	 of	 the	 T6SS	 was	 thought	 to	 be	 in	
virulence	 (Pukatzki	et	al.,	2006;	Schell	et	al.,	2007;	Aubert	et	al.,	2008).	However,	
subsequent	 investigations	 have	 implicated	 several	 alternative	 roles	 for	 the	 T6SS,	
the	 foremost	 being	 its	 importance	 in	 interactions	 between	 bacteria,	 including	 a	
major	 role	 in	 bacterial	 competition	 (Schwarz	 et	 al.,	 2010;	 Hood	 et	 al.,	 2010;	




The	 involvement	 of	 the	 T6SS	 in	 bacterial	 interactions	 has	 been	 widely	
documented.	 The	 first	 described	 instance	 was	 the	 identification	 of	 several	 anti-
bacterial	T6SS	effectors,	Tse1-3,	secreted	by	the	H1-T6SS	in	P.	aeruginosa	(Hood	et	
al.,	 2010).	 Identification	 of	 a	 variety	 of	 other	Gram-negative	 bacteria	 that	 used	 a	
T6SS	 to	 target	 anti-bacterial	 effectors	 quickly	 ensued,	 including	 V.	 cholerae	
(MacIntyre	et	al.,	2010),	Serratia	marcescens	(Murdoch	et	al.,	2011),	the	T6SS-1	of	
B.	 thailandensis	 (Schwarz	 et	 al.,	 2010)	 Pseudomonas	 fluorescens	 (Decoin	 et	 al.,	
2014),	Vibrio	 parahaemolyticus	 (Salomon	et	 al.,	 2013)	and	A.	 tumefaciens	 (Ma	et	
al.,	2014).		











Specific	 T6SSs	 of	 several	 human	 pathogens	 and	 their	 anti-eukaryotic	
effectors	 have	 been	 linked	 to	 eukaryotic	 virulence.	 T6SS	 contact-dependent	
cytotoxicity	 towards	 Dictyostelium	 and	 macrophages	 was	 first	 observed	 in	 V.	
cholerae	 (Pukatzki	 et	 al.,	 2006).	 It	 was	 later	 demonstrated	 to	 be	 caused	 by	 a	
modified	 VgrG	 (TssI)	 spike	 protein	 with	 a	 C-terminal	 actin	 cross-linking	 domain	
(ACD),	VgrG-1,	whose	ACD	was	delivered	to	the	cytosol	of	the	macrophage	host	cell,	
where	 it	 targeted	 its	 substrate	 G-actin	 (Pukatzki	 et	 al.,	 2007).	 The	 T6SS-5	 of	 two	










the	 T6SS	 at	 a	 transcriptional,	 post-transcription	 or	 post-translation	 level,	
summarised	in	Figure	1.5.		
1.4.3.1 Transcriptional	and	post-transcriptional	regulation	of	the	T6SS	
	 The	 T6SS	 gene	 clusters	 in	 various	 bacteria	 have	been	demonstrated	 to	 be	
controlled	 in	 part	 at	 a	 transcriptional	 and/or	 post-transcriptional	 level	 by	 diverse	
regulatory	mechanisms	(reviewed	in	Bernard	et	al.	(2010)).	This	includes	alternative	

























Figure	 1.5	 Mechanisms	 of	 T6SS	 regulation.	 Summary	 diagram	 showing	 selected	






component	 regulatory	 system	 AtsR-AtsT	 in	 B.	 cenocepacia	 (Aubert	 et	 al.,	 2008;	
Khodai-Kalaki	et	al.,	2013).		
Another	 mechanism	 of	 transcriptional	 regulation	 is	 by	 histone-nucleoid	
structuring-like	 proteins	 (H-NS)	 that	 specifically	 bind	 to	 and	 repress	 transcription	
from	 regions	of	DNA	 that	 are	AT-rich,	 including	 some	genes	within	 T6SS	 clusters.	
For	example,	MvaT,	a	H-NS-like	protein	in	P.	aeruginosa	represses	transcription	of	
H2-T6SS	 and	 H3-T6SS	 (Castang	 et	 al.,	 2008).	 Recently	 an	 H-NS	 protein	 has	 been	
discovered	to	regulate	the	T6SS	in	V.	parahaemolyticus	(Salomon	et	al.,	2014b).	
	Global	 virulence	 regulator	 RetS,	 of	 P.	 aeruginosa,	 post-transcriptionally	
suppresses	 the	 H1-T6SS	 through	 negative	 regulation	 of	 the	 Gac/Rsm	 pathway	










	 Due	 to	 the	 complex	 structural	 features	 of	 the	 T6SS	 and	 a	 rapid	 response	




the	H1-T6SS	of	P.	aeruginosa.	 In	particular,	 a	 threonine	phosphorylation	pathway	






The	 current	model	 suggests	 that	 Fha1	may	 complex	 with	 TssH	 and	 other	
components	 of	 the	 T6SS	 (Hsu	 et	 al.,	 2009).	 It	 has	 been	 suggested	 that	 Fha1	
phosphorylation	 localizes	 the	 Fha1	 to	other	 structural	 T6SS	 components	 and	may	
be	required	for	proper	assembly	of	the	T6SS	machinery	(Mougous	et	al.,	2007).	This	
would	 result	 in	correct	 firing	of	 the	complex	and	allow	contraction	of	 the	sheath.	
Whereby	 TssH	 can	 then	 disassemble	 the	 contracted	 sheath	 subunits,	 and	 recycle	
them,	 increasing	 the	 efficiency	of	 the	 system	 (Bönemann	et	 al.,	 2009;	 Basler	 and	
Mekalanos,	 2012;	 Kapitein	 et	 al.,	 2013).	 PppA	 is	 a	 phosphatase	 responsible	 for	
dephosphorylating	phosphorylated	Fha1	(Mougous	et	al.,	2007)	(Figure	1.6).		
It	 has	 also	 been	 suggested	 that	 a	 different	 T6SS,	 in	 A.	 tumefaciens,	 uses	








interacting	 with	 the	 periplasmic	 domain	 of	 PpkA	 (Hsu	 et	 al.,	 2009).	 An	 inner	
membrane	 ABC	 transporter	 TagT-TagS	 may	 also	 be	 involved	 in	 this	 process	
(Casabona	et	al.,	2013)	(Figure	1.6).		
Later,	 time-lapsed	 fluorescence	 microscopy	 suggested	 the	 H1-T6SS	 in	 P.	
aeruginosa	may	 be	 activated	 upon	 attack	 by	 another	 T6SS-containing	 bacterium,	
















Figure	 1.6	 Overview	 of	 the	 proposed	 post-translational	 regulatory	 mechanisms	 of	 the	
T6SS	 in	 P.	 aeruginosa.	 (1)	 Surface-growth	 induced	 (duelling)	 activation	 of	 the	 tyrosine	
phosphate	 pathway	 (TPP)	 and	 TagQRST	 system.	 Activation	 of	 this	 pathway	 may	 occur	
through	 membrane	 perturbations/or	 ROS	 production.	 This	 pathway	 results	 in	 the	
phosphorylation	 of	 Fha1	 and	 complex	 formation	 with	 TssH,	 where	 the	 complex	 is	 then	
localised	 to	 the	 T6SS	 complex	 to	 positively	 regulate	 T6SS	 activity.	 See	 text	 for	 further	
details.	 (2)	Phosphorylation	 independent	 post-translational	 regulation	of	 T6SS	 activity	 via	
the	cytoplasmic	protein	TagF	 (non-duelling).	 TagF	negatively	 regulates	 the	 recruitment	of	
unphosphorylated	 Fha1	 in	 complex	 with	 TssH	 to	 the	 T6SS	 apparatus,	 either	 directly	 or	








fha1)	 are	 absent	 from	 many	 T6SS	 clusters,	 including	 the	 T6SS	 cluster	 in	 B.	
cenocepacia,	suggesting	that	they	do	not	employ	the	TTP	as	a	mode	of	regulation.		
Interestingly,	 membrane	 perturbations	 caused	 by	 mating	 pair	 formation	
pilus	(a	type	of	T4SS)	can	also	 induce	the	assembly	and	firing	of	the	H1-T6SS	 in	P.	
aeruginosa	 at	 the	 site	 of	 contact,	 as	 well	 as	 artificial	 modulation	 of	 the	 outer	
membrane/or	 LPS	 by	 the	 anti-microbial	 peptide	 polymyxin	 B	 (Ho	 et	 al.,	 2013).		
Recent	 evidence	 has	 suggested	 that	 production	 of	 reactive	 oxygen	 species	 (ROS)	
can	be	induced	in	E.	coli,	as	a	consequence	of	membrane	perturbations	or	cell	wall	
damage	caused	by	the	T6SS	of	V.	cholerae	and	its	effector	VgrG3,	as	well	as	T6SS-
mediated	 attacks	 by	 Acinetobacter	 baylyi	 and	 P.	 aeruginosa	 (Dong	 et	 al.,	 2015).	
T6SS-independent	methods	 including	polymyxin	B	challenge	can	also	 induced	ROS	
(Dong	et	al.,	2015).	ROS	are	sensed	by	the	regulatory	protein	SoxR	which	activates	
transcription	 of	 soxS,	 encoding	 a	 transcriptional	 activator,	 that	 in-turn	 regulates	
genes	 involved	 in	 redox	 stress	 response	 (Greenberg	 et	 al.,	 1990;	 Amábile-Cuevas	




T6SSs.	 Recent	 evidence	 in	 S.	 marcescens	 has	 observed	 that	 the	 T6SS	 in	 this	
bacterium	is	fired	indiscriminately	without	being	triggered	by	a	T6SS-induced	attack	
from	a	surrounding	bacterium	(Gerc	et	al.,	2015).	PpkA	 is	also	 important	 for	T6SS	
activity	in	S.	marcescens	(Fritsch	et	al.,	2013),	but	it	has	been	suggested	that	rather	
than	 PpkA	 controlling	 the	 induction	 of	 the	 system	 (i.e.	 an	 on	 state),	 it	 is	 instead	
used	 as	 an	 control	 measure	 to	 prevent	 the	 system	 from	 firing	 (i.e.	 an	 off	 state)	






many	 T6SS	 gene	 clusters,	 including	 the	 Burkholderia	 T6SS-1,	 was	 found	 to	 be	 a	
negative	 post-translational	 regulator	 of	 H1-T6SS	 in	 P.	 aeruginosa.	 It	 acts	
independently	of	 the	PpkA-Fha1	phosphorylation	pathway,	 and	does	not	 respond	
to	surface	growth	stimuli	(Silverman	et	al.,	2011).	Even	though	TagF	is	not	involved	
in	 the	TPP,	 the	 two	 regulatory	processes	 converge	on	 recruitment	of	 TssH	 to	 the	
T6SS	 assembly.	 This	 recruitment	 requires	 Fha1,	 in	 which	 unphosphorylated	 Fha1	
forms	 a	 complex	 with	 TssH	 (Silverman	 et	 al.,	 2011)	 (Figure	 1.6).	 The	 other	

























and	 advances	 in	 detection	 methods	 have	 opened	 up	 a	 new	 era	 for	 effector	
identification.	 A	 variety	 of	 T6SS-dependent	 effectors	 have	 now	 been	 described.	
Many	 of	 which	 target	 other	 bacteria,	 either	 via	 their	 peptidoglycan	 layer,	
phospholipid	 membranes	 or	 cytoplasmic	 targets.	 A	 select	 few	 anti-eukaryotic	




Early	 findings	 suggested	 some	T6SS	effectors	might	be	variants	of	 the	TssI	
protein	 (TssI-related	effectors).	Several	variants	of	TssI	with	C-terminal	extensions	
possessing	 obvious	 effector	 activity	 were	 identified.	 These	 extensions	 included	 a	
peptidoglycan-binding	 domain	 and	 an	 actin-cross	 linking	 domain	 (ACD)	 in	 TssI	
proteins	 of	 V.	 cholerae,	 VgrG-3	 and	 VgrG-1,	 respectively	 (Pukatzki	 et	 al.,	 2007;	
Pukatzki	 et	 al.,	 2009)	 and	 a	metalloprotease	 domain	 in	 VgrG2b	 of	 P.	 aeruginosa	
(Sana	et	al.,	2015).	The	term	‘evolved	TssI’	has	been	used	to	describe	these	effector	
domain-containing	TssIs	(Pukatzki	et	al.,	2007).		
Subsequent	 work	 experimentally	 validated	 VgrG-1	 as	 an	 anti-eukaryotic	
effector,	 by	 demonstrating	 in	 vivo	 and	 in	 vitro	 inhibition	 of	 actin-cross	 linking	
activity	in	a	vgrG-1	mutant.	This	ACD	was	thought	to	be	responsible	for	a	particular	
round	cell	morphology	seen	in	macrophage	cells	infected	with	V.	cholerae	(Pukatzki	


















Figure	 1.7	 An	 overview	 of	 the	 molecular	 targets	 for	 anti-bacterial	 T6SS-dependent	
effectors.	 Illustration	 shows	potential	molecular	 targets	of	 T6SS	dependent	 anti-bacterial	
effectors,	(1)	the	peptidoglycan	layer,	(2)	phospholipid	bilayers	and	(3)	cytoplasmic	targets,	









the	 γ-tubulin	 ring	 complex	 (γTuRC),	 a	 component	 of	 the	 host	 cell’s	 microtubule	
machinery	(Sana	et	al.,	2015).	A	further	example	of	a	characterised	evolved	TssI	 is	
VgrG-1	 in	Aeromonas	 hydrophila	 (AHA_1119)	 that	 has	 an	 ADP-	 ribosyltransferase	





T6SS-dependent	 effector	 identification	 as	 it	 has	 allowed	 identification	of	 non-TssI	
effectors	which	would	 have	 been	more	 difficult	 to	 identify	 bioinformatically	 than	
TssI	derivatives.	Taking	a	shotgun	proteomics	approach	Hood	and	co-workers	were	
the	 first	 to	 demonstrate	 that	 H1-T6SS	 in	 P.	 aeruginosa	was	 able	 to	 export	 anti-
bacterial	effectors,	which	were	termed	Tse1-3	(Hood	et	al.,	2010).	These	effectors	




structure	 of	 alternating	 subunits	 of	 N-acetylglucosamine	 (GlcNAc)	 and	 N-
acetylmuramic	acid	(MurNAc)	linked	by	a	β-(1,4)-glycosidic	bond.	A	short	peptide	of	
differing	length,	but	usually	consist	of	L-Ala-D-Glu-m-DAP-D-Ala-(D-Ala),	is	attached	
to	 the	 lactyl	 ether	 group	 on	 the	 3-carbon	 of	MurNAc	 (reviewed	 in	 Vollmer	 et	 al.	
(2008)).	 Amide	 crosslinks	 are	 formed	 between	 the	 peptides	 on	 different	 glycan	
strands,	 specifically	 between	 D-Ala	 and	m-DAP,	 through	 their	 free	 carboxyl	 and	
amino	groups,	respectively	(Figure	1.8).		
It	 is	 now	 evident	 that	 there	 are	 superfamilies	 of	 small	 periplasmic	
peptidoglycan-degrading	effectors	(and	families	of	immunity	proteins)	prevalent	in	
many	T6SS-containing	species	that	are	anti-bacterial.	This	includes	a	superfamily	of	
amidase	 effector-immunity	 pairs	 that	 are	 responsible	 for	 the	 hydrolysis	 of	 amide	
bonds	 in	 the	 peptide	 crosslinks,	 Tae-Tai	 (for	 type	 VI	 amidase	 effector/immunity).	























Figure	 1.8	 Bond	 cleavage	 specificity	 of	 the	 peptidoglycan-degrading	 T6SS-dependent	
effectors.	 Diagram	 shows	 the	 simplified	 structure	 of	 Gram-negative	 peptidoglycan	 along	
with	the	bond	specificities	of	peptidoglycan	hydrolase	T6SS	effectors.	The	effectors	of	the	
Tae	 superfamily	 are	 amidases	 that	 hydrolyse	 amide	 bonds	 between	 and	 within	 peptide	
crosslinks	 (red	arrows),	as	 indicated.	The	Tge	effector	 superfamily	and	 the	CTD	of	VgrG-3	





























Another	 peptidoglycan	 hydrolysing	 superfamily	 is	 the	 glycoside	 hydrolase	
effector-immunity	 pairs,	 Tge-Tgi	 (for	 type	 VI	 glycoside	 effector/immunity).	 These	





et	 al.,	 2010;	 Russell	 et	 al.,	 2011),	 family	 2	 Tae	 effector	 Tae2BT	 in	B.	 thailandensis	
(Russell	et	al.,	2012),	and	family	4	Tae	effectors	Ssp1	(Tae4.1SM)	and	Ssp2	(Tae4.2SM)	
in	 S.	 marcescens	 (Murdoch	 et	 al.,	 2011;	 Fritsch	 et	 al.,	 2013).	 The	 family	 1	 Tge	














an	 ester	 bond	 by	water	 (hydrolysis)	 to	 produce	 an	 acid	 and	 alcohol	 (Figure	 1.9).	
Lipases	specifically	catalyse	the	hydrolysis	of	ester	bonds	in	lipid	molecules	in	a	base	
catalysed	hydrolysis	reaction.		A	variety	of	lipid	molecules	occur	in	nature,	including	































Nevertheless,	 it	 appears	 many	 lipases	 use	 a	 hydrolysis	 mechanism	 that	
involves	 a	 catalytic	 triad	 of	 serine,	 histidine,	 aspartate	 residues,	 including	 human	
pancreatic	 lipases	 (Winkler	 et	 al.,	 1990),	 fungal	 lipases	 (Brady	 et	 al.,	 1990)	 and	
bacterial	lipases,	such	as	the	LipA	lipase	from	B.	glumae	(Noble	et	al.,	1993)	and	the	
B.	cepacia	lipase	(Kim	et	al.,	1997).	The	catalytic	triad	of	many	of	these	enzymes	is	





The	 general	 accepted	 principle	 of	 the	 hydrolysis	 of	 an	 ester	 bond	 using	 a	
catalytic	 triad	 of	 serine,	 histidine	 and	 aspartate	 residues	 involves	 the	 following	
covalent	catalysis	mechanism	(reviewed	in	Dodson	(1998)).	To	begin,	the	acidic	side	
chain	of	 the	aspartate	 residue	causes	alignment	and	polarisation	of	 the	 imidazole	
side	chain	of	the	histidine	residue	due	to	hydrogen	bond	formation,	such	that	the	
imidazole	 moiety	 is	 able	 to	 act	 a	 strong	 general	 base	 that	 deprotonates	 the	
hydroxyl	 group	 of	 the	 serine	 side-chain,	 thereby	 activating	 the	 nucleophile.	 The	
serine	sidechain	oxygen	in	this	state	is	able	to	perform	a	nucleophilic	attack	on	the	
carbon	in	an	ester	carbonyl	group	in	the	substrate	(Figure	1.10A).	This	results	in	the	




residue	 to	 facilitate	 the	 first	 leaving	 group	 (Figure	 1.10B).	 Thus,	 the	 alcohol	
component	 of	 the	 ester	 is	 expelled,	 leaving	 the	 acid	 moiety	 as	 an	 acyl-enzyme	
intermediate.	The	carbonyl	carbon	of	the	intermediate	is	then	subjected	to	another	
nucleophilic	 attack,	 this	 time	 by	 an	 activated	 water	 molecule	 (hydroxyl	 anion)	
generated	 by	 proton	 transfer	 from	 the	 water	 molecule	 to	 the	 histidine	 residue	
(Figure	1.10C).	Again	 this	creates	a	 tetrahedral	 intermediate.	The	 final	 step	 in	 the	
reaction	is	the	re-generation	of	the	carbonyl	group	by	donation	of	a	proton	by	the	

















































Figure	1.10	Catalytic	mechanism	of	 the	 lipase	catalytic	 triad.	Diagrammatic	presentation	











(reviewed	 in	 Richmond	 and	 Smith	 (2011)).	 This	 includes	 the	 acyl	 hydrolases	
phospholipase	 A1	 (PLA1),	 which	 hydrolyses	 the	 ester	 bond	 at	 the	 sn-1	 carbon	
position	 in	 a	 phospholipid,	 phospholipase	 A2	 (PLA2),	 which	 cleaves	 at	 the	 sn-2	
carbon	position	 (Haas	et	al.,	1962)	and	phospholipase	B	 that	cleaves	at	both	sn-1	






A	 T6SS-dependent	 lipase	 effector	 superfamily	 has	 recently	 been	 identified	
that	 encompassed	 effectors	 that	 possess	 phospholipase	 A1,	 phospholipase	 A2,	 or	




active	 site	 of	 the	 enzyme.	 Tle1-Tle4	 family	members	 contain	 a	 conserved	 GxSxG	
motif	 in	 the	 active	 site,	 including	 the	 experimentally	 characterised	 Tle1BT	 anti-
bacterial	effector	encoded	by	BH_I2698	in	B.	thailandensis,	which	is	a	substrate	of	
T6SS-1	(Russell	et	al.,	2012;	Russell	et	al.,	2013).			
Tle5	 family	 members	 contain	 two	 separated	 HxKxxxxD	 motifs,	 which	
includes	 a	 previously	 identified	 P.	 aeruginosa	 phospholipase	 D	 enzyme	 termed	
PldA,	 renamed	 Tle5PA,	which	was	 also	 shown	to	 have	 anti-bacterial	 activity	 and	 is	
secreted	 by	 the	 H2-T6SS.	 Interestingly,	 Tle5PA	 has	 also	 been	 noted	 to	 have	 anti-	




















the	 specific	 ester	 bonds	 within	 a	 phospholipid	 molecule	 that	 are	 cleaved	 by	 particular	
classes	 of	 phospholipase,	 including	 phospholipase	 A1	 (PLA1),	 phospholipase	 A2	 (PLA2),	


















appear	 too	 large	 to	 be	directly	 transported	 through	 the	hollow	TssD	 tube,	 unlike	
the	small	peptidoglycan-degrading	Tae	effectors.		
As	 with	 the	 peptidoglycan-targeting	 effectors,	 the	 membrane-targeting	




Further	 membrane	 targeting	 effectors	 include	 a	 pore	 forming	 colicin-like	
effector	of	V.	 cholerae,	VasX,	 that	was	 found	 to	exhibit	 anti-amoeboid	properties	





VasX	 (Russell	 et	 al.,	 2012).	 As	 expected	 both	 of	 these	 effectors	 have	 cognate	
immunity	 proteins	 (Russell	 et	 al.,	 2012;	Miyata	 et	 al.,	 2013).	 Recently,	 both	 VasX	
and	BTH_12691	were	found	to	contain	a	similar	N-terminal	motif	that	is	present	in	

















suggested	 that	 it	 may	 function	 as	 a	 nuclease	 effector,	 although	 experimental	
evidence	is	lacking	(Li	et	al.,	2012).		
1.5.4.1 Nuclease	effectors	
Following	 on	 from	 this,	 a	 superfamily	 of	 DNase	 effectors	 has	 been	
described,	 termed	Tde	effectors	 (type	VI	DNase	effector).	 The	main	characterised	
examples	 occur	 in	 the	 plant	 pathogen	 A.	 tumefaciens	 (Ma	 et	 al.,	 2014).	 They	
contain	a	C-terminal	toxin_43	domain	with	a	conserved	HxxD	motif	that	is	required	





domains.	 Interestingly,	 Tde1	 and	 Tde2	 from	 A.	 tumefaciens	 aided	 inter-bacterial	




the	 following	 catalytic	 mechanism	 is	 typical	 of	 endonucleases.	 The	 active	 site	 is	
arranged	 in	 such	a	way	 that	a	histidine	 residue	 is	 central	 to	catalysis	by	acting	as	
general	base	that	causes	the	deprotonation	of	a	nearby	water	molecule.	This	in	turn	
results	 in	 a	 nucleophilic	 attack	 on	 the	 scissile	 phosphate	 group	 within	 the	
	
	 71	
phosphodiester	 bond	 between	 two	 nucleotides	 (Korczynska	 et	 al.,	 2012).	 This	 is	
facilitated	by	 the	metal	 ion	acting	as	a	 Lewis	acid,	 thereby	accepting	electrons	 to	





required	 for	 stabilisation	 of	 the	 catalytic	 product	 to	 limit	 a	 reverse	 reaction	
between	transition	states	(Korczynska	et	al.,	2012).		
1.5.4.1.2 Roles	of	extracellular	nucleases	and	nuclease	toxins	
A	wide	 variety	 of	 roles	 have	 been	 proposed	 for	 extracellular	 nucleases.	S.	
marcescens	extracellular	endonuclease	(Sm2)	has	been	postulated	to	be	involved	in	
scavenging	under	nutrient-limiting	conditions,	using	the	ribose	components	of	the	
nucleotide	monomers	as	a	 carbon	 source	or	 recycling	 the	nucleotides	 for	 its	own	
DNA/RNA	 synthesis	 (Beliaeva	 et	 al.,	 1976;	 Benedik	 and	 Strych,	 1998).	 However,	
experimental	evidence	 is	 lacking	 for	 this.	Other	secreted	endonucleases,	 including	
the	V.	cholerae	nuclease	Dns,	an	EndA	type	nuclease,	may	be	involved	in	resisting	
natural	 transformation	 events	 from	 exogenous	 DNA,	 as	 well	 as	 modulating	
extracellular	 DNA,	 an	 important	 component	 of	 bio-films	 structures	 (Focareta	 and	
Manning,	1991;	Blokesch	and	Schoolnik,	2008;	Seper	et	al.,	2011).		
Pertinently,	a	wide	array	of	nuclease	proteins	produced	by	both	prokaryotes	
and	 eukaryotes	 are	 known	 to	 be	 toxins.	 This	 includes	 the	 highly	 specific	 fungal	
nuclease,	α-sarcin,	produced	by	Aspergillus	giganteus	that	acts	as	an	RNase	enzyme	
to	cleave	a	single	phosphodiester	bond	in	28S	rRNA	(Korennykh	et	al.,	2007)	and	a	
DNase	 toxin	 in	 the	 snake	 venom	 of	 Bothrops	 atrox	 (Georgatsos	 and	 Laskowski,	
1962).		
It	 appears	 that	 bacteria	 harbour	 the	 largest	 reservoir	 of	 nucleic	 acid	
targeting	 toxins,	 many	 of	 which	 target	 other	 bacteria	 in	 a	 competitive	 growth	
environment,	 termed	 bacteriocins.	 These	 include	 colicin	 toxins	 in	 E.	 coli,	 such	 as	
Colicin	E2	 (Cascales	et	al.,	 2007)	and	 the	variable	C-terminal	domains	of	 the	CdiA	
protein	 contact-dependent	 growth	 inhibition	 system	 (CDI)	 (Poole	 et	 al.,	 2011).	
	
	72	
Some	nucleases	 are	 involved	 in	host	DNA	damage	 in	 toxin-antitoxin	 systems	 (TA)	
that	 ultimately	 result	 in	 cell	 death	 for	 the	 toxin-producing	 bacterium,	 which	 is	
usually	promoted	under	stress	conditions	(Yamaguchi	et	al.,	2011).	Moreover,	T6SS-
dependent	DNase	effectors	have	been	described	that	are	 important	for	 inter-	and	
intraspecies	 bacterial	 competition,	 including	 Rhs-related	 effectors	 (Zhang	 et	 al.,	
2012;	Koskiniemi	et	al.,	2013;	Hachani	et	al.,	2014;	Diniz	and	Coulthurst,	2015)	and	
a	 superfamily	 of	 DNase	 effectors	 that	 are	 important	 for	 in	 planta	 interspecies	
competition	in	A.	tumefaciens	(Ma	et	al.,	2014).	
1.5.4.2 Rhs	effectors	
Other	 cytoplasmic	 targeting	 effectors	 are	 components	 of	 Rhs	
(rearrangement	 hot-spot)	 elements.	 Rhs	 proteins	 are	 generally	 large	 filamentous	
proteins	 that	 contain	 an	N-terminus	with	 a	 PAAR	 domain,	 RHS	 sequence	 repeats	
(GxxxRYxYDxxGRl(I/T)),	an	RHS	repeat-associated	core	that	contains	a	self-cleavage	
site	 and	 then	 C-terminal	 toxin	 domain	 that	 is	 highly	 variable	 (Wang	 et	 al.,	 1998;	
Zhang	 et	 al.,	 2012;	 Busby	 et	 al.,	 2013).	 This	 latter	 feature	 defines	 them	 as	
polymorphic	 toxins	 (Jamet	 and	 Nassif,	 2015).	 The	 recent	 structure	 of	 an	 Rhs	
protein,	‘C	protein’	from	the	tripartite	ABC	insecticidal	toxin	from	entomopathogen	
Yersinia	 entomophaga,	 observed	 that	 the	N-terminal	 RHS	 repeat	 region	 forms	 as	
extended	β-sheet-containing	 protective	 shell	 around	 the	 C-terminal	 toxin	 domain	
(Busby	et	 al.,	 2013).	 This	 structure	 leaves	 the	RHS-associate	 core	 region	exposed,	
allowing	cleavage	and	release	of	the	toxin	when	required	(Busby	et	al.,	2013).	Each	
RHS	 repeat	motif	was	shown	to	correspond	 to	a	β-strand-turn-β-strand	structural	





an	 HNH	 endonuclease	 motif	 that	 confers	 a	 competition	 advantage	 over	 other	


















several	 methods	 to	 translocate	 effector	 proteins	 from	 out	 of	 the	 bacterial	
cytoplasm	 and	 into	 its	 target	 host	 cell,	 summarised	 in	 Figure	 1.12.	 It	 is	 possible	
several	 mechanisms	 may	 be	 used	 in	 one	 firing	 action	 of	 the	 system,	 delivering	
several	 different	 effectors	 at	 one	 time	 (Shneider	 et	 al.,	 2013).	 Two	 broad	
mechanisms	have	been	suggested,	where	 the	effectors	 secreted	by	each	of	 these	
mechanisms	 are	 classified	 as	 either	 cargo	 effectors	 or	 specialised	 effectors,	 and	
typically	 encoded	 close	 to	 cognate	 tssI	 or	 tssD	 genes	 (reviewed	 in	 Durand	 et	 al.	
(2014)).	 Small	 effector	proteins	may	be	 translocated	 through/with	 the	TssD	 inner	
tube,	 whilst	 larger	 effectors	 may	 delivered	 by	 association	 with/as	 a	 TssI	 spike	





unfolded	 (or	 partially	 folded)	 effectors	 (Mougous	 et	 al.,	 2006).	 However,	 rather	
than	 travel	 through	 the	 tubular	 structure	 there	 is	 now	 evidence	 to	 suggest	 that	
some	 small	 folded	 proteins,	 such	 as	 the	 Tse1-Tse4	 secreted	 by	 the	H1-T6SS	 in	P.	






















suggested	 for	 how	 T6SS	 effectors	 are	 delivered	 by	 the	 system.	 (1)	 and	 (2)	 are	 TssD-
mediated	delivery	methods,	either	by	TssD	entrapping	the	effector	within	its	lumen	(1),	or	
specialised	evolved	TssD	proteins	with	C-terminal	effector-like	domains	(2).	(3)-(6)	use	TssI	
as	a	mediator	 for	effector	delivery,	known	as	 the	MERV	model.	Effectors	delivered	by	 (3)	
are	TssI	proteins	with	C-terminal	effector	extensions,	(4)	are	specialised	PAAR	proteins	that	
have	 C-	 or	 N-terminal	 extensions,	 (5)	 are	 cargo	 effectors	 that	 can	 interact	with	 either	 a	
PAAR	 protein	 or	 the	 extension	 domain	 on	 a	 specialised	 PAAR	 protein	 and	 finally	 (6)	 are	







the	 inner	 face	 of	 TssD	 ring	 structures	 to	 stabilise	 the	 effectors.	 Thus,	 acting	 as	 a	
chaperone-like	 protein	 whilst	 also	 entrapping	 the	 cargo	 within	 the	 internal	 40	 Å	
lumen	 of	 the	 structure	 (Silverman	 et	 al.,	 2013;	Whitney	 et	 al.,	 2014)	 (1	 in	 Figure	
1.12).	The	effector	cargo	is	released	when	TssD	is	secreted	into	its	target	location.	
Other	small	effectors	such	as	EvpP	in	Edwardsiella	tarda	have	been	implicated	to	be	
translocated	 by	 this	 method	 (Lin	 et	 al.,	 2013).	 This	 method	 ensures	 that	 such	
effectors	are	only	secreted	by	a	particular	T6SS.	
Another	 TssD-mediated	 method	 may	 occur	 by	 specialised	 forms	 of	 TssD,	
‘evolved	 TssDs’,	 which	 contain	 C-terminal	 enzymatic	 domains	 (2	 in	 Figure	 1.12),	
such	as	that	discovered	in	Salmonella	enterica	subsp.	Arizonae.	This	TssD	is	fused	to	
a	 pyocin	 and	 a	 HNH	 endonuclease	 domain	 (Blondel	 et	 al.,	 2009).	 However,	 no	




delivery.	 This	 includes	 specialised	evolved	TssI	 proteins	with	C-terminal	 extension	
domains	 (number	 3	 in	 Figure	 1.12),	 as	 previously	 discussed	 in	 Section	 1.5.1.	
Moreover,	 it	may	also	include	additional	proteins	that	can	bind	to	TssI	proteins	to	









e.g.	 the	 transerythrin	 domain	 (Shneider	 et	 al.,	 2013).	 It	 was	 suggested	 some	




TssI	 spike	 proteins	 (5	 in	 Figure	 1.12).	 However,	 there	 is	 no	 direct	 evidence	 for	 a	
PAAR	protein-effector	interaction.	
Recent	 findings	 have	 provided	 evidence	 for	 a	 superfamily	 of	 additional	
adaptor	 or	 chaperone	 proteins	 that	 works	 independently	 of	 PAAR-containing	
proteins.	This	superfamily	contains	a	domain	of	unknown	function,	DUF4123,	and	is	
generally	encoded	directly	upstream	of	 its	cognate	effector	gene.	Representatives	
of	 this	 superfamily	 were	 termed	 TEC	 proteins	 (T6SS	 effector	 chaperone)	 or	 Tap	
(T6SS	accessory	protein).	An	exemplar	TEC/Tap	protein	is	in	V.	cholerae	encoded	by	
VC1417,	which	is	required	for	the	secretion	and	effector-mediated	bacterial	killing	
of	 the	T6SS	effector,	Tle2VC	(TseL)	 (Liang	et	al.,	2015;	Unterweger	et	al.,	2015).	 	A	
direct	interaction	between	the	VC1417-encoded	TEC	protein	and	its	Tle2VC	effector	
protein,	and	between	this	TEC	and	the	TssI	protein	encoded	in	the	vicinity	of	these	
genes	 (VgrG-1),	 and	 an	 interaction	 between	 Tle2VC	 and	 VgrG-1	 were	 all	
demonstrated	 (Liang	 et	 al.,	 2015;	 Unterweger	 et	 al.,	 2015).	 However,	 the	
chaperone	 protein	 is	 not	 secreted,	 implying	 that	 the	 chaperone	 is	 required	 for	




for	 the	 secretion	 and	 effector-mediated	 anti-bacterial	 activity	 of	 Rhs1	 (Diniz	 and	
Coulthurst,	2015).	This	adaptor	is	homologous	to	other	proteins	encoded	in	similar	
locations.	 These	 include	 genes	 encoded	 upstream	 of	 genes	 encoding	 Rhs-	 and	















types	 of	 effectors	 it	 secretes	 in	 other	 Gram-negative	 bacteria,	 as	 well	 as	 work	
previously	 undertaken	 in	 our	 laboratory,	 the	 following	 hypotheses	 may	 be	
proposed:	
1. Bcc	bacteria,	including	B.	cenocepacia	use	its	ancestral	T6SS-1	to	target	other	







include	 effectors	 with	 phospholipase	 activity,	 nuclease	 activity	 or	
peptidoglycan	hydrolase	activity.		
4. Each	of	these	effectors	will	have	a	corresponding	immunity	protein/antitoxin	
















To	 test	 the	 hypotheses	 proposed	 in	 Section	 1.6,	 this	 work	 centres	 on	 the	
following	aims	and	objectives:	
1. Evaluate	the	anti-bacterial	and/or	anti-eukaryotic	role	of	the	T6SS	in	the	Bcc	
bacterium	B.	 cenocepacia	 using	bacterial	 competition	 assays	 and	eukaryotic	
infection	models.		
2. Investigate	mechanisms	for	T6SS-1	regulation	with	the	aim	of	 increasing	the	
activity	 of	 the	 T6SS	 for	 novel	 effector	 discovery.	 This	will	 be	 carried	 out	 by	
genetic	inactivation	of	putative	regulators	identified	by	bioinformatic	analysis	
and	evaluation	of	their	effects	on	T6SS	activity	in	B.	cenocepacia.	
3. Identify	 putative	 T6SS-dependent	 effectors	 and	 their	 cognate	 immunity	
proteins	in	B.	cenocepacia	by	bioinformatic	analysis	and	mass	spectrometry.		
4. Characterise	 the	 enzymatic	 properties,	 function	 and	 secretion	 of	 selected	
putative	 T6SS-dependent	 effectors	 identified	 in	 B.	 cenocepacia.	 Verify	 the	
identified	 immunity	proteins/antitoxins	for	these	putative	effectors.	This	will	



















































































The	 bacterial	 strains	 used	 in	 this	 study	 (Table	 2.1)	 were	 routinely	 cultured	
from	 -80°C	 glycerol	 stocks	 (15%	 (v/v)	 glycerol)	 on	 appropriate	 agar	 plates	 and	
grown	at	 temperatures	between	25°C	and	37°C	for	16	 to	72	hours	dependent	on	
optimal	 culturing	 conditions	 for	 the	 species,	 as	 indicated	 (Table	 2.2).	 Plates	were	
sealed	with	parafilm	and	stored	in	the	dark	at	room	temperature	for	B.	cenocepacia	



















































































































































































































































P.	fluorescens	 LB	 25°C	 48	-	64		
P.	putida	 LB	 30°C	 24		




A.	baylyi	 LB	 37°C	 16	-	24		






above	with	 addition	of	 1.5%	 (w/v)	 bacteriological	 agar	 (VWR	 International).	Once	
cooled	 to	 ~55°C	 approximately	 25	 millilitres	 (mL)	 of	 the	 agar	 was	 poured	 into	
standard	 90mm	 plastic	 petri	 dishes	 (Thermo	 Scientific)	 and	 left	 to	 solidify.	 After	
solidification,	agar	plates	were	dried	at	42°C	for	30	minutes	before	use.	
Dialysed	Brain-Heart	Infusion	(D-BHI)	
To	 reduce	 the	 interference	 of	 larger	M.W.	 proteins	 present	 in	 BHI	 on	 the	
analysis	 of	 proteins	 in	 spent	 culture	 supernatants,	 dialysed-BHI	 (D-BHI)	 was	
employed.	For	500	mL	of	D-BHI,	9.25	g	BHI	was	made	up	to	25	mL	with	ddH2O,	this	







	 Iso-Sensitest	 medium	 was	 required	 when	 selecting	 for	 trimethoprim-
resistance	 in	 E.	 coli,	 as	 LB	 agar	 contains	 small	 amounts	 of	 thymidine	 that	 can	
interfere	with	trimethoprim	selection	if	low	levels	of	the	antibiotic	are	used.	23.4	g	
Iso-Sensitest	 broth	 (Oxoid)	 was	 dissolved	 in	 1	 L	 ddH2O,	 and	 sterilised	 by	
autoclaving.	 Iso-Sensitest	 agar	 was	 made	 as	 above	 with	 addition	 of	 1.5%	 (w/v)	
bacteriological	agar.	Antibiotics	were	added	after	cooling	to	~55°C.		
Lennox	broth	agar	
For	 improved	 selection	 of	 kanamycin-resistance	 in	B.	 cenocepacia,	 Lennox	
broth	agar	was	employed.	10	g	 tryptone	 (BD),	5	g	yeast	extract	 (Oxoid),	5	g	NaCl	





bacteriological	 agar	 before	 autoclaving.	 Antibiotics	 were	 added	 after	 cooling	 to	
~55°C.	
King’s	B	agar	






















pEX18Tp-pheS	 and	 pEX18TpTer-pheS-based	 plasmids.	 For	 200	mL	of	medium,	 2	 g	
casamino	 acids	 (BD)	 (final	 concentration	 1%)	 and	 1.5%	 (w/v)	 bacteriological	 agar	
were	combined	and	added	to	178	mL	of	ddH2O,	and	sterilised	by	autoclaving.	After	
cooling,	20	mL	of	10X	M9	salts	was	added	 to	give	a	 final	 concentration	of	1X	M9	
salts.	Sterile	solutions	of	50%	glycerol,	freshly	prepared	1%	thiamine,	100	mM	CaCl2	
and	1	M	MgSO4	were	 then	added	 to	give	a	 final	 concentration	of	0.5%,	0.0005%,	
100µM	 and	 1mM,	 respectively.	 Following	 which,	 IPTG	 and	 X-gal	 stock	 solutions	














	 	 E.	coli	 B.	cenocepacia	
Ampicillin		 100	in	ddH2O	 100		 n/a	
Chloramphenicol		 25	in	100%	ethanol	 25		 50		
Carbenicillin		 100	in	ddH2O	 200-500	(BHI)a	 	
Kanamycin	 50	in	ddH2O	 50		 50-100	
Rifampicin		 50	in	100%	methanol	 100		 100	
Streptomycin		 75	in	ddH2O	 75		 n/a	














































































































































































































































































































































































































































































































to	 anneal	 to	 specific	 regions	 of	 the	 gene.	 Primers	 used	 for	 cloning	 purposes	 had	
restriction	sites	and	a	GC-clamp	 incorporated	 into	the	5’	ends	of	 the	primers.	See	










































































































































































































Overnight	 cultures	 of	 transformants	 containing	 the	 desired	 plasmid	 were	
grown	by	 inoculating	3	mL	of	antibiotic-supplemented	 liquid	broth	and	 incubated	
overnight	at	37°C	with	shaking.	1.5	mL	of	overnight	culture	was	transferred	into	a	
microcentrifuge	 tube	 and	 centrifuged	 at	 15,000	 x	g	 for	 3	minutes	 to	 recover	 the	
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and	pelleted	as	 Section	2.2.4	 and	 then	 the	plasmid	extracted	as	 follows.	Bacteria	
were	gently	resuspended	in	100	µL	solution	I	(50	mM	Tris-HCl	pH	8.0,	10	mM	EDTA,	
100	 μg/ml	 RNaseA),	 and	 then	 lysed	with	 addition	 of	 150	µL	 solution	 II	 (200	mM	
NaOH,	1%	SDS)	followed	by	immediate	inversion	of	the	tube.	The	solution	was	then	
neutralised	and	proteins	precipitated	by	adding	200	µL	solution	N3	(4.2	M	GuHCl,	
0.9	 M	 Potassium	 acetate,	 pH	 4.8)	 and	 inverting.	 Precipitates	 were	 pelleted	 by	
centrifugation	 at	 16,000	 x	 g	 for	 10	minutes.	 700	µL	 of	 the	 cleared	 solution	 was	
applied	 to	 a	 recycled	 acid/alkali	 washed	 DNA	 spin	 column	 (Thermo	
Scientific/Dutscher	Scientific)	and	centrifuged	for	1	minute	for	the	solution	to	pass	
through	the	column,	allowing	the	DNA	to	bind	to	the	silica	membrane.	The	column	
was	dried	by	 centrifugation	 for	 2	minutes,	 transferred	 to	 a	 clean	microcentrifuge	
tube	and	then	bound	DNA	was	eluted	with	addition	of	20-40	µL	buffer	EB	(Qiagen).	
This	 was	 incubated	 for	 5	 minutes	 at	 room	 temperature	 and	 centrifuged	 for	 1	




	 An	 alternative	 crude	 plasmid	 extraction	 was	 as	 follows.	 Bacteria	 were	





incubated	on	 ice	 for	 5	mins.	 Following	 this	 150	µL	 of	 solution	 III	 (3	M	potassium	
acetate,	2	M	acetic	acid)	was	added,	the	solution	 inverted	and	then	 incubated	on	
ice	 for	 5	minutes.	 Supernatants	 were	 transferred	 to	 clean	microcentrifuge	 tubes	
and	 ethanol	 precipitated	 as	 follows.	 2	 volumes	 of	 100%	 ethanol	 (~800	 µL)	 was	
added	and	vortex.	The	 solution	was	 left	 to	precipitate	 for	15	minutes	on	 ice.	The	
precipitate	 was	 collected	 by	 centrifugation	 at	 15,000	 x	 g	 for	 5	 minutes,	 the	
supernatant	 removed	and	discarded.	Following	 this	 the	pellet	was	washed	with	1	
mL	 of	 70%	 ethanol,	 centrifuged	 again	 and	 the	 supernatant	 removed	 thoroughly.	







loading	 dye	 (4.2	 mg/ml	 bromophenol	 blue,	 5.5%	 (v/v)	 glycerol	 final	 conc.)	 and	
loaded	 onto	 a	 0.8%	 or	 1.0%	 agarose	 gel	 (Fisher)	 in	 1x	 TAE	 (40	mM	 Tris,	 20	mM	
acetic	acid,	and	1	mM	EDTA)	as	standard	protocol.	Appropriate	DNA	ladders	were	
included,	5	µL	of	pre-stained	DNA	 ladder	mix	 (Thermo	Scientific/York	biosciences) 
for	 linear	DNA,	or	1	µL	supercoiled	DNA	ladder	(New	England	Biolabs)	for	plasmid	
DNA.	Gels	were	then	visualized	by	post-electrophoresis	ethidium	bromide	staining	





DNA	 fragments	 in	 a	 PCR	 reaction	 using	 Hot-start	 KOD	 DNA	 polymerase	 (Merck	




(final	 concentration),	 0.6	 mM	 forward	 and	 reverse	 primers,	 2.5	 µL	 DMSO	 per	
reaction	(for	GC-rich	DNA)	and	0.5	U	KOD	DNA	polymerase.	Using	a	G-STORM	GS1	
thermal	cycler	(Gene	technologies),	samples	underwent	a	5	minute	95°C	hot-start	
step,	 and	 then	 30	 cycles	 of	 the	 following	 temperature	 steps	 to	 ensure	 full	
amplification	 of	 the	 DNA.	 DNA	 denaturation	 for	 30	 seconds	 at	 95°C;	 primer	
annealing	for	30	seconds	at	a	calculated	annealing	temperature	(this	temperature	
varied	due	to	primer	length	and	G+C	content,	using	the	formula	[2(A+T)	+	4(G+C)]-









it	 on	 the	 inside	 of	 a	 PCR	 tube,	 then	 patching	 the	 colony	 onto	 an	 appropriate	














To	 purify	 the	 corrected	 sized	 DNA	 fragment	 from	 a	mixture	 of	 differently	
sizes	 DNA	 fragments,	 the	 entire	 sample	 was	 separated	 by	 DNA	 agarose	 gel	
electrophoresis.	The	desired	band	corresponding	 to	 the	DNA	 fragment	of	 interest	
was	then	excised	from	the	gel	using	a	sterile	scalpel.	DNA	was	then	purified	using	a	
spin-column	 based	 gel	 extraction	 kit	 (Qiagen/Macherey-Nagel)	 according	 to	 the	




At	 least	 200	 ng	 of	 PCR	 fragment	 and	 plasmid	 DNA	 were	 subjected	 to	
restriction	digestion	by	the	appropriate	restriction	enzyme	(Promega/New	England	
Biolabs)	in	a	50	µL	reaction	volume	as	manufacturer’s	instructions	for	2	hours	at	the	
recommended	 temperature	 from	 the	 restriction	 enzyme.	 The	 digested	 DNA	 was	
then	purified	as	Section	2.2.10.		
For	diagnostic	restriction	digestions	of	plasmid	clones,	5	µL	of	plasmid	DNA	
















To	 insert	 a	 DNA	 fragment	 into	 a	 vector,	 digested	 DNA	 fragments	 and	 cut	
plasmids	were	combined	in	3:1	or	5:1	molar	ratio	of	insert:vector	(for	directional	or	
blunt	cloning,	respectively)	and	 ligated	using	T4	DNA	 ligase	(1	U/µL)	 (Promega)	as	
manufacturer’s	 protocol,	 in	 a	 total	 reaction	 volume	 of	 30	 µL.	 Ligation	 reactions	










Chemically	 competent	 E.	 coli	 cells	 were	 prepared	 according	 to	 Hanahan’s	
method	(Hanahan,	1983).	Briefly,	50	mL	LB	culture	was	 inoculated	with	0.5	mL	of	
overnight	starter	culture,	and	incubated	at	37°C	with	shaking	until	an	OD600	of	0.3-
0.5	 was	 achieved.	 Upon	 reaching	 the	 appropriate	 cell	 density,	 the	 culture	 was	
chilled	 on	 ice	 for	 15	minutes	 then	 pelleted	 by	 centrifugation	 at	 3,400	 x	 g	 for	 10	
minutes	 at	 4°C	 in	 an	 Allegra	 X-22R	 benchtop	 refrigerated	 centrifuge	 (Beckman	
Coulter).	 The	 bacterial	 pellet	 was	 resuspended	 in	 16	 mL	 of	 filter-sterilised	 RF1	
solution	 (100	mM	KCl,	 50	mM	MnCl24H2O,	 30	mM	CH3COOK,	 10	mM	CaCl22H2O,	
15%	(v/v)	glycerol,	pH	5.8	with	0.2M	CH₃COOH)	by	moderate	vortexing,	chilled	on	
ice	 for	 30	 minutes	 and	 then	 pelleted	 by	 centrifugation	 as	 previously.	 A	 fresh	
working	solution	of	RF2	was	made	by	combining	0.5	mL	RF2A	(0.5	M	MOPS,	pH	6.8)	
with	 9.8	mL	 RF2B	 (75	mM	 CaCl22H2O,	 10	mM	 KCl,	 15%	 (v/v)	 glycerol),	 and	 then	
filter-sterilised.	 The	 chilled	 bacterial	 pellet	 was	 resuspended	 in	 4	 mL	 of	 RF2	 and	
incubated	 for	 a	 further	 15	 minutes	 on	 ice.	 The	 bacterial	 suspension	 was	 then	
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subjected	 to	 a	 heat	 shock	 at	 42°C	 for	 2.5	 minutes,	 then	 returned	 to	 ice	 for	 5	
minutes.	 1	mL	 of	 liquid	 broth	was	 then	 added	 and	 the	 bacterial	 suspension	was	
incubated	 for	 1	 hour	 at	 37°C	 to	 allow	 plasmid	 replication	 and	 expression	 of	
antibiotic	 resistance	 genes.	 100	 µL	was	 spread	 onto	 an	 agar	 plate	 supplemented	
with	the	appropriate	antibiotics.	
Electroporation	assisted	transformation	
	 Electro-competent	B.	 cenocepacia	 cells	were	prepared	as	 follows.	6	mL	LB	
was	 inoculated	 and	 grown	 overnight	 at	 37°C.	 Cultures	 were	 harvested	 by	
centrifugation	at	3,500	x	g	in	an	Allegra	X-22R	benchtop	refrigerated	centrifuge	for	
10	minutes	at	room	temp.	The	supernatant	was	removed	and	bacteria	resuspended	
in	 6	 mL	 chilled	 300	 mM	 sterile	 sucrose	 solution,	 and	 then	 re-centrifuged	 for	 10	
mins.	The	supernatant	was	discarded	and	the	300	mM	sucrose	wash	was	repeated.	
Bacteria	were	 then	 resuspended	 in	 100	 µL	 300	mM	 sucrose.	 500	 ng	 vector	 DNA	
(prepared	 by	 kit	 plasmid	 minipreparation)	 was	 combined	 with	 100	 µL	 electro-
competent	 cells	 and	 transferred	 to	 a	 sterile	 2	mm	 electroporation	 cuvette	 (with	
longer	electrode	design)	(Geneflow)	and	subjected	to	an	electric	pulse	using	Gene	
Pulser	 Xcell	 (BioRad)	 set	 at	 25	 µF,	 200	 Ω,	 2.5	 kV.	 1	 mL	 LB	 was	 added	 and	 the	
suspension	was	transferred	to	a	25	mL	universal	tube	and	incubated	at	37°C	for	2	
hours	 to	 allow	 cells	 to	 recover.	 Cultures	 were	 transferred	 to	 a	 sterile	 micro-








E.	 coli	 donor	 strain	 and	 grown	 overnight	 at	 37°C.	 1	 mL	 of	 each	 culture	 was	
harvested	 by	 centrifugation	 for	 2	 minutes	 at	 16,	 000	 x	 g.	 The	 supernatant	 was	
discarded	and	the	pellets	resuspended	in	100	µL	0.85%	(w/v)	sterile	saline.	25	µL	of	
donor	 and	 recipient	 cultures	were	 combined	 in	 a	microcentrifuge	 tube	 and	 then	
spread	over	a	0.45	µm	nitrocellulose	filter	membrane	(Millipore)	placed	on	a	LB	or	
BHI	agar	plate.	Plates	were	incubated	at	37°C	for	8-16	hours.	Donor	and	recipient	
strains	 were	 also	 incubated	 on	 filters	 membranes,	 as	 above,	 to	 act	 as	 controls,	






















by	 an	 expression	 plasmid,	 the	 plasmid	 was	 introduced	 into	 an	 E.	 coli	 expression	
host	strain,	such	as	BL21(DE3)	or	BL21(DE3)/pLysS	by	transformation.	A	single	CFU	
was	used	to	inoculate	8	mL	BHI	broth	(with	appropriate	antibiotics)	and	cultured	at	
37°C	 until	 a	mid-log	 growth	 phase	was	 reached	 (OD600	 0.3-0.5).	 The	 culture	 was	
then	divided	into	two	separate	sterile	culture	tubes	to	allow	half	of	the	culture	to	
be	 induced	 and	 the	 remainder	 left	 uninduced.	 For	 induction	 of	 protein	 synthesis	
from	 T7	 based	 expression	 systems,	 such	 as	 the	 pET	 vector	 series,	 1	M	 IPTG	was	
added	 to	 give	 a	 final	 concentration	 of	 1	mM.	 For	 rhamnose-inducible	 expression	
systems,	 such	 as	 pSCrhaB2,	 10%	 (w/v)	 rhamnose	 was	 added	 to	 give	 a	 final	
concentration	of	0.1%	(w/v).	Cultures	there	then	incubated	for	a	further	4	hours	at	
37°C	or	30°C	to	allow	protein	synthesis	from	the	induced	expression	plasmids.	200	
µL	aliquots	of	 the	uninduced	and	 induced	samples	were	 taken	and	centrifuged	at	
16,000	x	g	to	isolate	the	bacteria.	The	pellet	was	then	resuspended	in	50	µL	of	2X	
SDS-PAGE	 sample	 buffer	 (250	 mM	 Tris-HCl,	 10%	 SDS,	 20%	 glycerol,	 10%	 β-
mercaptoethanol,	0.01%	bromophenol	blue)	and	boiled	for	10	minutes	to	lyse	the	





former	 being	 the	 ideal	 form.	 To	 determine	 the	 solubility	 of	 an	 overproduced	
protein	of	interest,	50	mL	BHI	was	inoculated,	grown	and	protein	synthesis	induced	
as	 Section	 2.3.1	 with	 minor	 alterations.	 Rather	 than	 dividing	 the	 culture	 before	
induction,	 a	 200	 µL	 aliquot	 of	 the	 culture	 was	 taken	 and	 the	 remaining	 culture	
induced	with	1	mM	IPTG.	After	induction,	the	culture	was	pelleted	by	centrifugation	
at	 3,500	 x	 g,	 the	 supernatant	 removed	 and	 cells	 resuspended	 in	 25	mL	 of	 wash	
buffer	 (25	mM	Tris-HCl	 (pH	7.5),	 150	mM	NaCl,	 and	2mM	EDTA).	 The	 suspension	
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was	 centrifuged	 again	 and	 the	 supernatant	 removed.	 The	 bacterial	 pellet	 was	
weighed	and	then	frozen	at	-20°C	overnight.	After	thawing	on	 ice,	5	mL	per	1g	of	
bacterial	pellet	of	lysis	buffer	(50	mM	Tris-HCl	(pH	8.0),	2	mM	EDTA,	200	mM	NaCl,	
and	 5%	 glycerol)	 was	 used	 to	 resuspend	 the	 cells.	 A	 fresh	 stock	 solution	 of	 10	
mg/mL	 lysozyme	 (Sigma)	was	made	 up	 in	 ddH2O	 and	 added	 to	 the	 resuspended	
pellet	 to	a	give	a	 final	concentration	200	µg/mL	and	 incubated	at	4°C	on	a	rolling	
mixer	 for	 30	 minutes.	 A	 fresh	 stock	 of	 serine	 protease	 inhibitor	 was	 made	 by	
dissolving	 25	 mg/mL,	 phenylmethylsulfonyl	 fluoride	 (PMSF)	 (Applichem)	 in	 100%	
ethanol,	 and	 added	 to	 the	 bacterial	 cells	 at	 a	 final	 concentration	 of	 25	 µg/mL.	
Freshly	 prepared	 sodium	 deoxycholate	 (Sigma),	 at	 a	 final	 concentration	 of	 500	
µg/mL,	was	 added	 to	 the	 lysing	 cells,	 and	mixed	 for	 a	 further	30	minutes	 at	 4°C.	
Sonication	 was	 then	 performed	 on	 the	 cell	 suspension	 using	 a	 SONICS	 Vibracell	
VCX750	Ultrasonic	Cell	Disrupter	with	a	micro-tip	probe.	This	was	performed	at	an	
amplitude	of	 22%	 in	30-second	bursts,	 followed	by	 a	 2-minute	 incubation	on	 ice,	









the	 insoluble	 pellet	 fraction.	 Uninduced	 and	 induced	 whole	 cell	 samples,	 total,	
soluble	 and	 insoluble	 samples	 were	 analysed	 by	 SDS-PAGE	 (Section	 2.5.2).	







To	 produce	 greater	 quantities	 of	 recombinant	 protein	 for	 purification	 by	
nickel	affinity	chromatography,	500	mL	to	1	L	cultures	were	 induced	and	samples	
lysed	as	described	in	Section	2.3.2	with	minor	alterations.	EDTA	was	omitted	from	
the	 lysis	 buffer	 and	 replaced	 with	 10	 mM	 imidazole	 (Fisher	 Scientific).	 After	
clarification	of	the	 lysate	by	centrifugation	the	supernatant	containing	the	soluble	
overproduced	 recombinant	 proteins	 was	 ready	 to	 be	 subjected	 to	 nickel	 affinity	
chromatography	(Section	2.3.4	and	2.3.5).		
	
2.3.4 Small-scale	 nickel	 affinity	 chromatography	 using	 a	 batch	
chromatography	method	
For	 small-scale	 nickel	 affinity	 purification	 a	 batch	 chromatograph	
methodology	was	undertaken	as	follows.	100	µL	charged	His-Buster	Nickel	Affinity	
Gel	 (Amocol	 Bioprocedure)	 was	 aliquoted	 into	 a	 micro-centrifuge	 tube	 and	
centrifuged	 at	 700	 x	 g	 for	 1	 minute	 to	 isolate	 the	 resin,	 the	 supernatant	 was	
discarded.	 The	 resin	 was	 then	 resuspended	 in	 500	 µL	 ddH2O	 to	 wash	 the	 resin,	




gently	 resuspended.	The	 resin	and	 lysate	suspension	was	 then	 incubated	at	 room	
temperature	with	inversion	on	a	rotary	mixer	(22rpm)	for	30	minutes	to	allow	the	
His-tagged	 proteins	 to	 bind	 to	 the	 nickel	 resin.	 After	 incubation,	 the	 resin	 was	
pelleted	by	centrifugation	and	the	supernatant	removed	and	retained	as	the	flow-
through	 sample.	 To	 wash	 the	 resin	 to	 remove	 non-specifically	 bound	 proteins	
500µL	 of	 the	 appropriate	 wash	 buffer	 (50mM	 Tris-HCl	 (pH	 8.0),	 200mM	 NaCl,	
10mM	imidazole	and	5%	glycerol	as	standard)	was	added	to	the	resin	and	vortexed.	
This	was	 followed	by	 centrifugation.	 The	 supernatant	was	 removed	and	 retained.	
This	process	was	repeated	twice	more.		




of	 the	 Histidine-Ni2+	 complex	 with	 an	 excess	 of	 imidazole	 acting	 as	 a	 metal	 ion	
ligand	 for	 the	Ni2+,	 by	 the	 addition	 of	 200	µL	 elution	 buffer	 (50	mM	Tris-HCl	 (pH	
8.0),	 200	 mM	 NaCl,	 ≥150mM	 imidazole,	 5%	 glycerol).	 This	 was	 followed	 by	
incubation	 at	 room	 temperature	 with	 inversion	 for	 30	 minutes.	 An	 alternative	
method	 for	 elution	 was	 to	 re-suspend	 the	 resin	 directly	 in	 100	 µL	 2X	 SDS-PAGE	
sample	buffer	and	boil	at	100°C	for	5	minutes	in	a	heat	block.	This	resin-SDS-PAGE	




2.3.5 Large-scale	 nickel	 affinity	 chromatography	 using	 a	 FPLC	 protein	
purification	system	
For	 large-scale	 His-tagged	 protein	 purification	 the	 following	 protocol	 was	
undertaken.	A	 charged	1	mL	HisTrap	HP	pre-packed	nickel	 sepharose	 column	 (GE	
Healthcare)	was	manually	washed	with	 10	mL	 ddH2O	 using	 a	 syringe	 and	 female	
connector,	at	a	flow	rate	of	1	mL/minute,	ensuring	not	to	introduce	air	bubbles	into	








The	 loaded	 HisTrap	 column	 was	 attached	 to	 an	 ÄKTA	 purifier	 10	 FLPC	
purification	 system	 (GE	 Healthcare)	 controlled	 by	 UNICORN	 control	 software	 (GE	
Healthcare).	The	ÄKTA	purifier	was	pre-equilibrated	with	a	low	imidazole	buffer	(50	
mM	Tris-HCl	(pH	8.0),	200	mM	NaCl,	10	mM	imidazole	and	5%	glycerol)	in	pump	A	






fractions	where	 collected	 in	 1mL	 aliquots	 automatically	 using	 a	 fraction	 collector	
Frac-950	 (GE	 Healthcare).	 UV	 absorption	 at	 280	 nm	 (A280)	 of	 the	 flow	 path	 was	
monitored	by	a	Monitor	UV-900	(GE	healthcare)	to	act	as	a	guide	to	identify	which	




For	proteins	 that	had	 to	be	purified	under	denaturing	 conditions,	 e.g.	His-
tagged	 proteins	 purified	 away	 from	 a	 protein-protein	 complex,	 the	 protocol	











their	molecular	 size	and	allows	 the	estimation	of	 the	molecular	weight	 (M.W.)	of	
proteins	 when	 calibrated	 with	 molecular	 standards.	 For	 separation	 of	 molecular	
weights	 from	 1000	 to	 300000	 a	 Superose	 12	 10/300	 GL	 pre-packed	 column	 (GE	
Healthcare)	 was	 employed,	 and	 for	 separation	 between	 5000	 and	 5000000	 a	
Superose	 6	 HR	 10/300	 GL	 pre-packed	 column	 (GE	 Healthcare)	 was	 used.	 Both	














calibration	 kit	 (GE	 Healthcare)	 as	 manufacturer’s	 instructions	 with	 alterations.	
Briefly,	 standards	were	 combined	 and	 dissolved	 in	 1	mL	 equilibration	 buffer	 at	 a	
concentration	of	1	mg/mL.	This	sample	was	further	concentrated	into	500	µL	using	
a	 10000	 MWCO	 Amicon	 Ultra-4	 centrifugal	 filter	 unit	 (Millipore).	 100	 µL	 of	 the	
sample	was	injected	onto	the	equilibrated	Superose	column	and	UV	absorbance	of	
eluates	monitored	 to	determine	 the	elution	volume	 (Ve)	after	 injection	 for	all	 the	
standards.	 This	was	 repeated	 to	 give	 an	 average	Ve	 for	 each	 standard.	 100	µL	 of	
Blue	 Dextran	 2000	 (1	 mg/mL)	 was	 injected	 onto	 the	 column	 to	 determine	 the	
column	void	volume	(Vo).	This	data	was	then	used	to	calculate	the	Kav	value	for	each	
standard	 using	 the	 equation	 Kav	 =	 (Ve-Vo)/(Vc-Vo),	 where	 Vc	 =	 geometric	 column	
volume.	 A	 calibration	 curve	 was	 then	 generated	 by	 plotting	 Kav	 values	 (x	 axis)	
against	 relative	molecular	mass	 (Mr)	 (y	 axis)	on	a	 log	 scale.	A	 semi-log	 regression	
curve	 was	 fitted	 to	 the	 data	 points	 using	 GraphPad	 Prism,	 resulting	 in	 a	 line	
equation	of	y=10^(mx	+	c),	where	m	equals	the	gradient	of	the	 line	and	c	 is	the	y	
intercept.	 The	 average	 elution	 volume	 (Ve)	 of	 a	 protein	 of	 interest	 was	







exchanged	by	dialysis	 against	 a	more	 suitable	buffer	 (50	mM	Tris-HCl	 (pH	8.0)	 as	


































To	extract	proteins	present	 in	 the	 liquid	 culture	 supernatant,	 15-40	mL	D-
BHI	broth	was	inoculated	with	an	overnight	culture	to	give	an	initial	starting	OD600	
0.03	 and	 incubated	 at	 37°C	 with	 shaking	 until	 an	 OD600	 of	 ~1.0	 was	 reached.	
Cultures	were	 centrifuged	 at	 3,400	 x	g	 in	 an	Allegra	 X-22R	benchtop	 refrigerated	
centrifuge	for	20	minutes	at	4°C	to	harvest	the	bacteria.	The	supernatant	was	then	
filter	 sterilised	 through	 a	 0.22	 µm	 syringe	 driven	 filter	 unit	 (Millipore).	 Proteins	
present	in	the	supernatant	were	precipitated	by	DOC-TCA	(Section	2.4.3).		








protocol	 was	 carried	 out.	 Sterile	 dialysis	 membranes	 were	 prepared	 by	 cutting	




37°C	until	OD600	 of	 0.5.	A	 sterile	 dialysis	membrane	was	placed	onto	 a	 LB	or	BHI	
agar	 plate	 and	 100	 µL	 of	 the	 culture	 spread	 over	 it	 using	 a	 p200	 tip.	 The	 plates	
where	 then	 incubated	 at	 37°C	 for	 16	 hours.	 After	 incubation,	 the	 dialysis	
membrane	was	removed,	transferred	into	a	universal	tube	containing	1	mL	sterile	
PBS,	and	gently	vortex	to	resuspend	the	bacteria.	Cultures	where	then	centrifuged	
for	 10	 minutes	 at	 3,400	 x	 g	 to	 isolate	 the	 bacteria.	 Culture	 supernatants	 were	






protocol	 was	 employed,	 according	 to	 Bensadoun	 and	 Weinstein	 (1976),	 with	
alternations.	A	20	mg/mL	 sodium	deoxycholate	 (DOC)	 (Sigma)	 solution	was	made	
up	in	ddH2O,	added	to	the	filter	sterilised	supernatant	at	a	final	concentration	0.2	
mg/mL	 and	 chilled	 on	 ice	 for	 30	minutes.	 100%	 chilled	 trichloroacetic	 acid	 (TCA)	
solution	 (w/v)	 (Sigma)	 was	 added	 to	 a	 final	 concentration	 of	 10%	 (v/v)	 and	 the	
solution	was	 incubated	at	 -20°C	overnight.	 For	 large	 volumes	of	 supernatant,	 the	
frozen	 supernatant-DOC-TCA-solution	was	 thawed	 on	 ice	 and	 aliquoted	 into	 four	
1.5	mL	microcentrifuge	tubes.	Proteins	were	pelleted	by	centrifugation	at	18,000	x	
g	 for	 10	 minutes	 at	 4°C	 in	 a	 Universal	 320R	 refrigerated	 benchtop	 centrifuge	
(Hettich).	 The	 supernatant	 was	 carefully	 removed.	 This	 process	 was	 repeated	
several	 times	using	 the	 same	microcentrifuge	 tubes	 to	 process	 the	 entire	 sample	





the	 initial	 culture	 supernatant	volume	 (e.g.	20	µL	 for	20	mL	culture	 supernatant).	

















instructions,	 with	 minor	 alterations.	 Briefly,	 1.0	 mg/mL	 to	 0.2	 mg/mL	 protein	
standards	were	made	using	a	10	mg/mL	BSA	stock	solution	(Promega)	diluted	in	an	
appropriate	 buffer	 (e.g.	 50	 mM	 Tris-HCl	 pH	 8.0).	 The	 protein	 sample	 to	 be	
quantified	was	 also	diluted	 in	 appropriate	buffer,	 at	 1:1,	 or	 1:3	dilution	 in	 a	 final	
volume	 of	 50	 µL.	 1	 part	 protein	 assay	 dye	 reagent	 concentrate	 (Bio-Rad)	 was	




room	 temperature.	 Absorbance	 at	 595nm	 (OD595)	 was	 measured	 using	 a	
spectrophotometer	blanked	with	1	mL	diluted	protein	dye	reagent.	Protein	samples	
with	 an	 OD595	 over	 the	 range	 of	 the	 spectrophotometer	 (>0.9)	 where	 further	
diluted	 and	 re-tested	 with	 fresh	 reagent.	 	 A	 standard	 curve	 was	 generated	 by	
plotting	the	average	absorbance	obtained	from	the	protein	standards	against	their	
protein	 concentration	 (in	 mg/mL).	 Using	 this	 standard	 curve,	 the	 protein	
concentration	 of	 the	 unknown	 sample	 was	 then	 estimated	 using	 the	 average	





	 An	 appropriate	 percentage	 Tris-glycine	 SDS-PAGE	 gel	 (0.75	 mm,	 10-well)	
was	 cast	 (typically	 15%)	 as	 standard	 protocol	 (Laemmli,	 1970)	 using	 a	 Mini-
PROTEAN-II	 or	 Tetra	 Cell	 system	 (Bio-Rad)	 with	 30%	 acrylamide/Bis-acrylamide	
solution	 (Fisher).	 For	 sample	 loading,	 an	 equal	 volume	 of	 2X	 SDS-PAGE	 sample	




minutes	 to	 denature	 the	 proteins,	 and	 then	 centrifuged	 at	 16,000	 x	 g	 for	 10	
minutes.	Samples	were	then	loaded	onto	the	gel	and	run	at	120V	for	1-1.5	hours	in	
Tris-glycine	SDS-PAGE	running	buffer	(25	mM	Tris,	192	mM	Glycine,	0.1%	SDS).	5	µL	
E.Z-Run	 unstained/pre-stained	 Rec	 protein	 ladder	 (Fisher)	 was	 also	 loaded	 as	 a	
protein	marker.	 Gels	were	 then	 stained	with	 Coomassie	 blue	 solution	 (50%	 (v/v)	
methanol,	 10%	 (v/v)	 acetic	 acid,	 2.5	 g/L	 Coomassie	 Brilliant	 Blue	 R-250)	 and	





	 SDS-PAGE	 gels	 were	 electro-blotted	 onto	 0.45	 µm	 PVDF	 membranes	
(Millipore),	using	a	Mini-trans	blot	cell	(BioRad),	at	100	V	for	1	hour	or	overnight	at	
30	V	according	to	manufacturer’s	instructions	or	using	a	Trans-Blot	Turbo	semi	dry	




powder	 (Marvel,	Premier	 foods)	 in	TBS-Tween	(TBS-T)	 (137	mM	NaCl,	25	mM	Tris	
base	and	3	mM	KCl,	0.05%	Tween-20,	pH	8.0)	for	1	hour	at	room	temperature.	The	
membrane	was	then	incubated	with	the	appropriate	primary	antibody	diluted	in	5	
mL	 blocking	 solution	 at	 4°C	 overnight	 on	 a	 rolling	 mixer,	 or	 2	 hours	 at	 room	
temperature.	The	membrane	were	subjected	to	three	10-minute	washes	 in	TBS-T,	
and	 then	 incubated	 for	 1	 hour	 at	 room	 temperature	 with	 an	 appropriate	 HRP-
conjugated	secondary	antibody	diluted	in	5	mL	blocking	solution.	This	was	followed	
by	 three	 10-minute	 washes	 in	 TBS-T,	 and	 a	 final	 wash	 in	 TBS.	 Detection	 of	
horseradish	 peroxidase	 (HRP)	 activity	was	 achieved	 by	 the	 addition	 of	 a	 luminol-
based	 enhanced	 chemiluminescence	 substrate,	 EZ-ECL	 (Biological	 Industries),	 as	











University	 of	 Sheffield.	 This	 protocol	 involved	 4	 intravenous	 injections	 of	 the	
antigen,	 with	 antibody	 titre	 of	 the	 immunised	 rats	 determined	 after	 the	 third	
antigen	injection.	
2.5.4.2 Analysis	of	antibody	titre	
	 Sample	 bleeds	 were	 taken	 from	 immunised	 rats	 after	 a	 third	 antigen	
injection	 to	 determine	 the	 antibody	 titre.	Western	 blotting	was	 used	 to	 estimate	
























































	 First,	 DOC-TCA	 precipitated	 proteins	 from	 culture	 supernatants	 were	
resuspended	in	solubilisation	buffer	containing	PBS,	0.05%	(w/v)	SDS	and	0.1%	(v/v)	
Triton	 X-100	 (Section	 2.4.1	 and	 2.4.3)	 and	 then	 transferred	 to	 Lo-bind	
microcentrifuge	 tubes	 (Eppendorf).	 Samples	 were	 reduced	 by	 the	 addition	 of	 50	
mM	 tris(2-carboxyethyl)	 phosphine	 (TCEP)	 to	 give	 a	 final	 concentration	 of	 5	mM	
and	 heated	 at	 65°C	 for	 1	 hour.	 Following	 this,	 200	 mM	 methyl	
methanethiosulfonate	 (MMTS)	was	added	 to	give	a	 final	 concentration	of	10	mM	
and	 incubated	 for	 10	mins	 at	 room	 temperature	 to	 alkylate	 the	 samples.	 Trypsin	
(MS	 grade,	 Sigma)	was	 then	 added	 to	 the	 samples	 at	 a	 1:25	 ratio	 and	 incubated	
overnight	at	room	temperature	to	digest	the	proteins	 into	peptides.	The	resulting	
peptides	 were	 dried	 using	 a	 vacuum	 concentrator	 (Eppendorf)	 and	 then	




	 Due	 to	 incompatible	 of	 the	 sample	 from	 Section	 2.6.1	 with	 mass	 spec	
analysis,	 the	 samples	 were	 subjected	 to	 detergent	 removal	 using	 a	 HiPPR™	
Detergent	 Removal	 Spin	 Column	 Kit	 (Thermo	 Fisher	 Scientific)	 as	 manufacturer’s	
instructions.	HiPPR™	Detergent	Removal	resin,	0.8	mL	spin	columns	provided	in	the	






dried	 after	 detergent	 removal,	 resuspended	 in	 100	 µL	 of	 buffer	 C	 (3%	 (v/v)	
acetonitrile,	 0.1%	 (v/v)	 trifluoroacetic	 acid	 (TFA)	 in	 HPLC	 grade	 H2O)	 and	 then	
subjected	 to	 C18	 resin	 clean	 up.	 To	 do	 this,	 a	 C18	 spin	 tip	 was	 fitted	 to	 a	 2mL	
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collection	 tube	 and	 conditioned	 by	 the	 addition	 of	 100	 µL	 100%	 acetonitrile	
(Sigma).	The	spin	tip	and	collection	tube	assembly	was	centrifuged	at	1000	x	g	for	
30	 seconds	 and	 the	 flow-through	discarded.	 100	µL	of	HPLC	 grade	H2O	was	 then	
added	to	the	spin	tip,	span	as	before	and	the	flow-through	discarded.	The	tip	was	
then	equilibrated	with	the	addition	of	100	µL	buffer	C,	centrifuged	and	the	resulting	






before	 and	 the	 flow-through	discarded.	 This	was	 repeated	 thrice	more.	After	 the	
final	 wash	 step	 peptides	 were	 eluted	 by	 the	 addition	 of	 100	 µL	 buffer	 B	 (97%	
acetonitrile,	 0.1%	 formic	 acid	 in	 HPLC	 grade	H2O),	 and	 centrifuged	 as	 above	 into	
clean	 Lo-Bind	 microcentrifuge	 tubes.	 Samples	 where	 then	 subjected	 to	

















The	 following	 pull-down	 assay	 is	 based	 on	 the	 principle	 of	 immobilising	 a	
His-tagged	‘bait’	protein	onto	a	nickel	matrix,	adding	a	labelled	‘prey’	protein	which	
is	 thought	 to	 interact	 with	 the	 bait	 protein,	 and	 then	 elution	 of	 the	 His-tagged	
protein	 from	 the	matrix.	 If	 the	 two	proteins	 interact	 to	 form	a	 complex	 then	 the	




separate	 overproduction	 of	 the	 two	 proteins	 of	 interest	 and	 then	 sequential	
addition	of	the	lysates	to	the	affinity	resin.	The	protocol	used	in	each	method	was	
based	 on	 the	 ‘small-scale	 batch	 chromatography	 method’	 (Section	 2.3.4),	 with	
minor	alterations.	For	co-production	lysates,	the	lysate	was	bound	to	nickel	affinity	
resin,	washed	 and	 eluted	 as	 standard	 procedure	 (Section	 2.3.4).	 For	 the	 classical	
pull-down	method,	 the	His-tagged	bait	 protein	was	 immobilised	onto	nickel	 resin	
and	washed	as	Section	2.3.4.	Following	this,	100	µL	of	lysate	containing	the	tagged-
prey	 protein	 (either	 FLAG	 or	 3xFLAG	 epitopes)	 was	 then	 added	 to	 the	 resin	
containing	 the	 immobilised	 bait	 protein	 and	 subjected	 to	 gentle	 inversion	 on	 a	
rotary	mixer	(at	22rpm)	for	30	minutes	at	room	temperature.	The	sample	was	then	
centrifuged	 at	 700	 x	 g	 for	 1	 minute	 to	 isolate	 the	 resin.	 The	 supernatant	 was	
removed	 and	 retained	 as	 flow-through.	 The	 resin	 was	 then	 washed	with	 500	µL	
wash	 buffer	 (50mM	 Tris-HCl	 (pH	 8.0),	 200mM	 NaCl,	 10mM	 imidazole	 and	 5%	
glycerol),	 span	 down	 to	 collect	 the	 resin	 and	 the	 supernatant	 removed	 and	
retained.	This	processed	was	repeated	twice	more.	After	the	final	wash	step	bound	
proteins	were	eluted	as	described	in	Section	2.3.4	by	the	addition	of	elution	buffer	
containing	 150-500	 mM	 imidazole.	 A	 negative	 control	 reaction	 was	 undertaken	
where	the	prey	protein	was	incubated	with	resin	that	did	not	contain	immobilised	
bait	 protein.	 This	 was	 to	 ensure	 that	 the	 prey	 protein	 was	 unable	 to	 bind	 non-




All	 samples	 including	 the	 load,	 flow-through,	 wash	 and	 imidazole	 elution	
samples	were	combined	with	2X	SDS-loading	buffer	and	subjected	to	SDS-PAGE	on	






The	 bacterial	 adenylate	 cyclase	 two-hybrid	 system	 (BACTH)	 (Euromedex)	
allows	analysis	of	protein-protein	 interactions	 in	 vivo.	 This	method	 is	 based	upon	
restoration	of	adenylate	cyclase	activity	(cyclic	AMP	(cAMP)	production	from	ATP)	
in	 a	 ΔcyaA	 E.	 coli	 strain	 by	 the	 formation	 of	 an	 active	 adenylate	 cyclase	 domain	
from	 Bordetella	 pertussis	 (CyaA).	 This	 occurs	 by	 a	 interaction	 between	 the	
complementary	T25	and	T18	fragments	of	CyaA	(Karimova	et	al.,	1998).	The	coding	
sequencing	 of	 the	 genes	 that	 encode	 the	 proteins	 of	 interest	 (i.e.	 that	 are	
hypothesised	to	interact)	are	fused	to	the	C-	or	N-terminus	of	coding	sequences	of	
T25	and	T18	 fragments	by	cloning	 into	 the	BACTH	vectors	pUT18,	pUT18C,	pKT25	
and	pKNT25.	If	the	hybrid	fusion	proteins	interact,	the	T25	and	T18	fragments	are	
brought	together,	restoring	activity	of	CyaA.	This	results	in	cAMP	production.	cAMP	
can	 then	go	on	 to	 form	a	 complex	with	dimeric	CRP,	 the	 cAMP	 receptor	protein.	
This	complex	acts	as	an	activator	of	gene	transcription,	 including	the	activation	of	









give	100-200	CFU	per	plate.	 	The	plates	were	 incubated	at	30°C	 for	up	 to	7	days,	
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and	 colony	 colour	 monitored	 for	 Mal+	 phenotype	 (purple	 appearance)	 after	 72	
hours.	 A	 positive	 control	 was	 included	which	 involved	 co-introducing	 pUT18C-zip	




































To	 analyse	 DNase	 activity	 of	 recombinant	 proteins	 DNA	 substrate	
zymography	 was	 performed	 as	 follows.	 Protein	 samples	 were	 combined	 with	 an	
equal	 volume	 of	 2X	 SDS-PAGE	 sample	 buffer	 without	 β-mercaptoethanol,	 and	
loaded	directly	onto	a	DNA	substrate	gel.	This	gel	was	made	by	co-polymerising	12-
15%	 SDS-polyacrylamide	 with	 30	 μg/mL	 sheared	 salmon	 testis	 DNA	 (Fluka).		
Samples	were	not	subject	 to	heat	treatment	prior	 to	 loading.	Sample	were	run	at	
120	 V	 for	 ~1.5	 hours.	 After	 separation,	 the	 gel	 was	 washed	 in	 wash	 buffer	
containing	 40	 mM	 Tris-HCl,	 pH	 7.6	 for	 30	 minutes	 with	 agitation	 at	 room	
temperature	 to	 help	 remove	 SDS.	 	 The	 gel	 was	 then	 incubated	 in	 renaturation	
buffer	(50	mM	Tris-HCl,	pH	7.5,	5	mM	MgCl2,	and	20%	2-propanol)	for	1	hour	with	
gentle	 rocking	 at	 room	 temperature,	 with	 two	 changes	 of	 buffer.	 The	 gel	 was	
transferred	to	a	reaction	buffer	(50	mM	Tris-HCl,	pH	7.5,	5	mM	MgCl2,	2	mM	CaCl2,	
and	0.1%	Triton	X-100)	and	incubated	at	37°C	for	2	hours.		The	buffer	was	removed	
and	 replaced	 with	 reaction	 buffer	 containing	 ethidium	 bromide	 at	 a	 final	





following	was	undertaken.	 100	ng	of	 supercoiled	plasmid	DNA	 (pBluescriptII)	was	
incubated	with	2	µL	of	purified	enzyme	in	a	reaction	buffer	containing	10	mM	Tris-
HCl	(pH	7.5)	with	or	without	2.5	mM	MgCl2,	0.5	mM	CaCl2	in	total	reaction	volume	
of	 10	 µL.	 The	 ability	 of	 EDTA	 to	 act	 as	 an	 inhibitor	 of	 DNase	 activity	 was	 also	
performed	 by	 addition	 of	 20	mM	 EDTA	 to	 the	 reaction	 buffer.	 Control	 reactions	
were	included	to	test	the	DNase	activity	of	the	enzyme	in	each	buffer	component	
separately,	 and	 a	 negative	 reaction	 lacking	 the	 addition	 of	 the	 enzyme.	 DNase	 I	
(Qiagen)	 was	 used	 as	 a	 positive	 control	 to	 demonstrate	 degradation	 of	 DNA	 in	




































each	 culture.	 An	 aliquot	 of	 each	 strain	was	 taken	 and	 normalised	 to	 give	 a	 1	mL	
bacterial	suspension	of	OD600	of	0.5.	Bacterial	suspensions	were	combined	in	a	5:1	
ratio	of	predator:prey	in	a	total	volume	of	60	µL.	For	example,	50	µL	B.	cenocepacia	
was	 combined	 with	 10µL	 P.	 putida.	 Monoculture	 controls	 of	 prey	 and	 predator	
strains	were	also	included	by	combining	cultures	with	sterile	LB	in	the	appropriate	
ratio,	 e.g.	 50µL	 sterile	 LB	 to	10µL	P.	putida.	 25	µL	of	 each	 co-culture	 and	 control	
culture	were	then	spread	over	a	0.45	µm	nitrocellulose	filter	membrane	placed	on	a	
pre-warmed	LB	agar	plate,	 left	to	soak	 in	and	then	 incubated	at	30°C	for	4	hours.		





the	 surface	 viable	 count	 method	 (Miles	 et	 al.,	 1938).	 Plates	 were	 incubated	 at	
either	37°C	or	30°C	overnight,	dependent	on	the	strain.	The	number	of	viable	CFU	




	 To	 determine	whether	 ectopic	 production	 of	 a	 candidate	 effector	 protein	
had	a	detrimental	effect	on	the	culture	the	following	protocol	was	undertaken.	For	
periplasmic	ectopic	overproduction	from	pET-22b(+)	based	vectors,	plasmids	were	
first	 introduced	 into	 E.	 coli	 BL21(DE3)/pLysS.	 A	 single	 colony	 was	 then	 used	 to	






removed	 and	 1	 mL	 fresh	 sterile	 BHI	 was	 used	 to	 resuspend	 the	 bacteria.	 The	
resulting	 bacterial	 suspension	 was	 then	 used	 to	 inoculate	 8	 mL	 of	 BHI-broth	
containing	500	µg/mL	carbenicillin	and	25	µg/mL	chloramphenicol	to	give	an	OD600	
of	0.03,	in	duplicate.	Cultures	were	then	grown	at	37°C	with	shaking	until	an	OD600	
of	~0.8.	One	of	 the	duplicate	cultures	was	 then	 induced	by	 the	addition	of	1	mM	
IPTG	 (final	 concentration),	 whilst	 the	 other	 remained	 uninduced.	 Both	 cultures	




	 The	 resulting	 culture	 optical	 densities	 measured	 over	 the	 course	 of	 the	
induction	 (from	 time	 0	 when	 the	 induced	 was	 added)	 were	 compared	 between	
uninduced	and	induced	samples	and	between	wild-type	and	a	catalytically	inactive	
mutant.	 Data	 was	 represented	 as	 a	 line	 chart,	 plotting	 the	 OD600	 value	 (y	 axis)	
against	the	time	after	induction	that	the	value	was	taken	(x	axis).	
Induced	 and	 uninduced	 samples	 were	 also	 subjected	 to	 SDS-PAGE	 and	
western	blot	analysis	to	verify	protein	production.	
For	 co-expression	 experiments	 using	 pET-22b(+)	 and	 pSCrhaB2	 derived	














2010).	 Briefly,	 a	 plasmid	 encoding	 DsRed,	 pIN29,	 was	 transferred	 into	 B.	
cenocepacia	strains	by	electroporation	(Section	2.2.16).	Bacteria	were	then	grown	
overnight	 in	LB	containing	 the	appropriate	antibiotics.	 In	preparation	 for	 injection	
into	 embryos,	 overnight	 bacterial	 cultures	 were	 harvested	 by	 centrifugation,	
resuspended	 in	 PBS	 and	 diluted	 to	 give	 approximate	 bacterial	 concentration	 of	
5x107	 CFU/mL.	 30	 hours	 post-fertilisation	 zebrafish	 embryos	were	 dechorionated	
and	 anesthetized	 in	 E3	 medium	 with	 0.02%	 buffered	 tricaine	 methanesulfonate	
(MS222,	Sigma)	ready	for	infection.	Embryos	were	then	microinjected	with	200-300	
CFU	of	DsRed-labelled	bacteria	directly	into	the	blood	circulation	and	maintained	in	
E3	medium	 at	 28°C	 for	 48	 hours.	 20	 embryos	 were	 infected	 per	 bacterial	 strain	
tested	and	the	experiment	performed	in	duplicate.	Embryo	survival	was	monitored	
at	 regular	 intervals,	 were	 dead	 embryos	 scored	 as	 those	 without	 a	 heartbeat.	
Percentage	embryo	survival	was	then	represented	using	a	Kaplan-Meier	plot.			
	 Bacterial	replication	within	the	embryos	was	assayed	by	injection	of	bacteria	
as	described	above.	5	 infected	embryos	per	 treatment	group	were	 taken	at	0,	24	
and	48	hours	post-infection	and	subjected	to	bacterial	enumeration	as	described	in	
(Vergunst	et	al.,	2010).	Briefly,	individual	embryos	were	washed	in	1	mL	sterile	PBS	




PBS)	was	added	 to	give	a	 final	 conc.	1%	Triton	X-10	and	 left	 to	 incubate	at	 room	
temperature	 for	20	minutes.	This	was	 then	 followed	by	 repeated	pipetting.	Serial	
dilutions	were	made	of	the	resulting	suspensions	in	PBS.	Bacteria	were	enumerated	
by	 spotting	 10	µL	 of	 each	 dilution	 in	 triplicate	 on	 LB	 agar	 containing	 100	µg/mL	
chloramphenicol	using	 the	surface	viable	count	method	described	 in	 (Miles	et	al.,	








UK	 and	 maintained	 at	 4°C	 before	 infection.	 	 For	 preparation	 of	 bacteria	 for	
injection,	 B.	 cenocepacia	 K56-2	 strains	 were	 cultured	 from	 -80°C	 glycerol	 stocks	
onto	 BHI	 agar.	 A	 single	 colony	 was	 then	 used	 to	 inoculate	 5	 mL	 BHI-broth	 and	
incubated	at	37°C	with	 shaking	 for	~5-6	hours	until	 an	OD600	of	0.6	was	 reached.	
The	bacteria	were	 centrifuged	at	 5000	 x	g	 for	 2	mins	 and	 resuspended	 in	PBS	 to	
give	an	approx.	OD600	of	0.5,	equating	to	approximately	4x108	CFU/mL.		
	 For	 optimization	 of	 bacterial	 dosage,	 serial	 dilutions	 of	 the	 bacteria	 were	
made	 in	 PBS	 to	 give	 of	 4x106	 to	 4x102	 CFU/mL.	 10	µL	 of	 each	 dilution	was	 then	
injected	 into	 the	hindmost	 left	proleg	of	 the	 larva	using	a	25	µL	Hamilton	syringe	
(702N	series,	 22s	gauge	 fixed	needle,	point	 style	2)	or	 semi-automatically	using	a	
PB-600-1	 Repeating	 Dispenser	(Hamilton)	 affix	 to	 a	 Gastight	 500	 µL	 Hamilton	
syringe	(Model	1750	RN	(large	hub)	SYR,	with	a	22	gauge,	large	hub	RN	NDL,	2	inch,	
point	 style	 2	 needle).	 20	 larvae	 were	 infected	 per	 treatment	 group.	 Control	
treatment	 groups	 were	 injected	 with	 10	 µL	 of	 sterile	 PBS,	 or	 10	 µL	 heat	 killed	
bacteria	 (the	 lowest	 dilution	 of	 the	 bacterial	 culture	 used	 boiled	 at	 100°C	 for	 10	
minutes).	 An	 additional	 group	 of	 larvae	 were	 left	 untreated.	 Larvae	 where	
incubated	at	37°C	for	48	hours	in	sterile	plastic	petri	dishes	lined	with	filter	paper	
discs.	The	numbers	of	alive/dead	larvae	were	assessed	for	each	treatment	group	at	
18,	 24,	 40	 and	 48	 hours	 post-treatment.	 Dead	 larvae	were	 classed	 as	 those	 that	




minor	 alterations.	 30	 larvae	 per	 treatment	 group	 were	 infected	 with	 4x104	 and	
4x102	 CFU/larvae	 of	 wild-type	 or	mutant	 strains,	 separately.	 	 Larval	 survival	 was	
	
	128
monitor	 from	16	hours	 to	26	hours	post-infection	at	2-hour	 intervals.	 Percentage	
larval	survival	after	infection	was	represented	as	a	line	chart.	
	 To	 approximate	 the	 initial	 bacterial	 load	 100	 to	 10-8	 serial	 dilutions	 were	
made	 from	 each	 bacterial	 suspension	 used.	 10	 µL	 of	 each	 dilution	 were	 then	
spotted	onto	LB	agar	contain	10	µg/mL	 tetracycline	 in	 triplicate	using	 the	surface	
viability	method	(Miles	et	al.,	1938).	A	10	µL	spot	of	heat-killed	bacterial	suspension	
was	also	plated	to	verify	the	effectiveness	of	heat	killing	of	the	control.	Plates	were	




























































































































Many	 T6SS-containing	 bacteria	 have	 multiple	 T6SSs	 encoded	 within	 their	
genome,	 including	some	of	 the	Burkholderia	 species.	B.	pseudomallei	 for	example	
has	 six	 T6SS	 clusters	 (Shalom	et	 al.,	 2007)	while	B.	 lata	 has	 three	 (M.	 S.	 Thomas,	
personal	 communication).	 However,	 most	 members	 of	 the	 Bcc,	 including	




genomes	 sequences	 are	 available,	 T6SS-1	 (when	 present)	 is	 located	 on	




the	 BCAL0337-BCAL0353	 locus,	 and	 the	 T6SS-1	 homologous	 cluster	 in	 B.	
cenocepacia	H111	is	similarly	located	on	chromosome	1	at	the		I35_0328-I35_0344	
locus.	 This	 ancestral	 cluster	 has	 a	 similar	 genetic	 organisation	 in	 not	 only	 the	
Burkholderia	 spp.,	 but	 other	 related	 proteobacteria	 such	 as	 the	 plant	 pathogen	
Ralstonia	 solanacearum	 and	 the	 water-dwelling	 photoheterotrophic	
Rubrivivax	gelatinosus.	 It	 is	 also	 present	 in	 the	 ϒ-proteobacteria	 species	
Xanthamonas	oryzae,	 an	 important	environmental	pathogen	 that	 causes	bacterial	
blight	in	rice	plants.		




tagM	 (Shalom	 et	 al.,	 2007),	 which	 have	 been	 experimentally	 confirmed	 (Shastri,	
2011)	and	between	two	additional	tag	genes,	tagV	and	tagX,	 located	upstream	of	
tssM,	neither	of	which	have	been	confirmed.	 In	B.	cenocepacia,	a	 tssI	gene	 is	not	




Figure	 3.1	 The	 ancestral	Burkholderia	T6SS	 gene	 cluster	 (T6SS-1)	 and	 orthologous	 T6SS	
gene	clusters.	 Illustration	of	the	genetic	arrangement	of	the	ancestral	Burkholderia	T6SS-1	
cluster,	containing	tssA	through	to	tssM,	along	with	the	conserved	tag	genes,	tagM,	tagN,	






































































































cluster:	 tagF,	 tagM,	 tagN,	 tagX,	 and	 tagV,	whose	products	may	 to	be	 involved	 in	
function	 or	 regulation	 of	 the	 system.	 Figure	 3.1	 also	 illustrates	 the	 presence	 of	
these	conserved	tag	genes	in	T6SS-1-like	clusters	in	other	Gram-negative	bacteria.	
Figure	3.2	 illustrates	 the	predicted	 topological	 arrangement	of	 the	 conserved	Tag	
proteins	in	relation	to	other	T6SS	subunits.		
TagN	 has	 a	 peptidoglycan-binding	 domain,	 that	 is	 proposed	 to	 act	
structurally	to	anchor	the	T6SS	to	the	cell	envelope	(Aschtgen	et	al.,	2010b).	This	is	
consistant	 with	 the	 fact	 that	 the	 TssL	 encoded	 by	 T6SS-1	 lacks	 a	 peptidoglycan-
binding	 C-terminal	 domain.	 	 The	 presence	 of	 a	 cytoplasmic	 TagF-like	 protein	
(BCAL0350	in	J2315),	suggesting	a	mechanism	similar	to	that	seen	in	P.	aeruginosa,	
as	a	TPP-independent	negative	post-translation	regulator	(Section	1.4.3)	(Silverman	
et	 al.,	 2011).	 An	 additional	 conserved	 Tag	 protein,	 TagM	 (BCAL0340	 in	 J2315),	
contains	 an	 N-terminal	 Sec-dependent	 signal	 peptide	 and	 is	 predicted	 to	 be	 an	
outer	membrane-anchored	lipoprotein.	TagM	may	be	involved	in	post-translational	
regulation	 of	 the	 T6SS	 encoded	 by	 T6SS-1.	 This	 protein	 also	 contains	 two	




A	 further	 potential	 post-translational	 regulator	 is	 the	 uncharacterized	
conserved	 hypothetical	 protein	 TagX	 (BCAL0353	 in	 J2315).	 tagX	 is,	 without	
exception,	located	upstream,	but	in	the	opposite	orientation	to	tagV.	tagV	encodes	
a	 putative	 Sec-dependent	 membrane-anchored	 VanY-like	 D-alanyl-D-alanine	
carboxypeptidase,	 therefore	may	 specify	 peptidoglycan	 hydrolase	 activity	 (Wright	













	 Figure	3.2	 	 	Predicted	structural	organisation	of	conserved	Tag	proteins	 in	 the	ancestral	
Burkholderia	 T6SS.	TagF,	TagM	and	TagX	are	candidate	post-translation	regulators	of	 the	
T6SS	in	B.	cenocepacia.	Also	shown	are	the	two	T6SS	core	subunits	that	are	largely	located	





Sec-dependent	 peptidoglycan	hydrolase/endolysin,	which	 is	 also	 likely	 to	 be	 anchored	 to	
the	 inner	 membrane.	 Zigzag	 motifs	 represent	 acyl	 moiety	 at	 the	 N-terminus	 of	 OM-
anchored	 lipoproteins.	 Cylindrical	 motifs	 in	 the	 inner	 membrane	 represent	 TMDs.	 OM,	








In	 regard	 to	 tagX,	 bioinformatic	 analysis	 of	 the	 encoded	 protein	 has	
highlighted	 some	 interesting	 features,	 discussed	 in	 Section	 5.2.	 These	 include	 a	
putative	 cytoplasmic	 N-terminal	 domain,	 followed	 by	 transmembrane	 a	 domain,	
and	 a	 periplasmic	 linker	 connecting	 the	 transmembrane	 domain	 to	 a	 C-terminal	
domain.	Notably,	this	C-terminal	domain	contains	four	conserved	cysteine	residues.	






to	 tssI	 (vgrG)	 gene	 clusters.	 TagY	 is	 likely	 to	 be	 a	 type	 of	 PAAR	protein,	 as	many	
contain	 homology	 to	 the	 pfam05488	 PAAR_motif	 of	 the	 PAAR-superfamily	
(CL15808)	(Shneider	et	al.,	2013).	Tagβ	is	predicted	to	be	a	cytoplasmic	membrane-


































Figure	3.3	The	T6SS-a	gene	 cluster	of	B.	 cenocepacia	H111	and	 similar	 clusters	 in	other	
bacteria.	 Illustration	 of	 the	 genetic	 arrangement	 of	B.	 cenocepacia	 H111	 additional	 T6SS	
cluster,	 T6SS-a,	 found	 on	 chromosome	 2	 at	 I35_4151-I35_4168.	 Standard	 T6SS	
nomenclature	 gene	 names	 are	 indicated	 in	 black	 font	 above	 the	 genes	 (block	 arrows).	
Orthologous	T6SS	subunit	genes	between	clusters	are	depicted	in	the	same	uniform	colour,	
while	 tag	 genes	are	hatched	or	 chequered.	Predicted	non-tssI	 effector	genes	are	 filled	 in	
purple	bubbles.	Genes	shown	in	white	are	of	unknown	function	and	are	not	conserved	in	
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missannotated	 translation	 inititation	 sites,	 including	 tssM-a	 located	 at	 I35_4164.	
The	 start	 codon	 is	 probably	 located	 approximately	 237	 bp	 upstream,	 meaning	 a		
further	79	 codons	are	present.	By	using	 this	 earlier	 start	 site,	 TssM-a	would	 then	
contain	 two	 additional	 transmembrane	 helices,	 bringing	 the	 total	 to	 three	 rather	







the	AraC-type	 global	 positive	 regulator,	AggR	 (Dudley	et	 al.,	 2006).	 It	 is	 also	 fine-
tuned	 by	 Fur-dependent	 regulation	 of	 the	 Sci-1	 T6SS	 promoter,	 which	 in	 turn	 is	
susceptible	 to	 DNA	 methylation	 of	 sites	 within	 the	 Sci-1	 promoter,	 where	 DNA	
methylation	reduces	the	ability	of	Fur	to	bind	to	its	specific	binding	region	(Brunet	
et	 al.,	 2011).	 In	 H111	 T6SS-a	 there	 is	 a	 pair	 of	 putative	 divergent	 promoters	
between	tssB-a	and	tssK-a,	neither	of	which	contain	potential	Fur	binding	sites	(‘Fur	
boxes’),	 so	T6SS-a	 is	probably	not	 regulated	by	Fur.	However,	 transcription	of	 the	












Genes	 encoding	 proteins	 that	 are	 homologous	 to	 the	 TssI	 subunit	 found	 in	
other	T6SS-containing	bacteria	have	been	identified	in	the	B.	cenocepacia	genome	
(Aubert	et	al.,	2008).	There	are	eleven	tssI	orthologues	in	the	B.	cenocepacia	J2315	
genome,	 although	 only	 nine	 of	 them	 are	 intact.	 A	 BLASTP	 search	 of	 the	 B.	
cenocepacia	H111	genome	using	the	TssI	encoded	by	BCAM0148	identified	twelve	
genes	 encoding	 TssI	orthologues.	 Table	 3.1	 shows	 the	 tssI	 gene	 loci	 identified	 in	
H111	and	 indicates	 the	corresponding	gene	 in	 J2315.	Note,	 that	an	orthologue	of	
the	disrupted	 tssI	 gene	BCAL2503	 is	 not	 present	 in	H111,	 and	 two	additional	 tssI	
genes	 are	 found	 in	 H111	 that	 are	 not	 present	 at	 the	 same	 genomic	 location	 in	
J2315.	The	encoded	products	do	however,	share	homology	with	TssI	proteins	found	
in	 J2315.	 One	 is	 encoded	 by	 I35_7565,	 found	 on	 chromosome	 three,	 which	 is	
similar	 to	 the	 TssI	 encoded	 by	 BCAL1359,	 and	 the	 other	 is	 I35_4159,	 found	 on	
chromosome	2,	which	 is	 similar	 to	BCAM0148.	The	 latter	 is	 located	 in	 the	T6SS-a	
gene	cluster	(Section	3.1.3).		
All	 of	 these	 TssI	 protein,	 bar	 that	 encoded	 by	 BCAL2503,	 contain	 the	 core	
gp27-gp5-like	region	common	to	all	TssI	proteins	 (Pukatzki	et	al.,	2007;	Leiman	et	
al.,	 2009)	 (Figure	 3.4).	 Interestingly,	 all	 but	 four	 contain	 a	 C-terminal	 DUF2345	
domain,	which	 is	 hypothesised	 to	 act	 as	 an	 adaptor	 domain	 for	 interactions	with	
specific	 T6SS-dependent	 effectors	 to	 allow	 their	 export	 (M.S.	 Thomas,	 personal	
communication).	The	DUF2345	domain	is	present	at	the	C-terminus	of	TssI	proteins	
































































gp5-like	 region	 is	 depicted	 in	 red	 and	 DUF2345	 domain	 is	 shown	 in	 green.	 Evolved	 TssI	
proteins	 are	 shown	 with	 additional	 C-terminal	 extension	 domains	 as	 indicated.	 An	 N-
terminal	 extension	 of	 65	 amino	 acids	 is	 present	 in	 two	 non-DUF2345	 containing	 TssI	
orthologues,	depicted	in	pink.	A	TssF	fusion	is	indicated	in	purple,	and	the	black	triangular	
marker	 indicates	 IS1356	tnpase	disrupted	region.	*,	 indicates	orthologue	 is	disrupted;	**,	





















Most	 of	 the	 TssI	 proteins	 encoded	within	 the	B.	 cenocepacia	 genome	 are	
evolved	 TssIs	 (discussed	 in	 Section	 1.5.1)	 as	 they	 contain	 C-terminal	 extension	
domains,	 although,	possibly	not	 all	 of	 these	domains	have	effector-like	 functions.	
Only	 two	 TssIs	 encoded	 by	 the	 J2315	 genome	 (TssI1359A	 and	 TssI0667)	 and	 an	
additional	 TssI	 encoded	 by	 H111	 (TssI1359B)	 could	 be	 predicted	 with	 any	 definite	
certainty	to	possess	effector	function.	These	are	reviewed	below.		
	
3.3.1 TssI1359A	 and	 TssI1359B	 as	 evolved	 TssI	 proteins	 with	 a	 putative	
metalloprotease	domain	
An	evolved	TssI	protein	identified	in	B.	cenocepacia	strains	J2315	and	H111	
is	 TssI1359A,	 which	 is	 encoded	 by	 BCAL1359	 in	 J2315	 and	 I35_1254	 in	 H111.	 This	
evolved	TssI	has	a	M6	family	metalloprotease	domain	(TIGR03296)	at	its	C-terminus	
(Figure	 3.5A).	 The	 M6	 family	 metalloproteases	 include	 the	 experimentally	
characterised	 immune	 inhibitor	 A	 from	 Bacillus	 thuringiensis,	 which	 has	 been	
shown	to	require	a	conserved	HExxH	motif	for	catalytic	activity	that	 is	common	in	
many	zinc	metalloproteases.	It	is	thought	that	both	conserved	histidine	residues	are	
required	 for	 zinc	 ligand	binding	and	 the	 conserved	glutamate	 residue	 is	 an	active	
site	residue	(Lovgren	et	al.,	1990).	TssI1359A	contains	this	catalytic	HExxH	motif,	and	
additional	conserved	residues	surrounding	this	motif.	 In	particular,	both	contain	a	
conserved	 alanine	 residue	 before	 the	 first	 histidine	 residue,	 a	 conserved	 glycine	
residue	 before	 the	 second	 histidine	 residue	 and	 then	 a	 PDEY	 motif	 located	 five	
amino	 acids	 C-terminal	 to	 the	 HExxH	 motif,	 giving	 a	 consensus	 motif	 of	
AHExGHxxgxPDEY.		
TssI1359B	 encoded	 by	 I35_7665	 also	 contains	 a	 C-terminal	 M6	 family	
metalloprotease	 domain	 at	 its	 C-terminus.	 The	 catalytic	 motif	 of	 this	 protein	
partially	follows	the	consensus	AHExGHxxgxPDEY	found	in	TssI1359A	with	one	amino	









                                                               	* 
P23382      197 HL-------MIIHAGVGQEAGGGKLGDDAIWSHRWTVGPKPFAIEGTQAKVPYWGGKMAA 
MC69_02910  268 HL-------MIFHSSVGEEAGGGDLGEDAIWAHRWNLGA-PYPIPGTSSPSQNFGGQFAA 
I35_7565    958 GAACGCRVKVHFKVDLRVSIKG-----APIKGFEPHVTLKLFP-EVFRADTGSWGERH-K 
BCAL1359   1084 GKACTCKVKVKLEVELVQT-------------GRCHAEINLFP-KVTRANSENWGEVQVE 
I35_1254   1062 GKACTCKVKVKLEVELVQT-------------GRCHAEINLFP-KVTRANSKNWGEVQVE 
                                     * 
                                 *HExxH    **** 
P23382      250 FDYTIEP--EDGAVGVNAHEYGHDLGLPDEYDTDYTG-H-----GEP------------- 
MC69_02910  320 YDYTIQP--IDAAAGVCAHEYGHDLGLPDEYDTKYTG-K-----GEP------------- 
I35_7565   1011 WKDELKIKHDYPGANVEAHECGHFFNFPDEYYDQGGWIHHSYIKGEQIDFSLVDAKAGAM 
BCAL1359   1130 WNPQQQRFVPVSTQNAIAHESGHLFGWPDEYFVDGGAVFGKYINSRHLVDVT--MAQLDD 
I35_1254   1108 WNPQQQRFVPVSTQNAIAHESGHLFGWPDEYFVDGGAVFGKYINSRHLVDVT—MAQLDD 
 
	
                           HExxH               * 
PA0262         928 -QRQGLFIHEMTHVWQHQHGVNVLLVGAY------ 
P23382         260 --AVGVNAHEYGHD--------LGLPDEYDT---- 
MC69_02910     331 ---AGVCAHEYGHD--------LGLPDEYDTK--- 
I35_7565      1023 --GANVEAHECGHF--------FNFPDEYYDQGGW 
BCAL1359      1140 VSTQNAIAHESGHL--------FGWPDEYFVDGG- 





TssI1359A	 in	 B.	 cenocepacia	 J2315	 and	 H111	 (BCAL1359	 and	 I35_1254,	 respectively),	 and	
TssI1395B	 in	 B.	 cenocepacia	 H111	 (I35_7565) were	 aligned	 with	 characterised	 M6	
metalloprotease	 protein	 immune	 inhibitor	 A	 from	 B.	 thuringiensis	 (P23382),	 and	 an	
additional	 M6	 metalloprotease	 encoded	 by	 MC69_02910	 in	 A.	 hydrophila	 using	 Clustal	
Omega.	(B)	The	HExxH	region	of	proteins	in	(A)	were	aligned	with	the	corresponding	region	
of	 the	 experimentally	 characterised	 evolved	 VgrG2b	 protein	 encoded	 by	 PA0262	 in	 P.	
aeruginosa.	 The	 conserved	 motif	 indicated	 in	 red	 above	 the	 alignment.	 Black	 shading	
indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	 grey	










internalisation	 of	 bacteria	 into	 epithelial	 cells	 (Sana	 et	 al.,	 2012).	 The	 C-terminal	
extension	domain	of	VgrG2b	contains	the	conserved	HExxH	metalloprotease	motif,	
but	not	within	the	AHExGHxxgxPDEY	motif	seen	in	the	M6	family	metalloproteases	
(Figure	 3.5B).	 Rather,	 it	 is	 defined	 as	 a	 PS00142	 zinc-dependent	metalloprotease.	
This	 evolved	 TssI	 is	 one	 of	 only	 a	 few	 T6SS-dependent	 effectors	 that	 have	 been	
shown	to	target	eukaryotic	cells	rather	than	other	bacterial	species.		
VgrG2b	 is	 thought	 to	 interact	 with	 key	 components	 of	 the	 host	 cell’s	
microtubule	 structure,	 through	 the	γ-tubulin	 ring	complex,	which	aids	 in	bacterial	
internalisation	 (Sana	 et	 al.,	 2015).	 Sana	 and	 colleagues	 postulated	 that	 the	 C-
terminal	metalloprotease	 domain	 is	 critical	 for	 this,	 as	 they	 demonstrated	 that	 a	
truncated	 TssI	 derivative,	 lacking	 the	 C-terminal	 metalloprotease	 domain,	 was	
unable	 to	 interact	 with	 the	 γ-tubulin	 ring	 complex,	 nor	 promote	 bacterial	
internalisation.	 Thus,	 it	 is	 possible	 that	 the	metalloprotease-containing	 TssI1359A	or	
TssI1359B	proteins	of	B.	cenocepacia	may	also	be	involved	in	similar	interactions	with	
the	 cytoskeletal	 network	 of	 eukaryotic	 host	 cells,	 which	 is	 consistent	 with	 the	




TssI0667	 is	 encoded	 by	 the	 BCAS0667	 gene	 in	 B.	 cenocepacia	 J2315	 and	
I35_7843	gene	 in	H111,	both	of	which	are	 located	on	chromosome	3.	Amino	acid	
sequence	 analysis	 of	 TssI0667	 from	 both	 J2315	 and	 H111	 indicated	 that	 the	 two	
orthologues	are	nearly	identical.	In	line	with	other	TssI	proteins,	TssI0667	contains	an	







upstream	 from	 the	 first	 ATG	 codon	 (Figure	 3.6).	 However,	 translation	 from	 this	
codon	results	in	a	65	amino	acid	N-terminal	extension	that	is	not	common	to	other	
TssI	 orthologues.	 Although,	 one	 other	 TssI	 orthologue	 present	 in	 B.	 cenocepacia	
that	 lacks	 a	 DUF2345	 domain,	 TssI2254,	 also	 has	 this	 N-terminal	 65	 amino	 acid	






A	BLASTP	 search	 using	 the	 amino	 acid	 sequence	 of	 the	 TssI0667	 C-terminal	
domain	as	the	query	indicated	homology	to	phospholipase	enzymes,	specifically	to




Hatic	 et	 al.,	 2002)	 and	 the	 phospholipase	 A1	 produced	 by	 Trypanosoma	 brucei,	
TbPLA1	(Richmond	and	Smith,	2007)	(Figure	3.7).	All	of	which	contain	a	conserved	
lipase	 specific	 motif	 of	 GxSxG	 or	 GxSxxG	 and	 align	 well	 with	 an	 experimentally	






the	 enzymatic	 features	 of	 the	 C-terminal	 domain	 of	 TssI0667	 (Jones,	 2012).	 It	 was	
found	that	the	shortest	active	region	of	the	CTD	contained	the	final	258	amino	acids	
of	 TssI0667,	 and	 showed	 specificity	 toward	 phospholipase	 A1	 substrates,	 as	 it	 was	


















GAGACGAAAATAAAG GGAATTCAAATGAGT TTCGCCCCGAATGGC 
                          M  S   F  A  P  N  G  
GGTATTCCGGCCGGT TCCGGCGGAAATCTG TTGGGCTCGCTGAGC 
 G  I  P  A  G   S  G  G  N  L   L  G  S  L  S  
GCGCTTGGCGGCCTT GCCGGGCCGGTCGCA TCCACGGTGGCAGGA 
 A  L  G  G  L   A  G  P  V  A   S  T  V  A  G  
CAGATTGGCCCGCTC GCCGGCGTCGCAAGT CATATCGACACCGTG 
 Q  I  G  P  L   A  G  V  A  S   H  I  D  T  V  
CAACGCGCGGTTCAG CTTGCGCAGACCGGC TTCTCGCTGATGAAC 
 Q  R  A  V  Q   L  A  Q  T  G   F  S  L  M  N  
AAAACGCCGGCCGCG ATTGCG 
 K  T  P  A  A   I  A 
	
Figure	3.6	Presence	of	 two	putative	 translation	 initiation	 sites	 in	BCAS0667.	Analysis	of	
the	 DNA	 sequence	 of	 BCAS0667	 identified	 two	 potential	 initiation	 sites	 for	 BCAS0667	







YplA/1-324               1 ----------------------------------MTTTQAPKIAEAIHRSTPTLADNVLY 
YPTB2902/1-320           1 -MSASVSLTTPVSVSCLINDVNPSVKAKKEDATAVTTTQAPKIAEAIHRSTPTLADNVLY 
PhlA/1-320               1 ---MSMPLSFTSAVSPVAAIPKPRAAAETATAALPAATPANPAPVASPSQNTLNAQNLLN 
XlpA/1-354               1 MTLSVIGGFFSELGTYSLQENVQPQSSPTTTPPLGKKADGTHSASISLSENTKQASLLYQ 
BCAL1296-CTD/134-391     1 -----------------------AREKAASMPPGPERSKLEAAANRFEQNNTAVEKARLA 
ETA_06430-CTD/141-417    1 ------------------------------KGKQSSDAKVRAAAERLELNNAGVEKARLA 
BCAS0667-CTD/735-999     1 -----------------------------AKGLASPDPATRAAAAKLASSLKAQQLAKLA 
XCV3039/1-306            1 -----------------------MSPSESSSSTPFAESMRGQQPHPEDRQLPAMLQDLYA 
Tbrucei/1-268            1 -------------------------MSESVDQLLKTYLQSCDYSIDSSSRKKALEMSCLC 
 
 
YplA/1-324              27 DSTSYTHGVTTGSTNVP--ISSGQRPQQADYSLALLAKDVYAPTSGNLNGFVRLSDERLL 
YPTB2902/1-320          60 DSTSYTHGVTTGSTNVP--ISSGQRPQQADYSLALLAKDVYAPTSGNLNGFVRLSDERLL 
PhlA/1-320              58 TLVGDISAAAPTAAAAPG-VTRGQQSQEGDYALALLAKDVYSLNGQGAAGFNRLSDSALL 
XlpA/1-354              61 SLINNLSASAMAVPELSANDIAGKQSKRIDYELTLVTRDVYREQSLGIPGYERISDEELL 
BCAL1296-CTD/134-391    38 ENVYHPG------QAAPEGWTNVSGDPAKLAQFKLKPNDFSIPG-TNFRAQVYEPDPAVF 
ETA_06430-CTD/141-417   31 DYVYEPRDATKPTPPIPEGWNDISDDAKALSKYGLKSSDLEIEGQPGFRSRVYVPDKRVF 
BCAS0667-CTD/735-999    32 DHVYHPN------DPPPTGWKMATNDPEALKAFGLKPSDFEKSG-SNFGSQMYIPDPNVF 
XCV3039/1-306           38 TAAQRREGGAETFAALPNGWSRMDDR--ALQQAGIDPALLHDAKSGFDAAFYR------- 
Tbrucei/1-286           36 CHVYGGE------GHLPDGWLVCTREVEGLKKRDESCGFRSELYTNGSK----------- 
 
 
YplA/1-324              85 AAGIDPTALSDSASGFLAGIYSDNQQYVLSFAGTNDRHDWLSNIRQAVGYEDVQYNEAVA 
YPTB2902/1-320         118 AAGIDPTALSDSASGFLAGIYSDNQQYVLSFAGTNDRHDWLSNIRQAVGYEDVQYNEAVA 
PhlA/1-320             117 GFGIDPASLHDAGSGFQAGIYSNDKQYVLAFAGTNDWRDWLSNVRQATGYDDVQYNQAVA 
XlpA/1-354             121 KAGIDPDTLNDYSTGFQAGVYKHKGLYIVSFTGSNELQDFMTSINQGLGYKTKQYDQAIE 
BCAL1296-CTD/134-391    91 GN-------------------DFKTQVVFQGTDKYKWSDWANNIAQGANKNSAYYDRAVK 
ETA_06430-CTD/141-417   91 AD-------------------DMSASVVFRGTRMPEWIDWKNNLQQGIGLKSEYYKEAVK 
BCAS0667-CTD/735-999    85 GD-------------------SMKPTVAFKGTQQLFGEDMSNNMAQGLGADAPYYRNAVT 
XCV3039/1-306           89 ---------------------NDQGQVVLGFCGTDEGKDWKHNIGQGLGLDDAQYASAIQ 
Tbrucei/1-286           79 --------------------------YVLAFAGVHDNRSAFESALQLVG-KSDAYKLAAG 
                                              * 
                                            GxSxxG 
YplA/1-324             145 LGKTAKMA-FGDALVITGHSLGGGLAATAALATGTFAVTFNAAGVAKNTLKRLGMDSAKA 
YPTB2902/1-320         178 LGKTAKMA-FGDALVITGHSLGGGLAATAALATGTFAVTFNAAGVAKNTLKRLGMDSAKA 
PhlA/1-320             177 AAKSAKAA-FGDALVIAGHSLGGGLAATAALATGTVAVTFNAAGVSDYTLNRLGIDPTAA 
XlpA/1-354             181 LAHKSLKV-FGENIIFTGHSLGGGLATVAALATGKPAVIYNSAGVSDATLKNMGVSPQVA 
BCAL1296-CTD/134-391   132 IGRALEKS--GTDVDIVGHSLGGGMGSAASRASGLAATTFNAAGLNPATVARYGGTPVAS 
ETA_06430-CTD/141-417  132 IGTLTRNS--AEHIDIVGHSLGGGLASAASQASGKPGWTYNAAGLKSGTVEKYGGTVVTP 
BCAS0667-CTD/735-999   126 IGKNIETTGASAGVDFTGHSLGGGLASAAAEASGGSAVTFNAAGLNPETVAQYGGTAQPA 
XCV3039/1-306          128 LGSQAKQA-FGDQVVISGHSLGGGLAAASAMVNDIPAVTYNAAGVNDRTLERQGLDASAA 





                                           * 
YplA/1-324             204 RRSAENGGIRSYSEKYDLLTGIQELTSLIPNAVG----HKIVLANSDKLTGVDDWLPHKH 
YPTB2902/1-320         237 RRSAENGGIRSYSEKYDLLTGIQELTSLIPNAVG----HKIVLANSDKLTGVDDWLPHKH 
PhlA/1-320             236 KKDAEAGSIRRYSEQYDMLTSTQESTSLIPDAIG----HNITLANNDTLTGIDDWRPSKH 
XlpA/1-354             240 REMADSGLIRHYTVQHDWLSNLQKKFP-VPKPMG----NTIELEYEFDWQNIWNALPYKY 
BCAL1296-CTD/134-391   190 D-------IQAYRVEGEILTKVQEGSHG-----------------MMPTAVGTPHILPG- 
ETA_06430-CTD/141-417  190 KGTEN---INAYRVNGEVLTSIQEPGFWGGAALIYGFGALGAGVVMAPKSVGIRHDMEGG 
BCAS0667-CTD/735-999   186 N-------ITAYRVDGDILTGLQEGRLG---------PISDGTAALMPKAVGSPVTLDGE 
XCV3039/1-306          187 KDYANSELIRGYHVKNEILTHLQEDSIPLKWAMPNAAGHQIELPEPDPLSFGQRLVPGMM 
Tbrucei/1-286          172 VIN-----YVIFAEALDVFQRHPQLLNSVPAGAFFAGLLSNSKIQQFGTFKYIYCKVIHD 
 
                                  * 
YplA/1-324             260 LERRISAHSIEKVLSSMSEQQPWERRYV-------------------------------- 
YPTB2902/1-320         293 LERRISAHSIEKVLSSMSEQQPWERRYV-------------------------------- 
PhlA/1-320             292 LDRSLRAHGIDKVISSMAEQKPWEAKANA------------------------------- 
XlpA/1-354             295 GLHVFKAHFLEAVLELMTQQKPWLNNGDAMLASTDDIDEEMLSLREPSMQALAMDNPAVR 
BCAL1296-CTD/134-391   225 TGGAVARHGMNQVIDGIEAQKTADQATIVQETHP-------------------------- 
ETA_06430-CTD/141-417  247 TGSTVSKHGMDQVLHCIELEKHEDESILLSQ----------------------------- 
BCAS0667-CTD/735-999   230 SVTTVGRHLMGDVTNGINQQVAKDQLDLVSQLNSSH------------------------ 
XCV3039/1-306          247 LKHRLDLHGIDSVMKAQDMQSQDQARGTALQPGSQLFNDAVVQLDGQRDRLGLRDDTAFL 
Tbrucei/1-286          227 RPHYIDAHLIETIIEELRKENGEKISASDLAASSLHEDVMGGMAQLVQQKMSVIMEVVAS 
 
Figure	 3.7	 Alignment	 of	 the	 C-terminal	 domain	 of	 proteins	 encoded	 by	 BCAS0667	 and	
BCAL1296	with	other	phospholipase	A1	and	A2	enzymes.	The	amino	acid	sequence	of	the	
phospholipase	 domain	 encoded	 by	 BCAS0667	 and	 BCAL1296	 were	 aligned	 with	 other	
putative	 and	 experimentally	 confirmed	 phospholipase	 A1	 and	 A2	 proteins	 using	 Clustal	
Omega.	 The	 conserved	 lipase	 motif	 is	 indicated	 in	 red	 font	 above	 the	 sequence.	 The	
confirmed	T.	brucei	 Ser-His-Asp	 catalytic	 triad	 residues	are	highlighted	 in	 yellow,	and	 the	
corresponding	conserved	residues	are	indicated	with	an	asterisk	above	the	sequence.	Black	


















acid-containing	 substrates	 such	 as	 polysorbate	 80	 and	 a	 fatty	 acyl	 ester	 of	 4-
nitrophenyl,	 4-nitrophenol	 palmitate.	 Interestingly,	 it	 was	 also	 observed	 that	 the	
domain	was	its	most	active	at	10°C,	indicating	psychrophilic	properties.		
Furthermore,	 the	 catalytic	 triad	 region	 was	 defined	 as	 residues	 Ser879,	
Asp929	 and	 His971	 by	 enzymatic	 analysis	 of	 point-mutation	 variants	 at	 these	








wide	 range	of	T6SS-containing	bacteria	 (Russell	et	al.,	2013).	This	 superfamily	has	
four	 subfamilies,	 Tle1-	 Tle4,	 that	 are	 based	 on	 a	 specific	 GxSxG	 motif	 and	 the	
flanking	 motifs	 surrounding	 it	 (Section	 1.5.3).	 Alignment	 of	 the	 phospholipase	
domain	 of	 TssI0667	 and	members	 of	 the	 Tle2	 family	 indicates	 conservation	 of	 the	
GxSxG	 motif,	 yet	 TssI0667.CTD	 lacks	 similarity	 in	 the	 regions	 flanking	 this	 motif	
(Figure	3.8).	Therefore,	the	creation	of	an	additional	Tle	family,	Tle6,	to	encompass	
the	 CTD	 domain	 of	 TssI0667	 and	 any	 other	 T6SS-dependent	 PLA1	 that	 shares	
significant	 homology	 to	 this	 domain	 would	 be	 suitable.	 	 This	 includes	 a	 putative	






the	 BCAS0666	 gene	 product,	 it	 was	 found	 to	 contain	 four	 ankyrin	 repeat	 motifs	
(cd00204)	 located	 between	 residues	 80-210.	 This	 structural	 motif	 consists	 of	 a	
relatively	 loosely	 conserved	 sequence	 of	 33	 amino	 acids	 that	 is	 usually	 repeated	










BCAS0667    174 MS----------------------------------NN------------MAQGLGA-DA 
BCAL1296    244 WA----------------------------------NN------------IAQGANK-NS 
SARI_00063  332 T-----------------------------------DV---SFGPKRCPAELGGMGDVHG 
VC1418      281 KPPVDNTKFKIIKAASGMAAVIADKIESATDSPGMKDLIITDLDAAQIAPEEFGGTYVHR 
PSPTO_3485  375 ---------------------------------S-TSDAFRDLDAAQV-PFEEGVGKVHN 
PSEEN5483   346 ---------------------------------EKIPDLLRDVDALQV-PFEEGHGKVHR 
 
                                                 GxSxG 
BCAS0667    187 PYYRNA--------VTIGKNIETTGASAGVDFTGHSLGGGLASAAAEASGGSAVTFNAAG 
BCAL1296    257 AYYDRA--------VKIGRALEKSGT--DVDIVGHSLGGGMGSAASRASGLAATTFNAAG 
SARI_00063  354 GFLEAYQLPKRKFGDKLDAVKDSLGKRKTLFVCGHSLGGALALLYAAEMKA--------- 
VC1418      341 GFYQYTMALL----SLMEKDLG-LHKIKKFYCCGHSLGGAGALLISALIKD-------SY 
PSPTO_3485  400 GFYGSAKAVI----NFVTSYLDRFHVGQKVIVTGHSLGGAVAFLVAEMLRR------RKG 
PSEEN5483   372 GFYLAAKRAL----QFVEVYMDKFYQSQQLIICGHSLGGAVALLLAQMLR-------TGG 
 
BCAS0667    239 LNP-ETVAQYGGTAQPANITAYRVDGDILTGLQEGRLGPISD------------GTAALM 
BCAL1296    307 LNP-ATVARYGGTPVASDIQAYRVEGEILTKVQEGSH--------------------GMM 
SARI_00063  405 --FNPVLYTYGMPRTFSRLAAYLLRGIIHYRHA-NDNDTVTQIPPEVDLDSELYEKLGWL 
VC1418      389 HPPVLRLYTYGMPRVGTRSFVERYQNILHYRHV-NNHDLVPQIPTV------------WM 
PSPTO_3485  450 YDYDIVLYTYGAPRAVDETFATAATALIHHRTV-NHTDPVPSVPTT------------WM 




TssI0667	 and	 BCAL1296	 with	 Tle2	 family	 proteins.	 The	 amino	 acid	 sequences	 of	 the	 C-
terminal	predicted	phospholipase	regions	of	TssI0667	and	BCAL1296	were	aligned	with	Tle2	
family	 proteins	 (Russell	 et	 al.,	 2013).	 The	 conserved	 phospholipase	 signature	 motif	 is	
indicated	in	red	font	above	the	sequences.	The	red	line	indicates	sequences	from	proteins	













forms	 a	 helix-turn-helix	 structure,	 where	 repeats	 stack	 in	 a	 super	 helical	 bundle	
(Gorina	and	Pavletich,	1996).		
Alignment	 of	 the	 protein	 encoded	 by	 BCAS0666	 and	 proteins	 encoded	
downstream	of	other	TssI0667	CTD-like	phospholipase	effectors	genes,	including	the	




activity	 (Givskov	 and	Molin,	 1993;	 Schmiel	 et	 al.,	 1998).	 This	 suggests	 that	 these	
proteins,	 including	 that	 encoded	 by	 BCAS0666,	 are	 likely	 to	 form	 similar	 super	
helical	bundles	based	on	the	helix-turn-helix	structures	of	the	ankyrin	repeat	motif,	














W5S_2405      1 -----------------MKRNLSKFIIVTLCYLFS----------SSGSAMRFYPPESFF 
BCAL1297      1 MRTHTTTSPARSVRYTARWRWMALAAVSALTIIVSGCN------------MSANSPSKYF 
BCAS0666      1 ---------------MRYKKAITAGAIAALVGVSSPLWWPTQAQGTNMTGFKRYAPEDFF 
EAMY_3554     1 -----------------MKRILIAITILLSALMVQGCK-----------KGMDLNAQDYF 
F518_20048    1 -----------------MKKIILIITMVVSTLIMQGCK-----------QGMDLQPQDYF 
YplB          1 ---------------MRVKRHLRYAIYGVLMPLISFEG-----------QAMTEINIAFT 
 
 
W5S_2405     34 SGEQLTLAQAIEKGD---LTAVTSLAFYTNLNQAGKQDMTLLFYALQIAKSRK----TYQ 
BCAL1297     49 DGSYLSAAKAISDGD---VAQLKSALSGIDVNKPGRQEMTLLWFAISTKN---------- 
BCAS0666     46 SGQQLTLAQAIHDGD---LTRVQQLAPKTDLNAPGAKNTTLLSYAVQEIVPVKNDASNPR 
EAMY_3554    33 EGKQLALAKGIEKGDQDEIRKILPEMSAEELNRPAKASMTLLFWAISSSLYDQATP--ER 
F518_20048   33 EGTQLDIANIIYEGDRQKLDKVLPTVSKETLNRPAKAEMTLLFWAINNAIFDKSTP--ER 
YplB         35 DPLVMPIADAIVHGN---VKQIHQLATKSLLQQQGEQAVTLMQWAILNQ----------Q 
 
 
W5S_2405     87 LLIITQLIKDGADPLQQVPNMG-SVAEVLATSPYPIYMQALLDGGMSANAKIMG--RPVF 
BCAL1297     96 FPAISELIAHGSKPDAQIVEGLGSAMYFAITNEDTRYLKAMLDGGLSPDTVDSDGTSLLQ 
BCAS0666    103 YQIISVLVKNGADPKAPVGASGGSVVDVALRADTPNLLRVLLNSGLDPNWQYNG-DTPMI 
EAMY_3554    91 LRIITELVKAGADPLQPQPNMPGSPAETMMQADKGIWIKALLDGGLSPDARDNVHHEPII 
F518_20048   91 LKIITDLVKAGADPLQPRPEGRSSPAEYVMKADKGVWIQAMLEGGLSPNARDEINNQPII 
YplB         82 PESLAALLQEHADPFQP-GMQGDTAWHTAATVQDAHYMQILLKNNIRPDARNSVTLATPL 
 
 
W5S_2405    144 YRAASDNTLSTLKLMVERGGDINQGDSLGRSVLMYALDGMQLDTVEWLLNHGANPNIVET 
BCAL1297    156 RAMEGNGAMERVKLLVEHHANINHRDSIGGTALDSALDVAKPDIAIFLVEHGADVNAHTT 
BCAS0666    162 FAVAENRLLPQLKLLIEHKANVNARDSLGKTALFEATMIQQWDVVDYLLSHGADPKIASQ 
EAMY_3554   151 FESFNAMNTETLKILIDYRANLNIQDSLKRTPLINALYSGKIEHIKLLLSNGASPLIKDR 
F518_20048  151 FKSFQAVNTETLSTLIDYKADVNIKGAMNRTPLINALYNSCPEHIEVLLAHGANPLAKDD 
YplB        141 AAAIMAGREIQVILLLVAGVDPNIADRVGDTPLHLAGKSNAPDLALRLLKAGADPEARNK 
 
 
W5S_2405    204 N---TGWSFMRQLDYVITRNNGD----------------------------AGATHKKLM 
BCAL1297    216 NGVSVAYSVQKDIDALQPEAKQATVTDISLDKDGQPVRTAQTPPAPGLSPEGKERLEKFE 
BCAS0666    222 LGVSYGWVLQNELKNHTTADSAARTRIEDIRRK---------------IVTAGAPWPPLD 
EAMY_3554   211 FNDDFISLINNEISKGDKGN---------------------------------EYIKSLV 
F518_20048  211 FNDSFLSLISAEIDKGDKSN---------------------------------AYIKKLI 
YplB        201 QGATFQQYLAMTPLNIQS----------------------------------AEMQQKYQ 
 
 
W5S_2405    233 EILQLAKQKGGHPHH------------- 
BCAL1297    276 RLRALMIAKGAKFPPDPPAKVREQMSKK 
BCAS0666    267 PKAQRAAMRARGEKVVTPAGQTD----- 
EAMY_3554   238 SIRDSIGGD------------------- 
F518_20048  238 KIKEKIKQVN------------------ 
YplB        227 QLNVWLRGKKLAEIYQQ----------- 
 
Figure	 3.9	 Putative	 immunity	 proteins	 encoded	 by	 BCAS0666	 and	 BCAL1297	 contain	
ankyrin	repeat	motifs.	(A)	Schematic	representation	of	ankyrin	structural	motif	showing	α-
helices	and	β-turns	 in	relation	to	the	conserved	33-residue	sequence.	Red	 letters	 indicate	
highly	conserved	residues.	(B)	An	alignment	of	amino	acid	sequences	of	putative	immunity	
proteins	 encoded	 by	 BCAS0666	 and	 BCAL1297	 with	 other	 ankyrin-containing	 proteins	
downstream	 of	 genes	 encoding	 Tle6-like	 proteins.	 Coloured	 boxes	 indicate	 the	 four	















 Putative	 T6SS-dependent	 effectors	 in	 B.	 cenocepacia	3.4
localised	to	tssI	gene	clusters		
Several	 characterised	 T6SS	 effectors	 have	 been	 shown	 to	 belong	 to	
superfamilies	 of	 effectors,	 including	 those	 based	 on	 their:	 predicted	 enzymatic	
function,	 such	 as	 the	 Tae	 effectors	 with	muramidase	 activity	 (Hood	 et	 al.,	 2010;	
Russell	et	al.,	2011);	localisation		of	their	genes	with	tssI	or	tssD	genes	of	the	T6SS	
and	 associated	 accessory	 proteins	 (Hachani	 et	 al.,	 2014;	 Liang	 et	 al.,	 2015);	 or	
presence	 of	 conserved	motifs	 identifying	 them	 as	 T6SS	 effectors,	 such	 as	 the	 N-
terminal	 MIX	 motif	 (Salomon	 et	 al.,	 2014a).	 Here,	 using	 what	 is	 known	 about	
previously	 characterised	 T6SS-dependent	 effectors,	 coupled	 with	 bioinformatic	
tools	it	was	sought	to	identify	putative	T6SS-dependent	non-tssI	effectors	encoded	






A	 brief	 analysis	 of	 the	 tssI	 cluster	 located	 at	 BCAL1165	 indicated	 a	 960	
amino	acid	protein	encoded	by	the	gene	located	directly	downstream	of	BCAL1165	
as	 a	 potential	 effector,	 the	 gene	 BCAL1166	 (Figure	 3.10A).	 A	 BLASTP	 alignment	






terminus	 (Figure	 3.11).	 The	 M23	 peptidase	 domain	 specifies	 amidase/peptidase	
activity,	so	may	hydrolyse	amide	bonds	within	and	between	the	peptide	crosslinks	
in	peptidoglycan	(Figure	1.8,	Section	1.5.2)	(Firczuk	et	al.,	2005).	The	lysozyme-like	



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure	 3.11	 Domain	 organisation	 of	 a	 putative	 T6SS-dependent	 effector	 encoded	 by	
BCAL1166.	 Diagrammatic	 representation	 of	 the	 conserved	 domains	 identified	 in	 the	




















	Taking	 together	 these	 observations,	 it	 is	 hypothesised	 that	 the	 protein	
encoded	 by	 BCAL1166	 may	 specify	 peptidoglycan	 hydrolase	 activity,	 with	 both	
muramidase	activity	and	amidase	activity,	hence	 is	 a	 strong	candidate	as	an	anti-
bacterial	 effector.	 Analysis	 of	 the	 protein	 encoded	 directly	 down-stream	 of	
BCAL1166,	 BCAL1167,	 identified	 an	 N-terminal	 Sec-dependent	 signal	 sequence,	






Several	 potential	 T6SS-dependent	 effectors	 are	 present	 in	 the	 BCAL1294	
cluster	 (Figure	 3.10B).	 A	 BLASTP	 search	 of	 the	 product	 of	 the	 BCAL1292	 gene	
suggested	 that	 it	 encodes	 a	 Tse4	 family	 effector	 (periplasmic-targeting	 effectors),	
with	significant	homology	to	the	P.	aeruginosa	Tse4	encoded	by	PA2777	(Whitney	
et	al.,	2014).	This	search	also	highlighted	an	additional	Tse4-like	protein	encoded	by	
BCAL2504	 in	 B.	 cenocepacia	 J2315	 that	 is	 located	 adjacent	 to	 the	 truncated	 tssI	
gene	 BCAL2503	 (Figure	 3.12).	 Located	 directly	 downstream	 of	 BCAL1292	 is	
BCAL1291.	 An	 alignment	 of	 the	 protein	 encoded	 by	 BCAL1291	 and	 the	 immunity	




and	an	orphan	Tsi4	protein	encoded	by	BCAM1200	 that	was	not	 linked	 to	a	Tse4	
effector	(Figure	3.13).	
3.4.2.2 Phospholipase	A	encoded	by	BCAL1296	
A	 further	 putative	 effector	 identified	 as	 being	 encoded	 in	 the	 BCAL1294	
cluster	 was	 the	 product	 of	 BCAL1296.	 BLASTP	 search	 using	 the	 391	 amino	 acid	









BCAL1292    1 MSYLRK------SKWKYDTGAGGGVSVDIVVATGGNIILTDPQKHSQSFYYGGVGIGYGW 
BCAL2504    1 MSLLRL------SDWTYNTGAGGGASVEFVTATGGLLRLTDPTKQDHDYYYGGLGIGYGL 
PA2774      1 MSQLPIPLPLNESRWRYVTASGGGMTVAFLAGSGGSITLLSPEGENVSFRYGGVGGGIGL 
 
 
BCAL1292   55 GARIPKIKLPRFTIPELKLPNFGSHDASAAGSTYAFPSHGTVYMTSAFKGSELTRSDLQG 
BCAL2504   55 GLKIPKIRFPKFTTPEIKLPPIGGRDAAAAGAGVHTPSGGWVYMTHAFQGKELSANDFRG 
PA2774     61 G-----MRLPRFGKVNLNVK---GKSVGGAGALEALPSTGTVLVADGLVGRDLSRGDFTG 
 
 
BCAL1292  115 GTVYLDGYGGVVVAQGATVMLLGINPAMLALG-------LTSPAMSMILADAVANAPALL 
BCAL2504  115 ATVYLDASLSAIIGQAGDIMLMGIDSAMLALG-------LSSPALSMLAEEAIANAPVLL 
PA2774    113 PCMYVELGAGVIAGGSGTAILFGLDPKLLAAVALASASPLTAALGASMSRQLLQSSRGAL 
 
 
BCAL1292  168 YMHGRTAGFQAGVGGGILAGYLH 
BCAL2504  168 ITHGRTYGFQAGFGVGLLVGYVH 
PA2774    173 LMAGVNVGAQFGGGAAAYLGALF 
 
Figure	3.12	Alignment	of	putative	Tse4	proteins	 from	B.	 cenocepacia	 J2315.	Amino	acid	
sequences	encoded	by	BCAL1292	and	BCAL2504	 from	B.	cenocepacia	 J2315	and	a	known	
Tse4	protein	encoded	by	PA2774	in	P.	aeruginosa	PAO1	were	aligned	using	Clustal	Omega.	




	 	 	 	 				Sec-dependent	signal	sequence	
BCAL1291    1 ----------------MFKGISAIVIGVGLLVAAAISAQSTREFLRTSIVVPGLVVKLNA 
BCAL2505    1 ----------------MFKAMGAIVIGVGFLIAAAFSVQSTREFLRNSIIVPGRVVKLNA 
PA2775      1 MTTSSGSRIGG-----LLHASLFSLLGLGLLLAGGFKTVERYHFLRTAQEAQGTVSALNA 
BCAM1200    1 MATEIGRPAAQHIEWRIAKGIVFTIVGTCMLIGTALYAQSTREFLRTSVVVPGRVVKLNA 
 
 
BCAL1291   45 GGYHPEIQFTTKTGQQISYPQGGIVT-KVELGQRVEVRYQADDPDGSATMNVFAAIWDST 
BCAL2505   45 GGYHPEIEFVTKSGEHVSYPQGGILIAAMKVGQDVEVRYLPEQPIPTATVNTFRAIWDMP 
PA2775     56 GGSHPQIDFTSVSGERISYPQGGFIFG-YQVGEPVRVLYEAGRPAASAIVDDAGALWGTG 
BCAM1200   61 GPHHPEITFTTLAGEQVDYAQGGEVS--VEDGATVEVRYAPDAPRTTARMNTFGAIWGTV 
 
 
BCAL1291  104 IVFAFMGAVAIVCGIMNLPS-----RT-------- 
BCAL2505  105 IFLTTMGLGAILVGLMNLPS-----RK-------- 
PA2775    115 AFLCGFGALFGIVGFRGLLG----LRSSQPTSKGH 
BCAM1200  119 LTIGAMGMVFFAVGVGQVWSGVRASRSGRHPPVR- 
	
Figure	 3.13	Alignment	 of	 putative	 Tsi4	 proteins	 from	B.	 cenocepacia	 J2315.	Amino	acid	
sequences	 encoded	 by	 BCAL1291,	 BCAL2505	 and	 BCAM1200	 from	 B.	 cenocepacia	 J2315	
and	a	 known	Tsi4	protein	encoded	by	PA2775	 in	P.	 aeruginosa	 PAO1	were	 aligned	using	
Clustal	Omega.	Black	shading	 indicates	 identical	 residues	at	 the	corresponding	position	 in	
50%	of	sequences,	grey	shading	indicates	similar	residues	at	the	corresponding	position	in	





(Shneider	 et	 al.,	 2013).	 In	 the	 case	 of	 evolved	 PAAR	 proteins,	 such	 as	 BCAL1296,	
effector	 domains	 may	 also	 be	 present	 on	 the	 N-	 or	 C-terminus	 that	 are	 also	
attached	to	the	TssI	spike	when	the	PAAR	domain	 interacts	with	 its	TssI	substrate	
(Shneider	 et	 al.,	 2013).	 DUF4150-containing	 proteins	 have	 been	 previously	
designated	as	TagD	proteins	(Shalom	et	al.,	2007).	Functional	DUF4150-containing	
effectors	have	been	described	elsewhere,	this	includes	the	product	of	PA0099	in	P.	
aeruginosa,	 which	 acts	 as	 an	 anti-bacterial	 DNase	 effector	 requiring	 the	 VgrG1b	
protein	for	export	(Hachani	et	al.,	2014).		
Rather	 than	 a	 DNase	 domain,	 BCAL1296	was	 identified	 as	 containing	 a	 C-
terminal	extension	 incorporating	an	esterase/lipase	superfamily	domain	according	
to	 the	 CDD	 database.	 Lipases	 hydrolyse	 ester	 bonds	 within	 lipid	 molecules	
(discussed	 in	 Section	 1.5.3).	 Further	 investigation	 of	 this	 region	 indicted	 that	 the	
CTD	 region	 shared	 similar	 features	 to	 the	 phospholipase	 domain	 of	 the	 protein	
encoded	 by	 BCAS0667,	 and	with	 other	 predicted	 phospholipases,	 including	 those	
encoded	 by	 ETA_0640	 from	 Erwinia	 tasmaniensis,	 YE1005	 from	 Y.	 enterocolitica	
and	 XCV3039	 from	 Xanthomonas	 euvesicatoria,	 containing	 the	 conserved	 lipase	
motif	 of	 GxSxG	 or	 GxSxxG	 (Figure	 3.8,	 Section	 3.3.5).	 Notably,	 the	 product	 of	
BCAL1296	 contained	 a	 catalytic	 triad,	 but	 instead	 of	 a	 serine-aspartate-histidine	





An	 additional	 putative	 candidate	 effector	 encoded	 within	 the	 BCAL1294	
gene	cluster	 is	 the	protein	encoded	by	BCAL1298.	A	BLASTP	search	using	 the	349	
amino	 acid	 sequence	 encoded	 by	 BCAL1298	 as	 a	 query	 indicated	 a	 C-terminal	






were	 not	 identified.	 However,	 several	 proteins	 were	 identified	 that	 showed	
homology	 to	 the	 N-terminus	 of	 the	 product	 of	 BCAL1298,	 including	 AK36_2612	
from	 B.	 vietnamiensis,	 DO62_782	 from	 B.	 pseudomallei	 BDD	 and	 a	 PAAR	 motif	
containing	protein	encoded	by	Herbaspirillum	rubrisubalbicans	(C798_RS0113785).	
Proteins	with	homology	to	just	the	C-terminus	were	also	identified,	corresponding	
to	 other	 putative	 GH-E	 superfamily-domain	 proteins,	 including	 a	 PAAR	 motif-
containing	protein	encoded	by	EOS_31360	in	B.	glathei,	a	DUF4150	and	PAAR-motif	
containing	 protein	 encoded	 by	 ON18_RS05025	 in	 the	 bacteria	 Pusillimonas	
noertemannii	(of	the	Burkholderiales	order)	and	NR99_RS29435	in	a	P.	aeruginosa	
strain.	
3.4.2.3.2 Putative	 GH-E	 HNH/Endo	 VII	 superfamily	 domain	 encoded	 by	
BCAL1298	
Nucleases	 function	 as	 esterases	 to	 catalyse	 the	 cleavage	 of	 the	
phosphodiester	link	between	the	3’	carbon	and	5’	carbon	of	two	pentose	molecules	
in	 adjacent	 nucleotides	 by	 a	 base	 catalysed	 hydrolysis	 reaction.	 Endonucleases	




or	 structure	 (Flap	 endonuclease	 (FENS))	 specific	 and	 can	 have	 a	 preference	 for	
single	 stranded	 or	 double	 stranded	DNA,	 RNA,	 or	 be	 fairly	 non-specific	 regarding	





to	 the	 ββα-Metal(Me)-finger	 nucleases	 clan,	 meaning	 they	 contain	 a	 structural	
motif	made	up	an	anti-parallel	β-hairpin	 followed	an	α-helix	 (Scholz	et	al.,	 2003).	
This	 structure	 harbours	 essential	 residues	 required	 for	 catalysis	 and	 metal	 ion	
coordination.	Well	studied	endonucleases	that	contain	this	common	ββα-Me-finger	
motif	 include	 the	 bacteriophage	 T4	 endonuclease	 VII	 (Biertümpfel	 et	 al.,	 2007),	
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Serratia	 endonuclease	 (Nestle	 and	 Roberts,	 1969;	 Kühlmann	 et	 al.,	 1999),	
Streptococcus	 pyogenes	 Spd1	 endonuclease	 (Korczynska	 et	 al.,	 2012),	 the	
periplasmic	Endo	 I	nuclease	encoded	by	endA	 in	E.	coli	 (Cordonnier	and	Bernardi,	
1965;	Jekel	and	Wackernagel,	1995)	and	eukaryotic	endonucleases,	such	as	Nuc1	of	
Saccharomyces	cerevisiae	(Vincent	et	al.,	1988)	and	the	mammalian	endonuclease	
G,	which	are	 involved	 in	mitochondria	DNA	replication	and	 repair	 (Côté	and	Ruiz-
Carrillo,	1993).		
These	 enzymes	 typically	 require	 a	 metal	 ion	 (usually	 Mg2+)	 and	 essential	
aspartate,	histidine,	and	asparagine	 residues	 for	 catalysis	 (Giraud-Panis	and	Lilley,	
1996;	 Golz	 et	 al.,	 1997).	 The	 conserved	 histidine	 residue	 is	 essential	 for	 the	 de-
protonation	 of	 a	 water	molecule	 for	 nucleophilic	 attack	 of	 the	 phosphate	 in	 the	
phosphodiester	bond	between	two	nucleotides,	and	the	aspartate	and	asparagine	




preceding	 the	 catalytic	 histidine	 and	 glutamate	 residue	 further	 downstream.	
However	 no	 GH-E	 HNH/Endo	 VII	 proteins	 have	 yet	 to	 be	 experimentally	
characterised.		
Alignment	 of	 the	 C-terminal	 domain	 of	 the	 protein	 encoded	 by	 BCAL1298	
with	 other	 GH-E	 HNH/Endo	 VII	 containing	 proteins	 identified	 potential	 catalytic	
aspartate,	 histidine	 and	 asparagine	 residues	 at	 positions	 290,	 293	 and	 333,	
respectively,	 that	 corresponded	 to	 a	 similar	 experimentally	 characterised	 class	 of	
nucleases,	Endo	VII	(Figure	3.14).	Yet	the	conserved	residues	defined	by	Zhang	and	




that	 is	homologous	 to	other	predicted	proteins	 located	 in	close	proximity	 to	T6SS	
clusters,	including	C798_RS0113785	from	H.	rubrisubalbicans	and	AK36_2612	from	












                                                                 # * 
BCAL1298/267-345       1 -----------------REDPFTGEKEFEYKGNWYPLKDADMAHQTDAV-TWWNNVGREY 
METAL_1840/1381-1447   1 ------------SKPGSKACPTCSKDV-E-VAPTQGRRDWDVDHQPKWSER-----SL-S 
BSU25860(YQCG)/451-522 1 ------------DSTGSVKDPLT-------KQVMKKDEPWDMGHKPGYEFRKHQQSAMER 
CA_C1640/300-377       1 ------------DIDGKVYDPNTGEELSW-DTSKSRAGQWDMGHTPENKYSEWHKKYIDG 
EUBREC_3327/27-110     1 RMLKVLMDWLEIQIQVRLL---IG---HQ-ENLEKGYGVWDMGHIPEAKYSEMHEAYMNG 
 
                                                 #     
BCAL1298/267-345       43 GAKAPEVRAWMLDSKNYDLQPYWVNRSLGAKLGERYL 
METAL_1840/1381-1447   41 GMDRKQVLDEYNKD--VRLRCPSCNRSDN-------- 
BSU25860(YQCG)/451-522 42 NISRKQFLDEHNNPDHYQPELPSSNRSHKGE------ 
CA_C1640/300-377       48 EITKKEFLEWYRNPNNYRPESPSANRSHKYE------ 




Figure	 3.14	 Alignment	 of	 the	 C-terminal	 domain	 of	 the	 protein	 encoded	 by	 BCAL1298	
with	members	 of	 the	 GH-E	 HNH/ENDO	 VII	 nuclease	 superfamily.	 The	C-terminal	 amino	




residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences.	 The	 asterisk	 indicates	 a	
conserved	histidine	 needed	 for	 activation	 of	 a	water	molecule	 for	 hydrolysis,	 red	 hashes	













proteins.	 The	 DUF2169-containing	 proteins	 in	 Figure	 3.15	 show	 homology	
particularly	 at	 the	 N-	 and	 C-terminus.	 Proteins	 containing	 this	 domain	 that	 are	
encoded	with	T6SS	subunit	genes	have	previously	been	designated	as	TagA	proteins	
(Shalom	et	al.,	2007).	In	some	cases,	TagA	proteins	contain	a	C-terminal	extension	
harbouring	 pentapeptide	 repeats	 (evolved	 TagA)	 (Shalom	 et	 al.,	 2007).	 These	
observations	may	 suggest	 that	 TagA	 acts	 as	 an	 adaptor	 or	 chaperone	 protein	 to	
facilitate	 the	 secretion	 of	 downstream	 effectors	 by	 the	 T6SS,	 similar	 to	 TEC	 and	
EagR1	chaperones	recently	described	(Liang	et	al.,	2015;	Diniz	and	Coulthurst,	2015;	
Unterweger	et	al.,	2015).	
3.4.2.5 Putative	 endonuclease	 immunity	 proteins	 encoded	 by	 BCAL1299	
and	BCAL1300	
Located	 immediately	 downstream	 of	 BCAL1298	 are	 two	 genes	 encoding	
small	148	and	144	amino	acid	proteins,	that	share	homology	with	each	other.	Both	
proteins	 contain	 three	 tetratricopeptide	 repeat	 (TPR)	 structural	 motifs,	 each	

















H.rub            1 MRFINHTPFPALAFGGVGHNGEAFHVLVLRQTFTWNAAS-----------ELIFADEQQP 
AK36_2615        1 MEFRNLTPLHAMAFNAVDVPGNEIHVVALKAVYRLEPAQSLDAEGDTHRCVLLSGDSAVP 
I35_1209         1 MEFRNLTPLHAMAFNAVDVPGNEIHVVALKAAYRLEPVQSFDPDGDTHRCVLLSGDNAVP 
DO62_785         1 MEFRNLTPLHAMAFNAVDIPGNEIHVVALKAAYRLEPAQSFEPDGDTHRCVLLSGDNAVP 
BCAL1295         1 MEFRNLTPLHAIAFNAVDVPGNEIHVVALKAAYRLEPAQSFDPDGDTHRCVLLSGDNAVP 
GHAL_1578        1 MEFRNLTPFSVMEYAMDDKHNERHHVIAMKTGFRLVQDV------EGHWQAQLMENPPLP 
SBG_1847         1 MEFRNLTPFSVMEYAMDDKHNKRYHVIAMKTGFRLVRDA------VGHWQAKLMDYPPLP 
XBFFL1_230005    1 MEFKNLTPFSVMHYKMLDTEDEEYHVVAMKIVYQLRPVG------DGPYYQAVLTEPFGE 
S70_18065        1 MEFRNLTPFSVLNYKMLNVEDIEHHVIAMKVGYALVPTE------NKGEYVPSLLTD-LN 
 
 
H.rub           50 LCEADEFFGDDLQGSVRQESDLCPYKPRCDVIINAMAYPPRALNGKPPHRFPVRVVVKRP 
AK36_2615       61 LTMADEYEGETGKSSVKWESDLAPFKPKCDVLVRATAHAPHG---TPAASWPARVRVFD- 
I35_1209        61 LAMADEYEGKTGTSSVKWESDLAPFKPKCDVLVRATAHAPHG---TPAASWPARVRVFD- 
DO62_785        61 LAMADEYEGKTGASSVKWESDLAPFKPKCDVLVRATAHAPHG---TPAASWPARVRVFD- 
BCAL1295        61 LAMSDEYEGETGKSSVKWESDLAPFKPKCDVLVRATAHAPHG---TPAASWPARVRVFD- 
GHAL_1578       55 LCLEDEFIGEMNMSPVLRESDLAPLKTACDIIINGTAYTPGG---VAVPEMMAGVLMRSP 
SBG_1847        55 LSVEDKFSGEMNVSPVVHESDLAPFKPACDIIVNGTAYAPDG---IAVPEIIAGVVMRSP 
XBFFL1_230005   55 LALQDEFSGELNQSSVRQESDLAPLKPKCDVIVNGVAYAPGG---IPAERVPVRLLVTTA 
S70_18065       54 FEFEDQFISKPNSSSVLVESDLAPFKPHCDVLINGIAYAPDN---TPAESITVSFTMTSR 
 
 
H.rub          110 DTPVPPPPKPQGLNPFMPASPEALAAWRVEVERAKNSVIPGERLIDKSLVIHGQRRFVKR 
AK36_2615      117 ---------------------------------------AGTMVIDKGLRVTGPRAFTKG 
I35_1209       117 ---------------------------------------AGTMVIDKGLRVTGPRSFTKG 
DO62_785       117 ---------------------------------------TGTMVIDKGLRVTGPRSFTKG 
BCAL1295       117 ---------------------------------------AGTMVIDKGLRVTGPRSFTKG 
GHAL_1578      112 ---------------------------------------LGDVILDKKIRVTGPRFYRRQ 
SBG_1847       112 ---------------------------------------SGEVLLGKKLKITGQRFYRRQ 
XBFFL1_230005  112 ---------------------------------------DWQPLIDKTLLVWGEREFQR- 
S70_18065      111 ---------------------------------------DNKVLIEKSLRCFGARQFVLD 
 
 
H.rub          170 AGLLRLAATLLKFGTLGIMRLPAWRLTKPEPAKVLPVRLEHAYGGQCRIDGNRRAASKVP 
AK36_2615      138 --------------------WRGWRLGEPEPTRAVPVRWEQAYGGTSRVALTQSAKGASA 
I35_1209       138 --------------------WRGWKLGEPEPTRAVPVRWEQAYGGTSRVTLAQSAKGASA 
DO62_785       138 --------------------WRGWKLGEPEPTRAVPVRWEQAYGGTSRVALAQSAKGASA 
BCAL1295       138 --------------------WRGWKLGEPEPTRAVPVRWEQAYGGTSRVALAQSAKGTSA 
GHAL_1578      133 A------------------LTGQWSETEPEPFTFLPLNYRYAFGGECRVEAASEYAERVP 
SBG_1847       133 S------------------LTGQWDETAPEPFVSLPLDYRYAFGGECRVEADSGYADRIP 
XBFFL1_230005  132 T------------------SEDEWQLTPPQKFTELPIDYQYAFGGQCRVYEDDVAAAAVV 
S70_18065      132 E------------------KSGEWKLTSPSPIRQLPIDYRYAFGGECKVYENEKLAKPIP 
 
 
H.rub          230 QQYRLTQQQAAAHPEQRQPPVAHEALAANPVGQGWARDWYLDA----------------- 
AK36_2615      178 D------------------LELNEVCFTNPLGRGWVEKRFLDRATHKSVVASLCASSLPG 
I35_1209       178 D------------------LELNEVCFTNPLGCGWVERRFLDRATHKSVVASLCASSIPG 
DO62_785       178 D------------------LELNEVCFTNPLGRGWVEKRFLDRAIHKSVVASLCASSIPG 
BCAL1295       178 D------------------LELNEVCFTNPLGRGWVEKRFLDRATHKSVVASLCASSIPG 
GHAL_1578      175 EEFHLTEAQRGEHPDRDNPPLAHVVCEVNPLGLGYAQPWYLRA----------------- 
SBG_1847       175 EENRLTEEQRREHPEADNPPLAHMAWPVNPLGLGYTPSWYLRA----------------- 
XBFFL1_230005  174 DEFRLSAEQLGQHPEKDSPPIAHATFEYNPIGRGFVAPWYAKA----------------- 
S70_18065      174 DEALFPEALRAEHPEKDFAPIAHSTYEYNPLGQGFITPWYQQS----------------- 
 
 
H.rub          273 --TKTASVSAPQIEHPQQPITLSHFSQARTGQLDHA---------EMLVAGLGIRPKGHP 
AK36_2615      220 PLPKIAEIPAPQIEAWDVPITSLDVAEHSASGLDAKQMKEVVARYATTPVGLGVVGRAWT 
I35_1209       220 PLPKIAKIPAPQIEAWDIPITSLDVAEHSASGLDAKQMKEVVARYATTPVGLGVVGRAWT 
DO62_785       220 PLPKIAEIPAPQIEAWDIPITSLDVAEHSASGLDAKQMKEVVASYATTPVGLGVIGRAWT 
BCAL1295       220 PLPKIAEIAAPQIEAWDIPITSLDVAEHAASGLDARQMKEVVASYATTPVGLGVVGRAWT 
GHAL_1578      218 --CDIQQVEAPRLIATDSPFTLKQFTAVLDGK-------ADWNAPEFQPAGFGCLSRTWV 
SBG_1847       218 --GNIHQVEAPRIIAMDAPFTLQHFINVCEGK-------TDWSSPECQPAGFGCISRTWL 
XBFFL1_230005  217 --KALSRYPAPRIEHPDAPVIGEYFAPCSEPP-------TAITEPGYRPAGFGMIGRPWL 
S70_18065      217 --KEITVLPAPQIESLEYPITTEWLTSQLNNE-----------LQQNPVAGFGAIGRAWL 
 
 
H.rub          322 ERARLAGTIDEKFINSGAP-LPEDFDFAVWNAAWPDQQIEALQGDEIIELTNLCQRGTPG 
AK36_2615      280 PRLQFAGTYDEIWHKTRWPYHPVDHDFHYWNGAPADQQIEWPAPGLAFELANLAQPE--- 
I35_1209       280 PRLQFAGTYDETWHKTRWPYHSVDHDFHYWNGAPADQQIEWPAPGLAFELANLALPE--- 
DO62_785       280 PRLQFAGTYDETWHKTRWPYHPMDHDFHYWNGAPADQQIEWPAPGLAFELANLAPPE--- 
BCAL1295       280 PRLQFAGTYDETWHKTRWPYHPVDHDFHYWNGAPADQQIEWPAPGLAFELANLAPPE--- 
GHAL_1578      269 PRLRLAGTYDQKWLKNRHPGLPDDFNARYWNCAPRNQQIPFPAPGTEITLQGL------- 
SBG_1847       269 PRLSLAGTWDQAWLENRHPGLPEDFNFRYWNSAPRDQQIPFPAPGTTLTLYGL------- 
XBFFL1_230005  268 PRRTKAGTYDETWLKERHPYLPDDFDFSYWNNAPEDQQIDHPDNNIRISLFHL------- 





H.rub          381 VIEDEQGNSVLQLSMPPYQPYVLVRFESGQLAPLALSIDTLIVEPDARTVAMVSRAVLPV 
AK36_2615      337 ----HTRAGFLRARLPGHRALVALRFKSGEIVPLEMKLDTLLIDTEEMRVSATWRAVFPL 
I35_1209       337 ----HTHAGFLRARLPGHRALVALRFKSGEIVPLEMKLDTLLIDTEEMRVSATWRAVFPL 
DO62_785       337 ----HTRAGFLRARLPGHRALVALRFKSGEIVPLEMKLDTLFIDTEEMRVSATWRAVFPL 
BCAL1295       337 ----HTRAGFLRARLPGHRALVALRFKSGEIVPLEMKLDTLLIDTEEMRVSATWRAVFPL 
GHAL_1578      322 -----HPDGDITFTLPANWAGILLRMKSGEMVPQMMWSDMLHIDTDTLTVAQTWRYVLPV 
SBG_1847       322 -----HPDGEMTFTLPVNRAGILLRMDTGEWVPQMMWTDTLLIDADTLTLAQTWRYLLPV 
XBFFL1_230005  321 -----TREGILRVQLPGHRPFILLRMLSGEMLPDLMYPDTLIIDSEALTLSMTYRYHAEM 
S70_18065      317 -----TPSGELNTTLPGHRPFVLLRMLNGLFIPLHLNLDTLLIDTEKLQLSLTYRLMFEA 
 
 
H.rub          441 HPAIGCLEARQMSRAQ--------------WQAAWRSAATLNN 
AK36_2615      393 QPAVRVCEARFELDRHAPLLRMAVPKTSSEPEDAWQTT----- 
I35_1209       393 QPAVRVCEARLELDRHAPLLRMAVPKTTSEPEDAWQTT----- 
DO62_785       393 QPAARVCEARFELDRHAPLLRMAVPKTTSEPEDAWQTT----- 
BCAL1295       393 QPAVRVCEARFELDRHAPLLRMAVPKTTSEPEDAWQTT----- 
GHAL_1578      377 SSSIRVMEARYSLAGE--------------------------- 
SBG_1847       377 NPSVRVMEARYHVPGE--------------------------- 
XBFFL1_230005  376 DESIRLMEARFEMNPDAPLVRVDLGDGKELHYG---------- 





Figure	 3.15	 Alignment	 of	 the	 protein	 encoded	 by	 BCAL1295	 with	 other	 DUF2169-
containing	 proteins.	Amino	 acid	 sequences	 encoded	by	BCAL1295	 and	 I35_1209	 from	B.	
cenocepacia	 J2315	and	B.	 cenocepacia	H111,	 respectively,	 and	other	 identified	DUF2169-
containing	proteins	were	aligned	using	Clustal	Omega.	The	proteins	used	in	the	alignment	
are	encoded	by	genes	that	are	 located	 in	a	similar	position	as	BCAL1295,	 in	that	they	are	
located	upstream	from	a	gene	encoding	a	product	whose	NTD	shows	homology	to	the	NTD	
of	 the	 protein	 encoded	 by	 BCAL1298.	 Black	 shading	 indicates	 identical	 residues	 at	 the	
corresponding	position	in	50%	of	sequences,	grey	shading	indicates	similar	residues	at	the	

























                         
BCAL1300/1-144         1 ---MTRLPKKIQDGLDALSEQGNVLCDASKFDEAIQRWSAALELLPEPRVDWEA-YTWLC 
XFF4834Rchr30940/1-149 1 MQRKPEVEAVLRAEIDHLLEQSTQRFRSGALAESLALGLQAWALIPEPKANWDYYPQSLS 
TZ03_26795/1           1 MNDLSEINLPLSQEIVAIVEAGNLLHESGAYESALEKYGESWNMLPEPKEQWDL-AHWVA 
BTI_2256/1-143         1 ---MEDLNTSVRDEIDALFIQAKSKLESGDKSGAIQDAEAAWKTLPEPKFGWDV-SKSFT 
BCAL1299/1-148         1 MHMAMKLPEELTKDVYAYGAAGREAWKKGDIAEAEVNFTKAWEILPEPREQYDL-AQSMT 
X976_1940/1-146        1 --MAMKLPEELTKDVYAYGAAGREAWKKGDIAEAEVNFTKAWEILPEPREQYDL-AQSMT 
S.malt/1-149         1 --MALSLDAELEERFLAIAKRGRTAWLAGDIAEAEHCFLESWDMIPEPKSAYDY-GQITS 
P.aeru/1-102           1 --------------------------------------------MPEPKLEYDF-SQSAS 
 
                     
BCAL1300/1-144        57 ASIGDAQYQLEEFEAARQSFFDALN--GPGGQENPFVHY-RLGQSQVSLGDEEHGVASLL 
XFF4834Rchr3094/1-149 61 ASFVQDYATLHDRENVHQWIEVMALMYDDPDHTDHLVLM-TEGEAMLQLGDEARACAVFG 
TZ03_26795/1-144      60 KCYSRLYLELERYDEAKVWAVRAVQ----TKPPRETSSFIFLGASHLGANEKESAYEFFK 
BTI_2256/1-143        57 HALAKIYRDTGYFQNAIALMNELF-ASGSVKPYQDGPRF-VMATIYFEMGDNENAMKWFD 
BCAL1299/1-148        60 RGFVVFYRDTKQFDKAVHWLAEMKKAYGSGTGPDLTIGF-LSGTVYFEAGDLDKSAEFFV 
X976_1940/1-146       58 RGFVVFYRDTKQFDKAVHWLAEMKKAYGSGTGPDLTIGF-LSGTVYFEAGDLDKSAEFFV 
S.malt/1-149        58 YGIAVFYRDTAQFEKARAWAMVARGIYGEGEGATEYMDE-LAATIQFESGDLDGAYTLFE 
P.aeru/1-102          16 YGIAVFYRSTGQTEKAKLWLNIVKNAYGSGVAAEEYVNF-LEATIHFECGELDEAYKLFY 
 
             
BCAL1300/1-144       114 KAYMLDGEEIFDEDDEGEKYLQMLRDRKLVG---- 
XFF4834Rchr3/1-149   120 KIYALYGKKGFAGHQ--KPYLEMLRKQRPTGA--- 
TZ03_26795/1-144     116 KAFELGKGRAFQGFD--KKYLDFFTGYQEEK---- 
BTI_2256/1-143       115 EASQISKGRCFRGED--KKYQEFYKSRVAGK---- 
BCAL1299/1-148       119 PLYEQFGNRPFSGED--KKYLEFAKRASKGSK--- 
X976_1940/1-146      117 PLYEQFGNRPFSGED--KKYLEFAKRASKGRK--- 
S.malt/1-149       117 PQYRKYGRRVFEGHK--KGFIDFIKSRKKTGKVDQ 




Figure	 3.16	 Alignment	 of	 TPR-repeat	 containing	 proteins	 encoded	 by	 BCAL1299	 and	
BCAL1300	 from	B.	 cenocepacia	 J2315.	Amino	acid	 sequences	encoded	by	BCAL1299	and	
BCAL1300	 from	 B.	 cenocepacia	 J2315	 and	 other	 proteins	 containing	 TPR	 repeat	 regions	
from	 both	 Gram-negative	 and	 Gram-positive	 bacteria	were	 aligned	 using	 Clustal	 Omega.	
Coloured	 overline	 indicates	 34	 amino	 acid	 sequence	 corresponding	 to	 TPR	 predicted	
regions	 according	 to	 the	 CDD	 database	 and	 consensus	 sequence	 in	 Blatch	 and	 Lässle	
(1999).	Black	 shading	 indicates	 identical	 residues	at	 the	corresponding	position	 in	50%	of	
sequences,	grey	shading	indicates	similar	residues	at	the	corresponding	position	in	50%	of	








facilitate	 the	 binding	 of	 a	 cognate	 effector	 protein	 to	 the	 TssI	 subunit	 encoded	
within	the	vicinity	of	the	adaptor	and	effector	genes.	A	candidate	effector	protein	
for	 the	 putative	 chaperone	 encoded	 by	 BCAL1356	 is	 the	 protein	 encoded	 by	
BCAL1358.	 This	 contains	 a	 DUF2235	 domain,	 which	 has	 been	 linked	 to	 T6SS-
dependent	antibacterial	effectors.	This	includes	the	experimentally	confirmed	T6SS-
dependent	 substrate	 BTH_I2698	 that	 was	 identified	 in	 a	 mass	 spectrometry	
secretome	analysis	of	B.	thailandensis	(Russell	et	al.,	2012)	and	a	protein	containing	
a	 C-terminal	 DUF2235	 region	 encoded	 by	 v12G01_02265	 in	 Vibrio	 alginolyticus	
(Salomon	 et	 al.,	 2014a).	 	Moreover,	 the	 DUF2235-containing	 protein	 encoded	 by	




residues	 373-379	 and	 is	 flanked	 by	 the	motifs	 that	 define	 the	 Tle1	 class)	 (Figure	
3.17).	This	suggests	that	DUF2235-containing	proteins	are	Tle1	proteins.		
Similar	 to	 other	 Tle1	 effectors,	 BCAL1358	 has	 a	 predicted	 DUF3304-
containing	lipoprotein	encode	upstream	of	the	effector	(BCAL1357),	which	is	likely	
to	 be	 the	 effector’s	 cognate	 immunity	 protein,	 Tli1.	 A	 DUF3304-containing	
lipoprotein	encoded	upstream	of	a	tle1	gene	in	B.	thailandensis	(encoded	by	BTH_	
I2699)	 has	 been	 experimentally	 verified	 as	 the	 Tle1	 effector	 immunity	 protein	
(Russell	et	al.,	2013),	with	which	BCAL1357	has	sequence	homology	to	(Figure	3.18).
3.4.3.2 A	DUF4123	domain	protein	encoded	by	BCAL1363	
Interestingly,	 the	 BCAL1363	 gene	 located	 immediately	 downstream	of	 the	











V12G01_02265  523 ---------------LIRQQKYQAITHIEFDVFGFSRGAALARHFVNAVKDGLPDYNKPR 
BCAL1366      241 RLKAAVEDFKAAV---AGAKQAGTVNKIHVAIFGYDMGGGLALAFARQLLDEVA------ 
PA3290        203 ---PKLKELEEKLRQRQNSGQKPHILAMRLYIYGFSRGAAEARAFANWLQELTRVSDA-- 
BCAL1358      236 ---ARCAQLKVRVG-DLLVKGKPKLQRIRLYVFGFSRGAAEARTFSNWLADALD------ 
BTH_I2698     236 ---DRRAQLKARVG-DMLVKGKPRIQRIRLYVFGFSRGAAEARTFSNWLVDALE------ 
BTH_I2701     236 ---DRRAQLKERIG-DLLVKGKPKLQRIRLYVFGFSRGAAEARTFSNWLADALD------ 
BCAM0046      144 --------------------HMPAVSQINVAAFGFSRGATEARAFVRMLTEQLAENI--- 
BTH_II0937    147 -------------------GSWKHMREVTVAIFGFSRGATQARAFARRFIEQKCGKD--- 
 
 
V12G01_02265  568 DGESFGEVFPNLLTHQNDISSQLKHGYYPDETRTCSVRFVGLFDTVGSFYLAGNNDEGN- 
BCAL1366      292 -------------------------KGGKYDGVSVKIKFMGLFDCVTNRFDD-NLLTG-- 
PA3290        258 DGR----------------------VEYRFAGLPISIEFLGLFDTVAAVGLADSAPF--- 
BCAL1358      286 -------------------------PDFSLCGVPVSYDFLGIFDTVASVGIAQSTAATL- 
BTH_I2698     286 -------------------------SDFSLCGVPVSYDFLGIFDTVASVGIAQSAAATL- 
BTH_I2701     286 -------------------------PDFSLCGVPVSYDFLGIFDTVASVGIAQSAAATL- 
BCAM0046      181 GGR----LWWN-------------KKNMKGMRPEVVVYFMGILDTVASTGFGGSRLEKAA 
BTH_II0937    185 GGR----LYWA-------------AP--SGMRVPLRITFMGIFDTVASVGG--------- 
 
 
V12G01_02265  627 ------------------------FE------LGL---------------DTSCAERVFQ 
BCAL1366      324 -YI-----------------PLS---NAVSSDLILS----------------PDIEKCVH 
PA3290        293 --------------------AAGHMDWADDT-MRLPDEALSQCLPTILPEDCSFLKRCVH 
BCAL1358      320 --------------------FDGHGGWGRKELMGVP----------------RYVRRCVH 
BTH_I2698     320 --------------------FDGHGGWARKELMAVP----------------HYVRRCVH 
BTH_I2701     320 --------------------FDGHGGWGRKELMAVP----------------HYVRRCVH 
BCAM0046      224 PYIVGAILGPVYGGVLHGIDKGGHAEWAN--DIRIP----------------DYVRQCVH 
BTH_II0937    217 --------------------PALHLDWAS--ELAIP----------------AEVERCVH 
                                                             G.xSx.G 
V12G01_02265  642 ISAHHEYRKNFPLTSLLPSDSIL----------PSNFYEEVFAGCHTDIGGGYPSKEQYA 
BCAL1366      347 YAAAHELRVYKPLTMLGVDPSDM----------RGRRQERLFPGAQVDVGGGAIEGED-- 
PA3290        332 LVSCHEQRASFPLDSIRRRDMDANGRRTGPSCYRKWTVEYAYPGVHSDVGGGYGVGNQGK 
BCAL1358      344 MVAAHEPRGSFPLDLIDASR--------------DGHEEIVYPGVHSDVGGGYGPGEQGR 
BTH_I2698     344 MVAAHEPRGSFPLDLIDCSL--------------EGREEIVYPGVHSDVGGGYGPAEQGR 
BTH_I2701     344 MVAAHEPRGSFPLDLIDCSM--------------DGREEIVYPGVHSDVGGGYGPGEQGR 
BCAM0046      266 YVASHEVREKFPGDSVREDQKLP-----------ANCREVYYPGMHSDVGGGYERNYQ-- 
BTH_II0937    239 YVSAHEVRRAFPLDSVRVDKSYQ-----------GSCEEVVYPGVHSDVGGGYGPE-E-- 
 
 
V12G01_02265  692 KQGLP--ERYGMPLSATYNRELIKTES-------IREDIQAQQNVYG-----AAAYSERL 
BCAL1366      395 ---GISDKLARVPLEMMYHRAYGAGIPMPSLTALANEDGALYQQIVAPPEIQNFQLDYRL 
PA3290        392 AVGGSEFLLSQIALQHMYAEAFEAGAPLQVPAPAVHPDFHEEWRVMVPKIEAEFSVSEEL 
BCAL1358      390 GTGDA-DKLSQVPLLDMYREARKAGVPLDIKGPGVAAEAAA-----------AFAISPAL 
BTH_I2698     390 GRGDA-DKLSQVPLVDMYRAARIAGVPLDIQGPGITSEAAD-----------VFKISAGL 
BTH_I2701     390 GRDDT-DKLSQVPLLDMYREARKAGVPLDINGPGIGADVSA-----------SFKISAGL 
BCAM0046      313 -EGRT-NELANVALNNLFIEAWKAGVPFREPK-DVMETAGG-----------LFAISREL 








of	 P.	 aeruginosa	 (PA3290),	 an	 experimentally	 characterized	 DUF2235-containing	 protein	
encoded	by	V12G01_02265	in	V.	alginolyticus	and	a	further	Tle1	effector	in	B.	thailandensis	
encoded	 by	 BTH_II0937.	 Black	 shading	 indicates	 identical	 residues	 at	 the	 corresponding	
position	in	50%	of	sequences,	grey	shading	indicates	similar	residues	at	the	corresponding	









                                             * 
BCAM0045    1 -------------MNRCWITLLSVMVFSTAACSKSVNDAE-KDSLAPGEVNKWN---DPN 
BCAL1365    1 -----------MKFRAGMHAVALVGLGVLAACSKHGVDVS------------------AE 
PA3291      1 MQKLMSLICVGTKKSIGLVVFLST-FFGLVACQAG-PEVL-------------------- 
BTH_I2699   1 ----MNLHFGSMKIFIRLAVFLMV-FLVSTGCSRA-IDHSSENAIAGNE---SVAQSGDD 
BCAL1357    1 ----MSLNAGSTTFAARLLMFMAI-LLGTAGCSRA-TDMSPAASTAAGASSGAGAAAASG 
 
                                                               * * 
BCAM0045   44 YDVITAGSFNYTDYDIYGVYLLPPDKNSLDDAASADGAHATPRNAKYWSGGGGSRPSLAW 
BCAL1365   32 PHNVCVTGYNEYGRKLHEFWLDNEHKSGCF-----GNPSAREDGEAFGGGGGFACGCK-- 
PA3291     39 --SAPVMGYNHTSAAINEFTVNGAGGPN--------------LGPY--QGDGSQVCCGVI 
BTH_ I2699 52 MMSLKLDALNYTDIPVGTFYVDGVWGGN--------------VFSRIGSGGGGITCCVSL 
BCAL1357   55 TMGLKLNALNYTDVPIGAFYVDGTWGGT--------------VPARIGSGGGAIICCVAL 
 
                           *                                        * 
BCAM0045  104 DFRWKTPKTFKVWWERVVDKRAMEASSANYDPYTHRET----QPGMAWCEGEITVTRPPV 
BCAL1365   85 ---VTPGQKVKLFWEFAQPLDDIQRGIPPE-------------------RKTIDVTIPQP 
PA3291     81 PKRWNPNLKVIVEWEKDPNPR----AVIKRDKYGRLDESDYLRHASSYTRHKATVNVPRY 
BTH_ I269  98 PKKWHPGLSVTVEWRNDEMYK----KNPES-------------------VASRTVPVEKY 
BCAL1357  101 PKQWHPGLTVNLQWRDDNLYR----KDPKA-------------------LASRVVPVERY 
 
                         *                    * 
BCAM0045  160 KDK-SGGIVLHFFPDGRVEGDMDFEVDGP-D-PK-VA-------LSKRDAQHKLADRACL 
BCAL1365  123 ESPTSRYLRVYFRKNGTA---ELQWVDDMNA-PE----------LKPTQEK--------- 
PA3291    137 DEK-VCLLQVHFLPCDEVAVSTTCYGPNHPKYPDKAYFEMRKSTICPAN----------- 
BTH_ I2699135 GEFTGGYLWVLFFPGEGIKVYATPWLPGAADFPEGLQ---APSEACPGDFTLLNSDSRC- 
BCAL1357  138 DTFSDGFLWVLFFPHDRIKVYASQWMPGYRGFPENLQ---APDEACPGNFTLRNSDPQC- 
 
 
BCAM0045  209 KEIPNPFYGRKKPAQWN 
BCAL1365      ----------------- 
PA3291        ----------------- 
BTH_I2699 191 ---KNPDKR-IKP---- 




Tli1	 immunity	 proteins.	 Amino	 acid	 sequences	 encoded	 by	 BCAL1357,	 BCAL1365	 and	
BCAM0045	from	B.	cenocepacia	 J2515	were	aligned	with	an	experimentally	characterised	
Tli1	 immunity	 proteins	 from	 B.	 thailandensis	 (BTH_1266),	 and	 a	 Tli1	 in	 P.	 aeruginosa	
(PA3291)	 using	 Clustal	 Omega.	 Corresponding	 DUF3304-regions	 are	 boxed	 in	 red.	 Black	
shading	 indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	
grey	shading	indicates	similar	residues	at	the	corresponding	position	in	50%	of	sequences.	






lipoprotein	 that	 shares	 homology	 with	 Tli1	 immunity	 proteins	 Figure	 3.18).	
Therefore	it	is	likely	to	be	the	immunity	protein	of	the	BCAL1366.	Whether	the	Tle1-





Within	 the	 BCAL2279	 tssI	 cluster	 there	 is	 a	 predicted	 Tle3	 class	 of	
phospholipase	effector	encoded	by	BCAL2277	that	 is	 located	directly	downstream	
of	the	tssI	gene	(Figure	3.10D).	The	BCAL2277	gene	product	 is	homologous	to	the	
identified	 Tle3	 effector	 of	 B.	 cenocepacia	 PC184	 (ZP_04941041)	 (Russell	 et	 al.,	
2013),	 and	 also	 homologous	 to	 the	 experimentally	 verified	 anti-bacterial	 T6SS-
dependent	substrates	of	B.	thailandensis,	encoded	by	BTH_II0090	and	BTH_II3226	
(Russell	 et	 al.,	 2012).	 	 Alignment	 of	 the	 protein	 encoded	 by	 BCAL2277	 (residues	
203-283)	 with	 other	 Tle3	 phospholipases	 indicated	 that	 the	 protein	 contained	 a	




Analysis	 of	 the	 BCAL2272,	 BCAL2274	 and	 BCAL2276	 genes	 located	
downstream	 of	 BCAL2277	 suggested	 their	 products	 shared	 sequence	 homology	
with	 each	 other	 and	 with	 two	 Tli3	 proteins	 encoded	 downstream	 from	 the	
experimentally	 verified	 BTH_II0091	 and	 BTH_I3227	 Tle3	 effector	 genes	 of	 B.	
thailandensis	 (Russell	 et	 al.,	 2012)	 (Figure	 3.20).	 The	 two	 Tli3	 proteins	 from	 B.	
thailandensis	are	identified	as	containing	DUF2875	domains.	However,	the	putative	
Tli	 proteins	 encoded	by	 the	B.	 cenocepacia	 J2315	BCAL2279	 tssI	gene	 cluster	 are	
not	 identified	 as	 having	 this	 domain.	 Nevertheless,	 upon	 alignment	 of these	






BCAL2277      1 MFNYNFAQNPGGQPSTDDPSQTPVGGGLGTTLFNRNDLECVMQMPLPGVVIFVHGVNSEG 
PA0260        1 --------------MNDRVRSRTIVSAQSITLPKGGDVHLVPPPPKPCVTIVVHGVNDLA 
BTH_I3226     1 ------------------------------MANRPGDRPVPIPRDLPGVVIFIHGVNDPG 
BTH_II0090    1 ------------------------------MANRPGDRPVPIPRDLPGVVIFIHGVNDPG 
 
 
BCAL2277     61 EWFQEAEKGLCAGLNRRMGRYDDQLFHWGPVAGQMTPVSYIESLTPDGFLNPEMSSKTYI 
PA0260       47 GCYERIERGLCQGLNERLDMPPTLPGGQA--------N--PGYLTPAGYSLPADDEGKAE 
BTH_I3226    31 AAYATVERGLCQGLNERLSRSDLRPAEYG--------REYAEAIKAKDRKSPFFDSKIAN 
BTH_II0090   31 AAYATVERGLCQGLNERLSRSDLRPAEYG--------REYAEAIKAKDRKSPFFDSKIAN 
 
 
BCAL2277    121 KPD---------------PSFSPVIHFRWGYAANAQELKEYGDK---------------- 
PA0260       97 NPDVVYYRRKFASGAGGAAVRSVVVPFYWGFREEEQYINKTA-----------------A 
BTH_I3226    83 DPDMYLYRRAESG-----GAHSMFLPFYWGYRASDNEIAKINHPGEIKSRVADSDGNLMT 
BTH_II0090   83 DPDMYLYRRAESG-----GAHSMFLPFYWGYRASDNEIAKINHPGEIKSRVADSDGNLMT 
 
 
BCAL2277    150 ---------IMLNEKNYWGGGPFAGGCSSLPDLWNDGLNDRLFLWLTVQHM-NSIGNRKI 
PA0260      140 HGEWLDRNGNRLDKSGTKEGGQFVNATTNLPDMWGQGFNGKLFGFISLDW-FGGTMTHPL 
BTH_I3226   138 RGQYQDIHGNRLDAHFGKGGGFFANATNNIPQMYSRGFEPDKLERTVMQNALAGN-TIFA 
BTH_II0090  138 RGQYQDIHGNRLDAHFGKGGGFFANATNNIPQMYSRGFEPDKLERTVMQNALAGN-TIFA 
 
                                                               GxSxG 
BCAL2277    200 YSTPPRTYGVLGALRLARLVESIRKRQA------------DAPITIVCHSQGNMIGLAAA 
PA0260      199 FSAAGRKYMVLAAMRLAMLIKIIRKRYP------------DDTINVVGHSQGTLLTLLAH 
BTH_I3226   197 GKSPERRYFVLAAARLANLIKTIRTIQPSALALEHGMDPQHETITVMGHSQGTIITLLAQ 
BTH_II0090  197 GKSPERRYFVLAAARLANLIKTIRTIQPSALALEHGMDPQHETITVMGHSQGTIITLLAQ 
 
 
BCAL2277    248 FLGDRLPEVTDQWGKKGRCVADTYVLANPPYSLVEANMTD--SWAQRGVRDKNGHVGRET 
PA0260      247 AF----------LKDDGVAPADGVIMLNSPYGLFEPLNEKLQGWSSQQ-----------T 
BTH_I3226   257 AM----------LKQQGQRCVDCIIMVDTPYSLQFTK------DGSQQ-----------T 
BTH_II0090  257 AM----------LKQQGQRCVDCIIMVDTPYSLQFTK------DGSQQ-----------T 
 
 
BCAL2277    306 YVARKETLRAYFDILRARAELEMPAEDLDRAMES-ARP-SKDGGKPYSAA-------KDR 
PA0260      286 REA---RLATLKGILEFICGRRHPVPALSSVALRNCQGYGAIGGPGWVGGQGCQTTIDG- 
BTH_I3226   290 GHA---KLKTLVDIVNAVTSEPHTIPDLAELMIDSAHSCGR-AGQNWSQTQGKRLDKSGK 
BTH_II0090  290 GHA---KLKTLVDIVNAVTSEPHTIPDLAELMIDSAHSCGR-AGQNWSQTQGKRLDKSGK 
 
 
BCAL2277    357 EAHGLYQKNTYGRVTLYCCPHDQVISALTVQGIGWRGMSIDEISATNAWGVFSQRVFASN 
PA0260      342 ERLSFDERDNRGSVYLYFTPQDQTVGLANVQGIGWRGIAEQVKGL------------PG- 
BTH_I3226   346 HWITFDERDNRGKVYLYFCPEDTVVGLDKVRGIGTFGVPDEVPADGAAA-SRG-KTMPA- 
BTH_II0090  346 HWITFDERDNRGKVYLYFCPEDTVVGLDKVRGIGTFGVPDEVPADGAAA-SRG-KTMPA- 
 
 
BCAL2277    417 FEVGGESKLYRYWQDDWRKDKNQKEG-----FWYPPSPPARYGLGRG---MHSNEGWIAK 
PA0260      389 ---RTG-LPQGFHQRIFTVRKRN----GEKEKIGGHAPPHVYPLLLAGEKT-----WEDT 
BTH_I3226   403 ---MTALEPKRFFQRMWTRLERDQDGRGRRSKVAVGTPPARVPVRDPFQRLTPGPDTDGT 
BTH_II0090  403 ---MTALEPKRFFQRMWTRLERDQDGRGRRSKVAVGTPPARVPVRDPFQRLTPGPDTDGT 
 
 
BCAL2277    469 IFTLATSPVFYLFNLTDMAVNAEPPKNWEIPITAPMLDK--ETRFL--PQALRYGKPSGA 
PA0260      436 GL-----------GGKDRFGRANFDQGDSVLLTAPRLPLPTEARFDFDGAV----TAPGE 
BTH_I3226   460 MLGTLV------ESGKNMALQASFKRNDIRLINGEQLKPAYEP-DLYGGEVQKGGQVPGH 
BTH_II0090  460 MLGTLV------ESGKNMALQASFKRNDIRLINGEQLKPAYEP-DLYGGEVQKGGQVPGH 
 
 
BCAL2277    525 CDAQGKPIEEGRFNEGYDPPSAGRDANKENKRDDDPYDNFDAKSEKFKTEGDALKAQGDA 
PA0260      481 NSASGVY----QVRDTLDPIDAA-----------IGVSNGGWKE---KDSGHAVAQQVDA 
BTH_I3226   513 ADVAGLM----RPDDVTKNVALG-----------NQYAKFQWKD---VATTDD------- 
BTH_II0090  513 ADVAGLM----RPDDVTKNVALG-----------NQYAKFQWKD---VATTDD------- 
 
 
BCAL2277    585 A---------SEAAQRY-------E-DHSILRMEARRSGNRRWVDKEGN------VIGED 
PA0260      523 ALAYRYGRDARSVERALNEGKELAQQTHVFS---ARELGT-----------GMVLVTRAE 
BTH_I3226   548 -----PGASIEPHKQAFNRGRPVDEQSHNWRIVPSRSLGSMLSAAATGGRYQTYVIQREE 
BTH_II0090  548 -----PGASIEPHKQAFNRGRPVDEQSHNWRIVPSRSLGSMLSAAATGGRYQTYVIQREE 
 
 
BCAL2277    622 NPEAASADYTEWRNNEIFQILNGGDKNNPTNHSTIMTNKDHAERALAYDVAIGLCYLTED 
PA0260      569 TPYEAR---------LR-LQTAEGHLEPLSFHSAIPNNPEHNRRVLAYDLAIGAGDSVDD 
BTH_I3226   603 TPDEVR---------KR-MRTDADQLEANNYHSGVLLSSENHRWVTAMDVAIGQAVTLDD 






BCAL2277    682 --DFKYLRIQADWRFASDSKKGDPNFHL------MD------YINTGKHGDLFLPDWVKK 
PA0260      619 VVFYQYLCRVADWRLDWKASDKGIFSQGDASVDLPDEEVRALYRAEESKNSQLIDATVAY 
BTH_I3226   653 PDWRQLLLLMADWKMTPSAQKKITNCKS--------------FARLDDHTQGFIDACAKY 
BTH_II0090  653 PDWRQLLLLMADWKMTPDVYRNIQKCKN--------------FERLDEHTREFVKACVDY 
 
 
BCAL2277    728 DESAA----------MPGKIHD----ERDGGFFMKLGGIL 
PA0260      679 RKSGEFPVV--VGNRLPSLVGTQTILDRYHEQAVRFGGTI 
BTH_I3226   699 YQKGLFPSEKFVSLALPSLITSELKLDQKT---------- 
BTH_II0090  699 YKTGRFPDEKYVPLILPPLVTSELKVESKT---------- 
	
Figure	3.19	Alignment	of	the	BCAL2277	protein	product	with	characterised	and	putative	
Tle3	 effectors.	 Amino	 acid	 sequences	 encoded	 by	 BCAL2277	 from	B.	 cenocepacia	 J2315	
was	 aligned	 with	 an	 experimentally	 characterised	 T6SS-dependent	 Tle3	 phospholipase	 A	
effectors	from	B.	thailandensis	(BTH_I3266	and	BTH_II0090),	as	well	as	an	identified	Tle3	of	
P.	 aeruginosa	 (PA0260).	 Black	 shading	 indicates	 identical	 residues	 at	 the	 corresponding	
position	in	50%	of	sequences,	grey	shading	indicates	similar	residues	at	the	corresponding	
position	 in	 50%	 of	 sequences.	 The	 conserved	 Tle3	 motif	 is	 indicated	 in	 red,	 the	 red	





BTH_II0091    1 ------------------------------------------MARSIRNGVLVALGVVAA 
BTH_I3227     1 ------------------------------------------MVSSIRNGVLVAAGVAVA 
BCAL2276      1 MKAVIATWPRRVGVASLALFFALGASFLILISSGKPAGELLGMGNLLKR-LVLVPGLVAI 
BCAL2274      1 ----------------------------------------MHCFTLAR-----RIGCVSI 
BCAL2272      1 ----------------------------------------MHCFTLAR-----RIGCVSI 
 
 
BTH_II0091   19 -AFAVSYVWLHRAPQEPMPAAVSSAAAVSETTEAVIRGNNGTPALLAQTGEKFVLEVRGL 
BTH_I3227    19 -AFVASFVWIKRAPVESSHAAASSTSASPVLPAAATHGNNGAPALLAQTGDKFVLEVRGL 
BCAL2276     60 MVFAF-ATVIAAPRA-----------------MAASSADKAVPIAGASSSKPFVAQVVGL 
BCAL2274     16 ---VM-ATFLSSPPL-----------------RAETRAASTQ-SVEGASAAPFVAQVVGL 
BCAL2272     16 ---VM-ATFLSSPPL-----------------RAETRAASTQ-SVEGASAAPFVAQVVGL 
 
 
BTH_II0091   78 GLVTGHNAN------DEIWKAIDAKANNHSTYMSQNPTDYPDNKDSRMTYLGVATGLSFQ 
BTH_I3227    78 GLVTGRNAN------DEIWNAIEAKADNHSTYMSQNPADYPDSEDSRMTYLGVGTGLSFQ 
BCAL2276    102 GWMNPLQRRDYPTEWQILWTLGLVKPNVNDDMVRTNPKKYSTLQAISIVADGNGGGESFA 
BCAL2274     54 EWLNPLQRRDYPTEWQLLWTLGLASANKNDDMVRANPKKYSAVQAISIIADGSSGRESFG 
BCAL2272     54 EWLNPLQRRDYPTEWQLLWTLGLVKPNANDDMVRTNPKKYSTLQAVSIVADGRRGRESFA 
 
 
BTH_II0091  132 LAAHHSVEYWPVPVFIWEPPKDRRFGRPGAALDGIRQEASLGVTLLLWQEDANTDDGASI 
BTH_I3227   132 LAAHHSVGYWPVPVFIWEPPKASHVSRPANELSGIRQEASLGVTLLLWQEDANTNDGSTI 
BCAL2276    162 GFYE------------------------------------------------------KY 
BCAL2274    114 GFYE------------------------------------------------------KY 
BCAL2272    114 GFYK------------------------------------------------------KY 
 
 
BTH_II0091  192 VEKLFAFFDSHPDVPEAIIYTLDGSMKRWLNETPGYIDTFGQSNIPSMPDSMVAMLVSRS 
BTH_I3227   192 IEKLFEFFDAHPDIPEAIIVTFDGAATRDLNQTPGYVDTFKQSNIPTMPDSMAAMLVSRS 
BCAL2276    168 VDKLLLLFRAPYFTGEDYFYTVSSDDKRKWRELAGVHVELAIPSERIEPASAASYL---- 
BCAL2274    120 IDELLVLFRTRYFTDSNYFYTVKPGDRSRWRELAGVHVELAI-SGRLDPIKAKAYL---- 
BCAL2272    120 VRELLVLFRTRYVMNPDYFYTIGSKYKREWRELAGVHVELALPAGRLDPEGAGAFL---- 
 
 
BTH_II0091  252 DRVDRLIRPYAVEQTENVNNGTADYDVTRLWNFFW----KVNQDRGPDSFTAHYEAEEKR 
BTH_I3227   252 DRVDRLIRPYAVEQTENVDKNTTEYDITKLWNFFW----EKNNGEGPGSFEAYYQEQQKA 
BCAL2276    224 --RNRIVNIFEIGNP----------SAKNLWSRDTPPDVHVTTGHGNAGFTSLNAALDYL 
BCAL2274    175 --RDQIISTFEIGNS----------SAKDLWSHDTPPDVHVTSGQGNAGFTSLNAALDYL 







BTH_II0091  308 AGVNTPMSAGFATSAWWQTKLPDFWKTISNKGPGEF-----KPTPYIPVRWTTWQVGQFD 
BTH_I3227   308 AGIRPRAFLGFMSAQWWQTQLPDFWKTISNKGPGEF-----KPTPYIPVRWTTWQVRQFD 
BCAL2276    272 AT-HPDKS--AWVMNWDAPSFPPNDEQINENMVVLFLAGPDLKTEREPLAWIGK------ 
BCAL2274    223 AA-HPDKS--AWVMNWDAPSFPPNDEQINENMVVLFLAGPDLKTEREPLAWIGK------ 
BCAL2272    224 AA-HPDKS--VWVMNWDAPSFPPQDEQINENMVVLFLAGPDLKTEREPLAWIGK------ 
 
 
BTH_II0091  363 NAPLLGYLHRPIDVKLADAHGKPLKTAQQAQALKAGWQQAVDTLPTGETP--KRIFYD-- 
BTH_I3227   363 NAPLLGYLHRPIDVKLADAHGKPLKTAQQAQALKAGWQQAVDTLPTGETP--KRIFYD-- 
BCAL2276    323 ---------------AARSNVKDFDAKQGASRAVQAWKSTIDTAASNAGVPVSSVNYIVH 
BCAL2274    274 ---------------AARSNVKDFDAKQGASRAVQAWKSTIDTAATNAGVPVSSLNYIVH 
BCAL2272    275 ---------------AAQGSVQDFDAKQGEGRAVQAWKSTIDAAAANAGVAVSSLNYVIP 
 
 
BTH_II0091  419 TT--GD---RAWVAPINQALAQSGPSAPSLDDVKEGYDIGRRIGNTGISSPLVQIGLGLI 
BTH_I3227   419 TT--GD---RAWVAPINQALAQSGPSAPSLDDVKEGYDIGRRIGNTGISSPLVQIGLGLI 
BCAL2276    368 DAGKGSDAASTRIASLSQTLTE---VLPEYDFRTQTFNTSALLGDMGAGAALTDVVLAIG 
BCAL2274    319 DAGKGSDAASTRIASLSQTLTE---VLPEYDFRTQTFNTSALLGDMGAGAALTDVALAIG 
BCAL2272    320 DAGKGSAAASSRAASLSQGLAE---AVPESDLRGETFNTSALLGDMGAGAALTDVALAIG 
 
 
BTH_II0091  474 ASYNEGGASATIHRRPNGTA-TIVMVSPPTH--KQPDVNPFR------------------ 
BTH_I3227   474 ASYNEGGASATIHRRPNGTA-TIVMVSPPTH--KQPDVNPFR------------------ 
BCAL2276    425 RANHLGGNVLVAGTTDAEHPTAVVVVAPSKLTPIDATKNWFRARGGNNAYLPWWGRRHDA 
BCAL2274    376 RANHLGGNVLVAGTTDPEHPTAVVVVAPSKLTPIDAGKDWFRARGENNAYLPWWGRRHDA 
BCAL2272    377 RANHLGGNVLVAGTTDTEHPTAVVVVAPSKLTPIDPGKDWFRARGENNAYLPWWGRRHDA 
 
BTH_II0091      --------- 
BTH_I3227       --------- 
BCAL2276    485 SPTTQGYSK 
BCAL2274    436 RPASQGYSE 
BCAL2272    437 RPASQGYSD 
 
Figure	3.20	Alignment	of	the	BCAL2276,	BCAL2274	and	BCAL2272	protein	products	with	
characterised	 Tle3	 immunity	 proteins.	 Amino	 acid	 sequences	 encoded	 by	 BCAL2276,	
BCAL2274	and	BCAL2272	from	B.	cenocepacia	J2315	were	aligned	with	the	confirmed	Tli3	
proteins	 from	 B.	 thailandensis,	 encoded	 by	 BTH_II0091	 and	 BTH_I3227.	 Black	 shading	
indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	 grey	
shading	 indicates	 similar	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences.	





































The	product	of	 the	BCAM0046	gene	 located	 several	 genes	downstream	of	
the	BCAM0043	 tssI	 gene	 (Figure	3.10E)	 has	previously	 been	 identified	 as	 an	 anti-
bacterial	 Tle1	 phospholipase	 by	 bioinformatic	 analysis	 (Russell	 et	 al.,	 2013).	
Alignment	 of	 the	 protein	 encoded	 by	 this	 gene	 with	 the	 experimentally	






BCAM0046,	 BCAM0045,	 is	 a	 predicted	 periplasmic	 lipoprotein	 that	 contains	 a	








identified	 in	B.	 cenocepacia	 H111	 and	 AU1054,	which	 are	 phospholipase	 D	 (PLD)	
enzymes	(Russell	et	al.,	2013).	Alignment	of	the	BCAM0149	gene	product	highlights	
the	presence	of	 two	 conserved	HxKxxxxD	motifs	 (residues	263-270	and	581-588),	




PA3487(pldA)       1 -------MLQKKPYNGLHEKELNQIN-QQDGSPCVAISAPGCFIK------GSNLFSEKR 
RALTA_B1035        1 --------------MGAPDKQVYQIVGGDQKAAKTATSAPGCFVH------GKDVFSEPV 
HMPREF9418_1021    1 MPNDSKTQSKSKPKNGQMP-----IT---QKK---STVAESWFVGKGG---NKNVPSAEQ 
BCAM0149           1 MA------NINKS--ITTP-----IAQNHTSS---AMACLPWFVCNS-------EYSPSA 
CV_1234            1 MS---QPLAKHKP--RQHN-----VDPSQHQT---TRTSTPWFLADDHPVGYKPEFHEVN 
 
 
PA3487(pldA)      47 AGNRVRFFTTGRDYFSDLASALDSASSSIFITGWQVNYDVLLDGRRSLWQ---CLRQA-L 
RALTA_B1035       41 KGNAVQFFVTGTEYFDNVARAIEGAQSSVFITGWQVNFDVVLTGKKTLWN---CLRTA-V 
HMPREF9418_1021   47 A--TFLSLVNGEVAFGELYDSIEKAKKSVEIVCWGFQPSMYFKRGVNLAG---------- 
BCAM0149          38 A--GFRPLVNGRDAFAAVYKAIADAKHSIDIICWGFQPSMYFLRDGTGK----------- 
CV_1234           48 A--TFEPLINGERAFGAIYDAILAAKHSVDIVCWGFQPSMYFKRGAGAPPIQYYLQQPQL 
 
 
PA3487(pldA)     103 E------------------------------------------RSPALKVYVMPWLSPSG 
RALTA_B1035       97 R------------------------------------------NG--ASVYVMPWMSPKV 
HMPREF9418_1021   95 --------------------------------APIGELLMEKFIQNNVDVKILCWQT--- 
BCAM0149          85 ---------------------------------RIGELLEQK-GKEGVKVRLLCWRD--- 
CV_1234          106 PPLTADNIDKIADDMAGKLPFTRRKLHPKDKIMPIGELLEMK-SLEGVKVRILTWND--- 
 
                                                                      HxKxxxxD 
PA3487(pldA)     121 SLGTYDFETMLAVFQLNAGLEGGARAFCTPAIQQSDM-QGLGVAFSHHQKSVVIDNRIGY 
RALTA_B1035      113 GVDTGDLETALTVIQLNAGLPSP-RAFVLPAVSQCDQPGALGIAFSHHQKLVVIDNKFAY 
HMPREF9418_1021  120 ------------------------NPFATEKFLEDNTPGRSTLLFMHEYLA--YEHFLDF 
BCAM0149         108 -------------------------PFYMAELSENNMPGNDFITPLKRAL---------- 
CV_1234          162 -------------------------PISQIP--EVMNPGYNV------------------ 
 
 
PA3487(pldA)     180 VGGIDLAY---------------------GRRDDNDFSLDASGRRGNDAYNPGLPHLGWM 
RALTA_B1035      172 VGGIDLAY---------------------GRRDDGKYSLKAEGRQGSEFYNSCVPAIHSL 
HMPREF9418_1021  154 ILEPDNIYSHFEKLEKEKFLEPKVAMHKMGSRERHKFYR---GKR-SHSVEQRRFDWAWY 
BCAM0149         133 ---PKWVYDH-------------------------VSML---GRD-YQTDEERVFDINWY 
CV_1234          177 --------------------------------------K---RGD-NENFLQECYDIGWH 
 
 
PA3487(pldA)     219 AEDEHVSSMG--LMMATLF----DLSRPLASLTLHAPTLRLSPFPHIAASDEPLLSIPLA 
RALTA_B1035      211 SSVEQTAYLTRAELVAACF----DNKAGR--------------------AAQFFLSAPMK 
HMPREF9418_1021  210 DAVEGYNTITSDEEFHKTMEEFQSLHDEFHSLGMGAV--------------GFVL--RVK 
BCAM0149         161 QRANLNNVTNPVSH---------------------------------------------- 
CV_1234          195 QDIRANKN---------------------------------------------------- 
 
 
PA3487(pldA)     273 PSRARALNGAAYLSDLFRSPML-----PSLQW-LGRA--------------YNSSKEGLD 
RALTA_B1035      247 PLAG-AMDAYSSASDKIKDVNK-----QISDWWVTSD--------------V-------- 
HMPREF9418_1021  254 KSVGTGIDEFK---EFFDTHLLPDWIKELRDGWRNMRFGIREEIHFRLMNYVHTAAQGLY 
BCAM0149         175 -SVTDR------------------------------------------------------ 
CV_1234          203 ------------------------------------------------------------ 
 
 
PA3487(pldA)     313 EGFE-------------------------RLDALRRQMVASSIRAI-------------- 
RALTA_B1035      279 --------------------------------------VPEFVRKA-------------- 
HMPREF9418_1021  311 EEYRDGKLVKTAIGVVSKVTGLNSNGPVNDVDDLRIALFDKLFAKVKEEVKGSEPVHLID 
BCAM0149         180 -------IIED-----------TVNLPLNVVAAL-----S------KPFTSGSNPV---- 
CV_1234          203 ------------------------------------------------------------ 
 
 
PA3487(pldA)     334 --ANLI---ADNLDALPIEPELERRLRAWLEELRTAA-----------------LNLPEA 
RALTA_B1035      287 --QDKV---IDA------AQETAADASKWAYQQLGTT-----------------LQ---- 
HMPREF9418_1021  371 QVKGSVTSRLEKLGGLKDD-----LESIWDLFFNFNLFRNYVNCMNYYFLLRNEKKYPNT 
BCAM0149         207 ---------LHKIAGFPN------------IELATRGFD---------LS---------- 
CV_1234          203 ------------------------------IQFRTRHFD---------DI---------- 
 
                                                                             HxKx 
PA3487(pldA)     372 LRIKSLLLINQWMSET-ELGQVLTLISGKGFE-----------DIPQNLSG--------- 
RALTA_B1035      315 TKVEKLREYGGAQVAD-ATTALMAWLNGATLD-----------SLPPSLLQ--------- 
HMPREF9418_1021  426 MAFMRLRNQEDYKNRKQKVSFLPREINPAIFPKDFPFEDKGLSALTKDVLRFTPTHHQKS 
BCAM0149         227 -------------VRSEIVG----RISGYGTM---DGWSGGTKATTSAAMGGEPSHHQKM 
CV_1234          214 -------------DKN-----------AYILP---NLVRNGASTMHAAATSKFPSHHQKT 
                  
                     xxxD 
PA3487(pldA)     411 -----KAGELAGSLFWTLHRLMQA--------------------RAGGHQQPYRYLDEAP 
RALTA_B1035      354 -----NTADTIQAFVMRLVLALQA--------------------EGSQRKQCYANLEKLG 
HMPREF9418_1021  486 VMIDYTDPKSAVGFVMGHNMLDRYWDTSDHYALPDEYKTYTTSRKGPGEVVELEKLENIE 
BCAM0149         267 VLVDYDDSDLATGFVMGHNMLDQYWDTDKHSYQA-------------------------- 





PA3487(pldA)     446 QPLASPDNARLAADQPRMPWQDVHCRIEGPSVYDLARNFIDRWNGQQAYLAKTPALQDTA 
RALTA_B1035      389 KLLPAGGKCPDSSVQPRMPWHDVHCRIEGPSVYDLSRNFVRRWNGVALQYERSDGKTVDA 
HMPREF9418_1021  546 -ESQMRGRDPSAGAFFGTPRQDISCKLTGKVLYDIDANFVQGWNKAIEDNGYYQNRMD-- 
BCAM0149         301 -------MAPSKGRNGPYPWQDISSRVTGPILQYLNKNFCEAWDDATGQKLAKSR--E-- 
CV_1234          281 -------QEPHLGRNGATARHDISSRLTGPVLVHVNHNFVAGWDKATGENLTGKR--A-- 
 
 
PA3487(pldA)     506 LVRSALEAVMKWLNSLAAAAGLEN-YLDEKRNLRLELDPP--TPCWINAPEQLPQEPEVR 
RALTA_B1035      449 LLRH-----------LGIAARLKAPRIGAAHRPVRSKAQP--GSCWVQVLRSAPK----- 
HMPREF9418_1021  603 --------------KIEPVERVKR--E-QFKPQNVEKDDSQTELLYAQVLRTQPE----- 
BCAM0149         350 --------------HLAG--------I-HKIRN----DAPDDVSVMAQIVRTQSE----- 
CV_1234          330 --------------HLEL--------K-HFTPR-----PNLGSRAMAQIARTQSQ----- 
 
 
PA3487(pldA)     563 RGGMTVQVLRSAAARMLEQEQAGRLGAGVNLPLQVGVSTEGVQSNCKDAMLLAISGAQQF 
RALTA_B1035      491 --------------KMRVAEAAGEADK---------TTPSVAESSCLSAMLKNIEGASHF 
HMPREF9418_1021  641 ----------------------------------------YQEENILALYNQNFKMATSY 
BCAM0149         378 ----------------------------------------KNKREIQVMYLNAVNNATQC 
CV_1234          357 ---------------------TRPKGK---------VKDELTVQDIKHLYLNAVNHACQY 
 
 
PA3487(pldA)     623 IYIENQFFQSEFGKEG----EVFKDLPLSGPMASLRDVGSLRR--DFVVRIRLEEALEQR 
RALTA_B1035      528 IYIEGQFFQSDYGSTMIGNEEADGGAPVSGPMHALMDVKGSPGYQKYAAQLGILGVPPGQ 
HMPREF9418_1021  661 IYFENQYFRFPPFAEALRD------------------SCK--ERKNFAERFGIDASGMQP 
BCAM0149         398 IFIQNQYFRWNDLALKIKD------------------VAK--AHAKAGRDFG----RDGS 
CV_1234          387 IYIENQYFRWVNFAEATKQ------------------AVK--NQLAFGRDPG----QHGP 
 
 
PA3487(pldA)     677 DLWLLDWAEVEKIAQEPGTEARQFLKSMLAM------WGVNAQGWLTHKLGEAQHGLLNE 
RALTA_B1035      588 IYKSLKWSQIDDVQRDIRGGGADFVNDLKRV------MATQAQIAGFSALGPSQKSLKNP 
HMPREF9418_1021  701 LCVFVV----TNSSKEGLGPGMINTERMLASLGRRDVMPTVARERILEQAGYGN------ 
BCAM0149         434 IYLFVI----TNSSDDAVGNGTVRTYQMLESLGCGNSMPGVAQLQRSDDYAAQQKDLEAQ 
CV_1234          423 VYLMVV----TNDNAEGMGLGVKNTYKMLDALGKRSQMPTLARSSINEQVKQAER--EVQ 
 
 
PA3487(pldA)     731 IGEALARRIERAIQREHPF----------HVYLVLPVHPEGALNVPNIMHQVHLTQQSLV 
RALTA_B1035      642 ICKALGDRITRAIYDGKPF----------HVYMVLPVHPEGTLDTINIMTQQHLTMQSLV 
HMPREF9418_1021  751 -----------AIQRMFPNLSADSIWRKILPDFILPPPPLKPIEGLND------------ 
BCAM0149         490 LAAQ------QSIQHKFAAQGVDI----------NAASLQGAMNFYQD------------ 
CV_1234          477 IGEN------QN-----------------------AKRTSKPLSDL-------------- 
 
 
PA3487(pldA)     781 FGEQSLVKRIQRQMALKALEGK--SDPAQAREIIERK-DARGRPVYEQQDWSRYLTLLNL 
RALTA_B1035      692 FGSHSLVNRIRRALLAMKYVRERKMEVKRARDAAESAKIEDLNRNIRQGEWQKYLTLLNL 
HMPREF9418_1021  788 ----REVKERELAEKVKKTKNT--E---ELRKILKEDLEK-------EGIKVHICTLVAE 
BCAM0149         522 ----NMAKQQELQQALNELKRK--KQLNAHIDPDAPPLDI-------EGLKVQVCTLVAP 
CV_1234          494 ---------PERRKKLAALKQE--Q--AEANQGKFVDGDI-------PGLKTHVCSLVSM 
 
 
                                      HxKxxxxD 
PA3487(pldA)     838 RTWAVLGGRVVTEQIYVHSKLLIADDRVAILGSANINDRSLQGERDSELAVMVRDSEPLT 
RALTA_B1035      752 RNWDVLHGRPVTEQIYVHSKLLIADDRVVVLGSANINDRSQLGDRDSELAVVIHDDKAMS 
HMPREF9418_1021  832 ----------DWEEIYIHSKLCLINDTFATLGSANINTRSMQID--SELNVAVESQ---- 
BCAM0149         569 D-----SPGGNWLPVYVHAKLMTIDDAFMTIGSANVNLRSMNVD--SELNICHENS---- 
CV_1234          534 TG---YQQGQPWQYVYIHAKLMMIDDTFMTLGSANINLRSMVCD--SEINVCHCQP---- 
 
 
PA3487(pldA)     898 VRLDGKNDAIVGKAIHQLRVNLWKKHFGLSQGPGGFVKPASELSAYLSIPAAQEAWEAIQ 
RALTA_B1035      812 VRLDGQLVQPVGTFAHGLRKALWKKHFGLMGGVAPAT--ELGLPSILDGPGDLDTWQAVQ 
HMPREF9418_1021  876 ------------PASYKIRHETWGWHTNGNTEMNP----GEQLIDPSLAGDVFDTWYEEL 
BCAM0149         618 ------------VVTKSLRQRLWSMHAGDKGAQE-------D------FFKSFMAWHDIV 
CV_1234          585 ------------DITRAARQHLWNMHTVGQGNTA-------DASKPQPLADVYDRWERIM 
 
PA3487(pldA)     958 TLAKENTRAYER----TFNFIPQNISQTQLQLTPEPPKGFEDGFPASIWPTWAYRKPGEL 
RALTA_B1035      870 RVAQTNAEAYDK----AFPYVPRSKS------------------RSSVWPTWDDS----- 
HMPREF9418_1021  920 DNNKGAKDKNKKRLMPLLEFDLTNKNRVYTQDLD-------------------------- 
BCAM0149         653 EQNKVNKTKNLPPEKSLVKFVRTSAKRTYAD----------------------------- 




confirmed	 Tle5	 phospholipase	 T6SS	 effector	 encoded	 by	 PA3487	 in	 P.	 aeruginosa,	 and	
other	 predicted	 Tle5	 proteins	 identified	 in	 Cupriavidus	 taiwanensis	 (RALTA_B1035),	 N.	
	
	176
macacae	 (HMPREF9418_1021)	 and	 C.	 violaceum	 (CV_1234).	 Black	 shading	 indicates	
identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	 grey	 shading	
indicates	 similar	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences.	 Conserved	










The	 Tli5	 immunity	 protein	 for	 the	B.	 cenocepacia	 H111	 Tle5	 identified	 by	
Russell	et	al.	(2013)	is	homologous	to	both	the	BCAM0150	and	BCAM0152	encoded	
proteins	 in	J2315	and	homologous	to	other	Tli5	proteins,	 including	those	encoded	
by	 CV_1235	 in	 Chromobacterium	 violaceum	 and	 HMPREF9418_1022	 in	Neisseria	
macacae	 (Figure	 3.22).	 Both	 putative	 immunity	 proteins	 encoded	 by	 BCAM0150	
and	 BCAM0152	 contain	 a	 TPR	 repeat	 structural	 multi-domain,	 and	 SEL1	 repeat	
motifs	(a	TPR	subfamily)	within	this	region,	which	are	homologous	to	regions	within	







The	BCAM2254	 tssI	 cluster	encodes	a	 single	putative	T6SS	effector	 (Figure	
3.10G).	 Using	 the	 sequences	 of	 the	 predicted	 open	 reading	 frames	 neighbouring	
BCAM2254	 as	 queries	 in	 BLASTP	 searches	 at	 least	 two	 T6SS-related	 genes	 were	
identified.	The	product	of	BCAM2253a	is	a	small	140	amino	acid	protein	containing	
a	DUF1795	domain	located	at	residues	6-136.	This	domain	has	been	designated	as	a	
T6SS	 accessory	 protein	 to	 Rhs	 effectors,	 termed	 EagR,	 initially	 characterised	 in	 S.	
marcescens	by	the	protein	encoded	by	SMDB11_2277	located	upstream	of	the	rhs1	
effector	 gene	 SMDB11_2278	 (Diniz	 and	 Coulthurst,	 2015).	 EagR	 is	 also	 encoded	







PA3488             1 MKRVLMGLILLSSSNITWAE---AP-------------------SSKYQECLGRMTFEIP 
HMPREF9418_1022    1 MRIKILSTILISIPLLAACDIGRELAKTAIDVVKNPQTETGKQVMGSYSSKLKNLEFTCV 
CV_1235            1 MRL--A--WLVLPLLLAACGHKDTP----------------MEHQPDLKAVQAKLAFSCV 
BCAM0150           1 MNRHIL--IVFLSVSLCACTEKESK----------------VSQLPDLSAVRANLEFVCA 
BCAM0152           1 MRKSLV--IYTVVLLVCACTNKEDSV---------------DSNLPDMSDVRANLALTCV 
I35_4133           1 MRKSLV--IYTVVLLVCACTNKEDSV---------------DSNLPDMSAVRANLAFTCV 
 
 
PA3488            39 EEMEWATYDASRVWQISKGGGHNFTAEVTAVGDNGSYDYDSMIFYVSEKVDK-NEFHNAS 
HMPREF9418_1022   61 KE--QFPS-------LP-------------QEADQLYRYALYHDFKNRWLPKPGVLDRYL 
CV_1235           41 HEADHLPK-------LN-------------PEADKLFQYARWLQLQ----YKPELLPEAG 
BCAM0150          43 HESDHLPS-------LD-------------PNADILFKYARYLQKN----SGPKDYDDIL 
BCAM0152          44 HESEHLPP-------LD-------------PRADQLFQYGRYLQKI----DGPKDFDEIV 
I35_4133          44 HESEHLPP-------LD-------------PRADQLFQYGRYLQKI----DGPKDFDEIV 
 
 
PA3488            98 NYIKGTAEIYQDHLRENIKLDKKAISTLQKNKSEEKSIERIKKGIAEMEAKIPLAKIYEH 
HMPREF9418_1022   99 PYYRIA--AANGHWQANLTLQEILLKSKDI---NLETRERRGEGIYWNEKL--------M 
CV_1235           77 RLYRIA--AAHGHYKANNNLQRMVGKGEVA------SPDAVNEVLDLNEQL--------V 
BCAM0150          79 RYYRIA--AAYDHYKANTNAQLLISQGLAS------SPDAEKESVDLASRL--------V 
BCAM0152          80 RYYRIA--AAYGHYKANTNAQRLISQGLAN------SPDGAKETIALAKKL--------I 
I35_4133          80 RYYRIA--AAYGHYKANTNAQKLISQGLAN------SPDGAKETIALAKKL--------I 
 
 
PA3488           158 DLGIPDSHILGSKNIPFHVLLWR--NQRVYYFTFSKPTEN-SA-QRIKDLIARFRTR--- 
HMPREF9418_1022  146 KILPASAHYWWSLYIDVGYGPKHGPDDSFIYLRKAADLGNAKAQYEVGELLLKIKDEMVR 
CV_1235          121 ADNIPNGYYLTGHYLQIGYGYDQDNEKALMYFRKAADLGSADAQAYVGGLLNTPEL---- 
BCAM0150         123 DKGIPSGYYDIGHYLEGGYGLKKNPEMSLRYFRKAADLGSPEAQYYVADLLAPMDK---- 
BCAM0152         124 DDGVPGGYYDIGHYLEAGYGVKQDAEMALRYFRKAADMGSPEAQTYVAEQLAPHDR---- 
I35_4133         124 DDGVPGGYYDIGHYLEAGYGVKQDAEMALRYFRKAADMGSPEAQTYVAEQLAPHDR---- 
 
 
PA3488           211 -ELYEVPNEPGICF-----PYGFIADDGKTAYELKNSLRFTRTPNVIFSLLTASANDPWQ 
HMPREF9418_1022  206 PTVLKIVDKMRVCSLNQTYPDGMAAR--MMAADARNEENFQQS--LVFSHQALKAGE--- 
CV_1235          177 --APEIGRQMLRCAAEQGHAE--AAD--NLGVDLQGDKHYPDA--LYAYQLAVKAGH--- 
BCAM0150         179 --APEVAKQMRECATAQGFGK--AAS--ALGIDLKTDKHYAEA--VKAFQKGVESGD--- 
BCAM0152         180 --APEIARQMRQCATNQGYGD--AAN--YLGINFKNDSKYSDA--VLSFQKGVKAGS--- 
I35_4133         180 --APEIARQMRQCATNQGYGD--AAN--YLGINFKNDSKYSDA--VLSFQKGVKAGS--- 
 
 
PA3488           265 TRPTSGLYDSDFRPGYDRQKWKKSALLDSLHIGKRLAAFEGWRLDPRPDSGERERAWFGL 
HMPREF9418_1022  259 --SSSGL-----------------TLSRAFYTENSKSKHKNWGIPTDLERSKRYRIIRDF 
CV_1235          226 --SASAL-----------------GLQEAFDAEKGKSQLYNLALKPDPERVKRYEAIWTL 
BCAM0150         228 --VQSAS-----------------FLENGFEAPPESDRLYYLALSKDPERTRRYDLIARF 
BCAM0152         229 --AQAAL-----------------ALEEGFNGPEASNRLSYLALAHDPERSRRYRLIGKF 
I35_4133         229 --AQAAL-----------------ALEEGFNGPEASNRLSYLALAHDPERSRRYRLIGKF 
 
 
PA3488           325 AHTGGTLDPLVA---------------------IQVQTFQ-------------------- 
HMPREF9418_1022  300 LWKNAHLKPELNVHDLDEIVPLPPAKLPSWDGKIAIQRFV-EGPAPAKPSDELVRKLAQQ 
CV_1235          267 LKRYDGRNP--KVPDIDKIVPLPPAKLPPWDGTFEWEKEWKANAAPAKPDEKLVVKLAKA 
BCAM0150         269 LDHNDGRNP--KVPDIDKIVPLPPAKLPPWDGTFQWQKEQDAATPPQKPSDEFINEMAKA 
BCAM0152         270 LDSNESRNP--KVPDLDKIVPLPPAKLPPWDGTFQWQKEQDAATPPQKPSDEFINEMAKA 
I35_4133         270 LDSNESRNP--KVPDLDKIVPLPPAKLPPWDGTFQWQKEQDAATPPQKPSDEFINEMAKA 
 
 
PA3488           344 K-----------GTDDLTDYTPPPEEVLPRLKAL-------------------------- 
HMPREF9418_1022  359 AGLDPKTGLPK------------------------------------------------- 
CV_1235          325 KNLDPATGLPKVELPK--------PQTPPKIKLGYVAQSHAVCPQSGSWCAELSAHGMAS 
BCAM0150         327 KHLDPATGLPLPGSADKTSQAEQPENVASRLPLGTVAHTGQTCPEDGVWCAKLGAGQF-G 
BCAM0152         328 KHLDPATGLPLPGSADKTSQAEQPENVASRLPLGTVAHTGQTCPEDGVWCAKLGAGQF-G 




PA3488           367 --------------------------------SQSIEQRLAR----------- 
HMPREF9418_1022      ----------------------------------------------------- 
CV_1235          377 SVSRNFIAGERFPAIPVSQ--RLSWLDRLRGKPDQLEAAVTWTLQSYEKEAQG 
BCAM0150         386 DTQRRFLKGDALPSVVVHEPRKLAVLDSMMGTRRHV-EQVAWELVAYLDQA-- 
BCAM0152         387 DTQRRFLKGDALPSVVVHEPRKLAVLDSMMGTRQHV-EQVAWELVAYLDQA-- 







orthologues.	 Amino	 acid	 sequences	 encoded	 by	 BCAM0150	 and	 BCAM0152	 from	 B.	
cenocepacia	 J2315	 was	 aligned	 with	 the	 confirmed	 Tli5	 immunity	 proteins	 encoded	 by	
PA3488	 in	 P.	 aeruginosa,	 and	 other	 predicted	 Tli5	 proteins	 identified	 in	 C.	 violaceum	
(CV_1235),	 N.	 macacae	 (HMPREF9418_1022)	 and	 the	 BCAM0150	 orthologue	 in	 B.	
cenocepacia	 H111	 (I35_4133).	 Black	 shading	 indicates	 identical	 residues	 at	 the	
corresponding	position	in	50%	of	sequences,	grey	shading	indicates	similar	residues	at	the	
corresponding	position	in	50%	of	sequences.	Predicted	TPR	repeat	multi-domain	boxed	in	











                              **          *                     * 
STM0290          1 ---MDRPYRIQEGCFVL-PETFTDRSVNIFILEGNERTSPSLNISRDTLKPDEDLPAYID 
BCAS0664         1 MTDSENRIRIHEGSIVL-PNGFEDRTTNLFVPA-DTAAQPNLSVARDWLKDGETLAPYID 
SMDB11_2277      1 -----MDYLFQEGHFTLPAIAWQDCTVNILKNPQTG---ASLVITRGIIPQGATLEDEFE 
ECL_01566        1 -----MKYTLQEGSFSLFPAAWQDNTMNIIRDDESG---LSVVVSRGVIPDGSDHEKEFH 
BCAM2253a        1 ------MYQMQEGTLAL-PVEWQDKTMNVFVSAATGTEGVSFVITRERLPWGMKFAEYVS 
Dda3937_01759    1 ------MYQMNEGTLAI-PAGWRDESLHVFVLPGDT---ANLVVNRTPIEFGLSPDTVYE 
 
                                                                    * 
STM0290         57 RQIALMKKNLGQHRVLSRAPAQAGTGNDALMGEQIAATHKSGKTEVYQRQAGFIA-TPGK 
BCAS0664        59 RQIALLKSRLQGHRVLSRQAERLGPETDGMPGERIDAAYRNGPKTVFQRQGAFIV-APGR 
SMDB11_2277     53 KQWQALLPQISDLQQSPRRRISAGPQGHLKAIEVTSRFIRAGH-HHHQHQLAVQPDESQT 
ECL_01566       53 RQWELLRPQMGEIVQSEFQRVKAGPDGKINGLAVETSFDRNGQ-RLWQKQLAVQTPGKPV 
BCAM2253a       54 SEIRKVAKQVPDYAEVANE--DATVSGRAA---HVHEFTWTNN-QAPIHQRLTMVEYGQV 
Dda3937_01759   51 QTLAQFSAHLKGYEERAAW--ELTLDGQPA---RGLEYTWRSP-EGPMHQVVVMQVRGEL 
 
                       * 
STM0290        116 VLVFTLTSPRPFDDKADLLWNTWLAGFQPDKNE-- 
BCAS0664       118 VLIFTASSAKSFGETLDALWRNWLDGYRPAEQESA 
SMDB11_2277    112 LLIVTYAAMRPFTPEDDAHWQQVKASLVLTEHSEQ 
ECL_01566      112 LMIFTLSALRAFNEEDEARWSALKQSLTLNDNRNV 
BCAM2253a      108 VLMLTFTAPGTLSDTQREQIRAVIQSLQLRDPI-- 
Dda3937_01759  105 LLTFTVTAAGELKDEQKTALLAVIETFKAAS----	
	
	
Figure	 3.23	 Alignment	 of	 proteins	 encoded	 by	 BCAM2253a	 and	 BCAS0664	 with	 EagR	
family	orthologues.	Amino	acid	sequences	encoded	by	BCAM2253a	and	BCAS0664	from	B.	
cenocepacia	 J2315	 were	 aligned	 with	 the	 confirmed	 EagR	 protein	 encoded	 by	













encode	 a	 large	 1515	 amino	 acid	 multi-domain	 protein.	 Bioinformatic	 analysis	
identified	 a	 PAAR_RHS	 (cd14742)	 region	 at	 residues	 204-277,	 three	 RHS	 repeat	
sequences	 (pfam05593)	 at	 residues	 552-587,	 759-800,	 826-863,	 a	 YD_repeat	
sequence	(TIGR01643)	at	residues	868-909,	an	RHS	repeat-associated	core	domain	
(TIGR03696)	at	residues	1280-1365,	and	a	C-terminal	region	predicted	to	contain	a	
RES	 domain	 (smart00953),	 residues	 1400-1512,	 which	may	 function	 as	 an	 RNase	
(Zhang	et	al.,	2012)	 (Figure	3.24).	All	of	which	are	 typical	of	Rhs	proteins	 (Section	
1.5.4).		
The	 open	 reading	 frame	 located	 immediately	 downstream	 of	 BCAM2253,	
BCAM2252,	 is	 unusual	 in	 that	 it	 potentially	 starts	 from	a	 TGG	 start	 codon,	which	
would	 result	 in	 the	 production	 of	 a	 420	 amino	 acid	 protein	 also	 containing	 RHS	
repeat	 sequences.	 However,	 it	 likely	 that	 this	 is	 the	 result	 of	 a	 premature	 stop	
codon	 occurring	 in	 a	 fused	 BCAM2253-BCAM2252	 open	 reading	 frame,	 so	 is	
unlikely	 to	 give	 rise	 to	 a	protein	product.	Alternatively,	 it	 could	be	an	 rhs	vestige	
that	 resulted	 from	 recombination	 with	 another	 rhs	 that	 became	 or	 gave	 rise	 to	
BCAM2253.		
Finally,	 BCAM2251a	 encodes	 a	 small	 132	 amino	 acid	 protein	 with	 no	
discernible	conserved	domains	when	analysed	using	the	amino	acid	sequence	as	a	
query	in	a	BLASTP	search.	However,	it	could	potentially	be	the	immunity	protein	for	






tssI	 gene	 cluster	 (Figure	 3.10H),	 which	 encodes	 the	 evolved	 TssI	 protein,	 TssI0667	
(discussed	 in	 Section	 3.3.2).	 BLASTP	 searches	with	 the	 protein	 products	 of	 genes	
located	within	close	proximity	to	BCAS0667	identified	a	further	DUF1795-containing	
























Figure	 3.24	Domain	 organisation	 of	 putative	 T6SS-dependent	Rhs	 effectors	 encoded	by	








































of	 BCAS0664	 was	 predicted	 to	 be	 a	 small	 protein	 of	 152	 amino	 acids,	 with	 the	
DUF1795	homology	region	spanning	from	residues	12	to	143	(Figure	3.23).		
Further	 analysis	 of	 the	 Rhs	 protein	 encoded	 by	 BCAS0663	 indicated	 the	
presence	of	several	conserved	domains	distributed	throughout	the	protein	(Figure	
3.24),	as	defined	by	the	conserved	domain	database	(Marchler-Bauer	et	al.,	2014).	
These	 included	 the	 typical	 features	 of	 a	 Rhs	 protein:	 a	 PAAR_RHS	 domain	 at	
residues	 75-147;	 YD	 repeats	 between	 residues	 527-588;	 several	 RHS_repeat	
sequences	at	residues	720-746,	977-1010,	1053-1092	and	a	RHS	repeat-associated	
core	domain	at	residues	1208-1287.	It	also	has	C-terminal	domain	with	homology	to	
a	 group	 of	 nucleases	 within	 the	 HNH/ENDO	 VII	 superfamily	 that	 contain	 a	
conserved	WHH	 domain	 (pfam14414)	 (Zhang	 et	 al.,	 2011)	 (Figure	 3.25).	 This	 is	 a	
colicin-DNase	 type	 nuclease	 which	 is	 a	 member	 of	 the	 His-Metal-finger	
endonuclease	clan	(CL0263)	as	defined	by	the	Pfam	database	(Finn	et	al.,	2014).	It	
contains	 a	 conserved	 WHH	 motif	 at	 residues	 1380-1382,	 with	 two	 additional	
conserved	 histidine	 residues	 at	 position	 1397	 and	 His1402.	 The	 first	 histidine	
residue	 is	 thought	 to	 be	 involved	 in	 metal	 ion	 binding,	 whilst	 the	 others	 are	
involved	 in	 the	 arrangement	 of	 water	 molecules	 within	 the	 active	 site	 to	 allow	
water	activation	and	subsequent	involvement	in	a	hydrolysis	reaction	(Zhang	et	al.,	
2011).		
Two	 genes,	 BCAS0662	 and	 BCAS0661c,	 follow	 BCAS0663,	 each	 of	 which	
encodes	a	small	protein,	one	with	a	SMI1_KNR4	domain	(pfam09346)	(SUKH	clan)	
and	the	other	with	an	Imm-NTF2	domain	(pfam15655),	respectively.	Many	proteins	
that	 contain	 these	 domains	 are	 thought	 to	 be	 antitoxin	 proteins	 in	 polymorphic	















                             WHH                      H         H GG 
HP_0063        448 AKGFIPKGYLWHFDANV-------LGNVALVREEL-----LLGVKHTKGYLLWKQF 
Fluta_0332     180 ----QSSLYTWHHMDDFEIINGEAYCTMQLVQKTAHQGTGVFGMAHSGSASQWRSY 
CJA_3689       392 TTNLRSGKWTWHHLPAT--------YKMVLVDMTVHAK-----HGHNGGVYLW--- 
CA_C1646       267 RNFRKKNKYTWHELNDC--------KTIQLVPSKINNA-----FGHVGGVGEINAG 
Sinac_4765    9254 --TKTPANFIWHHNQDL--------GLMQLVDEKVHSQ-----FWHSGGMSLNRNR 
Caci_0187       92 PNTATPQGWTWAHAAES--------RMLHCVPIELHGA-----FRHHGGMATLKAD 
SCO3116         93 PAVATPHGWTWHHVAGS--------RRMELVPVEVKAL-----LRHHGGISTAV-- 
Halhy_4020     938 ---THFPNHTWHHHQDT--------RTLLLVPRDLNTASFG-GIPHTGGAAIIRY- 
BCAS0663      1374 ----DYTKNTWHHHENM--------VTMQEIPKDIHSE-----FTHRGGVSNLKNQ 
sce6982        360 GLKETPSGMTRHHHQDG--------RTMQLVPRAIHQK-----TGHTGGFVSAK-- 
PSE_p0119      221 SSWERPRDHTWHHKEDG--------VTMQLIPSKYHATGGGASTPHTGGAALYRPG 
 
	
Figure	 3.25	 Alignment	 of	 C-terminal	 of	 BCAS0663	with	members	 of	 the	WHH	 nuclease	
domain-containing	 superfamily.	 The	 C-terminal	 amino	 acid	 sequence	 encoded	 by	













































































Burkholderia	 T6SS	 that	 lacks	 a	 tssI	 gene,	 and	 several	 TssI-encoding	 gene	 clusters,	
which	 together	 give	 a	 full	 complement	 of	 the	 T6SS	 genes	 that	 are	 required	 for	 a	
functioning	 system,	 shown	 in	 Figure	 3.1.	 However,	 little	 is	 known	 regarding	 the	
main	function	of	this	system	in	Bcc,	and	the	nature	of	the	effectors	it	utilises.				
	 Observations	 in	 another	Burkholderia	 species,	B.	 thailandensis,	 found	 that	
the	 first	 of	 its	 five	 T6SSs,	 the	 ancestral	 T6SS-1	 cluster,	 was,	 like	 other	 better	
characterised	T6SSs	in	P.	aeruginosa	and	V.	cholerae	(Hood	et	al.,	2010;	MacIntyre	
et	 al.,	 2010),	 responsible	 for	providing	 the	bacteria	with	a	 fitness	advantage	over	
other	 competing	 bacterial	 strains	 sharing	 the	 same	 environment	 (Schwarz	 et	 al.,	
2010).	It	has	also	been	shown	that	direct	attack	from	a	T6SS-bearing	bacterium	can	
induce	the	T6SS	to	target	attacking	bacteria,	 in	a	‘tit-for-tat’	manner	(Basler	et	al.,	





	 One	 T6SS	 in	 other	 Burkholderia	 species	 has	 been	 linked	 to	 eukaryotic	
interactions	 and	 virulence,	 namely	 the	 T6SS-5	 in	 the	 Pseudomallei	 group	 of	
Burkholderia	(Schell	et	al.,	2007;	Shalom	et	al.,	2007;	Burtnick	et	al.,	2010;	Schwarz	
et	 al.,	 2010;	 Schwarz	 et	 al.,	 2014;	 Toesca	 et	 al.,	 2014)	 (Section	 1.2.5.5).	 B.	
cenocepacia	 does	 not	 encoded	 a	 T6SS-5.	 However,	 it	 does	 have	 the	 ability	 to	
survive	intracellularly	within	macrophages,	persisting	in	membrane	bound	vesicles,	
thus	subverting	the	frontline	defence	of	the	innate	immune	system.	In	this	regard,	
the	 T6SS	 has	 been	 shown	 to	 be	 important	 for	 actin	 rearrangements	 in	 these	
infected	 macrophages,	 but	 not	 for	 direct	 vacuole	 arrest,	 specifically	 using	 a	 B.	
cenocepacia	mutant	that	hypersecretes	TssD	(Aubert	et	al.,	2008;	Rosales-Reyes	et	
al.,	2012a;	Rosales-Reyes	et	al.,	2012b).	The	T6SS	in	B.	cenocepacia	is	also	required	
to	 initiate	pyrin	 inflammasome	activation	 in	 infected	host	cells,	which	 results	 in	a	
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pro-inflammatory	 response	 (Gavrilin	 et	 al.,	 2012).	 It	 does	 this	 by	 mediating	 the	
deamination	of	 a	 particular	 residue	 in	 the	RhoA	GTPase	protein,	 via	 an	unknown	
mechanism,	 which	 leads	 to	 an	 increase	 in	 active	 RhoA	 (GTP	 bound),	 and	
subsequent	downstream	effects	 on	 the	 actin	 cytoskeletal	 network	 (Rosales-Reyes	
et	 al.,	 2012b;	Xu	et	 al.,	 2014).	Using	a	hypersecreting	TssD	mutant,	 the	T6SS	was	
also	shown	to	be	important	for	the	ability	of	B.	cenocepacia	to	resist	predation	by	
Dictyostelium	 discoideum	 (Aubert	 et	 al.,	 2008).	 It	 was	 also	 shown	 to	 be	 a	
contributor	to	 in	vivo	survival	 in	a	rat	agar	bead	lung	infection	model	(Hunt	et	al.,	
2004).	 But	 further	 evidence	 for	 an	 anti-eukaryotic	 role	 for	 the	 T6SS	 in	 B.	
cenocepacia	is	lacking.	
	To	understand	whether	the	T6SS	in	B.	cenocepacia	plays	a	dual	role	in	both	
anti-bacterial	 and	 anti-eukaryotic	 interactions	 it	 was	 decided	 to	 determine	 if	 the	
T6SS	contributed	to	virulence	 in	simple	eukaryotic	 infection	models,	 the	zebrafish	
infection	model	and	the	Galleria	mellonella	 infection	model.	Previous	experiments	
using	the	Galleria	model	system	and	C.	elegans	failed	to	establish	a	role	for	the	B.	
cenocepacia	 T6SS	 in	 virulence	 (Shastri,	 Schwager,	 Eberl,	 Thomas,	 unpublished	
observations).	 However,	 the	 B.	 cenocepacia	 strains	 employed	 (H111	 and	 Pc715j)	
are	not	particularly	virulent	in	animal	model	systems.	But	as	the	K56-2	strain	of	B.	
cenocepacia	 has	 been	 demonstrated	 to	 be	 virulent	 in	 the	 zebrafish	 embryo	 and	
Galleria	models	 (Seed	 and	Dennis,	 2008;	Vergunst	 et	 al.,	 2010)	 it	was	 decided	 to	



















The	K56-2	 isolate	of	B.	 cenocepacia	 has	previously	been	 shown	 to	be	more	
virulent	 than	 other	 isolates	 in	 eukaryotic	 infection	 models,	 particularly	 in	 a	
zebrafish	embryo	infection	model	(Vergunst	et	al.,	2010)	and	a	Galleria	mellonella	
infection	 model	 (Seed	 and	 Dennis,	 2008).	 Therefore,	 to	 investigate	 whether	 the	
T6SS	plays	any	role	 in	 the	virulence	of	B.	cenocepacia,	T6SS	mutants	of	 the	K56-2	
strain	were	required.		
Disrupting	 any	 of	 the	 thirteen	 core	 subunit	 genes	 in	 the	 T6SS	 cluster	 (tssA-
tssM)	leads	to	malfunction	of	the	T6SS	(Zheng	and	Leung,	2007;	Zheng	et	al.,	2011).	
tssM	encodes	a	membrane	protein	observed	to	form	a	trans-envelope	sub	complex	
with	 other	 components	 of	 the	 T6SS	 complex	 to	 anchor	 the	 complex	 to	 the	 cell	
membrane	 (Durand	 et	 al.,	 2015),	 and	 the	 product	 of	 tssA	 is	 an	 uncharacterised	
predicted	 cytosolic	 protein.	 tssA	 and	 tssM	 are	 located	 in	 separate	 transcriptional	
units	 in	 the	B.	 cenocepacia	 T6SS	 cluster.	Mutant	 strains	 of	B.	 cenocepacia	 K56-2	
with	either	a	non-functional	tssA	or	tssM	gene	were	generated	by	disruption	with	a	
gene	conferring	 trimethoprim	resistance,	dfr.	 	This	was	achieved	by	conjugating	a	
previously	 constructed	 suicide	 vector,	 pSHAFT2-tssM::Tp(rev)	 (Shastri,	 2011),	
containing	 the	 sequence	 encoding	 the	 cytoplasmic	 domain	 fragment	 of	 TssM	
disrupted	 by	 dfr	 (in	 the	 reverse	 orientation	 with	 respect	 to	 tssM),	 and	 pSHAFT-
tssA::Tp	 (Shastri,	 2011),	 containing	 tssA	 disrupted	by	 dfr	 (in	 the	 same	orientation	









recombinants,	 in	 which	 the	 vector	 backbone	 is	 integrated	 into	 the	 genome,	 and	
double	crossover	recombinants,	in	which	the	vector	backbone	is	not	present	in	the	
genome.	 Candidate	 tssM	 and	 tssA	 mutants	 resulting	 from	 double	 crossover	
recombination	 were	 identified	 by	 virtue	 of	 their	 resistance	 to	 trimethoprim	 and	
sensitivity	 to	 chloramphenicol.	 These	 candidates	were	 then	 verified	 by	 PCR	 using	
primers	 that	 annealed	 to	 genomic	 DNA	 just	 outside	 of	 the	 tssM::Tp	 or	 tssA::Tp	
homology	 region	 contained	 on	 the	 introduced	 plasmid	 (outside	 primers),	 and	
primers	 that	 annealed	 within	 the	 tssM::Tp	 or	 tssA::Tp	 homology	 region	 (inside	
primers).	 Candidate	 15	 for	 both	 mutants	 was	 identified	 as	 a	 potential	 double	
recombinant,	and	 selected	 for	 further	 colony	purification	and	 then	 rescreened	by	
PCR	 using	 the	 outside	 annealing	 primers,	 to	 verify	 insertional	 inactivation	 (Figure	
4.3).	Both	candidates	proved	to	be	true	double	recombinants,	as	the	PCR	fragments	
amplified	 from	 them	 were	 ~650	 base	 pairs	 (bp)	 larger	 than	 the	 wild-type	 (WT)	





generated.	 To	 do	 this,	 the	 suicide	 vector	 pSHAFT2-tssM::Tp(rev)	 was	 introduced	
into	 B.	 cenocepacia	 H111	 by	 conjugation.	 Single	 crossover	 recombinants	 were	
selected	 by	 their	 acquisition	 of	 resistance	 to	 trimethoprim.	 Candidate	 double	
crossover	recombinants	were	identified	by	sensitivity	to	chloramphenicol	and	then	
confirmed	 by	 PCR	 screening	 using	 outside	 and	 inside	 primers	 as	 described	 in	
Section	 4.2.1	 (Figure	 4.4).	 This	 confirmed	 the	 presence	 of	 the	 trimethoprim	

























recombination	 events	 occur	 between	 the	 allele	 contained	 within	 the	 vector	 and	





cassette),	 trimethoprim	 in	 this	 example.	 The	 pSHAFT2	 system	 uses	 a	 second	 antibiotic	
resistance	 gene	 contained	within	 the	 vector	 (cat,	 Cmr)	 to	 distinguish	 between	 single	 and	























































tssA::Tp	 and	 pSHAFT2-tssM::Tp(rev)	 respectively.	 DNA	 fragments	 were	 amplified	 by	 PCR	
from	candidate	K56-2-tssA::Tp	and	-tssM::Tp	mutants	using	outside	diagnostic	primers	and	
resolved	in	a	0.8%	agarose	gel.	Wild-type	(WT)	H111	and	K56-2	genomic	DNA	was	used	as	
control	 templates	which	 gave	 rise	 to	 products	 of	 1400	bp.	Mutants	 resulting	 from	allelic	









































































Figure	 4.4	 Confirmation	 of	 insertional	 inactivation	 of	 the	 tssM	 gene	 in	 B.	 cenocepacia	
H111	 by	 PCR	 screening.	 tssM	 in	 B.	 cenocepacia	 H111	 was	 inactivated	 by	 homologous	
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 Construction	 of	 a	 T6SS-deficient	mutant	 in	B.	cenocepacia	4.3
by	in-frame	deletion	
	 In	 general,	 by	disrupting	 a	 gene	with	 an	 antibiotic	 resistance	 cassette	one	
has	to	be	aware	of	potential	polar	effects	to	downstream	genes	located	within	the	
same	transcriptional	unit.	In	the	case	of	B.	cenocepacia,	which	exhibits	a	high	level	
of	 intrinsic	 resistance	 to	many	 antibiotics	 commonly	 used	 to	 select	 for	 plasmids,	
construction	 of	 a	mutant	 by	 insertional	 inactivation	 with	 an	 antibiotic	 resistance	
cassette	 can	make	 subsequence	 genetic	manipulations	 problematic.	 	 Thus	 it	 was	
decided	 to	 generate	 an	 in-frame	 deletion	 mutant	 of	 a	 core	 T6SS	 gene	 in	 B.	
cenocepacia	that	 lacks	an	 inserted	antibiotic	resistance	cassette,	 i.e.	an	unmarked	





allelic	 replacement	 to	 use	 a	 vector	 containing	 a	 counter-selectable	marker.	Here,	
initial	 selection	 is	 made	 for	 integration	 of	 the	 plasmid	 into	 the	 genome	 via	 a	
homologous	recombinant	event.	In	the	second	step	this	counter-selectable	marker	
is	 used	 to	 select	 for	 a	 second	 homologous	 recombination	 event	 that	 results	 in	
excision	of	 the	vector	 (Figure	4.5).	This	should	result	 in	either	 replacement	of	 the	
wild-type	gene	by	the	mutant	allele	or	reversion	back	to	wild-type.		
	 One	such	vector	developed	for	use	in	the	Burkholderia	species	is	the	pEX18-
pheS	 vector	 series	 (Barrett	 et	 al.,	 2008).	 This	 uses	 incorporation	 of	 toxic	 p-
chlorophenylalanine	(cPhe)	into	growing	polypeptide	chains	by	a	mutant	version	of	
the	 α-subunit	 of	 phenylalanyl	 tRNA	 synthetase	 (PheS)	 from	 B.	 pseudomallei,	
encoded	 on	 the	 plasmid	 as	 a	 counter-selectable	marker.	 pEX18-pheS	derivatives,	
































antibiotic	 to	which	 the	vector	 specifies	 resistance	 to	and	 spontaneous	 recombinants	 that	
result	in	excision	of	the	plasmid	are	selected	for	on	M9-glucose	plates	containing	0.1%	cPhe	
(2).	Incorporation	of	cPhe	by	the	mutated	PheS	encoded	on	the	vector	is	toxic	to	the	cell.	





















unpublished	 observations).	 Another	 problem	 with	 this	 vector	 concerned	 the	
effectiveness	of	the	cPhe	counter-selection	step	in	H111	(Fazli	et	al.,	2015).	
	 It	 was	 noted	 that	 other	 pEX18-pheS	 vectors	 (such	 as	 pEX18Tet-pheS)	
contained	 their	 antibiotic	 resistance	 gene	 downstream	 of	 and	 in	 the	 same	
orientation	 as	 the	 pheS	 gene,	 whereas	 pEX18Tp-pheS	 did	 not.	 Interestingly,	
pEX18Tet-pheS	was	used	effectively	in	B.	cenocepacia	by	the	Winans	group	(Ryan	et	





as	 pheS	 with	 the	 addition	 of	 a	 strong	 transcriptional	 terminator	 to	 prevent	 read	
though	 transcription	 into	 the	 replication	 region	 of	 the	 plasmid.	 To	 do	 this,	 a	
previously	 constructed	 version	 of	 the	 dfr	 gene	 with	 the	 tandem	 transcription	
terminators	T1	and	T2	of	the	rrnB	rRNA	operon	(rrnBT1T2)	located	downstream	of	
the	 stop	 codon,	 termed	 TpTer,	 was	 used.	 A	 diagrammatic	 representation	 of	 the	
construction	of	this	modified	allelic	replacement	vector	is	depicted	in	Figure	4.6.		
	 First,	 it	 was	 required	 to	 remove	 a	 rrnBT1T2	 region	 already	 present	 in	
pEX18Tp-pheS	 to	 prevent	 possible	 internal	 self-homologous	 recombination	
between	 duplicated	 rrnBT1T2	 sequences.	 To	 do	 this,	 pEX18Tp-pheS	 was	 digested	
with	 AfeI	 (Eco47III)	 and	 BsaI	 (Eco31I)	 and	 3’	 overhangs	 filled-in	 with	 T4	 DNA	
polymerase.	 This	 generated	 a	 3975	 bp	 linear	 fragment	 that	was	 then	 self-ligated	
using	 T4	 DNA	 ligase,	 to	 generate	 the	 intermediate	 plasmid	 pEX18Tp-
pheSΔrrnBT1T2.		









































































pEX18TpTer-pheS.	 (A)	 Depicts	 construction	 of	 pEX18TpTer-pheS,	 where	 pEX18Tp-pheS	
(Top)	 was	 digested	 with	 AfeI	 and	 BsaI	 to	 remove	 the	 rrnBT1T2	 region	 to	 give	 pEX18Tp-
pheSΔrrnBT1T2	 (middle	 left).	 pEX18TpTer-pheS	 was	 constructed	 by	 replacing	 the	 SpeI-










transformants	 were	 selected	 for	 trimethoprim-resistance.	 Candidate	 clones	 were	
subjected	 to	 plasmid	 isolation	 and	 the	 size	 of	 resulting	 plasmids	 were	 analysed	
following	DNA	gel	electrophoresis	(Figure	4.7).	Clones	of	the	expected	size	of	4216	
bp	 were	 then	 sequenced	 using	 the	 primers	 pEX18Tpfor	 and	 pEX18Tprev	 to	
determine	the	orientation	of	the	introduced	TpTer	cassette.	Clone	6	contained	the	
TpTer	 cassette	 in	 the	 desired	 orientation,	 i.e.	 the	 same	 orientation	 as	pheS.	 This	




One	 disadvantage	 of	 pEX18Tp-based	 vectors	 is	 that	 selection	 for	
trimethoprim-resistant	 transformations	 following	 ligation	 of	 the	 mutated	 target	
gene	 requires	 use	 of	 Iso-sensitest	 agar	 (a	 nutrient	 rich	 medium	 containing	 2%	




use	of	 the	blue-white	screening	capability	of	pEX18Tp-derivatives	as	 its	 catabolite	
represses	the	lacZ	promoter	on	the	vector.	To	overcome	this	problem	glycerol	was	
employed	 as	 a	 carbon	 source.	 However,	 it	 was	 found	 that	 this	 worked	 more	
effectively	at	30°C,	meaning	it	took	3	days	for	potential	clones	to	be	large	enough	
to	be	identified	and	screened,	at	some	inconvenience.	Therefore,	it	was	decided	to	
further	modify	pEX18TpTer-pheS	 to	 include	a	different	antibiotic	 selection	marker	
(cat)	 to	 allow	 a	more	 convenient	 selection	medium	 to	 be	 used,	which	 permitted	
quicker	 identification	 of	 recombinant	 clones	 by	 growth	 on	 rich	medium	 at	 37°C.	
Figure	4.8	illustrates	the	construction	of	this	modified	vector.	



















Figure	 4.7	 Size	 analysis	 of	 candidate	 pEX18TpTer-pheS	 clones.	 Transformant	 colonies	
containing	 pEX18TpTer-pheS	 were	 grown	 overnight,	 subjected	 to	 plasmid	 extraction	 and	




































Figure	 4.8	 Construction	 of	 pEX18TpTer-pheS-Cm.	 The	 cat	 cassette	 from	 p34E-Cm2	 was	
excised	as	an	EcoRI	fragment	(top	right),	filled-in,	and	then	ligated	into	the	ScaI	restriction	
site	 of	 pEX18TpTer-pheS	 (top	 left),	 to	 give	 a	 5040	 bp	 vector,	 pEX18TpTer-pheS-Cm	









Concurrently,	 pEX18TpTer-pheS	 was	 digested	 with	 the	 blunt-end	 generating	
restriction	enzyme	ScaI	and	 then	blunt-end	 ligated	 to	 the	Cm2	cassette.	The	DNA	
fragments	used	for	this	ligation	reaction	are	shown	(Figure	4.9A).	Ligation	reactions	
were	introduced	into	E.	coli	JM38	and	transformants	selected	for	trimethoprim	and	
chloramphenicol-resistance.	 Several	 transformants	 were	 subjected	 to	 plasmid	
extraction	 and	 the	 subsequent	 plasmids	 were	 analysed	 following	 electrophoresis	








4.3.3 Generation	 of	 a	 tssM	 in-frame	 deletion	 mutant	 in	 B.	 cenocepacia	
H111	
	 It	was	decided	to	generate	a	B.	cenocepacia	mutant	containing	an	in-frame	
deletion	 in	 the	 tssM	 gene.	 For	 this,	 a	 previously	 generated	 plasmid	 containing	 a	
mutated	tssM	was	used	as	 the	source	of	 the	ΔtssM	allele,	pBBR1MCS-tssMΔXhoI.	
This	mutant	tssM	allele	was	generated	from	pBBR1MCS-1-tssM	by	utilising	naturally	
occurring	 XhoI	 sites	 in	 tssM,	which	 after	 digestion,	 excised	 a	 large	 section	 of	 the	





To	 generate	 an	 allelic	 replacement	 vector	 for	 tssM	 deletion	mutagenesis,	
the	DNA	fragment	containing	tssMΔXhoI	(hereon	referred	to	as	ΔtssM)	was	excised	


























from	p34E-Cm2	with	 EcoRI	 and	 ScaI	 cut	 pEX18TpTer-pheS,	 following	 electrophoresis	 in	 a	
1.0	 %	 DNA	 agarose	 gel.	 These	 were	 used	 in	 a	 ligation	 reaction	 to	 generate	 the	 vector	
pEX18TpTer-pheS-Cm.	(B)	Plasmids	were	extracted	and	size	determined	by	electrophoresis	
in	 a	 0.8	 %	 agarose	 gel,	 with	 an	 expected	 size	 of	 5040	 bp,	 as	 indicated	 by	 arrow.	 M,	
Supercoiled	DNA	ladder.	(C)	Determination	of	the	orientation	of	the	cat	gene	in	clone	1	by	
















































































recombinant	 plasmids	 (clones	 6	 and	 14)	 were	 identified,	 that	 gave	 rise	 to	 the	
expected	 plasmid	 size	 of	 6038	 bp	 (Figure	 4.10).	 Both	 were	 confirmed	 by	 DNA	
sequencing.		
For	 construction	 of	 a	ΔtssM	mutant	 in	B.	 cenocepacia	 H111,	 pEX18TpTer-
pheS-ΔtssM	was	transferred	to	this	strain	by	conjugation	using	E.	coli	SM10(λpir)	as	
a	donor	 strain.	 Single	 crossover	 recombination	events	 that	occurred	between	 the	
homologous	deletion	allele	on	the	plasmid	and	the	wild-type	allele	 in	the	genome	




results	 of	 this	 screen.	 All	 colonies	 gave	 rise	 to	 a	 DNA	 fragment	 of	 ~1800	 bp,	
corresponding	to	the	size	of	the	ΔtssM	fragment	present	on	the	allelic	replacement	
plasmid.		
Co-integrates	 were	 then	 streaked	 onto	 M9-glucose	 without	 trimethoprim	
but	 containing	 cPhe,	 to	 select	 for	 a	 second	 recombination	 event	 that	 resulted	 in	
excision	of	the	vector	backbone.	Several	colonies	that	grew	in	the	presence	of	cPhe	
were	re-streaked	onto	the	same	medium.	After	this,	candidates	were	subjected	to	
PCR	 colony	 screening	 using	 outside	 primers	 that	 annealed	 to	 the	 genomic	 region	
outside	 of	 the	ΔtssM	 fragment,	 iotMOPfor	 and	 tssMrevOP2.	 The	wild-type	 allele	
was	 expected	 to	 give	 rise	 to	 a	 DNA	 fragment	 of	 4066	 bp	 fragment,	whereas	 the	
ΔtssM	allele	would	generate	a	1951	bp	DNA	fragment.	Analysis	of	the	resulting	DNA	




specific	 primers,	 pEX18Tpfor	 and	 pEX8Tprev	 to	 verify	 the	 absence	 of	 the	 vector	
backbone	 from	 the	 genome.	 All	 four	 isolates	 of	 candidate	 #5	 gave	 rise	 to	 the	


















Figure	 4.10	 Size	 analysis	 of	 candidate	 pEX18TpTer-pheS-ΔtssM	 clones.	 The	 tssMΔXhoI	
allele	 was	 transferred	 from	 pBBR1MCS-tssMΔXhoI	 to	 pEX18TpTer-pheS	 as	 an	 XbaI-KpnI	
restriction	fragment.	Candidate	clones	were	subjected	to	plasmid	mini-preparation	and	the	
resulting	 plasmids	 were	 subjected	 to	 electrophoresis	 in	 a	 0.8%	 DNA	 agarose	 gel.	 The	










































A H111	+	pEX18TpTer-pheS-ΔtssM co-integrates	 
#1	-	#8 













































ΔtssM	 allelic	 replacement	 vector	 was	 transferred	 into	 H111	 WT.	 (A)	 Recombinants	
containing	an	integrated	plasmid	were	verified	by	PCR	screening,	using	primers	iotMfor	and	
iotMrev2	that	annealed	to	the	ΔtssM	fragment	contained	within	the	vector,	and	visualised	




visualised	 following	electrophoresis	 in	a	0.8%	agarose	gel.	Replacement	of	 the	 tssM	 gene	
with	ΔtssM	allele	was	expected	to	give	rise	to	a	1951	bp	DNA	fragment,	as	indicated	by	the	
arrow.	 (C)	Candidate	#5	was	re-streaked	then	re-screened	using	the	outside	tssM	primers	
(left)	 and	 screened	 for	 absence	 of	 the	 pEX18TpTer-pheS	 backbone	 using	 vector	 specific	
primers,	pEX18Tpfor	and	pEX18Tprev	(right),	expected	to	give	rise	to	a	379	bp	fragment	if	
the	 plasmid	 is	 still	 present.	 Resulting	 DNA	 fragments	 were	 visualised	 following	



































presence	 of	 TssD	 in	 the	 culture	 supernatant	 is	 indicative	 of	 an	 active	 T6SS.	 A	
polyclonal	rabbit	antibody	raised	against	B.	cenocepacia	TssD	had	been	generated	
previously	(Ahmad,	2013)	but	it	was	found	to	be	of	poor	quality.	Therefore,	it	was	
decided	 to	 generate	 a	 new	 anti-TssD	 antibody	 to	 monitor	 T6SS	 activity	 in	 B.	
cenocepacia.		
	
4.4.1 Construction	 of	 a	 plasmid	 for	 overproduction	 of	 epitope-tagged	
TssD	for	purification	by	IMAC	
	 To	generate	sufficient	amounts	of	pure	TssD	for	antibody	production	a	pre-
existing	 T7	 promoter	 based	 plasmid	 encoding	 N-terminally	 His-tagged	 TssD	 was	
modified.	The	TssD	protein	specified	by	this	plasmid,	pET14b-His6.tssD	contained,	in	
addition	 to	 a	 His-tag	 and	 a	 thrombin	 cleavage	 site,	 four	 additional	 amino	 acids	
(MRRA)	 following	 the	 epitope	 tag	 (Shastri,	 2011).	 pET14b-His6.tssD	 was	 digested	
with	 NdeI,	 and	 re-ligated	 to	 excise	 a	 21	 bp	 fragment	 that	 encompassed	 the	 4	
additional	 codons	 and	 the	 first	 three	 codons	of	 the	native	 tssD	 coding	 sequence.	
This	 generated	 a	 5158	 bp	 plasmid,	 pHLS22.	 Transformants	 containing	 candidate	






TssD	 from	 E.	 coli	 for	 purification	 an	 initial	 test	 expression	 was	 undertaken	 on	 a	
small	 volume-culture.	pHLS22	was	 introduced	 in	BL21(DE3),	and	protein	 synthesis	
in	 the	 resulting	 strain	was	 induced	with	 1	mM	 IPTG	 at	 37°C	 for	 4	 hours	 (Section	
2.3.1).	 The	 resulting	 cultures	were	 lysed	 (Section	 2.3.2)	 and	 samples	 analysed	 by	
SDS-PAGE	 (Figure	4.13).	A	protein	of	 approximately	20	kDa	was	produced	 in	high	
























non-native	 amino	 acids	 and	 the	 first	 three	 native	 amino	 acid	 of	 the	N-terminus	 of	 TssD,	
generated	 a	 plasmid	 termed	 pHLS22.	 (A)	 Transformants	 containing	 candidate	 pHLS22	
clones	were	 identified	 by	 colony	 PCR,	 using	 primers	 pETDuet-T7-1for	 and	 T7rev.	 Positive	
clones	 were	 expected	 to	 give	 rise	 to	 a	 slightly	 smaller	 DNA	 fragment	 than	 the	 pET14-
His6.tssD	control,	indicated	by	the	arrows.	M,	GeneRuler	DNA	ladder	mix.	(B)	Clones	1	and	
15	were	 selected	 for	mini-prep	extracted	and	analysed	by	electrophoresis	 in	a	0.8%	DNA	




























































coli.	 The	 expression	 plasmid	 pHLS22,	 specifying	 the	 overproduction	 of	 His6.TssD	 was	
introduced	into	BL21(DE3)	cells.	Liquid	cultures	were	grown	to	mid-log	phase	and	protein	
synthesis	 was	 induced	 with	 1	 mM	 IPTG	 for	 4	 hours	 at	 37°C.	 Cultures	 were	 lysed	 and	
sonicated	 as	 standard	 protocol	 and	 resulting	 lysate	 cleared	 by	 centrifugation.	Whole	 cell	
extracts	 from	 uninduced	 (-)	 and	 induced	 cultures	 (+),	 and	 the	 total	 (T),	 soluble	 (S)	 and	
insoluble	 (P)	 protein	 fractions	 of	 the	 lysate	 from	 the	 induced	 culture	were	 separated	 by	
SDS-PAGE	 in	a	12%	SDS-PA	gel	 and	 stained	 the	Coomassie	blue.	 Samples	were	 loaded	as	






















	 To	 obtain	 purified	 TssD,	 a	 clarified	 cell	 lysate	 from	 an	 induced	 culture	 of	
BL21(DE3)	 containing	 the	 plasmid	 pHLS22	 was	 first	 subjected	 to	 nickel	 affinity	
chromatography	 (Section	 2.3.5).	 The	 bound	 His-tagged	 protein	 was	 eluted	 by	
addition	of	a	10-500	mM	imidazole	gradient.	Protein	elution	was	monitored	at	A280,	
which	showed	that	His6.TssD	dissociated	from	the	nickel	resin	at	225	mM	imidazole	
(Figure	 4.14A).	 Eluted	 fractions	 were	 collected	 and	 analysed	 by	 SDS-PAGE	 to	





6	 10/300	 GL	 column	 equilibrated	 in	 PBS.	 Eluted	 fractions	 were	 collected	 and	
analysed	by	SDS-PAGE	(Figure	4.14D).	A	protein	migrating	at	approximately	20	kDa	
was	 present	 in	 high	 abundance	 in	 all	 fractions.	 Fractions	 were	 then	 pooled	 and	
concentrated	 using	 a	 10000	 MWCO	 concentrator	 and	 the	 protein	 concentration	
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a	 1mL	 His-Trap	 nickel	 affinity	 column	 couple	 to	 an	 ÄKTA	 purifier	 to	 bind	 the	 His-tagged	
protein.	The	column	was	washed	and	then	bound	proteins	were	eluted	by	addition	of	10-
500	mM	 imidazole	 gradient.	 (A)	 The	 resulting	A280	 trace	 of	 column	 eluates.	 (B)	Unbound	
flow-through	 (FT),	wash	 and	 imidazole	 eluted	 fractions	 (A7-B6)	 collected	 from	 the	 nickel	
column	during	purification	of	His.6TssD	(‘load’)	were	analysed	on	a	15%	SDS-PA	gel.	M,	EZ-
Run	Rec	 protein	 ladder.	 Arrow	 indicates	 identify	 of	 the	 protein	 eluted	 from	 the	 column.	
Pooled	 fractions	 were	 then	 concentrated	 (Pre-SEC)	 and	 purified	 further	 by	 SEC	 using	 a	
Superose	 6	 10/200	 GL	 column,	 with	 a	 flow	 rate	 of	 0.5	 mL/min	 in	 PBS.	 (C)	 A280	 trace	 of	



























 Analysis	 of	 T6SS	 activity	 in	 B.	 cenocepacia	 strains	 H111,	4.5
Pc715j	and	K56-2	
	 In	 many	 T6SS-containing	 bacteria	 the	 system	 is	 inactive	 under	 standard	
laboratory	 conditions,	 making	 investigating	 the	 role	 of	 the	 system	 and	 T6SS-
dependent	effector	identification	difficult.	Therefore,	it	was	vital	to	first	investigate	
T6SS	 activity	 in	B.	 cenocepacia	 to	 determine	 what	 conditions	 (if	 any)	 resulted	 in	
activation	 of	 the	 system.	 This	 is	 normally	 determined	 by	 the	 secretion	 of	 a	 T6SS	
subunit,	 TssD,	 into	 the	 culture	 supernatant.	 Previous	 work	 by	 our	 group	 had	
observed	 no	 phenotypic	 differences	 between	 H111	 and	 Pc715j	 strains	 and	 their	
tssA,	 tssK	 and	 tssM	 insertion	mutant	 counterparts	 in	Dictyostelium	 or	C.	 elegans	







	 To	 investigate	 T6SS	 activity,	 extracellular	 proteins	 from	 the	 culture	
supernatant	 of	 late	 exponential	 grown	 broth	 cultures	 of	 wild-type	 and	 T6SS-
defective	B.	 cenocepacia	 strains	were	precipitated	by	 trichloroacetic	acid	 (TCA)	 in	
the	presence	of	sodium	deoxycholate	(DOC)	(Section	2.4.1).	This	method	is	known	
to	 be	 useful	 if	 the	 protein	 concentration	 is	 very	 low	 (1-50	µg)	 and	 reproducible	
precipitation	 is	 required	 (Bensadoun	 and	Weinstein,	 1976).	 Extracellular	 proteins	
from	B.	cenocepacia	H111,	Pc715j	and	K56-2	T6SS	mutants	were	extracted	by	this	
method	and	concentrated	a	1000-fold.	Resulting	samples	were	then	separated	by	
































































































































Figure	 4.15	 Analysis	 of	 secreted	 protein	 profiles	 from	 liquid	 cultures	 of	B.	 cenocepacia	
strains	H111,	K56-2	and	Pc715j.	Culture	supernatants	of	B.	cenocepacia	strains	grown	in	D-
BHI	 broth	 were	 concentrated	 1000-fold	 by	 DOC-TCA	 precipitation	 and	 analysed	 by	 SDS-
PAGE.	Cell-associated	proteins	were	prepared	by	concentrating	the	bacterial	cell	pellet	20-
fold,	combined	in	1:1	ratio	with	2x	SDS-sample	buffer	and	then	boiled.		(A)	15%	SDS-PA	gel	
of	 secreted	 (left)	 and	 cell-associated	 (right)	 proteins	 from	B.	 cenocepacia	H111	wild-type	
and	corresponding	 tssA::Tp,	 tssK::Tp,	 tssM::Tp	 (upper)	 and	ΔtssM	mutants	 (lower).	 (B)	 as	
(A)	 but	 with	 samples	 extracted	 from	 B.	 cenocepacia	 K56-2	 and	 tssA::Tp	 and	 tssM::Tp	
mutants	thereof.	(C)	as	(A)	and	(B)	but	using	samples	extracted	from	B.	cenocepacia	Pc715j	













































H111	 supernatants.	 Interestingly,	 the	 18	 kDa	 protein	 was	 not	 present	 in	 the	
supernatants	 derived	 from	 Pc715j.	 This	 strain	 also	 appeared	 to	 have	 a	 less	
extensive	 range	 of	 extracellular	 proteins	 present	 in	 the	 culture	 supernatant	 in	
comparison	to	the	H111	and	K56-2	strains.		
	 By	 immunodetection	 using	 the	 custom	 polyclonal	 anti-TssD	 antibody	
described	in	Section	4.4,	 it	was	found	that	the	18	kDa	protein	present	 in	secreted	
fractions	 of	 H111	 and	 K56-2	 reacted	 positively	with	 the	 antibody,	 confirming	 the	
identity	of	this	protein	as	TssD	(Figure	4.16).	However,	it	was	it	was	not	detected	in	
the	 supernatant	 derived	 from	 Pc715j.	 	 Intracellular	 TssD	was	 also	 detected	 in	 all	
strains	 and	 their	 T6SS-deficient	 derivatives	 indicating	 that	 TssD	 was	 still	 being	




the	 secreted	 protein	 derived	 from	 H111	 was	 excised	 from	 an	 SDS-PA	 gel,	 and	
subjected	 to	 in-gel	 tryptic	 digestion	 and	 protein	 identification	 using	 tandem	
MS/MS.	 A	 database	 search	 of	 the	 resulting	 peptide	 masses	 and	 sequences	







concentrated	 by	 DOC-TCA	 precipitation	 (Section	 2.4.2).	 SDS-PAGE	 analysis	 of	 the	
resulting	 samples	 showed	 no	 obvious	 differences	 in	 the	 secreted	 protein	 profile	
between	 the	 wild-type	 or	 T6SS	 mutant	 for	 both	 H111	 and	 Pc715j	 strains	 when	
visualised	by	Coomassie	blue	staining	(Figure	4.17).	A	large	quantity	of	a	40	kDa	and	
a	 36	 kDa	 protein	 was	 present	 in	 all	 samples.	 The	 latter	 is	 likely	 to	 be	 the	 T2SS-
dependent	extracellular	metalloproteases	ZmpA	and/or	ZmpB	(Corbett	et	al.,	2003;	





















supernatants	 of	 wild-type	 B.	 cenocepacia	 H111	 (A),	 K56-2	 (B)	 and	 Pc715j	 (C)	 and	
corresponding	 T6SS	mutants	were	 subjected	 to	 DOC-TCA	 precipitation	 and	 concentrated	
1000-fold.	Cell-associated	proteins	were	prepared	by	concentrating	the	bacterial	cell	pellet	
20-fold,	 combined	 in	 1:1	 ratio	 with	 2x	 SDS-sample	 buffer	 and	 then	 boiled.	 	 	 Resulting	
secreted	 and	 cell-associated	 samples	 were	 separated	 by	 SDS-PAGE,	 as	 indicate,	 and	 the	
presence	of	TssD	analysed	by	anti-TssD	western	blotting	using	1:1000	dilution	of	a	custom	
polyclonal	 anti-TssD	 antibody	 (top	 panel	 in	 A,	 B	 and	 C).	 A	 commercially	 available	 anti-β-
RNAP	antibody	was	used	as	an	indicator	of	lysis	in	preparations	(lower	panel	in	A,	B	and	C).	












































































































































and	 corresponding	 T6SS	 mutants	 grown	 on	 solid	 medium.	 B.	 cenocepacia	 strains	 were	
cultured	on	a	dialysis	membrane	overlaid	on	solid	medium	for	24	hours	at	37°C,	following	
which	 the	 resulting	 bacterial	 growth	was	 removed	 from	 the	membrane	 and	 extracellular	
proteins	extracted	by	DOC-TCA	precipitation.	Wild-type	(WT),	tssA::Tp,	tssM::Tp	strains	of	










































protein	 corresponding	 in	 size	 to	 TssD	 was	 not	 observed.	 Furthermore,	 western	
blotting	 for	TssD	 indicated	 that	TssD	was	not	present	 in	 the	extracellular	 samples	
for	either	wild-type	strain,	or	it	was	at	a	concentration	below	the	limits	of	detection	




	 For	 the	construction	of	a	tssA	 complementation	plasmid	with	an	antibiotic	
resistance	 gene	 that	 did	 not	 confer	 resistance	 to	 chloramphenicol	 (and	 was	
therefore	compatible	with	downstream	uses	 for	 complementation	 in	experiments	
described	in	Section	4.6.2),	a	previously	generated	plasmid,	pBBR1MCS-1-tssA,	was	
used	 as	 the	 source	 of	 tssA.	 This	 plasmid	 contained	 the	 tssA	 gene	 and	 its	 native	
Shine-Dalgarno	 sequence	 under	 the	 control	 of	 the	 vector	 lac	 promoter,	 but	
conferred	 resistance	 to	chloramphenicol.	 tssA	was	 transferred	on	a	BamHI-HindIII	
restriction	 fragment	 from	pBBR1MCS-tssA	 into	 the	 corresponding	 restriction	 sites	




4.5.4 Construction	 of	 tssM	 complementation	 plasmids,	 pBBR1-tssM	 and	
pBBR2-tssM		
	 For	 the	 genetic	 complementation	 of	 the	 in-frame	 H111-ΔtssM	mutant	 a	





the	 vectors	pBBR1MCS-1	and	pBBR1MCS-2,	 to	 give	 the	plasmids	pBBR1-tssM	 and	






















































Figure	 4.19	 Construction	 of	 tssM	 complementation	 plasmids	 pBBR1-tssM	 and	 pBBR2-
tssM.	 (A)	 The	 coding	 sequence	 of	 tssM	 and	 its	 native	 Shine-Dalgarno	 sequence	 were	
amplified	 on	 a	 3999	bp	DNA	 fragment	 from	H111	 genomic	DNA	 and	 visualised	 following	
electrophoresis	 in	 0.8%	 DNA	 agarose	 gel.	 (B)	 tssM	 was	 cloned	 into	 pBBR1MCS-1	 and	
pBBR1MCS-2	 between	 the	 XbaI	 and	 Acc65I	 sites.	 Positive	 clones	 were	 identified	 by	 PCR	
screening,	giving	rise	to	an	expected	DNA	fragment	of	4136	bp	indicated	by	the	arrow.	(C)	
Candidate	 clones	 where	 then	 subjected	 to	 plasmid	 minipreparation	 extraction	 to	
determine	 the	 plasmid	 sizes,	 and	 visualised	 following	 electrophoresis	 in	 a	 0.8%	 DNA	
agarose	 gel.	 Plasmids	 had	 an	 expected	 size	 of	 8613	 bp	 for	 pBBR1-tssM	 and	 9050	 bp	 for	



















































appearance	 on	 medium	 containing	 IPTG	 and	 X-gal,	 and	 those	 containing	
pBBR1MCS-2-based	 clones	 by	 acquisition	 of	 kanamycin	 resistance.	 Candidate	
recombinant	plasmids	containing	tssM	were	 identified	by	PCR	screening	using	the	
vector	primers	M13for	and	M13rev	(Figure	4.19B).		Candidate	pBBR1-tssM	clones	4	
and	 5	 and	 candidate	 pBBR2-tssM	 clones	 3,	 4	 and	 5	 produced	 the	 expected	 sized	





4.5.5 Complementation	 of	 TssD	 secretion	 in	 tssA	 and	 tssM-deficient	
mutants	in	B.	cenocepacia	H111	
	 To	confirm	that	the	absence	of	secreted	TssD	was	due	to	a	direct	effect	of	
inactivation	 of	 the	 disrupted	 T6SS	 genes	 it	was	 decided	 to	 analyse	whether	 TssD	
secretion	 could	 be	 restored	 by	 genetic	 complementation.	 To	 do	 this,	 the	
appropriate	 complementation	 plasmid	 and	 empty	 vector	 were	 transferred	




	 Secretion	 of	 TssD	 was	 restored	 in	 the	 H111-tssA::Tp	 mutant	 by	
complementation	 with	 pBBR1MCS-tssA	 and	 pBBR2-tssA	 (Figure	 4.20A).	
Complementation	 of	 the	 tssA::Tp	 mutant	 by	 the	 pBBR1-based	 plasmid	 restored	
TssD	secretion	to	levels	similar	to	that	of	the	wild-type.	However,	the	pBBR2-based	
plasmid	 did	 not.	 Curiously,	 it	 restored	 TssD	 secretion	 only	 to	 the	 levels	 observed	
when	 wild-type	 H111	 contained	 the	 pBBR2-tssA	 construct,	 which	 for	 some	
unknown	 reason	 appeared	 to	 impair	 TssD	 secretion.	 This	 inhibition	 of	 TssD	
secretion	 in	 the	 wild-type	 stain	 was	 not	 observed	 in	 the	 presence	 of	 the	 empty	
vector.		
	 TssD	 was	 detected	 in	 the	 secreted	 protein	 fraction	 of	 ΔtssM	 harbouring	



















Figure	 4.20	 Genetic	 complementation	 of	 B.	 cenocepacia	 H111	 tssA::Tp	 and	 ΔtssM	
mutants.	pBBR1-tssA,	pBBR2-tssA	and	pBBR2-tssM	complementation	plasmids	and	empty	
vectors	were	 transferred	 into	H111	and	 the	 respective	B.	 cenocepacia	H111-tssA::Tp	and	
H111-ΔtssM	 mutants.	 Extracellular	 proteins	 were	 then	 extracted	 from	 liquid	 grown	
cultures	 by	 DOC-TCA	 precipitation	 and	 analysed	 for	 the	 presence	 of	 TssD	 by	 anti-TssD	
western	blotting.	Cell-associated	proteins	where	also	analysed.	(A)	The	resulting	anti-TssD	
blots	 from	 H111-tssA::Tp/pBBR1-tssA	 (left)	 and	 H111-tssA::Tp/pBBR2-tssA	 (right)	
complementation.	(B)	Analysis	of	TssD	secretion	following	introduction	of	pBBR2-tssM	into	































































































































































(Figure	4.20B).	However,	 this	TssD	secretion	was	not	 restored	 to	wild-type	 levels,	
but	instead	to	levels	similar	to	wild-type	H111	harbouring	the	pBBR2-tssM	plasmid,	
























 Investigation	 into	 the	 role	 of	 the	 B.	 cenocepacia	 T6SS	 in	4.6
inter-bacterial	competition		
	 The	main	function	of	T6SSs	in	other	bacteria	appears	to	be	in	inter-bacterial	
competition	 (Section	 1.4.2).	 It	 is	 thought	 that	 the	 T6SS	 can	 target	 surrounding	




4.6.1 Analysis	 of	 antibiotic	 susceptibility	 of	 several	 Gram-negative	
bacteria		
	 In	order	to	help	determine	which	bacterial	species	and	selection	conditions	
would	be	most	 appropriate	 to	use	 in	 an	 inter-bacterial	 competition	assay	with	B.	
cenocepacia,	several	bacterial	species	were	streaked	out	onto	a	range	of	selection	
media	to	determine	antibiotic	sensitivity	and	other	phenotypic	differences.	Findings	
from	 this	 screen	 for	 B.	 cenocepacia	 H111,	 Pc715j,	 S.	 marcescens	 Db10,	 P.	






















To	 determine	 the	 effect	 of	 the	 T6SS	 on	 the	 competitive	 fitness	 of	 B.	
cenocepacia,	 P.	 putida	 KT2440	was	 used	 in	 a	 4-hour	 co-culture	with	wild-type	B.	
cenocepacia	 H111	 and	 two	 different	 T6SS	 mutants,	 tssA::Tp	 and	 ΔtssM	 (Section	
2.9.1).	 Surviving	 bacteria	 were	 enumerated	 on	 two	 different	 selection	 plates,	 LB	
agar	 containing	 chloramphenicol	 (25	µg/mL)	 for	P.	 putida	and	 LB	 agar	 containing	
tetracycline	 (10	µg/mL)	 for	B.	 cenocepacia.	 The	 resulting	 data	 is	 shown	 in	 Figure	
4.21.	 It	 was	 observed	 that	 P.	 putida	 recovery	 was	 significantly	 greater	 when	 co-
cultured	with	the	tssA::Tp	mutant	than	with	wild-type	H111	by	a	factor	of	57,	which	
was	 statistically	 significant	with	 a	 P	 value	 of	 0.0067	 using	 a	 student’s	 t-test.	 This	
difference	was	mirrored	with	the	ΔtssM	mutant,	which	resulted	in	an	increase	of	P.	
putida	 by	 a	 factor	 of	 58	 compare	 to	 wild-type,	 which	 again	 was	 statistically	
significant	 with	 a	 P	 value	 of	 0.0261.	 	 No	 significant	 difference	 was	 observed	
between	 the	 numbers	 of	 B.	 cenocepacia	 strains	 recovered	 for	 all	 co-cultures.	
Together,	this	data	suggests	show	that	the	B.	cenocepacia	H111	T6SS	is	 important	
for	interspecies	competition	under	the	conditions	tested.		
	 B.	 cenocepacia	 Pc715j	 was	 demonstrated	 to	 have	 an	 inactive	 T6SS	 under	
standard	laboratory	conditions	(Section	4.5.1).	To	investigate	whether	it	plays	a	role	
in	 inter-bacterial	 competition	wild-type	 Pc715j	 and	 a	 corresponding	 T6SS	mutant	
(715-tssA::Tp)	 were	 tested	 in	 the	 interspecies	 competition	 model.	 However,	 no	
difference	 was	 observed	 between	 the	 number	 of	 recovered	 P.	 putida	 when	 co-
cultured	with	wild-type	Pc715j	or	a	Pc715j	T6SS	mutant	(data	not	shown).		
	
4.6.3 Analysis	 of	 B.	 cenocepacia	 H111	 T6SS-mediated	 bacterial	
competition	with	Escherichia	coli	CC118(λpir)	
	 To	determine	whether	other	species	could	be	susceptible	to	T6SS-mediated	


























Figure	 4.21	 Analysis	 of	 the	 contribution	 of	 the	 T6SS	 to	 competitive	 fitness	 of	 B.	
cenocepacia	 H111	 against	 P.	 putida.	 B.	 cenocepacia	 H111	 and	 P.	 putida	 KT2440	 were	
combined	in	a	5:1	ratio,	incubated	on	solid	medium	for	4	hours	at	30°C.	Surviving	bacteria	





























































































































































agar	 containing	 rifampicin	 (100	 µg/mL)	 were	 used	 to	 select	 for	 growth	 of	 B.	









4.6.4 Analysis	 of	 B.	 cenocepacia	 H111	 T6SS-mediated	 bacterial	
competition	with	Escherichia	coli	SM10(λpir)	





differential	 selection	 on	 LB	 agar	 containing	 tetracycline	 (10	 µg/mL)	 for	 B.	
cenocepacia	growth	and	 Lennox	agar	 containing	kanamycin	 (50	µg/mL)	 for	E.	 coli	
SM10(λpir).	Results	shown	 in	Figure	4.23	 indicate	that	a	greater	number	of	E.	coli	
SM10(λpir)	 were	 recovered	 when	 co-cultured	 with	 the	ΔtssM	 T6SS	 mutant	 than	
when	 co-cultured	 with	 wild-type	 H111	 by	 a	 factor	 of	 10,	 which	 again	 was	
statistically	significant	with	a	P	value	of	0.0005.	This	was	a	slight,	but	not	significant,	

















Figure	 4.22	 Analysis	 of	 the	 contribution	 of	 the	 T6SS	 to	 competitive	 fitness	 of	 B.	
cenocepacia	H111	against	E.	coli	CC118(λpir).	B.	cenocepacia	H111	and	E.	coli	CC118(λpir)	
were	 combined	 in	 a	 5:1	 ratio,	 incubated	 on	 solid	medium	 for	 4	 hours	 at	 30°C.	 Surviving	
bacteria	were	recovered	and	enumerated	on	selection	plates.	(A)	Number	of	recovered	P.	
putida	after	co-culture	with	H111,	H111-tssM::Tp	or	in	absence	of	competing	bacteria	(‘No	











Figure	 4.23	 Analysis	 of	 the	 contribution	 of	 the	 T6SS	 to	 competitive	 fitness	 of	 B.	
cenocepacia	H111	against	E.	 coli	 SM10(λpir).	B.	cenocepacia	H111	and	E.	coli	SM10(λpir)	
were	combined	in	a	5:1	ratio,	incubated	on	solid	medium	for	4	hours	at	30°C,	where	upon	
surviving	 bacteria	 were	 recovered	 and	 enumerated	 on	 selection	 plates.	 (A)	 Number	 of	
recovered	P.	putida	after	co-culture	with	H111,	H111-tssM::Tp	or	in	absence	of	competing	
bacteria	 (‘No	 Bcen’)	 and	 (B)	 the	 number	 of	B.	 cenocepacia	 recovered	 after	 each	 culture.	
































































































































































niches	P.	 fluorescens	was	 tested	 in	 the	 bacterial	 competition	model	 against	wild-
type	 H111	 and	 a	 T6SS	 mutant.	 To	 do	 this,	 a	 spontaneous	 rifampicin	 resistant	
version	 of	 P.	 fluorescens	 ATCC	 17571	 was	 selected	 (HLS1)	 and	 verified	 as	 P.	
fluorescens	by	 its	 ability	 to	 fluoresce	 upon	 exposure	 to	UV	 light	 on	 King’s	 B	 agar	
(Figure	 4.24).	 Use	 of	 the	 P.	 fluorescens	 rifampicin	 resistant	 strain	 allowed	
differential	selection	between	B.	cenocepacia	and	P.	fluorescens,	by	enumerating	B.	
cenocepacia	 recovery	 on	 LB	 agar	 containing	 tetracycline	 (10	 µg/mL)	 and	 P.	
fluorescens	 on	 LB	 agar	 containing	 rifampicin	 (100	 µg/mL).	 By	 enumeration	 of	
recovered	 P.	 fluorescens,	 shown	 in	 Figure	 4.25,	 it	 was	 observed	 that	 when	 co-
cultured	with	 the	H111-ΔtssM	mutant	 the	number	of	surviving	P.	 fluorescens	was	
greater	 than	 when	 co-cultured	 with	 wild-type	 H111,	 by	 a	 factor	 of	 5.	 This	 was	
significant	 with	 a	 P	 value	 of	 0.0186,	 but	 only	 with	 an	 n	 of	 2	 for	 H111-ΔtssM.	
However,	 there	 was	 also	 a	 decrease	 in	 the	 number	 of	 recovered	 P.	 fluorescens	
when	 cultured	 alone	 relative	 to	 co-culture	 with	 the	 T6SS	 mutant,	 which	 was	
significant.	 Furthermore,	when	co-cultured	with	wild-type	H111	 the	number	of	P.	
fluorescens	 recovered	was	 similar	 to	 the	 number	 recovered	when.	 P.	 fluorescens	




used	 in	this	 interspecies	competition	assay	with	P.	 fluorescens	and	a	similar	 trend	








































(A)	 Number	 of	 recovered	 P.	 fluorescens	 after	 co-culture	 with	 H111,	 H111-tssM::Tp	 or	 in	
absence	 of	 competing	 bacteria	 (‘No	 Bcen’)	 and	 (B)	 shows	 number	 of	 B.	 cenocepacia	
recovered	after	each	culture.	Statistical	analysis	by	student’s	t-test,	n≥2,	p<0.05,	error	bars	
=	±SD.	*,	p<0.05;	**,	p<0.01;	ns,	not	significant.	
A B C 














































































 Investigation	 into	 anti-eukaryotic	 properties	 of	 the	 B.	4.7
cenocepacia	T6SS	using	eukaryotic	infection	models	
		 In	 vivo	 B.	 cenocepacia	 survival	 in	 an	 animal	 model	 has	 been	 tentatively	
linked	to	the	T6SS	(Section	1.2.5).	Therefore,	it	was	decided	to	determine	whether	





	 B.	cenocepacia	K56-2	and	 its	corresponding	T6SS	mutants	were	tested	 in	a	
zebrafish	 (Danio	 rerio)	 embryo	 infection	model	 in	 collaboration	with	 A.	 Vergunst	
(University	of	Montpellier).	A	preliminary	experiment	found	that	the	parental	wild-
type	 strain	 of	 B.	 cenocepacia	 K56-2	 used	 to	 make	 initial	 T6SS	 mutants	 had	 an	
attenuated	 virulence	 in	 the	 zebrafish	 infection	 model	 (data	 not	 shown).		
Subsequent	to	this,	it	was	found	that	this	attenuated	wild-type	isolate	(K56-2att)	and	
corresponding	mutants	gave	a	shiny	pink	colony	morphology	on	Congo	red	plates.	
This	 was	 consistent	 with	 a	 strain	 defective	 in	 ShvR-related	 genes	 encoded	 on	
chromosome	 3	 that	 correlated	 with	 loss	 of	 virulence	 (Bernier	 et	 al.,	 2008;	
Subramoni	 et	 al.,	 2011).	 Therefore	 the	 tssA::Tp	 and	 tssM::Tp	 alleles	 were	
introduced	 into	 a	 new	 isolate	 of	 wild-type	 K56-2	 (K56-2vir)	 (Section	 4.2.1).	 This	
strains	and	the	resulting	T6SS	mutants	were	confirmed	to	have	a	SHV-positive	(red	
and	rough)	phenotype	on	Congo	red	plates	(Table	4.2	and	Figure	4.26).	
	 Upon	 infection	of	30	hours	post-fertilisation	 (hpf)	 embryos	with	~100	CFU	
per	embryo	of	wild-type	K56-2vir	and	its	T6SS-deficient	derivatives,	it	was	found	that	
infection	with	 either	 T6SS	mutant	 resulted	 in	 no	 significant	 difference	 in	 embryo	
survival	compared	to	wild-type	(Figure	4.27A).	The	majority	of	embryos	were	killed	


































affinity	 (shiny	 and	 pink),	 and	 plates	 photographed.	 Top	 row	 shows	 resulting	 colony	
morphology	of	original	attenuated	B.	cenocepacia	K56-2	wild-type	(WT)	lab	stock	(K56-2att)	
(left),	and	corresponding	tssA::Tp	(middle)	and	tssM::Tp	(right)	mutants.	Bottom	row	shows	
non-attenuated	 B.	 cenocepacia	 K56-2	 isolate	 (K56-2vir)	 and	 corresponding	 T6SS	 mutants	
generated	from	this	parental	strain.		





























Figure	 4.27	 Effect	 of	 T6SS-inactivation	 on	 the	 virulence	 of	 B.	 cenocepacia	 K56-2	 in	 a	
zebrafish	 infection	 model.	 30	 hpf	 zebrafish	 embryos	 were	 infected	 with	 wild-type	 B.	














moth,	 have	 previously	 been	 used	 to	 model	 infection	 by	 B.	 cenocepacia	 for	
evaluating	 virulence	 determinants	 (Seed	 and	 Dennis,	 2008;	 Agnoli	 et	 al.,	 2012).	
Therefore,	 it	 was	 decided	 to	 employ	 this	 model	 to	 investigate	 whether	 the	 B.	
cenocepacia	 T6SS	 plays	 a	 role	 in	 virulence	 in	 this	 alternative	 infection	 model.		
	 Preliminary	 optimisation	 was	 undertaken	 to	 determine	 the	 most	
appropriate	bacterial	infection	load	to	use	and	the	infection	period.	To	do	this,	final	
instar	stage	larvae	were	injected	with	approx.	4	to	4	x	104	CFU/larva	of	wild-type	B.	
cenocepacia	 K56-2	 (K56-2vir)	 from	 a	mid-log	 phase	 liquid	 culture	 (Section	 2.10.2),	
and	larvae	survival	was	monitor	over	48	hours.	The	initial	inoculum	was	estimated	




over	 time	 for	 each	 infection	 group,	 and	 the	data	 for	 24	hpi	 is	 presented	 as	 a	 kill	
curve.	 Results	 from	 this	 pilot	 experiment	 indicated	 that	 larvae	 infected	 with	 the	
highest	dose	(4	x	104	CFU	per	larva)	were	the	only	group	to	show	larvae	death	at	18	
hpi.	Larvae	killing	became	rapid	between	18	and	24	hours	for	the	both	4	x	104	and	4	
x	 103	 dose	 groups.	 By	 48	 hours,	 even	 a	 very	 low	 inoculum	of	 ~3	 CFU	 resulted	 in	
>95%	death	of	the	larvae.	This	data	showed	a	good	dosage	response	of	bacteria	to	
killing	of	the	larvae,	suggesting	that	4	x	104	CFU	per	larva	and	4	x	102	CFU	per	larva	




























Figure	 4.28	 Analysis	 of	 the	 effect	 of	 initial	 bacterial	 inoculum	 on	 Galleria	 mellonella	
larvae	 survival	 following	 infection	 by	 B.	 cenocepacia	 K56-2.	 Final-instar	 G.	 mellonella	
larvae	were	 infected	with	serial	dilutions	of	B.	cenocepacia	K56-2	and	 larvae	survival	was	
monitored	over	48	hours.	(A)	Percentage	larvae	survival	for	each	treatment	group	(n=20	for	
each	 group),	 infected	with	 4	 x	 104	 to	 4	 CFU	 per	 larva,	 identified	 in	 the	 key	 to	 the	 right.	
Mock-infected	 (PBS	 treated),	 heat	 killed	 K56-2	 (HC)	 and	 uninfected	 larvae	 (UI)	 were	
included	as	 controls.	 (B)	A	 kill	 curve	at	 24	hours	post-infection	 for	G.	mellonella	 infected	
with	varying	inocula	of	B.	cenocepacia	K56-2.	n=	1.		
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Figure	 4.29	 Effect	 of	 T6SS-inactivation	 on	 the	 virulence	 of	 B.	 cenocepacia	 K56-2	 in	 a	
Galleria	 mellonella	 infection	 model.	 G.	 mellonella	 larvae	 where	 infected	 with	 B.	
cenocepacia	 K56-2	 wild-type,	 and	 tssA::Tp	 and	 tssM::Tp	 mutant	 derivatives	 and	 larval	
survival	 monitored	 over	 24	 hours.	 30	 larva	 per	 infection	 group	 were	 used.	 (A)	 Larval	
survival	over	time	for	larvae	infected	with	a	high	dose	(4	x	104CFU	per	larva)	of	wild-type,	
tssA::Tp	and	tssM::Tp,	as	indicated	by	the	key.	(B)	as	(A)	but	infected	with	a	lower	dose	of	
bacteria	 (4	 x	102	CFU	per	 larva).	 (C)	 Larval	 surival	 at	18	hpi	 in	high	dose-infected	groups.	
Statistical	 analysis	 by	 student’s	 t-test,	 where	 n=2	 and	 p<0.05,	 *,	 p<0.05.	 UI,	 uninfected;	













































































showed	 that	 inactivation	 of	 the	 T6SS	 resulted	 in	 no	 difference	 to	 the	 overall	
virulence	 of	B.	 cenocepacia	 K56-2	 in	 this	model	 as	 determined	 at	 24	 hours	 with	
either	dose	(Figure	4.29A	and	4.29B).	However,	larvae	survival	was	slightly	greater	
when	infected	with	a	high	dose	of	either	of	the	T6SS	mutants	than	with	a	high	dose	
of	 the	wild-type	 strain,	 but	 only	 at	 16	 and	18	hpi,	with	 18	hpi	 showing	 the	most	
prominent	 difference	 (Figure	 4.29C).	 Thus,	 an	 average	 of	 62%	 larval	 survival	
occurred	 at	 18	 hpi	 when	 infected	 with	 wild-type	 K56-2	 in	 comparison	 to	 85%	
survival	 following	 infection	with	 the	 tssA::Tp	mutant	 and	 79%	 following	 infection	
with	 the	 tssM::Tp	 mutant,	 which	 was	 statistically	 significant.	 However,	 no	
difference	was	observed	 in	 the	 low	dose	 infection	groups.	This	 trend	was	 seen	 in	
both	experiments	but	 it	 is	difficult	 to	draw	solid	conclusions	regarding	the	role	of	
the	 T6SS	 in	 this	 due	 to	 the	 limited	 n	 number.	 However,	 a	 difference	 in	 bacterial	
inoculum	can	be	ruled	out	as	a	cause	of	the	variation	in	larvae	survival	in	the	high	
dose	groups	at	the	18	hpi	time	point,	as	enumeration	of	the	inocula	showed	similar	















4.8.1 Generation	 of	 a	 genetic	 tool	 for	 in-frame	 allelic	 replacement	 in	B.	
cenocepacia		
The	 generation	 of	 in-frame	 deletion	 mutants	 in	 a	 useful	 tool	 for	
understanding	the	phenotypic	effects	of	deleting	a	gene	whilst	limiting	polar	effects	
on	 genes	 downstream,	 which	 can	 occur	 by	 insertional	 inactivation,	 i.e.	 with	 an	
antibiotic	 resistance	 cassette.	 	 This	 study	 generated	 a	 new	 allelic	 replacement	






single	 recombinants	 by	 virtue	 of	 their	 trimethoprim-resistance,	 which	 was	
hypothesis	to	be	due	to	transcription	from	the	strong	artificial	pheS	promoter	(PS12)	
converging	 with	 transcription	 from	 the	 reverse	 orientated	 dfr	 gene,	 resulting	 in	
down-regulation	 of	 dfr	 promoter	 activity.	 In	 the	 study	 describe	 here,	 this	 was	
overcome	by	placing	the	dfr	gene	in	pEX18Tp-pheS	in	the	same	orientation	as	pheS	
with	the	addition	of	a	strong	transcriptional	terminator.		
The	plasmid	was	successfully	used	 to	generate	an	 in-frame	deletion	of	 the	
tssM	 gene	 in	B.	 cenocepacia	H111.	 Inactivation	of	 the	 T6SS	 in	 this	ΔtssM	mutant	
was	confirmed	by	demonstrating	that	the	strain	had	reduced	T6SS	activity	and	T6SS	
function,	 i.e.	absence	of	TssD	 in	 the	culture	supernatant,	which	could	be	restored	
by	 genetic	 complementation,	 and	 reduced	 competitive	 fitness	 in	 a	 co-culture,	 as	
observed	for	other	T6SS	mutants.	Thus,	indicating	in-frame	deletion	mutagenesis	in	
B.	cenocepacia	was	possible	using	this	new	allelic	replacement	vector.		
Other	 methods	 for	 generating	 in-frame	 deletion	 mutants	 in	 Burkholderia	
species	 are	 possible,	 including	 sucrose	 counter-selection	 using	 sacB	 (López	 et	 al.,	
2009),	and	a	method	based	of	the	yeast	homing	endonuclease	I-SceI	(Flannagan	et	
al.,	2008).	The	former	is	based	on	the	production	of	levansucrase	from	sacB,	which	
catalyses	 the	 hydrolysis	 of	 sucrose	 to	 produce	 fructose	 polymers,	 this	 action	 is	
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lethal,	 thus	growth	on	medium	containing	sucrose	 is	 toxic	 (Steinmetz	et	al.,	1983;	
Gay	et	al.,	1983).	This	allows	selection	of	a	second	recombination	event	in	a	similar	
manner	 to	 cPhe	counter-selection.	However,	 this	 approach	cannot	be	 taken	 in	all	
cases,	 as	 some	 Burkholderia	 species	 posses	 a	 sacB	 homologue,	 and	 sucrose-
sensitivity	has	been	observed	 to	be	variable	even	 in	 strains	 that	do	not	 contain	a	
sacB	homologue	(Essex-Lopresti	et	al.,	2005).		
The	 I-SceI	 system	 uses	 a	 I-SceI	 recognition	 site	 located	 in	 an	 allelic	
replacement	 vector,	 where	 once	 integrated	 into	 the	 genome	 by	 a	 single	
recombinant	event,	the	site	is	then	cut	by	the	homing	endonuclease	I-SceI	provided	
in	 trans	 by	 an	 expression	 plasmid	 (Plessis	 et	 al.,	 1992;	 Posfai	 et	 al.,	 1999).	 This	
produces	a	double	stranded	DNA	break	in	the	genome	at	the	I-SceI	recognition	site,	




encoded	within	 the	 I-SceI	 encoding	 expression	 plasmid.	 The	 strategy	 used	 by	 the	
vector	 constructed	 in	 this	 study	 does	 not	 required	 an	 additional	 transformation	
step	for	selection	of	a	second	recombinant	event	like	that	required	using	the	I-SceI	
system,	so	in	that	regards,	pEX18TpTer-pheS	has	its	advantages.	 
However,	 the	 pEX18TpTer-pheS	 plasmid	 is	 not	 perfect,	 cPhe	 counter-
selection	was	still	observed	to	be	inefficient	in	some	cases.	The	reasons	for	this	are	
unknown,	 but	 sensitivity	 of	 the	 system	 to	 trace	 amounts	 of	 contaminating	
phenylalanine	may	be	a	contributing	factor	(Barrett	et	al.,	2008).	Furthermore,	the	
mutated	pheS	 allele	 carried	on	pEX18TpTer-pheS	 is	derived	 from	B.	pseudomallei,	
not	B.	cenocepacia,	which	is	similar	but	not	identical	to	the	B.	pseudomallei	version,	
sharing	96%	amino	acid	sequence	identify.		Hence,	the	vector	may	be	improved	by	
replacing	 the	 B.	 pseudomallei	 pheS	 allele	 with	 one	 derived	 from	 B.	 cenocepacia,	
which	may	overcome	the	variation	in	cPhe	sensitivity	observed.			
The	 plasmid	 could	 be	 improve	 further	 still	 by	 the	 introduction	 of	 a	 colour	
chromogenic	marker,	such	as	gusA,	allowing	the	insertion	and	excision	of	the	vector	
into	 the	 genome	 to	 be	 easily	 distinguished	 by	 colour	 selection	 on	 appropriate	
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medium,	 e.g.	 containing	 X-Gluc.	 Although,	 issues	 regarding	 the	 ease	 of	 use	when	
cloning	in	E.	coli	with	the	pEX18TpTer-pheS	vector,	in	regards	to	growth	conditions	
and	 media	 requirements,	 when	 selecting	 for	 trimethoprim-resistance	 and	 using	
blue/white	 colony	 selection,	 have	 been	 improved	 by	 the	 addition	 of	 the	 cat	
cassette,	 conferring	 resistance	 to	 chloramphenicol,	 meaning	 rich	 medium	 and	 a	





	 The	 T6SS	 is	 typically	 inactive	 under	 standard	 laboratory	 conditions,	
necessitating	 the	 use	 of	 bacterial	 strains	 that	 have	 a	 constitutively	 active	 T6SS,	
either	 by	 modification	 of	 regulatory	 genes	 in	 the	 wild-type	 strain,	 e.g.	 the	 retS	
mutant	 of	 P.	 aeruginosa	 (Mougous	 et	 al.,	 2006),	 or	 identification	 of	 wild-type	
isolates	that	have	an	active	system,	such	as	cholerae	V52	(Pukatzki	et	al.,	2006),	E.	
tarda	PPD130/91	(Zheng	and	Leung,	2007)	or S.	marcescens	Db10	(Murdoch	et	al.,	
2011),	 in	order	 to	 investigate	 their	 function.	The	results	presented	 in	 this	chapter	
indicate	 differential	 activity	 of	 the	 T6SS	 amongst	 B.	 cenocepacia	 strains,	 where	
strains	 H111	 and	 K56-2	 both	 showed	 constitutive	 T6SS	 activity	 as	 judged	 by	
secretion	 of	 TssD	 in	 liquid	 cultures,	 whereas	 the	 Pc715j	 strain	 did	 not	 show	 any	
detectable	extracellular	TssD.	Even	the	two	strains	that	exhibited	constitutive	T6SS	
activity	 showed	 differential	 levels	 of	 TssD	 secretion.	 These	 results	 are	 consistent	
with	previously	published	work.		
A	2-DE	coupled	mass	spectrometry	analysis	of	total	proteins	produced	by	B.	
cenocepacia	 H111	 identified	 a	 haemolysin-coregulated	protein	 (later	 identified	 as	
TssD)	 in	 its	extracellular	 fraction	 (Riedel	et	al.,	2006),	 indicating	TssD	secretion	by	
H111	 under	 standard	 laboratory	 conditions.	 A	 functional	 T6SS	 in	 B.	 cenocepacia	
K56-2	was	 demonstrated	 by	 Aubert	 and	 colleagues	 upon	 inactivation	 of	 a	 global	
virulence	regulator	AtsR,	which	caused	hypersecretion	of	TssD	(Aubert	et	al.,	2008).	




Dictyostelium	 discoideum	 in	 a	 T6SS-dependent	 manner	 (Aubert	 et	 al.,	 2008).	 In	
contrast	to	the	findings	here,	Aubert	and	co-workers	were	only	able	to	detect	TssD	
in	liquid	supernatants	of	the	hypersecreting	ΔatsR	mutant	and	not	wild-type	K56-2.	
However,	 this	 was	 only	 analysed	 using	 Coomassie	 blue	 staining,	 rather	 than	
immuno-detection,	 and	 a	 different	 precipitation	 method	 was	 employed	 for	 the	
concentration	 of	 extracellular	 proteins.	 	 So	 it	may	well	 have	 been	 that	 TssD	was	
present	 in	 the	wild-type	K56-2	 isolate	used	 in	 their	 study	but	 it	went	undetected	
due	to	the	methodology	employed.			
	 The	constitutive	nature	of	the	T6SS	in	some	B.	cenocepacia	strains	but	not	in	




T6SS	 activity	 (Miyata	 et	 al.,	 2010).	 It	 was	 found	 that	 the	 genetic	 control	 of	 T6SS	
activity	in	V.	cholerae	was	dually	negatively	regulated	by	both	quorum	sensing	(via	
LuxO	 and	 HapR	 regulators)	 and	 a	 global	 regulator,	 TsrA,	 and	 strains	 that	 have	 a	
constitutive	T6SS	(i.e.	V52)	contain	mutations	in	these	key	regulators,	 in	particular	
HapR	 (Zheng	 et	 al.,	 2010).	 One	 can	 postulate	 that	 reasons	 for	 the	 differential	
activation	 of	 the	 T6SS	 in	 B.	 cenocepacia	 strains	 may	 be	 due	 to	 a	 similar	
phenomenon.		
B.	cenocepacia	H111	is	derived	from	a	non-ET12	lineage	and	lacks	the	CciIR	
QS	 system	 encoded	 on	 the	 B.	 cenocepacia	 island	 (cci)	 associated	 with	 the	 ET12	
lineage	 strains	of	B.	 cenocepacia	 (Baldwin	et	 al.,	 2004;	O’Grady	et	 al.,	 2009).	 The	
CciIR	system	was	suggested	to	have	a	negative	regulatory	effect	on	the	T6SS	cluster	
(O’Grady	et	al.,	2009).	K56-2	is	of	the	ET12	lineage	(Varga	et	al.,	2013)	and	contains	
the	 cci	 and	 thus	 the	 CciIR	 QS	 system.	 An	 MLST	 analysis	 performed	 on	 Pc715j	































supernatants.	 The	 presence	 of	 the	 CciIR	 QS	 system,	 a	 potential	 negative	 regulatory	
























	 The	 role	of	 the	T6SS	 in	 interspecies	and	 intraspecies	bacterial	 competition	
has	 become	 a	 prominent	 feature	 of	 the	 system	 in	 a	 variety	 of	 T6SS	 containing	
bacteria.	 Here,	 there	 is	 evidence	 to	 support	 a	 similar	 role	 for	 the	B.	 cenocepacia	




Nevertheless,	 these	 findings	 do	 coincide	 with	 observations	 of	 B.	
thailandensis,	 where	 its	 ancestral	 Burkholderia	 T6SS-1	 cluster	 was	 found	 to	 be	
important	for	bacterial	competition	against	S.	proteamaculans,	P.	fluorescens	and	P.	


















cenocepacia	 strain	 Pc715j	 was	 unable	 to	 provide	 a	 competitive	 advantage	 in	 co-
culture	with	P.	putida.	Although,	perhaps	this	is	a	little	unsurprising	as	the	T6SS	in	
Pc715j	 appeared	 to	 be	 inactive	 under	 standard	 laboratory	 conditions.	Work	 in	V.	
cholerae	 demonstrated	 something	 similar,	 where	 a	 strain	 with	 a	 constitutively	
active	 T6SS,	 V52,	 exhibited	 T6SS-dependent	 interspecies	 competitive	 fitness	






	 Intracellular	survival	within	phagocytic	cells	 is	 thought	to	one	of	 the	major	
virulence	 determinants	 employed	 by	 B.	 cenocepacia	 to	 allow	 evasion	 of	 the	
immune	 system	 and	 subsequent	 dissemination	 throughout	 the	 host,	 where	
bacteria	reside	in	arrested	membrane	bound	vacuoles,	termed	BcCVs	(Burns	et	al.,	
1996;	Saini	et	al.,	1999;	Martin	and	Mohr,	2000;	Rosales-Reyes	et	al.,	2012b).	This	




T6SS	 of	 a	 particular	 virulent	 strain	 of	 B.	 cenocepacia,	 K56-2,	 has	 been	 linked	 to	
eukaryotic	virulence.	Mutants	 lacking	an	active	T6SS	were	shown	to	have	reduced	
in	 vivo	 survival	 in	 a	 rodent	 lung	 infection	model	 (Hunt	 et	 al.,	 2004;	Aubert	 et	 al.,	
2008)	 and	 the	 causal	 agent	 of	 actin	 rearrangements	 in	 B.	 cenocepacia-infected	
macrophages,	 after	 up-regulation	 of	 T6SS	 through	 deletion	 of	 a	 global	 virulence	
regulator	(Aubert	et	al.,	2008;	Rosales-Reyes	et	al.,	2012b;	Aubert	et	al.,	2012).		
However	 in	 this	 study,	 using	 two	 different	 infection	models,	 the	 zebrafish	
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embryo	 and	 G.	 mellonella	 larvae,	 there	 was	 no	 evidence	 to	 suggest	 an	 anti-
eukaryotic	 role	 for	 the	 T6SS	 in	 B.	 cenocepacia	 K56-2	 in	 overall	 virulence.	 Both	
models	 did	 not	 exhibit	 a	 significant	 increase	 in	 overall	 survival	 of	 the	 host	when	
infected	with	T6SS	mutants	in	comparison	to	the	wild-type.	




showing	 that	 the	 T6SS	 was	 not	 responsible	 for	 the	 delayed	 maturation	 of	 B.	
cenocepacia	 containing	 vacuoles	 or	 for	 intracellular	 survival	 of	 the	 bacterium	
(Rosales-Reyes	et	al.,	2012a;	Rosales-Reyes	et	al.,	2012b).	
	 Nonetheless,	regarding	the	G.	mellonella	infection	results,	there	was	a	slight	
increase	 in	 larval	 survival	 at	 16	 and	 18	 hpi	 when	 inoculated	with	 a	 high	 dose	 of	
either	T6SS	mutant,	than	when	compared	to	infection	with	the	wild-type	strain.	The	
experiment	 was	 performed	 twice	 and	 showed	 the	 same	 trend,	 but	 until	 this	 is	
repeated	 solid	 conclusions	 cannot	 be	 drawn	 from	 the	 data.	 However,	 it	 may	
tentatively	suggest	that	the	T6SS	is	in	some	way	important	for	early	establishment	
of	the	infection	in	this	model.	Yet	the	high	dose	of	bacteria	required	to	manifest	the	
difference	 between	 wild-type	 and	 T6SS	 mutant	 infections	 does	 place	 a	 question	
mark	over	the	role	of	the	T6SS	in	this	model,	as	it	difficult	to	see	how	this	would	be	
clinically	relevant.		
	 As	 B.	 cenocepacia	 K56-2	 is	 able	 to	 replicate	 within	 G.	 mellonella	 larvae	
throughout	 the	 infection	 (Seed	 and	 Dennis,	 2008),	 it	 would	 be	 intriguing	 to	
investigate	whether	the	T6SS	mutants	were	as	effective	at	 intracellular	replication	
as	 the	 wild-type	 in	 this	 model.	 This	 could	 account	 for	 the	 higher	 proportion	 of	
larvae	 surviving	 at	 16	 and	 18	 hpi.	 The	 competitive	 fitness	 the	 T6SS	 provides	 B.	
cenocepacia	 in	 the	 presence	 of	 some	 other	 bacterial	 species	 could	 also	 be	 a	
contributing	factor	to	the	phenotype	seen	here,	as	G.	mellonella	 larvae	have	been	
shown	to	contain	a	microflora	of	other	organisms,	particularly	 in	 the	gut	 (Bucher,	
1963;	Bucher	and	Williams,	1967),	linking	the	two	observations	made	in	this	study.	

























































One	of	 the	approaches	 to	be	undertaken	 involved	 the	use	of	mass	 spectrometry,	
taking	 a	 bottom	 up,	 shotgun	 proteomics	 approach	 for	 the	 analysis	 of	 the	 T6SS-
dependent	 secretome	 of	 B.	 cenocepacia,	 centred	 on	 protein	 identification	 by	
tandem	MS	analysis.	 This	mass	 spectrometry	 based	discovery	 approach	has	 been	
similarly	utilised	for	the	 identification	of	effectors	of	the	H1-T6SS	of	P.	aeruginosa	
(Hood	 et	 al.,	 2010),	 T6SS-1	 and	 T6SS-5	 of	 B.	 thailandensis,	 (Russell	 et	 al.,	 2012;	
Schwarz	et	al.,	2014),	and	other	T6SSs	such	as	S.	marcescens	 (Fritsch	et	al.,	2013)	
and	a	more	targeted	approach	in	V.	cholerae	(Miyata	et	al.,	2011).	It	has	also	been	
used	 for	 the	 analysis	 of	 the	 bacterial	 secretome	 dependent	 on	 other	 protein	
secretion	 systems,	 including	 the	 T2SS-dependent	 secretome	 of	 B.	 pseudomallei	
(Burtnick	et	al.,	2014).		
Such	an	 approach	 requires	 conditions	 for	 growth	of	 the	bacterium	 that	will	
result	 in	detectable	 levels	of	T6SS-dependent	effectors.	This	 study	has	 found	 that	
the	 T6SS	 has	 differentially	 activity	 in	 three	 different	B.	 cenocepacia	 strains	when	
growing	 in	 broth	 cultures,	 as	 demonstrated	 by	 the	 secretion	 of	 the	 T6SS	 subunit	
TssD,	which	is	the	hallmark	of	a	functional	T6SS.	Strains	H111	and	K56-2,	of	differing	
lineages,	both	have	an	active	T6SS,	where	TssD	secretion	was	found	to	be	greater	in	
H111	 than	 K56-2,	 whereas	 strain	 Pc715j,	 which	 is	 more	 closely	 related	 to	 K56-2	
than	H111	did	not	exhibit	any	detectable	T6SS	activity	(Section	4.5.1).	Thus,	it	was	
decided	to	utilise	the	H111	strain	as	a	model	organism	in	order	to	help	identify	B.	
cenocepacia	 T6SS-dependent	 effectors.	 However,	 despite	 the	 fact	 that	 H111	
possesses	 the	most	 active	 T6SS	 under	 the	 laboratory	 conditions	 employed,	 TssD	
was	detectable	only	following	1000-fold	concentration	of	the	culture	supernatants.	
To	 apply	 the	 mass	 spectrometry	 technique	 it	 was	 deemed	 necessary	 to	 try	 and	
establish	conditions	that	would	result	in	a	higher	level	of	T6SS	activity	in	this	strain.		
	 Several	 potential	 regulators	 of	 the	 T6SS	 in	 B.	 cenocepacia	 H111	 were	
identified	 by	 bioinformatic	 analysis,	 due	 in	 part	 to	 their	 homology	 with	
characterised	 T6SS-regulatory	 proteins	 in	 other	 T6SS-containing	 bacteria,	 their	
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conservation	 in	 the	 ancestral	 Burkholderia	 T6SS-1	 cluster	 but	 not	 in	 other	 T6SS	
clusters,	or	interesting	predicted	structures	and	functional	domains	(Section	3.1.2).	
This	 includes	 potential	 post-translational	 regulators	 TagF,	 TagM,	 and	 TagX	 and	 a	
orthologue	of	 the	hybrid	 sensor	 kinase	AtsR,	 involved	 in	a	 two-component	global	
transcriptional	regulatory	system	characterised	in	B.	cenocepacia	K56-2	(Aubert	et	
al.,	 2008;	 Aubert	 et	 al.,	 2012;	 Khodai-Kalaki	 et	 al.,	 2013)	 (Figure	 5.1).	 	 The	 work	
discussed	in	this	chapter	centres	on	the	possible	role	of	tagX,	tagF	and	atsR	in	T6SS	
















candidate	 post-translational	 regulators	 of	 the	 T6SS	 in	 B.	 cenocepacia.	 TagF	 may	 be	 a	
cytoplasmically	located	negative	post-translational	regulator,	possibly	acting	against	TssM,	
which	 results	 in	 reduced	 TssH	 recruitment	 to	 the	 T6SS	 complex,	 reducing	 TssB/TssC	 tail	
sheath	disassembly	and	recycling,	leading	to	a	reduction	in	T6SS	activity.	TagX	is	predicted	
to	contain	a	transmembrane	domain,	and	a	long	linker	region	extending	into	the	periplasm	
with	 a	 CTD	 containing	 four	 conserved	 cysteine	 residues.	 This	 may	 be	 involved	 in	 iron-
sulphur	cluster	formation	and/or	disulphide	bond	oxidation	or	reduction,	which	is	used	to	
sense	an	external	signal.	TagM	is	an	OM-anchored	 lipoprotein	that	contains	TPR	domains	
that	suggests	 involvement	 in	protein-protein	 interactions.	(B)	AtsR	acts	as	a	sensor	kinase	
that	 results	 in	 the	 phosphorylation	 of	 the	 response	 regulator,	 AtsT,	 in	 a	 phosphorelay	










Bioinformatic	 analysis	 of	 Burkholderia	 T6SS-1-related/type	 gene	 clusters	
revealed	 a	 pair	 of	 divergently	 transcribed	 genes,	 tagX	 and	 tagV,	 that	 are	 located	
upstream	 of	 tssM	 in	 all	 such	 clusters	 that	 retain	 the	 full	 complement	 of	 T6SS	
subunit	 genes,	 i.e.	 intact	 clusters	 (Section	 3.1.2).	 One	 of	 these	 genes,	 tagV	
(corresponding	to	BCAL0352	in	B.	cenocepacia	J2315	and	I35_0343	in	strain	H111),	
is	 likely	 to	 be	 part	 of	 the	 same	 transcriptional	 unit	 as	 tssM	 (Figure	 5.2).	 In	 some	
non-Burkholderia	 species,	 one	 or	 two	 genes	 that	 are	 associated	 with	 tssI	 gene	
clusters	 in	the	genus	Burkholderia	are	 interposed	between	tssM	and	tagV.	tagV	 is	
predicted	 to	 encode	 a	 Sec-dependent	 cytoplasmic	membrane-anchored	VanY-like	
D-alanyl-D-alanine	 carboxypeptidase	 belonging	 to	 the	 peptidase	M15	 family.	 The	




tagX	 (corresponding	 to	 BCAL0353	 in	B.	 cenocepacia	 J2315	 and	 I35_0344	 in	
strain	H111)	is	 located	upstream	of	tagV	and	transcribed	in	the	opposite	direction	
(Figure	5.2).	 It	 is	 expected	 to	be	 constitute	a	monocistronic	operon	based	on	 the	
presence	 of	 a	 putative	 Rho-independent	 transcription	 termination	 sequence	
located	 35	 bp	 downstream	 from	 the	 tagX	 stop	 codon	 (M.	 Thomas,	 personal	
communication).		
Analysis	of	the	predicted	coding	sequence	of	tagX	identified	a	sequence	of	17	
amino	 acids	 approximately	 55	 residues	 from	 the	 N-terminus,	 which	 are	 highly	
conserved	in	TagX	orthologues	in	the	Burkholderia	spp.,	and	are	likely	to	constitute	
a	 transmembrane	domain	with	 the	N-terminus	 located	within	 the	 cytoplasm.	The	
55	 amino	 acid	 N-terminal	 region	 contains	 two	 conserved	 amino	 acid	 sequence	
motifs	 (PSLLS	 and	 RILAxLEGR)	 separated	 by	 11-13	 amino	 acids,	 suggesting	 that	 it	
may	constitute	a	small	domain.		The	putative	transmembrane	domain	is	proceeded	














































region	 of	 ~40	 amino	 acids	 containing	 four	 cysteine	 residues	 (Cys294,	 Cys305,	
Cys310,	 Cys320)	 in	 the	 H111	 TagX	 orthologue)	 (Figure	 5.3).	 This	 domain	
arrangement	 was	 likened	 to	 the	 inner	 membrane-anchored	 periplasmic	 protein	
TonB,	 which	 functions	 as	 an	 energy	 transducer	 in	 energy-dependent	 outer	
membrane	transport	processes	in	Gram-negative	bacteria	(Figure	5.4)	(Noinaj	et	al.,	
2010).	 It	was	envisaged	 that	 the	unusual	 cysteine-rich	C-terminal	domain	of	TagX	
may	 act	 as	 redox	 or	 metal	 ion	 sensor	 by	 oxidation	 or	 reduction	 of	 thiol	 groups	
between	 pairs	 of	 cysteine	 residues.	 This	may	 involve	 formation	 or	 collapse	 of	 an	
iron-sulphur	cluster.		
This	 led	 to	 the	 hypothesis	 that	 TagX	may	 be	 involved	 in	 regulation	 of	 the	
T6SS	at	a	post-translational	level.	The	CTD	may	sense	periplasmic	signals	related	to	




membrane.	 This	 sensed	 signal	 may	 then	 be	 transduced	 to	 the	 cytoplasmic	 NTD	
facilitating	 an	 interaction	 with	 unknown	 regulatory	 components,	 which	 go	 on	 to	
regulate	the	assembly,	disassembly	or	firing	of	the	T6SS	complex.		
Therefore,	 it	 was	 decided	 to	 generate	 an	 insertional	 tagX	 mutant	 in	 B.	
cenocepacia	 H111	 to	 investigate	 whether	 deletion	 of	 this	 gene	 affected	 T6SS	
activity.	 If	 inactivation	 of	 tagX	 led	 to	 an	 increase	 in	 T6SS	 activity	 it	 could	 be	
concluded	that	TagX	acts	as	a	negative	post-translational	regulator	of	the	T6SS,	and	
the	mutant	would	be	used	to	facilitate	effector	identification.	On	the	other	hand,	if	
tagX	ablation	 caused	 a	 decrease	 in	 T6SS	 activity	 it	 could	 be	 concluded	 that	 TagX	











QWA_15390          1 ------------------------------------------------------------ 
PMI40_01839        1 MQVLHRNGEHRDSAAQASPAAVT----PADVG--ESDVIDTELEIRASH----------- 
RGE_25930          1 MP--ISPGSLNDSSATPRRPSLTDGM-QAGAVPQKQLSVLAALDAMPSPP---------- 
XOO3323            1 MN----NG----R---LNRPSLLSGRGQTQP--LGSGRILADMEGRATSAPSSVRVNKAP 
KYC_06270          1 MA--EEKKDARPT---TTAPSLL-SASPAARGEADSSRILAALEGRAPEA--EVKHLATP 
RSp0767            1 MS---NNGDLK-P---EGPPTLFESQSETDE--NGHTRILASLEGRVGAS------GKAP 
BTH_I2951          1 MS---APDDSN-S---KAPPSLLSSDAGKGSG-ANNSRILANLEGRVSPQ------TENA 
Bcep18194_A3577    1 MS---APENSN-S---KSPPSLLSDTKPAGDG-AQQSRILANLEGRVTPP------AEPP 
I35_0344           1 MS---APENSN-S---KTPPSLLSDTKPAGEGGPRQSRILADLEGRVTPP------AEPP 
BCAL0353           1 MS---APENSN-S---KTPPSLLSDTKPAGEGGPRQSRILADLEGRVTPP------AEPP 
 
 
QWA_15390          1 -----MPWRFIIAVLLLAAGASVWGGLELGNWLIAHGPEKSMVVS-----APDP------ 
PMI40_01839       44 -------ITAAA-----VAAAA----VTAAVAT----------------MAPLPE---PA 
RGE_25930         48 ARQG---MPSVKLWLLGLGGLA----IAVLVATMM-------------VRAPAA--KTPQ 
XOO3323           48 RTHRT-RLVLIAVLGVALLGAA----FTALRWNAGRA--EADAEFDAYTTVPATDTVSPA 
KYC_06270         53 RRSRARRWTALALLLALVAGGV--------AWVIHEDGTAPMLAQAP-AAAPAP-----A 
RSp0767           46 QKKGR-RYGIAAAVAVLVAGIG--------AWLVFSPSREPTPGPVAEQAAPAV--QAGA 
BTH_I2951         47 PRSRKGPIALVALAVVAVAGWG--------AWRLQQPSIESAEVAAS---APAA--VVPA 
Bcep18194_A3577   47 RRSLKAPIAAVVALVVAVGGWG--------AWRMQHS-GEQVAAVAA-EAAPAA--AAPA 
I35_0344          48 RRSLKAPIAAVVALVVAVGGWG--------AWRMQQSSGEQPAVVTA-ATAPAA--AAPD 
BCAL0353          48 RRSLKAPIAAVVALVVAVGGWG--------AWRMQQSSGEQPAVVAA-ATAPAA--AAPD 
 
 
QWA_15390         45 ---------------------------SDLPTLDADGKP-----------FTA-QPPQPL 
PMI40_01839       69 APMRPVHADPVAQP-----ATQAMPQPTSITATAPVKALSLR--AAVGNILTV-AVAALA 
RGE_25930         86 VPPTALASAPVPSPAAESMATEPVARPSSGVLV---------------AALENLPIHESA 
XOO3323          101 NPA------T--AAGTGTTATTPAPGGAMIVDDNAVSDPTHA--------V--------- 
KYC_06270         99 PA-----PAPAVTPPQASLSASSAA------GDNPL--RALEAPPAVASIVDEAPPARDA 
RSp0767           95 QPAAPVAEAASVPVVAE--AASAPPAAATIVNVETDEQRAPDKSA-----KEAPPPAKAL 
BTH_I2951         94 SHA--V-PASAVQI-----AQAPAPQPATIVNDDSIASDAKP--AAAASAVSESRLSRAL 
Bcep18194_A3577   95 KAA--AASDAAVQVAQNTASAASAVQPATIVNDDAASRTVASA--SSASAADNSRLSRAL 
I35_0344          97 KAT--PASGAAAQVAQNGASAASAVQPATIVNDDSASQAVASASASAASAADNSRLSRAL 
BCAL0353          97 KAA--PASGAAAQVAQNGASAASAVQPATIVNDDSASQAVASASASAASAADNSRLSRAL 
 
 
QWA_15390         66 VNGRL-GVPEEPTPIAWEIDTSTL----TEEKP----PIAL-ATTSISLE---------- 
PMI40_01839      121 WWGAD-RLPLPAHGLQPALQHLSLPSLPSLRKPGSVPPANVPVAVAPPVQQAVVVEAPEP 
RGE_25930        131 AVAATAAVP------TQPAQVESV-H--QKPKP-----A---NAARG---------LAGP 
XOO3323          136 ----D-GLPRAASAS-----TTSAAT--APAKP-----A---AAAS-------------- 
KYC_06270        146 NVG-R-GEPDPLGEPTNPLSVL------AMSQP-----P---A--AAP--------APGP 
RSp0767          148 AKAPA-GEPHPAASAAAG----------NAAKT-----D---DTAQGRAE-T------AK 
BTH_I2951        144 ANGAS-DVP--TTGAAAGATAAAVAV--AAAKP-----A---KSVEKSAAKST----AAK 
Bcep18194_A3577  151 ANGAD-DAS--GAATAGA----AAAA--AA--T-----T---KTAKADAAKGAKVAAHGK 
I35_0344         155 ANGAE-EGS--GGAAAAGVAATAAAA--AA--T-----S---KTAKADVSKSTKVAAHGK 
BCAL0353         155 ANGAE-EGS--GGAAAAGVAATAAAA--AA--T-----S---KTAKADASKSTKVAAHGK 
 
 
QWA_15390        106 ----------------------QAIQIAMSEQNREL------QGIARVNLGDAEAIQPVE 
PMI40_01839      180 RDAIAVLQQDAEMRAQQLAERR---AASQARRERED--AASAAREQRRRDAEAQLADA-- 
RGE_25930        165 SKPRATAKVKTKAK-----------PPAAAKQAKGA-SSGSAAPPGKGGDADVDLIAAMV 
XOO3323          162 -----------------------------QRKPRAA-P----ASGKHVQDDSSDLLATLM 
KYC_06270        180 TRQAAEL-------------RAQQGNATRAAKPAAATP----RKSAKPADTDAALLSALM 
RSp0767          182 LVAKSTLHADKDA------------PSAKAKPQSAAKPARNRKGALTADDPDADLLAALL 
BTH_I2951        187 QSKQDAAHAKAEAAARKRHEKTQAAQVAQAKKAR---HEA-AAKKNGKDDPDADLLAALV 
Bcep18194_A3577  192 TDTKA----DAKAEA-RKRRKEQQAELAQAKKHRDATPVR-TAKAGGKDDPDADLLAALV 
I35_0344         200 TDTKTEAKADTKAEA-RKHRKEQQAELAQAKKRREATPTR-TAKAAGKDDPDADLLAALV 
BCAL0353         200 TDTKTEAKVDTKAEA-RKHRKEQQAELAQAKKRREATSTR-TAKAAGKDDPDADLLAALV 
 
 
QWA_15390        138 VGTP--------------------PPPPPQD----------IQIASNNGGAWQAQLQQEL 
PMI40_01839      233 --RARAERA---------------P------AT--------VDTPAVVVTPAVPPLAEAV 
RGE_25930        213 QHMNRQEAN--------------------------------------AGDRGEISIADLV 
XOO3323          188 GIIKRDEKPTAKQDSIDSLIAKIQANDSKNATETDA----AFDAIGSRSASTSSNVQSQL 
KYC_06270        223 NYGL--------------------PPASPPGTRVY------KSEGVFMREMPGSPLSERL 
RSp0767          230 APHP--------------------ANTGKAPN-------PPNHG---------GQ----- 
BTH_I2951        243 ARTK--------------------PAGAAKSGEAAKSNATPKMAAAAATGSADASLAARV 
Bcep18194_A3577  246 ARTK--------------------PADKKLAAQKA--QAVPTK----TAATT-GSLASRV 
I35_0344         258 ARTK--------------------PADKKLAAQKG--QAVPTK----TAATTGGSLASRV 








QWA_15390        168 NACSKKGFFDRPSCSWEARNKYCGPNNAWGKVPGCPSKSF-------- 
PMI40_01839      262 RQCSALSVFAREGC----LWKLC--SGKWGKD-GCPSYQHDNEGA--- 
RGE_25930        235 RRCKSLAGNDALRC----RRRI---ENYWGKADACPRSLAPGKAAVRP 
XOO3323          244 RQCPDANTMAGLEC----RKNIC--AALTGKDPACPAH---------- 
KYC_06270        257 KECRRLSFIESEQC----RLRVC--AGQWGTAVECPTPQANIEP---- 
RSp0767              ------------------------------------------------ 
BTH_I2951        283 KACGERGFFEDQLC----RWRVC--ENHWGKDPACPTSATQNRQP--- 
Bcep18194_A3577  279 KECSERGFFEDQLC----RWRVC--EGHWGKDPACPSAAQSETRQ--- 
I35_0344         292 KECSERGFFEDQLC----RWRVC--DGHWGKDPACPSAAQSETRQ--- 
BCAL0353         292 KECSERGFFEDQLC----RWRVC--DGHWGKDPACPSAAQSETRQ--- 
                       C          C        C           C 
 
 
Figure	 5.3	 Amino	 acid	 sequence	 alignment	 of	 the	 product	 of	 BCAL0353	 and	 I35_0344,	
TagX,	 with	 homologous	 proteins.	 The	 amino	 acid	 sequences	 of	 the	 putative	 post-
translational	regulator,	TagX,	encoded	by	BCAL0353	and	I35_0344	in	B.	cenocepacia	J2315	
and	H111,	respectively,	and	other	homologous	proteins,	were	aligned	using	Clustal	Omega.	
Black	 shading	 indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	
sequences,	grey	shading	indicates	similar	residues	at	the	corresponding	position	in	50%	of	
sequences.	 The	 putative	 cytoplasmic	N-terminal	 region	 is	 indicated	 by	 blue	 overline,	 the	
putative	 transmembrane	 domain	 (TMD)	 indicated	 by	 the	 red	 boxed	 region,	 and	 the	
conserved	C-terminal	cysteine	residues	are	 indicated	in	red	font	below	the	alignment	and	



















is	 indicated	on	 the	 left,	 showing	a	 small	 cytoplasmic	N-terminal	 domain,	 transmembrane	
domain,	 followed	 by	 a	 periplasmic	 linker	 region	 connected	 to	 a	 cysteine	 rich	 C-terminal	
domain.		A	similar	domain	organisation	occurs	in	the	energy	transducer	TonB,	depicted	on	
the	right,	where	the	periplasmic	CTD	interacts	with	an	N-terminal	periplasmic	extension	of	
an	 TonB-dependent	 receptors	 (TBDR)	 in	 the	 outer	 membrane,	 facilitating	 energy-










For	 inactivation	 of	 the	 tagX	 gene	 a	 gene	 replacement	 plasmid	 was	
constructed	 by	 insertion	 of	 the	 dfr	 cassette	 (conferring	 trimethoprim-resistance)	
into	the	coding	sequence	of	tagX,	as	depicted	 in	Figure	5.5.	To	do	this,	a	1199	bp	
DNA	fragment	containing	the	tagX	open	reading	frame	(I35_0344	gene	locus	 in	B.	
cenocepacia	H111)	 and	 an	 additional	 105	bp	downstream	of	 the	 TAA	 stop	 codon	
was	 amplified	 from	 H111	 genomic	 DNA	 by	 PCR	 using	 primers	 BCAL0353For	 and	
BCAL0353Rev	and	then	gel	purified	(Figure	5.6A).	This	fragment	was	then	cut	with	





Tp	 using	 SmaI.	 Utilising	 a	 unique	 ZraI	 restriction	 site	 in	 the	 middle	 of	 tagX,	
pBluescriptII-tagX	was	cut	with	this	blunt-end	generating	enzyme	and	the	SmaI-cut	




pBluescriptII-tagX::Tp	 clones	 was	 determined	 by	 restriction	 digestion	 with	 BsrGI	
and	BamHI	(Figure	5.7).	All	the	clones,	except	5,	12-15,	produced	fragments	of	1033	
bp	 and	 3621	 bp,	 indicating	 that	 the	 dfr	 coding	 sequence	 was	 in	 the	 same	
orientation	 as	 tagX,	 as	 desired.	 The	 tagX::Tp	 insert	 was	 then	 transferred	 from	
pBluescriptII-tagX::Tp	 as	 a	 XhoI-XbaI	 fragment	 into	 the	 suicide	 vector	 pSHAFT2,	




strain	 was	 then	 used	 to	 transfer	 the	 plasmid	 into	 B.	 cenocepacia	 H111	 by	


















































generation	 of	 pSHAFT-tagX::Tp.	 tagX	 was	 cloned	 as	 an	 XhoI-BamHI	 fragment	 into	
pBluescriptII,	then	disrupted	with	a	dfr	cassette	excised	from	p34E-Tp	by	SmaI	and	inserted	




































Figure	 5.7	 Diagnostic	 restriction	 digestion	 of	 pBluescriptII-tagX::Tp	 to	 determine	 the	
orientation	 of	 the	 dfr	 insert.	 pBluescriptII-tagX::Tp	 plasmid	 clones	 were	 subjected	 to	
double	restriction	digestion	with	BsrGI	and	BamHI	to	determine	the	orientation	of	the	dfr	









































































Figure	 5.8	 Size	 analysis	 of	 pSHAFT2-tagX::Tp	 candidates.	 The	 tagX::Tp	 fragment	 was	
transferred	 from	 pBluescriptII-tagX::Tp	 to	 the	 suicide	 vector	 pSHAFT2	 as	 an	 XhoI-XbaI	

















Recombinants	were	 selected	 by	 virtue	 of	 their	 trimethoprim-resistance.	 pSHAFT2	
contains	 a	 cat	 gene	 conferring	 resistance	 to	 chloramphenicol,	 allowing	
discrimination	 between	 single	 and	 double	 crossover	 recombinants	 by	 challenging	
trimethoprim-resistant	 colonies	with	 chloramphenicol.	 Strains	 that	were	 sensitive	
to	 chloramphenicol	 but	 resistant	 to	 trimethoprim	 were	 identified	 as	 potential	
double	crossover	recombinants,	 in	which	the	mutant	copy	present	on	the	plasmid	
had	 replaced	 the	 wild-type	 copy	 of	 tagX.	 Chloramphenicol-sensitive	 candidates	
were	 identified	and	 then	PCR	screened	using	primer	pairs	annealing	 to	 regions	of	
the	 genome	 just	 outside	 the	 tagX::Tp	 homologous	 region,	 BCAL0353CompFor-OP	
and	 BCAL0353CompRev-OP,	 and	 inside	 primers	 annealing	 to	 the	 tagX	 homology	
region,	BCAL0353For	and	BCAL0353Rev.	Potential	H111-tagX::Tp	mutants	produced	
DNA	fragments	of	1900	bp	and	1750	bp,	respectively,	which	was	an	increase	of	650	
bp	 in	 comparison	 to	 the	 DNA	 fragments	 derived	 from	 the	wild-type	 parent,	 due	






secretion	 in	 comparison	 to	 the	 B.	 cenocepacia	 wild-type	 strain,	 extracellular	
proteins	 were	 extracted	 from	 liquid	 grown	 cultures	 (Section	 2.4.1).	 SDS-PAGE	
analysis	 demonstrated	 that	 the	 tagX::Tp	 mutant	 had	 similar	 secreted	 and	 cell-
associated	 protein	 profiles	 as	 the	 wild-type	 strain	 under	 the	 growth	 conditions	
tested	(Figure	5.10A).	Both	strains	secreted	similar	levels	of	TssD	as	shown	by	anti-
TssD	western	 blotting	 (Figure	 5.10B),	 indicating	 that	 both	 the	wild-type	 and	 tagX	
mutant	 had	 similar	 T6SS	 activity.	 The	 cell-associated	 level	 of	 TssD	 in	 both	 strains	
was	 also	 similar.	 Note,	 there	 is	 a	 slight	 but	 noticeable	 difference	 between	 the	

























PCR	 was	 used	 to	 amplify	 DNA	 fragments	 using	 ‘inside’	 (IP)	 and	 ‘outside’	 (OP)	 primers	
specific	 to	 the	 tagX	 region	 from	wild-type	H111	 (WT)	 and	H111-tagX::Tp	mutant	 #4	 and	


































activity.	 (A)	 15%	 SDS-PA	 gel	 of	 secreted	 proteins	 from	 wild-type	 H111	 (WT)	 and	 the	
tagX::Tp	mutant	(left)	and	cell-associated	proteins	(right).	Arrow	indicates	18	kDa	secreted	
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H111	 wild-type	 and	 the	 tagX	 mutant	 over	 time,	 it	 was	 observed	 that	 the	 tagX	
mutant	 had	 a	 similar	 growth	 rate	 in	 comparison	 to	 the	 wild-type	 strain	 (Figure	
5.11).		
Together	 these	 findings	 suggest	 that	 TagX	 does	 not	 play	 a	 role	 in	 the	
regulation	of	T6SS	activity	during	growth	in	nutrient	broth.	Therefore,	this	mutant	
would	 be	 of	 no	 benefit	 in	 effector	 identification.	However,	 it	 is	 still	 possible	 that	







































were	measured	at	 regular	 intervals.	Optical	density	measurements	were	plotted	on	a	 log	


































been	 identified	 in	 the	 Burkholderia	 T6SS-1	 gene	 cluster.	 This	 protein	 was	 first	






cenocepacia	 and	 P.	 aeruginosa)	 share	 a	 common	 DUF2094	 superfamily	 domain		
(COG3913)	 yet	 share	 only	 16%	 overall	 sequence	 identify	 and	 25%	 sequence	
similarity.	
In	 P.	 aeruginosa,	 TagF	 has	 been	 demonstrated	 to	 be	 a	 post-translational	
negative	regulator	of	the	T6SS,	that	acts	 independently	of	the	characterised	Fha1-
phosphorylation	 dependent	 T6SS	 activation	 pathway,	 the	 threonine	
phosphorylation	 pathway	 (TPP),	 which	 involves	 the	 TagQRST-PpkA-Fha1-PppA	
components	 (Figure	 1.6,	 Section	 1.4.3)	 (Mougous	 et	 al.,	 2007;	 Hsu	 et	 al.,	 2009;	
Silverman	et	al.,	2011;	Casabona	et	al.,	2013).	In	the	current	model,	deletion	of	TagF	
is	 thought	 to	 recruit	 TssH	 (in	 complex	 with	 unphosphorylated	 Fha1)	 to	 the	 T6SS	
apparatus.	 Thus,	 meaning	 the	 contracted	 tail	 sheath-like	 structure	 made	 of	
TssB/TssC	subunits	can	be	disassembled	and	recycled	ready	for	re-firing	of	the	T6SS.		
Intriguingly,	 the	 B.	 cenocepacia	 T6SS	 cluster	 does	 not	 contain	 a	 fha1	
homologue,	 nor	 homologues	 of	 the	 Ser/Thr	 protein	 kinase	 PpkA	 or	 phosphatase	
PppA,	 involved	 in	 the	TPP	T6SS	activation	pathway.	Yet	 the	conserved	position	of	
tagF	in	the	T6SS	cluster	of	both	B.	cenocepacia	and	P.	aeruginosa	(and	many	other	
T6SSs),	directly	downstream	of	 tssM,	 could	suggest	 that	TagF	may	be	exhibiting	a	















Figure	 5.12	 Comparison	 of	 the	 tagF	 orthologues	 in	 the	 T6SS	 clusters	 of	B.	 cenocepacia	
and	P.	aeruginosa.	Image	showing	the	genetic	arrangement	of	tagF	in	the	H1-T6SS	cluster	
of	P.	aeruginosa	PAO1	 in	comparison	 to	 the	 tagF	arrangement	 in	 the	T6SS-1	cluster	 in	B.	












































To	 evaluate	 the	 role	 of	 TagF	 in	 the	 regulation	 of	 T6SS	 activity	 in	 B.	
cenocepacia	it	was	decided	to	analyse	a	tagF	null	mutant	in	B.	cenocepacia	H111,	to	
determine	 whether	 inactivation	 of	 tagF	 resulted	 in	 increased	 T6SS	 activity,	 as	
documented	in	P.	aeruginosa.	
	




that	 was	 later	 found	 to	 be	 sensitive	 to	 complement-mediate	 killing	 (serum-
sensitive)	and	had	also	lost	its	entire	third	chromosome,	which	was	termed	H111S.	
At	 the	 time,	 the	 phenotypic	 effect	 of	 inactivation	 of	 tagF	 was	 not	 assessed.	
Therefore,	 it	 decided	 to	 first	 assess	 the	 secreted	 protein	 profile	 of	 the	 H111S-
tagF::Km	mutant	in	comparison	to	its	parental	strain,	H111S.	SDS-PAGE	analysis	of	
secreted	 proteins	 present	 in	 broth	 cultures	 indicated	 that	 a	 18	 kDa	 protein	 was	
overproduced	 in	 the	 tagF::Km	mutant	 in	 comparison	 to	 the	parental	H111S	strain	
(Figure	 5.13).	 Immuno-detection	 with	 an	 anti-TssD	 antibody	 indicated	 that	 this	
overproduced	protein	was	TssD.	Densitometric	analysis	of	the	difference	between	
secreted	TssD	 in	 the	parental	H111S	 strain	 to	 the	 tagF::Km	mutant	 indicated	 that	
TssD	secretion	was	increased	1.7-fold	in	the	tagF::Km	mutant,	which	as	statistically	
significant	with	a	P	value	of	0.026.	This	 result	 implied	that	deletion	of	 tagF	was	a	
potential	way	to	stimulate	T6SS	activity	further	in	B.	cenocepacia.		
Note,	 that	 the	 orientation	 of	 the	 kanamycin-resistance	 cassette	 inserted	






































cell-associated	 TssD	 may	 be	 due	 to	 the	 TCA	 precipitation	 treatment	 of	 the	 secreted	
proteins.	(C)	Densitometric	analysis	of	relative	difference	between	secreted	TssD	in	H111S	































































































secretome	analysis	 if	 this	strain	were	used	 for	a	discovery	experiment.	Therefore,	
the	tagF	gene	of	the	wild-type	B.	cenocepacia	H111,	containing	a	full	complement	
of	 chromosomes	 was	 insertionally	 inactivated.	 To	 do	 this,	 a	 suicide	 plasmid	
encoding	 an	 insertionally	 inactivated	 copy	 of	 tagF	 containing	 the	 kanamycin-
resistance	 cassette	 (nptII),	 pSHAFT-tagF::Km,	 was	 introduced	 into	 B.	 cenocepacia	
H111	and	 recombinants	were	selected	 	by	acquisition	of	kanamycin-resistance	on	
Lennox	 agar.	 Single	 and	 double	 crossover	 recombinants	 were	 distinguished	 by	
virtue	of	 their	chloramphenicol-sensitivity	 (Section	5.2.1),	where	double	crossover	










H111S-tagF::Km	 variant	 was	 mirrored	 in	 the	 newly	 constructed	 strain	 with	 a	 full	
complement	 of	 chromosomes.	 Unexpectedly,	 this	 was	 not	 the	 case.	 The	 level	 of	
extracellular	 TssD	 in	 comparison	 to	 the	 wild-type	 was	 variable	 between	 5	
independent	 experiments	 as	 determined	 by	 western	 blotting	 (Figure	 5.14B)	 and	
densitometric	analysis	(Figure	5.14C).	In	some	cases	TssD	secretion	was	the	same	as	
the	 wild-type	 and	 in	 others	 there	 was	 overproduction	 of	 TssD	 even	 though	 the	
same	protocol	was	undertaken.	An	average	1.8-fold	 increase	of	extracellular	TssD	




























amplified	 were	 analysed	 following	 electrophoresis	 in	 a	 0.8%	 agarose	 gel.	 Mutants	 were	
expected	to	give	rise	to	a	DNA	fragment	of	~2500	bp,	indicated	by	the	arrow.	Extracellular	
proteins	 were	 precipitated	 from	 liquid	 culture	 supernatants	 of	 H111	 wild-type,	 a	 T6SS	
mutant	 (tssA::Tp),	 and	 H111-tagF::Km.	 (B)	 Representative	 anti-TssD	 western	 blots	
demonstrating	 variable	 secretion	 of	 TssD	 from	 two	 independent	 experimental	 repeats.	
Cell-associated	TssD	is	also	shown,	as	indicated.	The	size	difference	between	secreted	and	
cell-associated	 TssD	may	 be	 due	 to	 TCA	 precipitation	 treatment	 of	 the	 secreted	 protein	
fraction.	 (C)	Densitometric	 analysis	 of	 relative	difference	between	 secreted	 TssD	 in	H111	

































































































5.3.3 Effect	 of	 a	 tagF	 null	 allele	 on	 T6SS	 activity	 in	 B.	 cenocepacia	
H111Δc3	
It	was	 thought	 that	H111S	 contained	an	additional	 lesion(s)	other	 that	 the	
loss	of	c3,	as	it	had	been	shown	to	be	less	virulent	than	a	chromosome	3-deficient	














Evaluation	 of	 TssD	 secretion	 in	 the	 B.	 cenocepacia	 H111S-tagF::Km	 and	
H111Δc3-tagF::Km	 mutants	 in	 comparison	 to	 their	 respective	 parental	 strains	
(Section	5.3.2	and	5.3.3)	and	the	inconsistency	between	them	led	to	the	hypothesis	
that	 another	 genetic	 lesion	 in	 the	 H111S	 strain,	 in	 combination	 with	 insertional	
inactivation	 of	 tagF,	 may	 be	 responsible	 was	 the	 reproducible	 increase	 in	 TssD	
secretion	 observed	 in	 the	 H111S-tagF::Km	 mutant.	 Therefore,	 it	 was	 decided	 to	
sequence	the	entire	genome	of	H111S	and	compare	it	to	the	B.	cenocepacia	H111	
reference	genome	sequence.	 This	was	undertaken	 in	 collaboration	with	 the	Eberl	
group,	University	of	Zurich,	and	 the	genetic	differences	between	H111	and	H111S	
were	identified	by	A.	Carlier.	This	analysis	indicated	over	100	genetic	lesions	in	the	
H111S	 strain,	 several	 of	 which	 were	 nucleotide	 insertions	 or	 deletions	 that	






















H111Δc3.	 tagF	was	 insertionally	 inactivated	 by	 the	 kanamycin	 resistance	 cassette	 in	 the	
chromosome	 3	 deletion	 mutant	 of	 B.	 cenocepacia	 H111,	 H111Δc3.	 Mutants	 were	
confirmed	 by	 PCR	 using	 primers	 that	 annealed	 just	 outside	 of	 the	 tagF::km	 homologous	
region	on	the	genome.	DNA	fragments	amplified	were	analysed	following	electrophoresis	
in	a	0.8%	agarose	gel	(A),	mutants	were	expected	to	give	rise	to	a	DNA	fragment	of	~2500	
bp,	 indicated	 by	 arrow.	 Extracellular	 proteins	 were	 precipitated	 from	 liquid	 culture	
supernatants	 of	 H111Δc3	 and	 H111Δc3-tagF::Km.	 (B)	 Profile	 of	 extracellular	 and	 cell-
associated	proteins	 as	 analysed	by	electrophoresis	 in	 a	 15%	SDS-PA	gel	 and	 stained	with	
Coomassie	 blue.	 (C)	 Representative	 anti-TssD	 western	 blot	 of	 samples	 from	 (B).	 (D)	
Densitometric	 analysis	 of	 relative	difference	between	 secreted	TssD	 in	H111Δc3	 strain	 in	
































































































involved	 in	 signal	 transduction	 in	 chemotaxis	 (Stock	 et	 al.,	 1988).	 Another	 such	
mutation	 occurred	 in	 I35_2333	 (wabR),	 which	 encodes	 a	 glycosyl	 transferase	
enzyme	 involved	 in	 LPS	 lipid	 A	 core	 biosynthesis,	 which	 resulted	 in	 a	 frameshift	
mutation	at	the	Arg214	codon,	two	thirds	into	the	coding	sequence	of	wabR.	wabR	
mutants	have	been	characterised	as	having	LPS	defects,	specifically	 lacking	the	O-
antigen	 and	 have	 a	 shorter	 lipid	 A	 core	 than	 the	 LPS	 of	 the	 wild-type	 strain,	
meaning	the	mutant	 is	more	sensitive	to	polymyxin	B	(Ortega	et	al.,	2009).	 It	was	
previously	observed	 that	H111S	had	a	 ‘rough’	 colony	morphology,	 suggestive	of	a	
defect	 or	 loss	 of	 O-antigen	 side	 chain	 (M.S.	 Thomas,	 unpublished	 observations).	
Therefore,	the	wabR	mutation	was	likely	to	account	for	these	observations	and	may	
also	account	for	the	serum-sensitivity.	However,	for	this	study	it	was	any	potential	







2013),	 by	 the	 T4SS	 of	 another	 species	 and	 by	 agents	 capable	 of	 binding	 and	
disrupting	 the	 outer	membrane,	 such	 as	 polymyxin	 B	 that	 binds	 to	Mg2+-binding	
sites	 in	LPS,	 including	those	 in	 lipid	A	 (Moore	et	al.,	1986;	Ho	et	al.,	2013).	 It	was	
noted	that	the	H111S	strain	had	a	slight	increase	in	TssD	secretion	in	comparison	to	
the	wild-type	H111	strain	(Figure	5.13B).	It	was	hypothesised	that	the	effect	of	the	
LPS	 defect	 in	 H111S	 may	 be	 mimicked	 in	 the	 wild-type	 strain	 by	 polymyxin	 B	
challenge,	resulting	in	 increased	activation	of	the	T6SS	in	this	strain,	which	can	be	
exaggerated	 by	 the	 inactivation	 of	 tagF.	 A	 liquid	 culture	 of	 wild-type	 H111	 was	
challenged	with	a	subinhibitory	concentration	of	polymyxin	B,	and	the	extracellular	






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































H111.	Wild-type	H111	 (WT)	and	a	waaL	 LPS-defective	mutant	were	grown	 in	 LB	medium	
with	 (+)	 or	 without	 (-)	 a	 sub-lethal	 dose	 of	 polymyxin	 B	 (600U/mL)	 (PmB).	 	 Extracellular	
proteins	were	precipitated	from	spent	culture	supernatants	and	analysed	for	the	presence	
of	 TssD	 by	 anti-TssD	 western	 blotting	 (left).	 Cell-associated	 proteins	 were	 also	 analysed	
























































was	 detected	 in	 a	 similar	 abundance	 in	 the	 culture	 supernatant	 from	 the	waaL	
mutant	and	wild-type,	together	suggesting	that	that	defects	in	the	LPS	or	challenge	









was	 decided	 to	 re-introduce	 chromosome	 3	 (termed	 pC3	 from	 herein)	 into	 the	
H111S-tagF::Km	 mutant,	 to	 return	 a	 full	 complement	 of	 chromosomes	 into	 the	
mutant,	which	would	mean	any	potential	effector	gene	on	the	third	chromosome	
could	now	be	expressed	 in	 a	 T6SS-proficient	 background.	 This	was	undertaken	 in	
collaboration	 with	 the	 Eberl	 group,	 University	 of	 Zurich	 by	 K.	 Agnoli,	 using	 a	
previously	 published	 procedure	 (Agnoli	 et	 al.,	 2014).	 The	 strategy	 involved	 re-
introduction	of	pC3	into	H111S	and	then	subsequent	transfer	of	the	tagF::Km	allele,	
rather	 than	 direct	 introduction	 of	 pC3	 into	 H111S-tagF::Km,	 as	 a	 H111S	 control	
strain	containing	a	full	complement	of	chromosomes	was	also	required.		To	do	this,	
a	 gene	 encoded	 on	 pC3,	 gabD	 (I35_7400)	 was	 cloned	 into	 the	 suicide	 vector	
pSHAFT2.	This	plasmid	was	then	introduced	into	H111	wild-type	and	its	integration	
into	 chromosome	3,	 by	 a	 single	 crossover	 homologous	 recombination	 event	with	
the	genomic	copy	of	gabD,	was	selected	for	by	the	acquisition	of	chloramphenicol	
resistance,	 to	 generate	 the	 strain	H111-pC3-gabD::pSHAFT2.	 This	 strain	was	 then	




acquired	 the	mobilised	 pC3	 (pC3-gabD::pSHAFT2)	were	 obtained	 by	 selection	 for	
rifampicin	 and	 chloramphenicol-resistance,	 generating	 the	 strain	 H111S/pC3.	 To	
verify	 that	 candidate	H111S/pC3	 strains	were	 indeed	derived	 from	H111S	and	not	
spontaneous	 rifampicin-resistant	 donor	 H111-pC3-gabD::pSHAFT2	 strains,	
candidates	were	sequenced	using	primers	that	amplified	a	region	of	the	wabR	gene	
that	 contained	 a	 segment	 of	 10	 nucleotides	 that	were	 present	 in	wild-type	H111	
strain	 and	 but	 not	 in	 the	 H111S	 strain.	 The	 integrity	 of	 the	 pC3	 insert	 was	 also	




	 An	 insertional	 inactivation	 mutant	 of	 tagF	 was	 then	 constructed	 in	 the	
H111S/pC3	strain.	Due	to	regions	of	homology	between	the	pSHAFT-tagF::Km	allelic	
replacement	vector	and	pSHAFT2	inserted	in	the	mobilised	pC3	it	was	required	to	




~6400	 bp	 plasmid	 pEX18TpTer-pheS-tagF::Km	 (Figure	 5.17A).	 This	 allelic	
replacement	 vector	 was	 introduced	 into	 H111S/pC3	 by	 conjugation	 and	
recombinants	 containing	 a	 chromosomally	 integrated	 plasmid	 were	 selected	 for	
their	 increased	 kanamycin-resistance.	 To	 identify	 double	 crossover	 recombinants,	
kanamycin-resistant	 colonies	 were	 checked	 for	 sensitivity	 to	 trimethoprim	 (the	
trimethoprim-resistance	 marker	 is	 contained	 on	 the	 pEX18TpTer-pheS	 vector).	
H111S-tagF::Km/pC3	 candidates	 that	were	 kanamycin-resistant	 but	 trimethoprim-
sensitive	 were	 screened	 by	 PCR,	 as	 described	 in	 Section	 5.3.2,	 and	 the	 resulting	
amplified	DNA	was	 analysed	 by	 electrophoresis	 to	 determine	DNA	 fragment	 size,	
verifying	the	candidates	as	tagF::Km	mutants	(Figure	5.17B).	
	 The	T6SS	activity	of	the	H111S-tagF::Km/pC3	strain	was	then	investigated	by	
analysis	 of	 TssD	 secretion	 by	 western	 blotting	 and	 image	 quantification	 (Figure	

























Figure	 5.17	 Construction	 of	 a	 H111S-tagF::Km/pC3	 mutant.	 Chromosome	 3	 was	 re-
introduced	 into	 H111S	 to	 generate	 H111S/pC3.	 pEX18TpTer-pheS-tagF::Km	 (shown	 in	 A)	
was	 then	 generated	 by	 transferring	 the	 tagF::Km	 allele	 as	 a	 HindIII	 restriction	 fragment	
from	 pBBR1MCS-tagF::Km	 into	 the	 corresponding	 restriction	 site	 in	 pEX18TpTer-pheS.	
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H111S/pC3.	 tagF	was	 insertionally	 inactivated	 by	 the	 kanamycin	 resistance	 cassette	 in	B.	
cenocepacia	 H111S/pC3.	 Extracellular	 proteins	 were	 precipitated	 from	 liquid	 culture	
supernatants	 of	H111S/pC3	 and	H111S-tagF::Km/pC3	 and	 compared	 to	H111S	 and	H111S-
tagF::Km	 without	 chromosome	 3	 and	 wild-type	 H111	 and	 a	 ΔtssM	 mutant.	 (A)	 Protein	
























































































































derived	 from	 in	 the	 tagF::Km	 mutant	 in	 comparison	 to	 the	 parental	 H111S/pC3	
strain.	 	 However,	 variation	 in	 the	 increase	 of	 secreted	 TssD	 was	 observed	 again	
between	 repeat	 experiments.	 Therefore,	 the	 difference	 was	 not	 statistically	
significant.	Interestingly,	it	was	also	observed	that	TssD	secretion	in	H111S/pC3	was	
reduced	 in	 comparison	 to	 the	 H111S	 strain	 lacking	 chromosome	 3.	 However,	 as	
TssD	secretion	was	still	unreliable	in	the	H111S-tagF::Km/pC3	mutant	it	was	decided	




















 Investigation	 of	 the	 role	 of	 AtsR	 in	 T6SS-regulation	 in	 B.	5.4
cenocepacia	H111	
	 Previous	 work	 has	 identified	 AtsR,	 a	 RetS-like	 inner	 membrane-anchored	
hybrid	 sensor-kinase	 that	 acts	 through	 the	 response	 regulator	 AtsT,	 as	 a	
transcriptional	 regulator	 of	 T6SS	 genes	 in	 B.	 cenocepacia	 (Aubert	 et	 al.,	 2008;	
Khodai-Kalaki	 et	 al.,	 2013).	 Briefly,	 the	AtsR	histidine	 kinase	domain	 (HK)	 is	 auto-
phosphorylated	 upon	 receiving	 an	 unknown	 signal.	 A	 receiver	 domain	 located	 C-
terminal	to	the	HK	domain	can	be	phosphorylated	by	phosphate	transfer	from	the	
phosphorylated	His245	residue	in	the	HK	domain.	Alternatively,	the	phosphate	from	
His245	 can	 also	be	 transferred	 to	 an	 aspartate	 residue	 (Asp208)	on	 the	 response	
regulator,	AtsT,	to	modulate	its	activity	as	a	transcriptional	repressor	(Khodai-Kalaki	
et	 al.,	 2013)	 (Figure	 5.1).	 Inactivation	 of	 atsR	 (and	 atsT)	 in	 K56-2	 leads	 to	
hypersecretion	 of	 TssD	 into	 the	 culture	 supernatant,	 and	 formation	 of	 actin	
protrusions	 in	macrophages	 infected	with	 this	mutant,	 which	 otherwise	 has	 very	
little	 T6SS	 activity	 (Aubert	 et	 al.,	 2008;	 Khodai-Kalaki	 et	 al.,	 2013).	 The	model	B.	




atsR	 in	 the	B.	 cenocepacia	 H111	 strain,	 which	 has	 been	 shown	 to	 have	 a	 higher	




	 For	 the	 generation	 of	 an	 in-frame	 deletion	 mutant	 in	 atsR	 an	 allelic	
replacement	vector	based	on	pEX18TpTer-pheS	was	constructed	(Figure	5.19).	The	











































allele	can	be	achieved	by	using	splice	overlap	extension	PCR	 (SOE-PCR)	 to	splice	 together	
two	DNA	fragments	either	side	of	the	gene	that	is	to	be	deleted.	To	do	this,	each	fragment,	




the	other	 fragment	 that	 is	 to	be	 fused.	Both	primers	are	 therefore	complementary	along	
their	 entire	 length.	 Thus,	 following	 amplification,	 amplicon	 AB	 contains	 ~500	 bp	 of	 DNA	
corresponding	to	upstream	genomic	sequences	that	flank	the	target	gene	followed	by	the	
first	 few	 codons	 of	 the	 target	 gene	 fused	 to	 the	 final	 few	 codons	 of	 the	 same	 gene.	
Amplicon	CD	contains	the	same	first	few	codons	of	the	target	gene	fused	to	the	final	few	
codons	of	the	same	gene	followed	by	~500	bp	of	 flanking	DNA	downstream	of	the	target	


























DNA	 located	downstream	of	atsR	 in	 the	H111	genome.	 	 Fragments	ΔatsR-AB	and	
ΔatsR-CD	were	 then	 combined	 in	 an	 equal	molar	 ratio	 and	used	 as	 the	 template	
DNA	in	a	second	round	of	PCR	using	primers	AtsRForAXbaI	and	AtsRRevDHindIII	to	





an	XbaI-HindIII	 restriction	 fragment,	 to	generate	pEX18TpTer-pheS-ΔatsR.	 Positive	
clones	were	 identified	by	PCR	screening	using	vector	 specific	primers	M13for	and	








B.	 cenocepacia	 H111	 and	 K56-2	 wild-type	 strains	 by	 conjugation	 to	 enable	
recombination	 between	 the	 homologous	 DNA	 sequence	 contained	 in	 the	 vector	
and	the	genome,	and	single	crossover	recombinants	were	selected	based	on	their	
resistance	 to	 trimethoprim.	 Single	 recombinants	 were	 then	 subjected	 to	 cPhe	
counter-selection	on	M9	agar	containing	0.1%	cPhe.	























































































outside	 annealing	 primers	 (Figure	 5.22B)	 and	 vector-specific	 primers	 pEX18Tpfor	
and	pEX18Tprev	 (Figure	5.22C),	 to	 indicate	 the	presence	or	absence	of	 the	vector	
within	the	genome.	Both	16	and	24	contained	the	correct	sized	ΔatsR	fragment	but	
24	also	 screened	positive	 for	 the	 vector	 region	whereas	16	did	not,	 indicating	16	
was	a	true	ΔatsR	mutant.		
	 For	 mutagenesis	 of	 K56-2,	 candidates	 where	 subjected	 to	 the	 above	
screening	procedure,	but	trouble-shooting	was	required	to	enable	amplification	of	
fragments	 from	 the	 atsR	 locus.	 This	 included	 dilution	 of	 the	 template	 DNA	 and	
using	 a	 high	 fidelity	 DNA	 polymerase	 (KOD).	 Candidate	 1	 was	 verified	 as	 a	 true	
ΔatsR	mutant	 (Figure	5.23).	Note,	 the	K56-2-ΔatsR	was	made	as	a	control	 for	 the	
H111-ΔatsR	 mutant,	 to	 ensure	 that	 inactivation	 of	 atsR	 in	 this	 manner	 gave	 the	
same	increase	in	T6SS	as	observed	previously	(Aubert	et	al.,	2008).	
	
5.4.3 	Analysis	 of	 the	 T6SS	 activity	 of	 B.	 cenocepacia	 atsR	 deletion	
mutants	
	 To	 investigate	 whether	 the	 disruption	 of	 atsR	 resulted	 in	 a	 sufficient	
increase	 in	 T6SS	 activity	 in	 B.	 cenocepacia	 to	 be	 beneficial	 in	 downstream	
applications,	 extracellular	 proteins	were	 precipitated	 from	 liquid	 cultures	 of	 both	
H111-ΔatsR	 and	 K56-2-ΔatsR,	 and	 compared	 to	 respective	 parental	 strains	 after	
SDS-PAGE	 and	 visualisation	 with	 Coomassie	 blue	 staining.	 The	 resulting	 analysis	
indicated	 an	 increase	 in	 the	 abundance	 of	 an	 18	 kDa	 and	 15	 kDa	 protein	 in	 the	
secreted	 fraction	 of	 the	 H111-ΔatsR	 mutant	 in	 comparison	 to	 wild-type	 H111	
(Figure	 5.24A).	 Similarly,	 an	 18	 kDa	 protein	 was	 more	 abundant	 in	 the	 secreted	
fraction	of	K56-2-ΔatsR	than	wild-type	K56-2,	and	this	difference	was	greater	than	
that	 seen	 in	 the	 H111	 strains.	 Immuno-detection	 of	 TssD	 verified	 that	 the	 over	


























Figure	 5.22	 Construction	 of	 a	 B.	 cenocepacia	 H111	 ΔatsR	mutant.	 (A)	 Following	 cPhe	
counter-selection,	 candidate	 H111-ΔatsR	 mutants	 were	 screened	 using	 outside	 primers	
annealing	 to	 regions	 outside	 of	 the	atsR	 homology	 region	 in	 the	 genome,	 and	 visualised	
following	electrophoresis	 in	a	0.8%	agarose	gel.	The	wild-type	 (WT)	was	expected	 to	give	
rise	to	a	3471	bp	DNA	fragment	and	potential	mutants	a	1734	bp	DNA	fragment,	shown	by	
arrows	with	 indicated	 labels.	Asterisks	 indicate	 two	 candidates	 subjected	 to	 further	 cPhe	
counter-selection	 and	 colony	 purification.	 (B)	 Rescreen	 of	 candidates	 16	 and	 24	 with	
outside	 primers	 (OP),	 as	 analysed	 by	 DNA	 gel	 electrophoresis.	 (C)	 PCR	 screen	 of	 same	
candidates	with	 primers	 specific	 to	 the	 pEX18TpTer-pheS	 vector.	Mutants	 still	 containing	







































































gel	 electrophoretic	 analysis	 of	 PCR	 fragments	 amplified	 from	 candidate	 K56-2-ΔatsR	
mutant	#1.	ΔatsR	 (1734	bp)	and	wild-type	(WT)	(3471	bp)	amplicons	are	 indicated	by	the	
labelled	 arrows.	 Boiled	 lysates	 were	 made	 from	 K56-2-ΔatsR	 candidate	 #1	 after	 colony	
purification	on	minimal	agar	with	(cPhe)	and	without	(M9)	cPhe	as	template	DNA.	(B)	PCR	
screen	 of	 K56-2-ΔatsR	 candidate	 #1	 using	 pEX18TpTer-pheS	 vector	 primers,	 with	 the	








































































Figure	5.24	Analysis	of	 TssD	 secretion	 in	B.	 cenocepacia	ΔatsR	mutants.	 (A)	Coomassie-
stained	 15%	 SDS-PA	 gels	 following	 electrophoresis	 of	 H111	 (upper)	 and	 K56-2	 (lower)	
extracellular	 proteins	 (left)	 extracted	 from	 liquid	 cultures	 of	 respective	 wild-type,	ΔatsR	
and	 T6SS-deficient	 mutants	 (ΔtssM,	 tssA::Tp	 or	 tssM::Tp).	 Cell-associated	 proteins	 are	























































































































of	each	 strain	 indicated	 that	deletion	of	atsR	 in	H111	 resulted	 in	approx.	1.5-fold	
increase	in	the	amount	of	TssD	to	the	wild-type	(Figure	5.25A).	The	difference	was	
greater	 in	the	K56-2	background,	with	atsR	disruption	causing	a	4-fold	 increase	 in	
extracellular	TssD	(Figure	5.25B).	However,	as	these	quantifications	were	only	taken	
from	 one	 experiment	 further	 repeats	 would	 be	 required	 to	 give	 statistical	
significance.		
As	 these	 strains	 were	 grown	 to	 a	 similar	 optical	 density	 and	 the	 same	
volume	of	spent	culture	medium	was	precipitated,	the	results	(like	those	presented	
in	 Section	 4.5.1)	 suggest	 that	 extracellular	 TssD	 is	more	 abundant	 in	wild-type	B.	
cenocepacia	 H111	 than	 in	 K56-2.	 Thus,	 by	 deleting	 atsR	 in	 K56-2	 it	 enabled	 up-
regulation	 of	 T6SS	 activity	 to	 levels	 similar	 to	 those	 seen	 in	 wild-type	 H111.	




T6SS	 activity	 in	 wild-type	 H111	 may	 be	 sufficient	 for	 what	 was	 required,	 as	 it	























Figure	 5.25	 Relative	 quantification	 of	 TssD	 secretion	 in	B.	 cenocepacia	ΔatsR	mutants.	





























































 Optimising	 a	 workflow	 for	 a	 secretome	 analysis	 of	 B.	5.5
cenocepacia	by	shotgun	proteomics	
To	 identify	 proteins	 in	 a	 complex	 mixture,	 bottom-up	 mass	 spectrometry	
techniques	can	be	used.	A	particularly	useful	method	is	the	shotgun	approach.	The	
basic	 principle	 involves	 a	 mixture	 of	 proteins	 being	 digested	 into	 peptides	 by	
proteolytic	enzymes	that	cut	with	a	low	level	of	specificity,	such	as	trypsin.	Trypsin	
hydrolyses	 peptide	 bonds	 on	 the	 C-terminal	 side	 of	 lysine	 and	 arginine	 residues.	
Peptides	are	then	separated	by	HPLC	and	subjected	to	tandem	mass	spectrometry.	
The	mass	and	 charge	 (m/z)	of	 ionised	peptides	 (precursor	 ion)	 are	determined	 in	
the	 first	 mass	 analyser,	 and	 then	 precursor	 ions	 are	 selected	 for	 subsequent	
fragmentation	 into	product	 ions,	which	are	analysed	 in	the	second	mass	analyser.	
This	 generates	 the	m/z	of	 the	product	 ions,	 and	 thus	generates	 sequence	 tags	of	
the	precursor	ions.	This	iterative	process	of	precursor	ion	selection,	fragmentation	
and	 product	 ion	 analysis	 allows	 the	 determination	 of	 a	 peptide’s	 mass	 and	
sequence.	 Thus,	 the	 experimentally	 derived	 peptide	 mass	 data	 and	 sequences	
generated	 can	 be	 compared	 to	 an	 in	 silico	 tryptic	 digest	 of	 hypothetical	 proteins	
from	B.	cenocepacia	using	a	database	search,	e.g.	MASCOT,	to	identify	proteins	the	
peptides	 correspond	 to.	 To	 help	 identify	 T6SS-dependent	 secreted	 proteins	 in	B.	
cenocepacia	 it	 was	 decided	 to	 try	 to	 employ	 this	 mass	 spectrometry	 analysis	
technique.			
	
5.5.1 Optimisation	 of	 secreted	 protein	 extraction	 from	 liquid	 broth	
cultures	
It	was	 found	 the	B.	 cenocepacia	 strain	H111	possessed	a	 functioning	T6SS	
that	was	active	under	standard	laboratory	conditions	(Section	4.5).	Attempts	were	
made	 to	 increase	 the	 activity	 of	 this	 system	 by	 generating	 mutants	 that	 lacked	
putative	 post-translational	 and	 confirmed	 transcriptional	 regulators	 of	 the	 T6SS,	
without	 success.	 Consequently,	 it	 was	 decided	 to	 attempt	 to	 analyse	 the	
extracellular	 proteins	 extracted	 from	 wild-type	 cultures	 of	 B.	 cenocepacia	 H111,	
and	 compare	 them	 to	 extracellular	 proteins	 extracted	 from	 a	 T6SS	 mutant.	 The	
greater	 the	protein	 content	of	 samples,	 the	more	 likely	 it	will	be	 that	proteins	of	
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interest	 will	 be	 reliably	 identified	 by	 mass	 spectrometry.	 Therefore,	 it	 was	 first	
required	 to	 optimise	 growth	 conditions	 and	 the	 extracellular	 protein	 extraction	
procedure	from	bacterial	liquid	cultures	for	an	optimal	yield	of	secreted	proteins.	
First,	B.	cenocepacia	H111	was	grown	 in	different	 types	of	 liquid	media	 to	
determine	if	this	effected	extracellular	protein	production.	Growth	media,	including	
LB	 broth	 and	 BHI	 broth,	 dialysed	 BHI	 (D-BHI)	 broth,	 and	 M9	 minimal	 medium	
containing	 glycerol	 and	 casamino	acids	or	 glucose	were	 tested.	 It	was	 found	 that	
upon	extraction	of	 extracellular	proteins	by	DOC-TCA	precipitation	 (Section	2.4.3)	
from	 BHI	 and	 LB	 broth	 cultures,	 components	 of	 the	 media	 itself	 interfered	 with	
analysis	of	the	extracted	proteins	by	SDS-PAGE,	causing	smearing	and	obscuring	of	
proteins	 below	 20	 kDa	 (results	 not	 shown).	 	 Growth	 in	 either	 minimal	 medium	




interference	 from	 the	 components	 of	 the	media	 when	 analysing	 the	 samples	 by	
SDS-PAGE	(see	Section	4.5).		
The	correlation	between	the	growth	phase	of	the	bacteria	and	extracellular	
protein	 production	was	 also	 investigated	 to	 determine	 if	 T6SS	 activity	 was	more	
active	at	a	particular	growth	phase.	Cultures	of	B.	cenocepacia	H111	were	grown	to	
an	OD600	 of	 ~0.6	 (mid-log),	 1.0	 (late-log)	 or	 as	overnight	 cultures	 (stationary)	 and	
secreted	 proteins	 extracted	 by	 DOC-TCA	 precipitation.	 It	 was	 observed	 that	
secreted	protein	 profiles	were	 similar	 between	 cultures	 grown	 to	 an	OD600	of	 0.6	
and	1.0	in	terms	of	the	range	of	proteins	produced.	But	the	abundance	of	proteins	
was	 greater	 in	 the	 culture	 at	 1.0	 than	 0.6	 (results	 not	 shown),	 as	 would	 be	
expected,	as	there	is	a	greater	cell	density.	However,	when	comparing	the	secreted	
proteins	 extracted	 from	 overnight	 cultures,	 the	 secreted	 protein	 profile	 was	
significantly	 different	 (Figure	 5.26).	 There	 was	 overproduction	 of	 a	 protein	 at	
approximately	 32	 kDa,	 and	 no	 observable	 18	 kDa	 protein	 corresponding	 to	 TssD	






















of	 1.0	 (late	 log-phase)	 and	 (B)	 overnight	 (stationary	 phase),	 whereupon	 culture	
supernatants	were	precipitated	 to	extract	 extracellular	 proteins	 (sec),	 and	 cell-associated	
proteins	(CA).	Samples	were	subjected	to	electrophoresis	in	a	15%	SDS-PAGE	gel	and	then	















































phase	H111	 cultures,	 as	 ascertained	 by	western	 blotting,	 yet	 cell-associated	 TssD	
was	still	detected	 (Figure	5.26).	This	 suggests	 that	 firing	of	 the	T6SS	 is	 reduced	 in	
stationary	phase	cultures	of	B.	cenocepacia	H111.	
The	 main	 method	 used	 for	 protein	 precipitation	 of	 the	 spent	 culture	
supernatants	employed	sodium	deoxycholate	(DOC)	and	trichloroacetic	acetic	acid	
(TCA)	in	combination,	with	an	acetone	wash(s)	to	remove	residual	TCA.	Alterations	
to	 this	 method	 were	 also	 tried,	 including	 using	 TCA	 precipitation	 without	 the	
addition	of	DOC,	acetone	precipitation	alone	and	concentration	of	the	spent	culture	
supernatants	 by	 a	 10000	MWCO	 centrifugal	 concentrator.	 However,	 all	 of	 these	






Attempts	 were	 made	 to	 process	 extracellular	 proteins	 samples	 extracted	










clean	 the	 samples	up	 further	using	 strong	cation	exchange	 resin	 (SCX)	but	due	 to	
constraints	 this	 was	 not	 possible.	 Therefore	 unfortunately,	 no	 secreted	 protein	






This	 study	 hypothesised	 that	 the	 product	 of	 a	 conserved	 gene	 associated	
with	 the	 ancestral	 T6SS	 cluster	 (T6SS-1),	 which	 is	 found	 in	 many	 Burkholderia	
species	 and	 selected	β-proteobacteria	 and	 ϒ-proteobacteria,	might	 be	 a	 putative	
post-translational	regulator	of	the	T6SS,	designated	as	TagX.	It	was	predicted	to	be	
an	 inner	 membrane	 protein	 that	 contains	 a	 periplasmic	 C-terminal	 domain	 with	
four	 conserved	 cysteine	 residues.	 This	 region	 was	 postulated	 to	 be	 involved	 in	
sensing	a	periplasmic	 signal,	 directly	or	 indirectly	 through	other	proteins,	 such	as	
the	 outer	 membrane	 anchored	 lipoprotein	 TagM.	 This	 signal	 could	 then	 be	
transduced	to	other	protein	components	to	regulate	the	assembly,	disassembly	or	
firing	of	the	T6SS	complex.		
Here,	 this	 study	 sought	 to	 determine	 the	 role	 of	 TagX	 in	 T6SS	 activity	 by	
analysing	 the	 phenotype	 of	 a	 tagX	 mutant.	 Unfortunately,	 it	 was	 found	 that	
insertional	 activation	 of	 tagX	 exerted	 no	 effect	 on	 the	 T6SS	 activity	 of	 B.	
cenocepacia	H111,	as	similar	levels	of	extracellular	TssD	were	detected	in	the	tagX	
mutant	 as	 the	wild-type	 strain.	 Although	 not	 the	 results	 that	were	 anticipated	 it	
does	imply	that	TagX	does	not	down-regulate	the	T6SS.	However,	if	TagX	was	to	act	
as	a	post-translational	activator	of	the	T6SS,	then	an	observable	difference	in	T6SS	
activity	may	only	be	observed	 if	 the	 signal	 to	which	 it	 is	 responding	 to	 is	actually	
present	(i.e.	bacteria	are	being	grown	under	T6SS	inducing	conditions),	rather	than	





complexes	 (Leiman	 et	 al.,	 2009).	 Interestingly,	 GpL	 of	 the	 long	 non-contractile	
bacteriophage	 λ	 contains	 a	 C-terminal	 domain	 with	 four	 conserved	 cysteine	
residues	 that	 co-ordinates	 a	 Fe-S	 cluster	 (Tam	et	 al.,	 2013),	 similar	 to	 the	CTD	of	








mutations	 in	 several	 tag	 genes	 encoding	 candidate	 post-translation	 regulator	
proteins	(TagQ,	TagT,	and	TagS)	had	no	effect	on	observable	TssD	levels	(Silverman	
et	 al.,	 2011).	 However,	 it	 was	 later	 shown	 that	 TagQ,	 TagT	 and	 TagS	 were	 each	
required	for	T6SS-dependent	fitness	against	other	bacteria	(Casabona	et	al.,	2013).	
They	 may	 do	 this	 by	 sensing	 and	 transducing	 signals	 received	 upon	 attack	 by	






This	 was	 not	 tested,	 as	 the	 aim	 of	 investigating	 TagX	 was	 to	 determine	 if	
modulation	 of	 TagX	 could	 be	 used	 to	 enhance	 T6SS	 activity	 for	 effector	
identification	under	normal	growth	conditions.		
To	further	evaluate	the	role	of	TagX	in	the	T6SS	of	the	Burkholderia	species,	
either	 as	 a	 regulator	 or	 structural	 protein,	 it	 would	 be	 rational	 to	 investigate	
whether	 TagX	 interacts	 with	 other	 components	 of	 the	 T6SS	 directly.	 This	 could	
include	 exploring	 interactions	 between	 the	 CTD	 or	 NTD	 of	 TagX	 with	 other	 Tag	




The	 Burkholderia	 T6SS-1	 cluster	 contains	 a	 putative	 post-translational	




from	 that	 of	 the	 threonine	 phosphorylation	 pathway	 (TPP),	 but	 it	 is	 thought	 to	
converge	on	the	recruitment	of	TssH	in	complex	with	Fha1	to	the	T6SS	complex,	but	
does	not	require	Fha1	to	be	phosphorylated,	like	in	the	TPP	(Silverman	et	al.,	2011).		
In	 this	 study,	 tagF	 was	 inactivated	 by	 insertion	 of	 an	 antibiotic	 resistance	
cassette	in	several	variants	of	B.	cenocepacia	H111	and	the	T6SS	phenotype	of	the	
mutants	assessed.	A	consistent	 increase	 in	TssD	secretion	was	observed	 in	a	 tagF	
mutant	 generated	 in	 an	 isolate	 of	B.	 cenocepacia	 H111	 that	was	 serum-sensitive	
and	 had	 spontaneously	 lost	 chromosome	 3	 (H111S).	 However,	 when	 the	 tagF	
mutant	 allele	was	 introduced	 to	 the	wild-type	 strain	 there	was	 a	 high	 degree	 of	
variation	in	the	level	of	secreted	TssD	between	repeat	experiments.	It	is	difficult	to	
understand	 why	 this	 was,	 but	 there	 is	 a	 possibility	 that	 there	 were	 unknown	
variations	between	each	experiment.		
It	 is	 plausible	 that	 the	 H111S	 mutant	 is	 more	 ‘leaky’	 than	 the	 wild-type	
strain,	in	regards	to	the	integrity	of	cell	membrane,	which	would	result	in	increased	
amounts	of	protein	in	the	extracellular	milieu.	However,	 it	 is	difficult	to	judge	this	
without	 a	 control	 for	 the	 amount	 of	 total	 secreted	 protein	 present	 or	 the	
precipitation	efficiency.	
It	 could	 be	 argued	 that	 the	 variation	 stems	 from	 the	 TCA	 precipitation	
procedure,	as	percentage	recovery	 in	protein	precipitation	by	TCA	can	be	variable	
(Bensadoun	 and	 Weinstein,	 1976;	 Manadas	 et	 al.,	 2006).	 However,	 the	 method	
used	in	this	study	included	sodium	deoxycholate	which	has	been	shown	to	improve	




of	 D-BHI	 media	 prepared	 for	 each	 experiment	 having	 a	 knock	 on	 effect	 of	 the	
bacteria	 and	 T6SS	 activity.	 The	 composition	 of	 BHI	 can	 vary	 between	 lots	 and	




However,	 rather	 than	 the	 variation	 being	 caused	 by	 the	 experimental	
procedure,	 it	was	 initially	 postulated	 to	be	due	 to	 the	absence	of	 chromosome	3	
having	 a	 stabilising	 effect	 on	 T6SS	 up-regulation	 in	 the	 H111S-tagF	mutant.	 For	
example,	 this	 could	 have	 been	 due	 to	 the	 removal	 of	 an	 unknown	 regulator(s)	
encoded	on	 chromosome	3.	 Chromosome	3	 (or	 pC3	 as	 it	 is	 now	 referred	 to)	 has	
been	 shown	 to	 be	 a	 non-essential	 megaplasmid	 that	 is	 important	 for	 virulence,	
proteolytic	 activity,	 anti-fungal	 activity	 and	 stress	 tolerance	 in	 some	 species	 of	
related	Bcc	bacteria	(Agnoli	et	al.,	2012;	Agnoli	et	al.,	2014).	Though,	when	a	tagF	
mutant	was	 constructed	 in	 an	 isolate	 of	 H111	 that	 had	 been	 engineered	 to	 lose	
chromosome	3	(H111Δc3)	only	a	marginal	increase	in	TssD	secretion	was	observed.	
This	 suggested	 that	 further	 mutations	 accrued	 by	 the	 H111S	 isolate	 may	 have	
contributed	to	the	phenotype	observed	in	the	H111S-tagF	mutant,	rather	than	or	in	
addition	to	deletion	of	chromosome	3.		
Entire	 genome	 sequencing	 of	 H111S	 indicated	 over	 100	 polymorphisms	 in	
the	 strain,	 several	 of	 them	 frameshift	 mutations	 in	 open	 reading	 frames.	 A	
particular	frame	shift	mutation	was	discovered	in	the	wabR	gene,	likely	resulting	in	
a	truncated	non-functional	variant	of	WabR.	WabR	is	a	heptosyltransferase	involved	
in	the	synthesis	of	 the	 lipid	A	core	 in	the	LPS	of	B.	cenocepacia,	 such	that	ΔwabR	
mutants	 lack	O-antigen	and	have	a	 truncated	 lipid	A	 core	 (Ortega	et	al.,	 2009).	 It	
was	 reasoned	 that	 an	 impaired	 outer	membrane	 LPS	 barrier	 in	 the	H111S	 isolate	
and	 H111S-tagF	 mutant	 may	 have	 been	 synergistic	 or	 stabilised	 the	 TssD	
hypersecretion	 phenotype	 of	 the	 tagF	 mutant,	 by	 an	 unknown	mechanism.	 One	
possibility	 was	 that	 the	 altered	 LPS	 layer	 allowed	 greater	 exposure	 to	 an	
environmental	 signal	 that	 is	 otherwise	 dampened	 down	 in	 strains	 harbouring	 a	
functional	TagF.	 It	 is	also	possible	 that	 the	altered	LPS	 layer	mimics	 the	signal	 for	
T6SS	 activation	 in	 B.	 cenocepacia.	 To	 investigate	 this	 a	 different	 LPS	 mutant,	
inactivated	 in	waaL,	which	had	 a	 slightly	 less	 truncated	 lipid	A	 core	 than	 a	wabR	
mutant	was	analysed.	 It	 appeared	secretion	of	TssD	 in	 this	mutant	was	 similar	 to	
the	wild-type	H111,	suggesting	that	the	latter	hypothesis	was	not	the	case.		
It	 is	possible	that	the	combination	of	the	LPS	mutation	and	the	absence	of	
chromosome	 3	 was	 allowing	 increased	 TssD	 secretion	 in	 the	 tagF	 mutant.	 To	
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between	 chromosome	 3,	 tagF	 and	 LPS	were	 to	 be	 fully	 investigated	 then	 a	 tagF	
mutant	should	be	constructed	in	a	wabR	mutant	that	is	otherwise	identical	to	the	
wild-type	 strain	 (i.e.	 lacking	 the	polymorphisms	present	 in	H111S).	A	derivative	of	
this	 strain	 should	 then	be	 constructed	 lacking	 chromosome	3,	 and	TssD	 secretion	
compared	to	the	tagF	wabR	mutant	possessing	a	full	complement	of	chromosomes.	
However,	 it	 was	 outside	 the	 scope	 of	 the	 project	 to	 further	 investigate	 this	





its	 T6SS	 cluster,	 indicating	 that,	 unlike	 P.	 aeruginosa,	 it	 is	 not	 regulated	 by	 the	
surface-growth	 stimulated	 TPP	 pathway	 involving	 TagQRST-PpkA-Fha1-PppA	
(Mougous	 et	 al.,	 2007;	 Hsu	 et	 al.,	 2009;	 Casabona	 et	 al.,	 2013).	 Note	 that	 B.	
cenocepacia	does	contain	a	FHA	Ser/Thr	protein	kinase-encoding	 locus	away	from	
the	T6SS	cluster,	on	chromosome	2.	However,	is	it	likely	to	be	involved	in	regulation	
of	 bacteriocin	 production,	 rather	 than	 T6SS	 regulation,	 due	 to	 the	 nature	 of	 the	
genes	located	downstream	of	the	FHA	locus.	Even	though	B.	cenocepacia	does	not	
encode	Fha1	at	the	T6SS	cluster,	evaluation	of	several	tagF	mutants	demonstrated	
a	 tendency	 for	 increased	 T6SS	 activity,	 as	 observed	 in	 the	 P.	 aeruginosa	 tagF	
mutant.	 This	 suggests	 they	 may	 share	 a	 TagF-mediated	 post-translational	
mechanism,	but	the	B.	cenocepacia	system	is	unlikely	to	require	complex	formation	





sheath	and	recycling	of	 the	TssB/TssC	subunits.	This	 is	 required	 for	 re-arming	and	








some	way.	 The	 cytoplasmic	NTD	of	most	TssM	proteins	have	NTPase	activity	 and	
contains	Walker	 A	 (ATP/GTP-binding)	 and	Walker	 B	 (ATP/GTP	 hydrolysis)	 motifs,	
including	TssM	 in	B.	 cenocepacia.	 TagF	 is	a	predicted	cytosolic	protein,	and	 it	has	
been	noted	that	where	there	is	no	evidence	for	post-translational	regulation	of	the	
T6SS,	the	Walker	A	motif	is	absent	or	is	not	required,	such	as	in	E.	tarda	(Zheng	and	
Leung,	 2007;	 Silverman	 et	 al.,	 2012).	 This	 may	 suggest	 that	 TagF	 directly	 or	
indirectly	 negatively	 regulates	 TssM	 through	 the	 ATP/GTPase	 domain.	
Conformational	 changes	 to	 TssM	 upon	 binding	 of	 TagF	 or	 another	 regulator	
involved	in	the	TagF-mediated	pathway	may	leave	the	NTPase	domain	in	an	inactive	
conformation,	resulting	in	suppression	of	T6SS	due	to	reduced	recruitment	of	TssH	





no	 effect	 on	 TssD	 secretion	 (Lin	 et	 al.,	 2014).	 Yet,	 when	 the	 protein	 was	
overexpressed	 TssD	 secretion	 was	 significantly	 decreased,	 suggesting	 that	 the	
fusion	protein	acts	as	a	repressor	(Lin	et	al.,	2014).	The	reason	deletion	of	the	gene	































Image	 showing	 the	 genetic	 arrangement	 of	 tagF	 and	 surrounding	 genes	 in	 various	 T6SS	

























































B.	 cenocepacia	 has	 a	 two	 component	 regulatory	 system,	 AtsR-AtsT,	which	
functions	 in	 global	 transcriptional	 regulation	 to	 exert	 a	 variety	 of	 downstream	
effects	 on	 the	 organism.	 This	 system	 negatively	 regulates	 the	 expression	 of	 the	
T6SS	system,	and	other	features	including	motility,	biofilm	production	and	protease	
production,	which	it	does	by	modulating	quorum	sensing	signalling	pathways,	CepIR	
and	CciIR,	 and	another	mechanism	 that	may	 involve	 the	orphan	 LuxR	homologue	
that	is	independent	of	AHL,	CepR2	(Aubert	et	al.,	2008;	Malott	et	al.,	2009;	Aubert	
et	al.,	2012;	Ryan	et	al.,	2013).				




may	 account	 for	 the	 difference	 in	 the	 effect	 of	 deleting	atsR,	 i.e.	 the	 increase	 in	
TssD	secretion	was	not	as	profound	in	H111	as	the	system	was	already	more	active	
to	begin	with.	
Greater	 basal	 T6SS	 activity	 in	 H111	 could	 be	 due	 to	 the	 lack	 of	 the	 CciIR	




cepIR	 genes	 were	 up-regulated	 in	 a	 K56-2	 ΔatsR	 mutant	 (Aubert	 et	 al.,	 2012).	




T6SS	 activity,	 which	 is	 overridden	 when	 the	 CepRI	 system	 is	 up	 regulated	 by	























H111	 and	 K56-2	 ΔatsR	 mutants.	 	 See	 text	 for	 details.	 Dashed	 arrows	 indicate	 positive	




















regulate	 the	CepRI	 system	 leading	 to	an	 increase	 in	T6SS	activity,	but	 the	 relative	
difference	in	TssD	secretion	is	not	as	great	because	the	T6SS	is	more	basally	active.	
There	 may	 be	 a	 limit	 to	 how	 much	 T6SS	 activity	 is	 possible,	 particularly	
regarding	 assembly,	 firing	 and	 dissemble	 of	 the	 complex,	 all	 of	 which	 require	
significant	 resources	 and	 energy	 input	 for	 the	 bacterium.	 Taking	 this	 into	
consideration,	 it	 was	 decided	 to	 cease	 trying	 to	 further	 activate	 the	 T6SS	 in	 B.	




5.6.5 T6SS	 effector	 identification	 by	 mass	 spectrometry-	 problems	 and	
solutions	
An	aim	for	investigating	the	regulation	of	the	T6SS	in	B.	cenocepacia	was	to	
help	 facilitate	 effector	 identification	 by	mass	 spectrometry.	 However,	 there	were	
issues	with	the	compatibility	of	the	extracellular	protein	preparation	method	used	
and	downstream	processing	steps	for	mass	spec	analysis	that	could	not	be	rectified	
before	 submission	 of	 this	 thesis.	 A	 contributing	 factor	 to	 the	 incompatibility	may	
have	been	due	to	interfering	detergents.	This	could	have	stemmed	from	carry	over	




in	 this	 clean	 up	 procedure,	 so	 the	 precipitate	 formed	 may	 have	 been	 due	 to	




alternative	 tryptic	 digestion	 method	 that	 is	 more	 compatible	 with	 detergent	





Despite	 initial	 efforts	 to	 try	 to	 design	 a	 system	 for	 the	 analysis	 of	 the	
secretome	of	B.	cenocepacia,	including	strain	manipulation,	optimisation	of	growth	
conditions,	 secreted	 protein	 extraction	 and	 sample	 preparation,	 the	 question	
regarding	 the	 most	 suitable/optimised	 workflow	 for	 sample	 preparation	 of	 the	

























































It	 has	 been	 observed	 that	 non-TssI	 T6SS	 effectors	 are	 often	 encoded	
adjacent	 to	genes	coding	 for	 the	homologous	 tail-spike	T4	bacteriophage	protein,	
TssI	 (Koskiniemi	 et	 al.,	 2013;	 Shneider	 et	 al.,	 2013;	 Hachani	 et	 al.,	 2014).	 B.	





such	 putative	 effector	 (Figure	 6.1A).	 Two	 proteins	 encoded	 by	 genes	 located	
immediately	 downstream	 of	 BCAL1298	 (i.e.	 BCAL1299	 and	 BCAL1300),	 were	
identified	as	candidate	BCAL1298	immunity/antitoxins.	
BLASTP	 searches	 of	 the	 genus	 Burkholderia	 revealed	 that	 proteins	
corresponding	to	BCAL1298	occur	in	only	a	handful	of	other	strains	(Section	3.9.2.3)	
and	 this	 did	 not	 include	 other	 B.	 cenocepacia	 strains.	 However,	 in	 strain	 B.	
cenocepacia	 H111,	 the	 ~6.5	 Kbp	 region	 located	 downstream	 of	 I35_1211	
(corresponding	 to	 BCAL1297	 in	 J2315)	 is	 not	 annotated	 as	 containing	 any	 ORFs	
apart	from	I35_1212,	which	corresponds	to	part	of	the	J2315	BCA1298	ORF.	In	the	
H111	 annotation,	 the	 translation	 initiation	 codon	 of	 I35_1212	 (a	 rarely	 used	 TTG	
codon)	 corresponds	 to	 the	 Leu91	 codon	 of	 the	 protein	 encoded	 by	 BCAL1299	 in	
J2315.	 BLASTX	 analysis	 of	 the	 unannotated	 region	 of	 H111	 has	 shown	 that	 ORFs	
corresponding	to	BCAL1298,	BCAL1299,	and	BCAL1300	are	present	downstream	of	
I35_1211	 (our	 unpublished	 observations).	 As	 they	 are	 unannotated	 (or	
misannotated	 in	 the	 case	 of	 I35_1212)	 these	 ORFs	 shall	 be	 referred	 to	 as	
BCAL1298H,	BCAL1299H	and	BCAL1300H	hereon	 (Figure	5.1A),	where	BCAL1299H	
and	 BCAL1300H	 correspond	 to	 putative	 immunity	 proteins	 for	 the	 product	 of	
BCAL1298H.	
The	proteins	encoded	by	BCAL1298H,	BCAL1299H	and	BCAL1300H	are	not	




















       # 
SPy_0712/87-252          1 -------------------------------------------------KDVR------- 
lp_0688/161-295          1 -----------LSTSQGA---WQQYGNLDSLNRVTAANALLNQSLMPK--AER------- 
BN636_00118/102-236      1 ----------TSSLLAND---FMLLSEFDDLGRCGMAISCLSLNTMPT--EKR------- 
HMPREF9243_0038/135-27   1 ----------SELELTTA---YANYGDLDFLQRVTGAEGLLGMELMPD--DAR------- 
EUS_10090/115-256        1 ---------SATELTTTG---YEKYSDLDSLGRCGVALASCGRDTMPGANETR------- 
EUBREC_2922/102-239      1 -----------SDMTTTA---FENYSDLDSLGRCGVAYANICRDIMPT--EER------- 
OBV_09180/54-191         1 -----------ADLTTTS---FESYSELDGLGRCGVAYACVSTDTMPT--EER------- 
Acfer_1673/78-215        1 -----------KDKTRKS---FERYSELDSLGRCGPAYANVGRETMPT--QKR------- 
LOC100162290/43-179      1 TESMVTCKNGKSVSVTTG-----------VKGELYALS---TTRTSFSGDK--------- 
LOC100572193/61-175      1 ------------------------------------AG---APRRSFNSDK--------- 
Exig_0300/104-237        1 -----------NVVVNIGFGDREYWAFTNEHAQLVKVV---AKKITLQNDAEE-TTSSGR 
Awo_c08100/62-196        1 ----------PNVVVDIGFGDREYYGYTNEYGQLIKVT---AAKIILQDETKEPVLSMGR 
DAPPUDRAFT304464/3-134   1 --------NDKSVKVKV-------LEKKNEYRKVYAVV---RSENFGNGSTVS------ 
Hoch_1403/91-222         1 ----------RSTWYSI----TGEHYYIDSKGRPSKAY----AYLPPAITEAR------- 
BHWA1_01227/45-173       1 ----------PNIKYNI----NGTLYSTDKQSRIYKVI---RKENLILSNAKR------- 
Tresu_0751/336-464       1 ----------PNIKYSVG--EHKYLYETDEFGRICNCS---ADELHLKKHLER------- 
BCAL1298H/226-364        1 ---------------IL---RNGYSYEFDAQGRVSKVG----GKLKLNKTQGR------- 
DO62_782/230-368         1 ----------------L---RNGYSYEFDAQGRVSKVG----GKLKLNKTQGR------- 
SAOUHSC_00268/472-604    1 ----------ANIEYTT---PTGHIYRTDHKGRIKEVY---VDNLSL-KDGDR------- 
Clole_3717/582-709       1 ----------SNVEYID---SNGYKYVTDDKGRISNVQ----GNLQL-GEGVR------- 
BSU06812/525-655         1 ----------PNIIYKT---KEGYTYTTDNYGRITSVK----ADLQL-GEAKR------- 
                                                          H                       N                      
                                                         +* ++    +      +        # 
SPy_0712/87-252          5 -TKINYDPVGWHNYQFPYGDGSKSSWVMNRGHLVGYQFCGLNDEPRNLVAMTAWLNTGAY 
lp_0688/161-295         38 E-ALNVRPTGWHNKR------ISSGWLYNRSHLIGYQLTGQNNNIKNLMTGTRSLN---- 
BN636_00118/102-236     39 D-SPRYNPTGWKSVQYD------GKYLYNRSHLLGFQLTGDGSTPENLITGTRHFN--- 
HMPREF9243_0038/135-27  39 EPLTSVTPTGWRQKSYV---NVPGGWLYNRCHLIGYQLTGENANAKNLMTGTRWFN---- 
EUS_10090/115-256       42 GSISSIKPSGWIQAKYN---GISGGYLWNRCHLIGWQLSAENANRKNLITGTRYMN---- 
EUBREC_2922/102-239     38 GKIGMIKPSGWHTVKYD---VIKDRYLYNRCHLIGYQLAGENANPKNLITGTRYLN---- 
OBV_09180/54-191        38 GSIGQIKPTGWHTVKYD---CIDGKYLYNRCHLIGYQLTAENANEKNLITGTRYLN---- 
Acfer_1673/78-215       38 GPIGSVKPSGWQTVKYE---GIDGKYLYNRCHLIGYQLTAENANPKNLITGTRYLN---- 
LOC100162290/43-179     38 ---WKRRMA----E-------LDRESDDEQGHVVASVFGGP-VETWNLVPQHRSVNRKIN 
LOC100572193/61-175     13 ---RFLAMDGIKNP-------TDKIDADERGHLVASTIGGPPDDTWNMVPQRTSVNRKIS 
Exig_0300/104-237       46 YYSDEAKVPG------------VESPQLDEGHVIADSLGGVSN-AYNITPQDSTLNR--- 
Awo_c08100/62-196       48 YYSDEAKVPG------------VESPTLDEGHVIADSLGGVSN-AYNITPQDSTLNR--- 
DAPPUDRAFT304464/3-134  36 INNEQK------KQ-------LGIDGDYHAGHIIAKMLGGSGSDVNNLVPMHKSFN---- 
Hoch_1403/91-222        36 NSSCQASVGQWGDA-------ANPGTDYDGGHLIGSQLGGWGA-RANLVPQQSNFN---- 
BHWA1_01227/45-173      37 NNYAQRKVVEL----------YGIKDHDQGGHIIGRQFGGSPN-IDNLIPINKKLN---- 
Tresu_0751/336-464      39 LKHNPNTPG--------------KLGGDHAGHLIADVFGGSPE-LDNIVSQAKDVN---- 
BCAL1298H/226-364       32 NVKAQREAGG-----------VDRLPDDQGGHYIGRRFDGPTD-DFNHFAQNGNFN---- 
DO62_782/230-368        31 NVKAQREAGG-----------VDRLPDDQGGHYIGRRFDGPTD-DFNHFAQNGNFN---- 
SAOUHSC_00268/472-604   37 NSHAQRTVGG-----------EDRLPDDDGGHLIARMFGGSKD-IDNLVAQSKFINRPFK 
Clole_3717/582-709      36 NEYAQRTVGG-----------VDRLPTDDGGHLIGSQFNGSGQ-IDNLVPQNSSINR--- 
BSU06812/525-655        36 NQYAQTNAGKP----------QDRKPDDDGGHLIATQFKGSGQ-FDNIVPMNSQINR--- 
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                                         # 
SPy_0712/87-252         64 SGANDSNPEGMLYYENRLDSW--LALHP----DFWLDY--KVTPIYSGN-EVVPRQIELQ 
lp_0688/161-295         87 -------DPEMTTYENQVAAY--LKESP----KNYVRY--QVTPIFKGN-ELLARGVQMR 
BN636_00118/102-236     88 -------TQSMIKLENQVASY--IKKSG-----NHVTF--RVTPVFYKN-ELVARGVIME 
HMPREF9243_0038/135-27  92 -------TEGMLPIENYVAAY--IEETN-----HHVRY--RVTPVFNQF-NQLASGVYME 
EUS_10090/115-256       95 -------IEGMLPFENMVADY--IKETN-----HHVAY--RVTPIFEGN-NLVCSGVQIE 
EUBREC_2922/102-239     91 -------VEGMLPFENLVADY--VNNTG-----NHVLY--RVTPMFSGS-NLVANGVLIE 
OBV_09180/54-191        91 -------VDGMLPFENMVADY--IKETD-----NHVLY--RVTPIFDGD-NLVASGVLME 
Acfer_1673/78-215       91 -------VTGMLPFENMVADY--VKETN-----HHVLY--RVTPIFQEN-DLVARGVQME 
LOC100162290/43-179     83 AQS--SLLNRWDEFEKWTREQLGKKNG------APVKF--TIKIKYATKNGCRPIGFEID 
LOC100572193/61-175     63 KES--NLMGRWDEFETWMVEEIKRK--------KTVYF--TIEVIYERASGCRPVSFKVD 
Exig_0300/104-237       90 -------HGDQAYMENTIRKAGA-----------VTDF--EATITYPDTTTQIPSHYHYT 
Awo_c08100/62-196       92 -------HGDQAYMEKVIRDAGG-----------CSNF--TAVITYPNTTTQIPNHYSYT 
DAPPUDRAFT304464/3-134  79 -------NSAYKSFEFEVRKM--IEDSEKFYPGKQVEARITVSLFYNQG-SNKPYR--IK 
Hoch_1403/91-222        84 -------RGNYVQLENKMANCDGLSSGR-------MLY--SVTVSYPSSSTLIPSNWNVF 
BHWA1_01227/45-173      82 -------IGEMRKTEMEWRES--IING-----DEINDI--VIDIKYIYT-NMRPNIIIIN 
Tresu_0751/336-464      80 -------LKQYREIEREWEKA--LKKVP---PDEITDL--KIEILYDGN-GARPTAFKIE 
BCAL1298H/226-364       76 -------NGAYKSLENSWQRS--IEQG-----K-SVEV--EIAPTYAGE-SLRPSAITVR 
DO62_782/230-368        75 -------NGAYKSLENSWQRS--IEQG-----K-SVEM--EIAPTYAGE-SLRPSAITVR 
SAOUHSC_00268/472-604   85 E------KGHWYNLEKEWQEF--LNSGK---E--VKNI--KMEVKYSGN-SQRPTIFKVE 
Clole_3717/582-709      81 A------GGEWYKMEKRWADA--LKEG-----S-SVNV--NITPIYEGG-SVRPSVFKVD 
BSU06812/525-655        82 S------GGKWYEMEQEWAKA--LSKKP---PK-KVAV--QIEPVYSGD-SLRPSYFDVT 
 
SPy_0712/87-252        115 YVGIDSSGELLTIRLNSNKESIDENGVTTVILENSAPNINLDYLNGTATPKN 
lp_0688/161-295        131 GQSVG----------------------------------------------- 
BN636_00118/102-236    131 AYSVE----------------------------------------------- 
HMPREF9243_0038/135-27 135 GYSIE----------------------------------------------- 
EUS_10090/115-256      138 AYSVE----------------------------------------------- 
EUBREC_2922/102-239    134 AKSVE----------------------------------------------- 
OBV_09180/54-191       134 AESVE----------------------------------------------- 
Acfer_1673/78-215      134 AWSVE----------------------------------------------- 
LOC100162290/43-179    133 ATSKA----------------------------------------------- 
LOC100572193/61-175    111 GRSSA----------------------------------------------- 
Exig_0300/104-237      130 YTLRG----------------------------------------------- 
Awo_c08100/62-196      132 YTLK------------------------------------------------ 
DAPPUDRAFT304464/3-134 127 YDVAMY---------------------------------------------- 
Hoch_1403/91-222       128 IKDQA----------------------------------------------- 
BHWA1_01227/45-173     125 YDIEK----------------------------------------------- 
Tresu_0751/336-464     125 YCING----------------------------------------------- 
BCAL1298H/226-364      118 QWIDGVPSDPIKFGNNIGGKLN------------------------------ 
DO62_782/230-368       117 QWIDGVPSDPIKFGNKIGGKLN------------------------------ 
SAOUHSC_00268/472-604  129 YEING----------------------------------------------- 
Clole_3717/582-709     124 YWIDG----------------------------------------------- 




(A)	 The	 labelled	 BCAL1291-BCAL1300	 gene	 cluster	 from	 B.	 cenocepacia	 J2315	 and	
corresponding	 cluster	 in	 H111,	 with	 the	 addition	 of	 unannotated	 BCAL1291,	 BCAL1292,	
BCAL1298,	 BCAL1299	 and	 BCAL1300	 related	 genes,	 described	 using	 the	 J2315	
nomenclature	with	H	suffix.	BCAL1298	and	BCAL1298H	are	drawn	with	different	C-terminal	
colourings	to	illustrate	the	difference	in	the	nuclease	domain	at	the	CTD	of	each	encoded	
protein.	 Corresponding	 putative	 immunity	 proteins	 encoded	by	BCAL1299	 and	BCAL1300	
and	 BCAL1299H	 and	 BCAL1300H	 are	 also	 shown.	 (B)	 The	 domain	 organisation	 of	 the	
product	 of	 BCAL1298H,	 characteristic	 feature	 of	 the	 domains	 are	 as	 indicated.	 (C)	 An	
alignment	 of	 the	 C-terminal	 domain	 (red	 font)	 encoded	 by	 BCAL1298H	 with	 diverse	
members	 of	 Endonuclease_NS2	 domain-containing	 proteins,	 including	 experimentally	
characterise	Spd1	protein	 from	S.	pyogenes	 (SPy_0712).	Predicted	 residues	 important	 for	
catalysis	(red	*),	metal	iron	coordinating	(blue	#)	and	other	conserved	residues	within	the	
active	site	region	(orange,	+)	are	shown.	Alignment	performed	using	Clustal	Omega.	Black	






domain	 (pfam14410)	 at	 the	 C-terminus	 of	 the	 protein,	 amino	 acid	 sequence	
analysis	of	the	product	of	BCAL1298H	identified	a	predicted	DNA/RNA	non-specific	
endonuclease	2	domain	(Endonuclease_NS_2,	pfam13930)	in	the	C-terminal	region	
of	 the	 protein.	 Yet,	 the	 N-terminal	 regions	 of	 the	 two	 proteins	 are	 virtually	
identical.	This	domain	arrangement	is	illustrated	in	Figure	5.1B.		
Interestingly,	 the	 two	 nuclease	 domains	 uncovered	 do	 however	 belong	 to	
the	 same	 domain	 clan,	 the	 His-(ββα)-Metal	 finger	 endonuclease	 (Cl0263),	 as	
classified	by	the	Pfam	database	(Finn	et	al.,	2014).	These	proteins	are	defined	by	a	
conserved	 histidine	 residue	 and	metal	 binding	 residues	 within	 a	 (β)βα	 structural	
fold	(Andreeva	et	al.,	2007).		
Due	to	their	predicted	enzymatic	function	and	association	with	tssI	clusters	
it	 was	 decided	 to	 name	 these	 proteins	 T6SS	 associated	 nucleases,	 Tan.	 It	 is	
proposed	 that	 this	 group	 should	 encompass	 T6SS	 effectors	 that	 contain	 nuclease	
domains	 from	 this	 defined	 clan	 of	 His-Metal	 finger	 endonucleases,	 including	 the	
‘HNH/ENDO	VII	superfamily	nuclease	with	conserved	GH-E	residues’	of	BCAL1298	in	
J2315	and	the	‘Endonuclease_NS_2’	of	BCAL1298H.	BCAL1298	will	be	referred	to	as	
a	 type	 A	 Tan	 (TanA)	 and	 BCAL1298H	 as	 a	 type	 B	 Tan	 (TanB)	 from	 herein.	
Furthermore,	 as	 an	 unannotated	 BCAL1298	 gene	 homologue	 is	 found	 in	 the	 B.	
cenocepacia	 K56-2	 strain,	 an	additional	 superscript	 to	distinguish	 the	orthologues	
between	 strains	 will	 be	 included	 e.g.	 TanAJ	 and	 TanAK	 for	 J2315	 and	 K56-2,	
respectively.	The	protein	product	of	BCAL1298H	will	 thus	be	 referred	 to	as	TanBH	






TaaA2J,	 TaaB1H	 and	 TaaB2H,	 encoded	 by	 BCAL1299,	 BCAL1300,	 BCAL1299H	 and	
BCAL1300H,	respectively.	Again	for	simplicity,	the	genes	will	thus	be	referred	to	in	a	





et	 al.	 2014).	 The	 toxin_43	domain	 (with	 a	 conserved	HxxD	motif)	 central	 to	 their	
superfamily	has	an	all	α-helical	arrangement,	therefore	does	not	fall	under	the	His-
(ββα)-Metal	finger	clan.	
An	 alignment	 of	 the	 C-terminal	 domain	 of	 TanBH	 with	 other	
Endonuclease_NS_2	domain-containing	proteins	highlights	conserved	residues	that	
are	 likely	 to	be	 important	 for	 the	 function	of	 the	enzymatic	domain	 (Figure	5.1C).	






thought	 to	 follow	 the	 general	 principle	 of	 nucleotide	 hydrolysis	 in	 endonucleases	
(Friedhoff	 et	 al.,	 1999)	 (Section	 3.4.2.3).	 These	 described	 residues	 are	 widely	
conserved	 in	 the	 Endonuclease_N2_2	 domain,	 including	 the	 domain	 in	 TanBH	
(Figure	6.1C).	Thus,	the	corresponding	residues	identified	in	TanBH,	Arg256,	His277,	
Asn300,	and	Glu308	are	likely	to	important	for	catalysis	and	metal	ion	coordination.	
Relatively	 conserved	 glycine	 residues	 (Gly276	 and	 Gly280),	 an	 isoleucine	 residue	
(Ile279)	and	a	further	asparagine	residue	(Asn291)	may	also	be	important.			
Comparison	of	TanAJ	and	TanBH	with	the	few	other	Burkholderia	strains	that	
encode	 a	 similar	 protein	 showed	 that	 the	 B.	 pseudomallei	 strain	 BDD	 protein	
(D062_782)	has	an	NTD	and	CTD	that	is	orthologous	with	that	of	TanBH	while	in	the	
only	other	B.	pseudomallei	strain	to	possess	a	related	protein	(MSHR7500)	the	CTD	
of	 the	 putative	 effector	 (X976_1941)	 belongs	 to	 the	 HNH/Endo	 VII	 GH-E	
superfamily,	 a	 TanA,	 yet	 the	 NTD	 is	 similar.	 One	 strain	 of	 B.	 vietnamiensis	
(LMG10929)	and	many	other	species	outside	the	genus	encode	a	protein	that	also	
has	a	 similar	NTD,	but	 it	 is	appended	 to	different	 toxin	domains.	This	 includes	an	




	 	 	 	 	 	      NTD	
S70_18055/124-342    1 ----GNTIGIITHI------ALTDNQEVGNANPIVTSEGQEETEVISQILNQAINQIPST 
GHAL_1579/119-348    1 -----NTTGLIIGQ------PPKAAIPASEADPAPKPETKEEQSIWDRML---------- 
SBG_1846/120-349     1 -----NTTGLIIGQ------PPVAADSVSKADPAPEPETKEEQSIWDTML---------- 
V_PARA/119-350       1 -----NTTGLIIGQ------PPAAAIPVSEADPAPEPETQEEQSIWDMML---------- 
ROD_20761/101-276    1 ----GNTLGKIVGQ------PPAGSVSARNANPAVTPETDEEKSFWDKAG---------- 
H_RUBRI/117-273      1 ----GGNNPGIYTTAQVPNGGIANGAPTKNTDPPIKAETPQEKS---------------- 
AK36_2612/1-245      1 MGDKGNTVGRLYGQ------ASMSSAPASSANPPVKAETPEEEGWFS------------- 
BCAL1298/1-232       1 MGDKGNTVGRLYGQ------ASMSSAPASSANPPVKAETPEEEGWFS------------- 
BCAL1298H/1-228      1 MGDKGNTVGRLYGQ------ASMSSAPASSANPPVKAETPEEEGWFS------------- 
 
 
S70_18055/124-342   51 QSESTKWILETQKKVRKTVNDLADDPIGGAIGAGKQFYNDIVDIGELLVTGLHYYSAFES 
GHAL_1579/119-348   40 -----MIQM----EQNRLEIDTAPLKVQMTIGFIKAIWNQIPDIATMLIQGSNLQYGGEM 
SBG_1846/120-349    40 -----MIQT----DQSRAQIEAAPVLLDITIGAAKAFWNQFPDLATILGQGAAMQSAGEM 
V_PARA/119-350      40 -----MIQM----DQNRAQIEAAPAQLDMTIGAAKAFWNQFPDLATMLGQGAVMQSAGEM 
ROD_20761/101-276   41 -----EWFS----EQGENIGEALTHPVEGVKGAAKGLWNMVPDMGTMLAQGNTYQTAGEM 
H_RUBRI/117-273     41 ------WWD----RTKDEVSEAVQHPWEATKGAVKGILNIPSDIGEMLMKGATLQSAGEM 
AK36_2612/1-245     42 -----KWWG----NTKHELSEAADHPWEATKGAVKGIANIPSDIGELLIKGSTLQTAGQM 
BCAL1298/1-232      42 -----KWWG----NTKHELSEAADHPWEATKGAVKGIANIPSDIGELLIKGSTLQTAGQM 
BCAL1298H/1-228     42 -----KRW--------HEVSEAAHHPWEATKGVVKGVANIPSDIGELLIKGSTLQTAGQM 
 
 
S70_18055/124-342  111 IKLAIIGKIFGIDSLADYAIKNAKNSLESAKNTDLDHLKAELTTPAENAGASIYEVASYA 
GHAL_1579/119-348   91 QMNAAILSAMGMDKMGESENQMGKEVMAHAGDFNLDKYRLEMSNETQKVGGRMFDYGSLV 
SBG_1846/120-349    91 QMNGAMLSAMGMDEMGEAQYRMGEEVMAHAGDFNLDEYRLKMSNRNQEIGGMAYDYGSLV 
V_PARA/119-350      91 QMNGAMLSVMGMEEMGEEQYQMGGEVMEHAGDFNLDEYRLKMSNRNQEIGGMAYDYGSLV 
ROD_20761/101-276   92 EQSAALMRLFDQSQQAEKMTGLAQDIREHAGEVNFNNYRLEMSNKAQEGGDLIATMASMV 
H_RUBRI/117-273     91 EQAAAMQSLFGQTKSAQELMQTAQEVRSSANAVEVPR--FQMSNPAQAGGDKIVTAASLL 
AK36_2612/1-245     93 EQAAAMQSVFGQTQSAEALTQGAQEVRASAGSVELPK--FKMSNAAQAGGDKIVTAVSLA 
BCAL1298/1-232      93 EQAAAMQSVFGQTQSAEALMQGAQEVKASAGSIELPK--FQMSNAAQAGGDKIATAASLL 
BCAL1298H/1-228     89 EQAAAMQSVFGQTQSAEALTQAAQEVKASAGSIELPK--FKMSNPAQAGGDLIATVASLA 
                 Interlinker 
 
S70_18055/124-342  171 T---GAGGLAKATVKTTAKTVKKANKARKDLDVPMGDISTPPSAGGTIKGKGKDNLNTPE 
GHAL_1579/119-348  151 F---AGYGLLKVGFTGLKAMRAVSELAREEAA--AGK---FTADLLKLD-KAGDAAKDTE 
SBG_1846/120-349   151 L---GGYGLARGGFMGLKTMRTASKLVHEGEA--GGK---FAAHMMKMD-NAEDAATDAE 
V_PARA/119-350     151 L---GGYGLARGGFMGLKAMWAASKLAREEAA--AGK---FAANMLKMD-KTGDAATDAE 
ROD_20761/101-276  152 TPAGWGKGILKTGKRVVKSGGKVRARGVV---------------------QSRINIANGQ 
H_RUBRI/117-273    149 A---GGAGIVRSGVRGVSALGKTAAAASEGAG--AAK---EASAAAKAL-GSEKALADEA 
AK36_2612/1-245    151 A---GGAGIVKGGIRGVAALGKVGAA--EGAE--LSK---TAAATGKVL-QAEGTIAEGT 
BCAL1298/1-232     151 A---GGAGLAKGGVRGMAALGKVGAA--EGAE--LTK---TASAAGKVL-KTEGAVAEGA 
BCAL1298H/1-228    147 A---GGAGLAKGGIRGMAALGKVGAA--EGAE--LTK---TASAAGKVL-KTEGAVAEGA 
                              Interlinker  
 
S70_18055/124-342  228 KTPEPPQTKINEDS--QKTKSSDGGKNNKNDD--------------------- 
GHAL_1579/119-348  202 KLADNV-------IPEGQDGANVSGEIEGTGESQGV----------------- 
SBG_1846/120-349   202 KLADDV-------VPEGRDGANIKGETQGNGDRGDG----------------- 
V_PARA/119-350     202 KLVDDV-------VPEGQDGANIKGKTQGNGDESDCVG--------------- 
ROD_20761/101-276  191 TRFTPT-RKTGEPVSAGFDHVLEGHFNRPLANSRSIFSVSPDRLKQILQSP-- 
H_RUBRI/117-273    200 AKATGTTAEAGKT---GAALKEEAAVAQPAGDGIKIVKR--ERLKPGTPE--- 
AK36_2612/1-245    200 KTADAT-ADAAKA---T-TATEGGGTGKVSGDGAKVEKL--PPLRQAYVDEVN 
BCAL1298/1-232     200 KAADAP-TAVGKA---T-GATEGAGAGDAVGDGAKVLR--------------- 




T6SS	 genes.	 BLASTP	 searches	 were	 performed	 to	 identify	 proteins	 with	 significant	
sequence	homology	towards	the	N-terminal	domain	of	TanAJ	and	TanBH	(blue	box),	many	
of	 which	were	 located	within	 close	 gene	 proximity	 to	 T6SS	 genes.	 A	 putative	 interlinker	
region	is	indicated	in	red.	The	alignment	was	performed	using	Clustal	Omega.	Black	shading	
indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	 grey	
shading	indicates	similar	residues	at	the	corresponding	position	in	50%	of	sequences.		The	










T6SS	 accessory	 protein	 (TagA)	 encoded	 by	 BCAL1295	 and	 I35_1209	 in	 B.	
cenocepacia	J2315	and	H111.	Furthermore,	a	sequence	that	could	possibly	serve	as	
an	 interdomain	 linker	 connecting	 the	 conserved	 NTD	 to	 the	 putative	 effector	
domain	 was	 observed	 to	 be	 located	 at	 the	 C-terminal	 end	 of	 the	 NTD.	 The	
conserved	 nature	 of	 the	 NTD	 and	 the	 possibility	 of	 different	 toxin	 domains	
appended	to	it	is	typical	of	polymorphic	toxin	families	(Zhang	et	al.,	2012),	some	of	
which	are	T6SS-dependent	effectors	(Jamet	and	Nassif,	2015).		
The	 putative	 immunity	 proteins,	 TaaA1J,	 TaaA2J	 and	 TaaB1H	 encoded	
downstream	 of	 both	 BCAL1298	 and	 BCAL1298H	 have	 predicated	 analogous	
functions	but	they	vary	significantly	in	sequence	and	predicted	secondary	structure,	
as	 shown	by	 the	amino	acid	 sequence	alignment	 in	 Figure	6.3A.	Both	TaaA1J	 and	
TaaA2J	 contain	 tetratricopeptide	 repeat	 structural	 motifs	 (TPR)	 consisting	 of	 α-
helices	 that	 are	 thought	 to	 mediate	 protein-protein	 interactions	 (Section	 3.4.2,	
Figure	3.16)	 (Blatch	and	 Lässle,	1999).	However,	 TaaB1H	aligns	well	with	DUF600-
containing	proteins	 (Figure	 6.3B).	 This	 domain	 is	 thought	 to	have	 a	winged	helix-
turn-helix	structure	(PDB	entry	3i0t	and	2ia1).	
Whereas	 TaaA2J	 is	 homologous	 to	 TaaA1J,	 the	 product	 of	 BCAL1300H	
(TaaB2H)	is	distinct	from	BCAL1299H	(TaaB1H).	However,	TaaB2H	shares	some	amino	
acid	sequence	similarity	with	other	proteins	encoded	downstream	of	genes	coding	
putative	 T6SS-dependent	 DNase/RNase	 proteins	 in	 other	 bacteria	 (Figure	 5.3C),	
including	the	immunity	protein	PA0100	located	downstream	of	the	experimentally	









BCAL1299H             1 ------MNQEIIAGADDIYPQLGQLIFD-----AIPDEFSIAWVRVEMIDDVSSCGMFYK 
BCAL1299              1 MHMAMKLPEELTKDV-YAYGAAGREAWKKGDIAEAEVNFTKAWEILPEPREQYDLAQSMT 
BCAL1300              1 ---MTRLPKKIQDGL-DALSEQGNVLCDASKFDEAIQRWSAALELLPEPRVDWEAYTWLC 
 
 
BCAL1299H            50 KSNGRFQYLNIGL-----------------------------------DDVERKFAELRE 
BCAL1299             60 RGFVVFYRDTKQFDKAVHWLAEMKKAYGSGTGPDLTIGFLSGTVYFEAGDLDKSAEFFVP 
BCAL1300             57 ASIGDAQYQLEEFEAARQSFFD--ALNGPGGQENPFVHYRLGQSQVSLGDEEHGVASLLK 
 
 
BCAL01299H           75 LFKKAGREPWTGATFRLSEDGEFSIDLTYEDISDFGRASERREVWIAKYLGENPAIDWR 
BCAL1299            120 LYEQFGNRPFSGE-------DKKYLE--------FAKR---------ASKGSK------ 





                                                          DUF600	
 
Rumal_2733/4-145       1 --------IESAQKELCEYLISIMPVEWKRICYYSECTTGSRT---SWIALIEEKTGRIC 
MXAN_6294/133-199      1 ---------------------------------------GQQR---SFAATDE------- 
Vpar_1628/59-188       1 --------TRRLSNNLAEATKVMIKKNWKTIYIKAVPTGDKDA----VRFYYKDNRGQV- 
Vpar_1417/1-142        1 --------MDRYIKKIRDILIDCMPIHWYKCYLFFECTESGMS---SACYNVKTPSGSII 
bpr_II352/2-134        1 --------KNKIYQKIFEKISIYLPKEWLKIVFFAGYTEGSYS----IKFFVKNN--K-- 
BN623_01170/7-160      1 --------MKELYKEIQHSLFDMIPEKWNKIFLYASVIDGRNSLETGEMYFYYIPKGILK 
L681_09515/1-136       1 MDERLTSALSALYHRIGQSLIDAVPTDQCGIWLNFEIIKNVWS---GWAFY-RKPSGS-- 
BCAL1299H/11-128       1 ----------DIYPQLGQLIFDAIPDEFSIAWVRVEMIDDVSS---CGMFY-KKS----- 
Clole_3716/5-153       1 --------LATLYNKLADKIISMIPVKWNKIYYLGEVEKGKLS---WSSVFYFEEINS-- 
OB04_00762/8-141       1 ----------DLYQRIANQINEIIPSEWDNVYLYAEILDDSS-----EVYFYFNIPGE-- 
SEVCU118_0366/63-145   1 ------------------------------------------------------------ 
SAOUHSC_00276/7-152    1 --------ISKLYNEIANEISSMIPVEWEKVYTMAYIDDGGG-----EVFFNYTKPGS-- 
                                                   
                                             DUF600 
 
Rumal_2733/4-145      50 TQEAF------WKRYTSYPYDEMKAYVMLNKLTRNLYNAYLEKFGEDKIWCTYYLTIESD 
MXAN_6294/133-199     12 ---------------VTDAFDELR-------------TRMATLSKNGHDWHTATLTITAD 
Vpar_1628/59-188      48 ----YNGQVIRNTGLSKGKYMAGSL--HQTEALQELVNHLQ--QNGQEVPSSIDIIITQE 
Vpar_1417/1-142       50 TDGD------LLYNCNDEKVKSIKA--GTSEIL-TYVRLLH--EASTEQWTWGTMYISRD 
bpr_II352/2-134       45 HDYVDCFALP---GISKTELIKLFM--DIDKILSA--------DRKDQGWSIFTMIIDNT 
BN623_01170/7-160     53 REPVNVYEVPNKFNLEENSYFKMAD--DLYGIIKKLRKEYI--AINGVLWTNIVISIA-D 
L681_09515/1-136      55 Y-----------------GYLEIPD--DAEAALLEMHQLFA--QWHHALWTSLTFHLDPE 
BCAL1299H/11-128      42 ------NGRF-------QYLNIGLD--DVERKFAELRELFK--KAGREPWTGATFRLSED 
Clole_3716/5-153      48 KEIVKSHGIPEKYNVSEKIYDELLD--ELDVILIEIYDCFI--KNNQEPWEQLSFELDMA 
OB04_00762/8-141      44 NEFLYSHNIPEYFNVSEDIYDDLLI--ELQESFEELREEYK--ENNPETWTNLTLKLDRT 
SEVCU118_0366/63-145   1 -----------LYNVSSDIYIDLLI--EVQEKFRKLRAIFK--KENQEPWTSCEFDFSNE 
SAOUHSC_00276/7-152   46 EDLNYYTDIPKEYNVSVQVFDDLWM--DLYDLFKNLRNLFK--EEGLEPWTSCEFDFTRD 
                                        	DUF600 
 
Rumal_2733/4-145     104 Y-TFHVDFGYEM-PEGDIVEQHDAVFEKFFNTKYEYLEGKY------------ 
MXAN_6294/133-199     44 G-KFAFDFNYDDLPQLEVVPICRQM---------------------------- 
Vpar_1628/59-188     100 GYRIKTIFNYNEDTSNLP----AYL----EQYEQQNFPT-------------- 
Vpar_1417/1-142       99 DYEPHCEFHNDPVTDDC---WLQNR----YKWEYQNFGVLAREDEFEPDIY-- 
bpr_II352/2-134       92 G-KIEVEFEYDEHSEDLI----TYE----ENWREKYLKQIRNKLVKIIYLN-- 
BN623_01170/7-160    108 Y-TFKVEYGFENLATSPY-SNYDRH----LVFRYKYLKTGLNAYSKREKQMVL 
L681_09515/1-136      94 N-KMEIELGYEQLSEDEFIDSLGRE----QAWQDRYLGADAQIDWQ------- 
BCAL1299H/11-128      85 G-EFSIDLTYEDISDFGR--ASERR----EVWIAKYLGENP------------ 
Clole_3716/5-153     104 G-KFKIDYLYNKISNTED-DQLQRE----IIWAYETFDFKPKEGSYTRKILE- 
OB04_00762/8-141     100 G-QFSIDYNYEDVIASEL-NGSQRK----AVWVYKNLGLMP------------ 
SEVCU118_0366/63-145  46 G-KLNVSFGYIDWKNSDF-GQYDRF----NYYRYKKFGVLPELD--------- 












PA0100/1-306         1 MLKKLSPIFSNITGVVRY-QDLAYVASVSDEIQEQNIAHSYVTEWDCGTWCVAGEDDDML 
Atu3638/1-374        1 MRVRL-------TSACALSKNTFCAA--F--S--------ESEYDDMYSFILVFEGDFEQ 
BCAL1300H/1-316      1 ---------------------MFYLSSTLDEL--------EATEDTPVSWMVFYQHQTAD 
 
 
PA0100/1-306        60 PWEIVSATVV-----------HEPVEQALFLGARGQVFCMGSGD--IHEEQLPDG--DDA 
Atu3638/1-374       42 PWTRFDVPRIID--STTGRLGADGKPVVYVKSDEGDVYSLSAGEEPRHEKIEGSGVYSED 
BCAL1300H/1-316     32 KWFYHDLPAWRVVSTCYPNPAPNNVRKIYALSEQGDVESYSRDG-SVIEKIADAGL-EPV 
 
 
PA0100/1-306       105 IGGRGNMRGVACIDGVAYACGMDRQVYRRFDENDWRAIDTGAR--PPAG----------- 
Atu3638/1-374      100 AEGLGYTNRIVAINETLFVTGYHSQLYRRTG-SAWEWFHREKLPRPEAGYEYLIFGDLAG 
BCAL1300H/1-316     90 SPNYGYVTRIREIDGHLYVCGYGGQVYKRDS-AGWAHIDAQLLQKKVD------IGSIE- 
 
 
PA0100/1-306       152 -------------------------SEAVVGFEAIGGFGAREIYAVG-------WDGEIW 
Atu3638/1-374      159 SSQNDIYMNVTYSPASTTRKLTEEEEERAAELFDLGRVDEALAIHHAAEGESRVLEGRLY 
BCAL1300H/1-316    142 ------------DPSELLAALTKS-ADETIGLIDINGLDEKSIYVVG-------NDGYMA 
 
 
PA0100/1-306       180 QYDGKRWQPRESPT-------NLILTAICCAEDGSVYACGQAGTLLRGR-NDHWEIIAQD 
Atu3638/1-374      219 HWNGTDWRVVATPRSGKFYAEPATLSDILVEDSERVWAVGNNGVILFGNARDGFQDVSFK 
BCAL1300H/1-316    182 FFDGTSWTKLPKAT-------AAHLNCVMPVSADSVWVAGSKGALLKGNFQTGFSAVARK 
 
 
PA0100/1-306       232 DVDEDLWSLAWFDGALYVSSATAVYTLVGGHLKEVDFG-----DEQPQRCFHLSAADGVL 
Atu3638/1-374      279 GNDEDLRSVTRFKDRMVIASDYALHWFDGHVLSPLKPVLDPRINKSVPTPVKVQAIDDVL 
BCAL1300H/1-316    235 SLSTDFYSLAWFNDRLFIGAGDGIYELDENVPQRL--MVSDK--FSLDGVSTVEAKDGVL 
 
 
PA0100/1-306       287 WS-IAAKDIFSFDGQQWTRID--------------- 
Atu3638/1-374      339 YYFDSKHGIHTFDGTAWNEIEVPTELLERNFKGLTR 
BCAL1300H/1-316    291 WV-LASRRLARYDGAQWEVFENPHNLP--------- 
	
Figure	6.3	Alignments	of	putative	immunity	proteins	encoded	by	BCAL1299,	BCAL1299H,	
BCAL1300	 and	 BCAL1300H.	 (A)	 Alignment	 of	 the	 products	 of	 BCAL1299	 (TaaA1J),	
BCAL1299H	 (TaaB1H),	BCAL1300	 (TaaA2J).	 (B)	A	BLASTP	 search	was	performed	 to	 identify	
proteins	with	 significant	 sequence	homology	 towards	 the	DUF600	 structural	motif	 of	 the	
product	of	BCAL1299H,	indicated	in	red,	and	the	returned	sequences	were	aligned.	(C)	An	
alignment	of	 the	product	of	BCAL1300H	 (TaaB2H)	with	other	putative	 immunity	proteins,	
PA0100	 from	 P.	 aeruginosa	 and	 Atu3638	 from	 A.	 tumefaciens	 encoded	 downstream	 of	
potential	nuclease	toxins.	Alignments	were	performed	using	Clustal	Omega.	Black	shading	
indicates	 identical	 residues	 at	 the	 corresponding	 position	 in	 50%	 of	 sequences,	 grey	
shading	indicates	similar	residues	at	the	corresponding	position	in	50%	of	sequences.		The	











Taking	 these	 observations	 together	 it	 was	 decided	 to	 characterise	 the	
product	 of	 BCAL1298H,	 TanBH:	 to	 verify	 the	 predicted	 enzymatic	 function	 of	 the	
purified	protein	as	a	nuclease	by	in	vitro	methods;	to	determine	the	inhibitory	role	
of	the	candidate	immunity	proteins	TaaB1H	and	TaaB2H	encoded	by	BCAL1299H	and	























 Cloning	 of	 the	 tanBH	 and	 tanBH.CTD	 coding	 regions	 into	 a	6.2
high	level	expression	vector	
To	 facilitate	 the	 overproduction	 and	 purification	 of	 candidate	 T6SS-
dependent	effector	TanBH	and	its	C-terminal	nuclease	domain	(CTD)	for	enzymatic	
studies,	it	was	decided	to	clone	the	coding	regions	of	tanBH	that	encoded	both	the	
full	 length	 protein	 and	 the	 CTD	 separately	 into	 an	 E.	 coli	 expression	 vector,	
incorporating	an	N-terminal	hexa-histidine-tag	 for	nickel	affinity	purification.	Note	
that	 DNA	 encoding	 the	 nuclease	 component	 of	 TanBH	 will	 be	 referred	 to	 as	
tanBH.CTD,	which	encodes	the	last	139	amino	acids	of	protein.	
	
6.2.1 Cloning	 of	 tanBH	 and	 tanBH.CTD	 in	 the	 absence	 of	 an	 immunity	
protein	
First,	the	coding	sequences	from	tanBH	and	tanBH.CTD	were	amplified	from	B.	
cenocepacia	 H111	 by	 PCR	 using	 primers	 BCAL1298ForNtermHisBamHI	 and	
BCAL1298RevHindIII	 for	 the	 entire	 open	 reading	 frame	 and	
BCAL1298CTDNtermHisForBamHI	 and	 BCAL1298RevHindIII	 for	 the	 CTD	 coding	
sequence,	to	generate	1120	bp	and	445	bp	DNA	fragments,	respectively.	Both	DNA	
fragments	 were	 purified	 (Figure	 6.4)	 and	 subjected	 to	 restriction	 digestion	 with	
BamHI	 and	HindIII.	 Each	DNA	 fragment	was	 then	 ligated	 into	pETDuet-1	digested	
with	the	same	enzymes,	that	cut	within	the	MCS	located	downstream	of	the	first	T7	
promoter,	 and	 transformants	 were	 selected	 for	 on	 LB	 agar	 containing	 ampicillin.	
Colonies	were	 screened	 by	 colony	 PCR	 using	 vector	 specific	 primers	 pETDuet-T7-
1for	 and	 pACYCDuet-T7-1rev	 to	 identify	 the	 desired	 clones.	 Unexpectedly,	 the	
success	 rate	 for	 the	 recovery	 of	 positive	 clones	was	 significantly	 lower	 than	was	
obtained	 when	 cloning	 other	 genes	 into	 this	 vector.	Moreover,	 the	 recombinant	
clones	 that	were	 identified,	 for	 both	 the	 full	 length	 and	 the	CTD,	 contained	base	
pair	substitution	mutations	or	deletions	resulting	in	mutants	than	contained	either	
early	stop	codons,	 frame	shifts	or	amino	acid	changes	 in	regions	 in	or	around	the	




















Figure	 6.4	 Amplification	 of	 DNA	 fragments	 corresponding	 to	 tanBH	 and	 tanBH.CTD.	
Diagram	showing	electrophoretic	analysis	of	products	from	the	amplification	of	tanBH	and	


























E.	 coli	 strain	 that	 lacks	 T7	 RNA	 polymerase),	 some	 leaky	 transcription	 was	 still	
occurring	 thereby	 selecting	 against	 plasmid	 clones	 expressing	 an	 intact	 copy	 of	
tanBH.		
In	 one	 of	 the	 tanBH	 clones,	 a	 single	 base	 change	 in	 the	 coding	 sequence	
resulted	in	the	substitution	of	Gly276	(an	amino	acid	residue	next	to	the	predicted	
catalytic	 His277	 residue	 in	 the	 active	 site	 of	 the	 protein)	 to	 a	 negatively	 charged	
aspartate	residue.	The	failure	to	clone	an	intact	copy	of	tanBH,	presumably	due	to	
its	 toxic	 activity,	 suggests	 that	 the	 G276D	 derivative	 has	 decreased	 or	 abolished	




An	 alternative	 approach	 used	 to	 facilitate	 cloning	 of	 tanBH	 was	 to	 re-
engineer	 the	pETDuet-1	 vector	 by	 inserting	 a	 strong	 reverse-orientated	promoter	
downstream	of	 the	 second	MCS	 (Figure	 6.5).	 This	was	 postulated	 to	 dampen	 the	





Tp	 as	 an	 EcoRI	 fragment,	 filled-in	 with	 Klenow	 fragment	 and	 then	 inserted	 into	
pETDuet-1	 via	 a	 filled	 in	 XhoI	 site,	 to	 give	 pETDuet-Tp.	 The	 resulting	 vector	 was	
selected	 for	 on	 IST	 agar	 containing	 ampicillin	 and	 trimethoprim.	 Positive	 clones	
giving	a	plasmid	size	of	approximately	6036	bp	were	identified	by	manual	plasmid	
minipreparations	 (Figure	 6.6).	 Due	 to	 the	 non-directional	 cloning	 nature	 of	 this	
approach,	 the	 orientation	 of	 the	 inserted	 dfr	 gene	 had	 to	 be	 determined	 by	





























pETDuet-1	 was	 digested	 with	 the	 restriction	 enzyme	 XhoI,	 and	 5’	 ends	 filled-in	 using	
Klenow	fragment.	The	dfr	gene	(TpR)	was	excised	from	p34E-Tp	as	an	EcoRI	fragment,	filled	
in	 with	 Klenow	 fragment	 and	 ligated	 into	 XhoI-cut	 pETDuet-1	 to	 generate	 the	 vector	
pETDuet-Tp.	 Clones	were	 selected	 for	 trimethoprim	 and	 ampicillin	 resistance.	 Constructs	




















Figure	6.6	 Size	analysis	of	pETDuet-Tp	 candidate	 clones.	Diagram	showing	plasmid	mini-
preparations	 of	 candidate	 pETDuet-Tp	 clones,	 selected	 after	 blunt	 ligation	 of	 dfr	 into	




























































	 Many	 T6SS-effectors	 have	 cognate	 immunity	 proteins	 that	 are	 usually	
encoded	directly	downstream	of	the	effector.	taaB1H	and	taaB2H	were	identified	as	
genes	 encoding	 potential	 TanBH	 immunity	 proteins.	 It	 was	 postulated	 that	 the	
presence	of	the	genes	of	either	or	both	 immunity	proteins	would	allow	cloning	of	
tanBH.	 Therefore	 both	 taaB1H	 and	 taaB2H	 were	 amplified	 separately	 from	 B.	
cenocepacia	 H111	 (Figure	 6.8),	 using	 primers	 BCAL1299ForNdeI	 and	
BCAL1299RevAcc65I,	and	BCAL1300ForNdeI	and	BCAL1300RevAcc65I,	respectively.	
DNA	fragment	sizes	of	435	bp	for	taaB1H	and	971	bp	for	taaB2H	were	produced	as	
expected.	 These	 fragments	 were	 purified,	 digested	 with	 NdeI	 and	 Acc65I,	 and	
ligated	 into	 the	second	MCS	of	pETDuet-1	cut	with	 the	same	restriction	enzymes,	
generating	pHLS1	(for	taaB1H)	and	pHLS2	(taaB2H),	with	expected	sizes	of	5790	bp	
and	 6325	 bp,	 respectively.	 Positive	 clones	 were	 identified	 by	 colony	 PCR	 using	
vector-specific	 primers	 pACYC-T7-2for	 and	 T7rev.	 Plasmid	 clones	 that	 generated	





(Figure	 6.10).	Desired	 clones	 containing	 tanBH	 and	 tanBH.CTD	were	only	 obtained	
with	 the	 pHLS1	 recipient	 plasmid,	 generating	 co-expression	 plasmids	 pHLS3	
(containing	tanBH	and	taaB1H)	and	pHLS4	(containing	tanBH.CTD	and	taaB1H),	which	
suggests	TaaB1H	is	the	main	immunity	protein	for	TanBH,	not	TaaB2H.	
tanBH	 was	 also	 successfully	 cloned	 when	 inserted	 into	 pETDuet-1	 as	 a	
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insertion	of	taaB1H	 into	pETDuet-1	as	an	NdeI-Acc65I	 restricted	PCR	product,	 to	generate	
the	plasmid	pHLS1.	pHLS1	was	then	digested	with	BamHI	and	HindIII	and	the	PCR	amplified	















primers	 BCAL1298NtermHisForBamHI	 and	 BCAL1299RevAcc65I,	 and	 inserted	
between	 the	 BamHI	 and	 Acc65I	 restriction	 sites	 of	 pETDuet-1,	 generating	 the	
plasmid	pHLS5,	with	a	size	of	6711	bp.	
	





DNA	 fragment	 containing	 the	 coding	 region	 of	 taaB1H	 was	 amplified	 from	 B.	
cenocepacia	 H111	 (Section	 6.2.3)	 and	 the	 resulting	 DNA	 fragment	 was	 inserted	




IST	 agar	 containing	 ampicillin	 and	 trimethoprim	 was	 used	 for	 selection	 of	
transformants.	 This	 allowed	 successful	 cloning	 of	 both	 tanBH	 and	 tanBH.CTD	 into	
pETDuet-1.	Interestingly	the	presence	of	the	pSCrhaB2	inducer,	rhamnose,	was	not	




















Figure	 6.11	 Analysis	 of	 candidate	 pHLS6	 plasmids.	 Comparison	 of	 the	 size	 of	 candidate	

























pHLS3,	 pHLS4	 and	pHLS5	were	 transformed	 separately	 into	 the	E.	 coli	expression	
strain	BL21(DE3)	harbouring	pLysS	and	small	volumes	of	exponentially	growing	cells	
were	induced	with	1	mM	IPTG	for	4	hours	at	30°C	(Section	2.3.1).	 In	addition,	the	
plasmid	 containing	 only	 taaB1H,	 pHLS1,	 was	 subjected	 to	 the	 same	 analysis.	 The	
expected	molecular	masses	 of	 His-tagged	 TanBH	 (His6.TanBH),	 His6.TanBH.CTD	 and	
un-tagged	 TaaB1H	 are	 39.1	 kDa,	 16.9	 kDa	 and	 15.4	 kDa,	 respectively.	 SDS-PAGE	
analysis	 of	 total	 cell	 proteins	 harvested	 from	 the	 induced	 cultures	 showed	 that	
His6.TanBH,	 His6.TanBH.CTD	 and	 TaaB1H	were	 present	 in	 the	 appropriate	 plasmid-
containing	 cells	 (Figure	 6.12).	 Proteins	 migrating	 with	 molecular	 masses	
corresponding	 to	40	 kDa,	 17	 kDa	and	14.5	 kDa	were	observed.	 It	was	noted	 that	
there	was	significantly	lower	production	of	His6.TanBH	and	TaaB1H	from	the	plasmid	
containing	 bicistronic	 tanBH-taaB1H	 (pHLS5)	 in	 comparison	 to	 the	 plasmid	
expressing	tanBH	and	taaB1H	from	two	separate	promoters	(pHLS3).		
	
6.3.2 Analysis	 of	 solubility	 of	 His6.TanBH,	 His6.TanBH.CTD	 and	 TaaB1H	
recombinant	proteins	
The	 solubility	 of	 His6.TanBH,	 His6.TanBH.CTD	 and	 TaaB1H	 were	 then	
determined	 (Section	 2.3.2).	 Following	 protein	 overproduction	 and	 sonication	 of	
harvested	 cells,	 similar	 amounts	 of	 His6.TanBH,	 His6.TanBH.CTD	 and	 TaaB1H	 were	
present	 in	 both	 the	 total	 (i.e.	 uncleared)	 cell	 lysate	 and	 the	 cleared	 cell	 lysate	
(Figure	 6.13).	 This	 indicated	 that	 the	 majority	 of	 overproduced	 His6.TanBH,	




















Figure	 6.12	 Test	 expression	 of	 plasmids	 containing	 tanBH,	 tanBH.CTD	 and	 taaB1H	 for	
protein	 overproduction.	 Plasmids	 pHLS1	 (containing	 taaB1H),	 pHLS3	 (tanBH	 and	 taaB1H),	
pHLS4	(tanBH.CTD	and	taaB1H)	and	pHLS5	(bicistronic	tanBH-taaB1H)	were	 introduced	 into	
the	 E.	 coli	 expression	 strain	 BL21(DE3)/pLysS.	 Strains	 were	 then	 grown	 at	 37°C	 until	 an	
OD600	of	0.4	and	induced	with	addition	of	1	mM	IPTG	for	4	hours	at	30°C.	Uninduced	(-)	and	
induced	 (+)	whole	 cell	 lysates	were	analysed	by	electrophoresis	 in	a	15%	SDS-PA	gel	 and	
stained	 with	 Coomassie	 blue.	 Labelled	 arrows	 indicate	 the	 location	 of	 proteins	 of	 the	
















- + - + 
pHLS5 
20 
- + - + 





























Figure	 6.13	 Solubility	 of	 His6.TanBH,	 His6.TanBH.CTD	 and	 TaaB1H.	 Cultures	 of	
BL21(DE3)/pLysS	containing	(A)	pHLS3	,	(B)	pHLS4	and	(C)	pHLS1	were	induced	with	1	mM	
IPTG,	 following	 which	 cells	 were	 harvested,	 treated	 with	 lysozyme	 and	 sodium	
deoxycholate	in	the	presence	of	PMSF	for	1	hour,	followed	by	4	rounds	of	sonication	at	30	
second	intervals	and	subsequent	clearing	by	centrifugation.	This	resulted	in	a	non-cleared	
lysate	 (T),	supernatant	 (S)	and	pellet	of	 insoluble	material	 (P).	Samples	were	subjected	to	
SDS-PAGE	in	a	15%	SDS-PA	gel	followed	by	staining	with	Coomassie	blue.	Labelled	arrows	
indicate	 presence	 of	 overproduced	 plasmid-encoded	 protein	 at	 the	 expected	 molecular	
















































TaaB1H.	To	do	 this,	 large-scale	cultures	of	BL21(DE3)/pLysS	cells	 containing	pHLS3	
and	pHLS4	were	induced,	and	after	cell	disruption	cleared	lysates	were	subjected	to	
immobilised	 metal-ion	 affinity	 chromatography	 (IMAC)	 using	 a	 HisTrap	 HP	 nickel	
column	 coupled	 to	 an	 ÄKTA	 FPLC	 system	 (Section	 2.3.5).	 Addition	 of	 excess	
imidazole	 allows	 elution	 of	 His-tagged	 proteins	 that	 are	 non-covalently	 bound	 to	
immobilised	 nickel	 ions	 due	 to	 competition	 with	 the	 imidazole	 moiety	 of	 the	
histidine	side	chain	for	the	nickel	ions.	Accordingly,	a	10-500	mM	imidazole	gradient	
was	 applied	 to	 the	 column	 to	 enable	 elution	 of	 the	 bound	 His-tagged	 proteins.	
Monitoring	of	the	absorbance	(A280)	of	the	eluates	 indicated	at	which	point	 in	the	
imidazole	 gradient	 proteins	 began	 to	 be	 eluted	 from	 the	 nickel	 column.	 	 Both	
His6.TanBH	 and	 His6.TanBH.CTD	 were	 eluted	 from	 the	 column	 at	 an	 imidazole	
concentration	 of	 approximately	 150	 mM.	 The	 purity	 of	 fractions	 collected	 were	
then	analysed	by	SDS-PAGE	(Figure	6.14).	The	presence	of	a	15	kDa	protein	present	
in	 the	 His6.TanBH	 and	 His6.TanBH.CTD	 eluted	 fractions	 indicated	 that	 TaaB1H	 was	
also	pulled-down	in	this	purification,	suggesting	that	His6.TanBH	and	His6.TanBH.CTD	
were	directly	interacting	with	TaaB1H	to	form	complexes.	As	TaaB1H	did	not	interact	
non-specifically	with	the	nickel	 resin	 (Section	6.7)	 it	 is	 likely	 that	 the	co-elution	of	
His6.TanBH	 and	His6.TanBH.CTD	 and	 TaaB1H	was	 due	 to	 complex	 formation	 rather	
than	non-specific	binding	of	TaaB1H	to	the	column.	
	
6.3.4 Analysis	 of	 the	 effect	 of	 urea	 on	 dissociation	 of	 the	 His6.TanBH-	
TaaB1H	complex	
In	 order	 to	 analyse	 the	 enzymatic	 activity	 of	 TanBH	 the	 protein	 had	 to	 be	
dissociated	 from	 the	 complex	 formed	 with	 TaaB1H.	 First,	 denaturation	 of	 the	
purified	His6.TanBH-TaaB1H	complex	with	8	M	urea	and	5	mM	DTT	was	undertaken.	

































































































10	 to	500mM	 imidazole	 gradient	using	an	ÄKTA	purifier	 FPLC	 system	and	 collected	 in	13	
1mL	fractions	(A1-A13).	SDS-PAGE	analysis	of	the	fractions	eluted	with	imidazole	during	the	
purification	of	(A)	His6.TanBH-TaaB1H	and	(B)	His6.TanBH.CTD-TaaB1H.	12%	and	15%	SDS-PA	
gels	 were	 used	 for	 the	 His6.TanBH-TaaB1H	 and	 His6.TanBH.CTD-TaaB1H	 complexes,	
respectively	 and	 were	 stained	 using	 Coomassie	 blue.	 Lanes	 are	 labelled	 accordingly	 and	
labelled	arrows	 indicate	purified	proteins	of	the	expected	molecular	mass.	M,	EZ-Run	Rec	

























equilibrated	 with	 8	 M	 urea,	 50	 mM	 Tris-HCl	 pH	 7.5,	 200	 mM	 NaCl	 and	 20	 mM	
imidazole.	Following	binding	of	His6.TanBH,	the	column	was	washed	with	the	same	
buffer,	 following	which	 the	protein	was	 eluted	 in	 the	 same	buffer	 but	 containing	
150	 mM	 imidazole.	 Samples	 of	 the	 eluted	 proteins	 were	 then	 analysed	 by	 SDS-
PAGE	 to	 determine	whether	 TaaB1H	was	 still	 present	 in	 complex	with	 His6.TanBH	
(Figure	 6.15).	 Presence	 of	 a	 15	 kDa	 protein	 alongside	 His6.TanBH	 in	 the	 samples	






Due	 to	 the	 observation	 that	 the	 presence	 of	 8	M	 urea	was	 ineffective	 at	
dissociating	the	His6.TanBH-TaaB1H	complex	an	alternative	strategy	was	undertaken.		
Using	 batch	 nickel	 affinity	 purification	 (Section	 2.3.4)	 the	 His6.TanBH-TaaB1H	
complex	was	 bound	 to	 nickel	 resin	 in	 the	presence	of	 8	M	urea	 and	 sequentially	
washed	with	denaturing	buffer	 (8M	urea,	 50	mM	Tris-HCl,	 200	mM	NaCl,	 and	20	
mM	 imidazole)	with	 increasing	pH	 (pH	4,	pH	6,	pH	8	and	pH	10).	All	 eluted	wash	
fractions	were	 retained	 and	 residual	 bound	 proteins	were	 then	 eluted	 by	 boiling	
the	resin	in	SDS-PAGE	sample	buffer.	Analysis	of	all	samples	by	SDS-PAGE	indicated	




6.3.6 Analysis	 of	 the	 effect	 of	 NaCl	 concentration	 on	 dissociation	 of	
His6.TanBH-TaaB1H	complex	




























retained.	 The	 column	 was	 then	 washed	 (wash)	 with	 the	 same	 buffer,	 following	 which	
bound	 proteins	 were	 eluted	 with	 the	 addition	 of	 the	 same	 buffer	 containing	 150	 mM	
imidazole.	 The	 same	 buffer	 containing	 500	 mM	 imidazole	 was	 then	 used	 to	 elute	 any	
proteins	 that	 remained	 bound	 to	 the	 column.	 Collected	 samples	were	 then	 subjected	 to	
SDS-PAGE	in	a	12%	SDS-PA	gel	stained	by	Coomassie	blue.	Lanes	are	 labelled	accordingly.	
































































































Residual	 bound	 proteins	 were	 eluted	 by	 boiling	 the	 resin.	 Each	 eluted	 sample	 was	
subjected	to	electrophoresis	in	a	15%	SDS-PA	gel	and	stained	by	Coomassie	blue.	Lanes	are	



















































































































































Several	 purification	 strategies	 using	 8	 M	 urea	 as	 a	 denaturant	 failed	 to	
dissociate	the	His6.TanBH-TaaB1H	complex.	Therefore	it	was	decided	to	analyse	the	
effect	 of	 6	 M	 guanidine	 hydrochloride	 (GuHCl)	 containing	 5	 mM	 DTT	 as	 a	





which	 a	 buffer	 containing	 6M	GuHCl,	 5mM	DTT,	 50mM	Tris-HCl	 pH	 7.5,	 200	mM	
NaCl	 and	20	mM	 imidazole	was	used	as	 the	wash	buffer	 and	protein	elution	was	
carried	 out	 by	 the	 sequential	 addition	 of	 the	 same	 buffer	 containing	 150	 mM	
imidazole	and	500	mM	 imidazole.	As	 samples	 that	 contain	high	concentrations	of	
GuHCl	 are	 incompatible	 with	 SDS-PAGE,	 a	 20	 µL	 aliquot	 of	 all	 samples	 was	
subjected	to	TCA-acetone	precipitation	and	resuspended	 in	10	µL	of	1X	SDS-PAGE	
sample	buffer	to	allow	analysis	by	SDS-PAGE	(Figure	6.18).	It	was	observed	that	that	
most	 of	 the	 TaaB1H	 protein	 was	 collected	 in	 the	 flow	 through	 and	 accordingly	
His6.TanBH	 was	 present	 in	 fractions	 eluted	 with	 high	 imidazole	 concentrations,	
indicating	 that	 the	 His6.TanBH-TaaB1H	 complex	 was	 successfully	 disrupted	 by	
exposure	 to	 6	 M	 GuHCl.	 Note	 that	 the	 abundance	 of	 TaaB1H	 in	 the	 His6.TanBH-
TaaB1H	complex	following	treatment	with	6	M	GuHCl	by	buffer	exchange	was	 less	
abundant	 than	 previously	 observed.	 This	 may	 have	 been	 due	 to	 the	 use	 of	 a	
centrifugal	concentrator	in	the	initial	buffer	exchange	stage.	Substantial	amounts	of	























Figure	 6.17	 Analysis	 of	 the	 effect	 of	 NaCl	 concentration	 on	 dissociation	 of	 His6.TanBH-
TaaB1H	 complex	by	 IMAC.	The	His6.TanBH-TaaB1H	complex	was	purified	by	 IMAC,	 treated	
with	8	M	urea	and	 subsequently	bond	 to	nickel	 resin	 (load)	equilibrated	 in	8	M	urea,	 50	
mM	Tris-HCl,	200	mM	NaCl	and	20	mM	imidazole,	and	the	flow-through	was	retained.	The	
immobilised	 complex	 was	 then	 washed	 sequentially	 with	 buffers	 containing	 increasing	
concentrations	of	salt	(50	mM,	100	mM,	200	mM,	400	mM,	800	mM	and	1000	mM)	(wash	
1-3).	 	Bound	proteins	were	then	eluted	 from	the	resin	by	boiling.	Samples	eluted	at	each	
stage	 were	 subjected	 to	 electrophoretic	 analysis	 in	 a	 12%	 SDS-PA	 gel	 and	 stained	 with	














































































































Figure	 6.18	 Analysis	 of	 the	 effect	 of	 guanidine	 hydrochloride	 on	 dissociation	 of	 the	
His6.TanBH-TaaB1H	 complex	 by	 IMAC.	 The	 His6.TanBH-TaaB1H	 complex	 was	 purified	 by	
IMAC,	 treated	with	6	M	GuHCl	and	5	mM	DTT	by	buffer	exchange	using	a	10000	MWCO	




imidazole.	 Collected	 samples	were	 subjected	 to	 electrophoresis	 in	 a	 15%	SDS-PA	 gel	 and	


























































for	 functional	 analysis,	 large-scale	 purification	 of	 His6.TanBH	 and	 His6.TanBH	 from	
their	 respective	 complexes	 with	 TaaB1H	 was	 undertaken	 as	 described	 in	 Section	
6.3.7,	using	a	1	mL	HisTrap	HP	column	rather	than	the	batch	purification	method.	
Renaturation	of	His6.TanBH	and	His6.TanBH.CTD	was	either	performed	by	in-column	







A	 spontaneous	 mutant	 copy	 of	 tanBH	 was	 identified	 during	 attempts	 to	
clone	 the	 gene	 in	 the	 absence	 of	 the	 putative	 immunity	 protein-encoding	 gene	
taaB1H.	 This	mutant	 contained	a	 single	base	pair	 substitution	 that	 resulted	 in	 the	
substitution	 of	 a	 glycine	 codon	 276	 by	 an	 aspartate	 codon,	 within	 the	 coding	
sequence	of	 the	CTD	of	 TanBH.	 This	 residue	was	near/within	 the	predicted	active	
site	of	 the	enzyme,	next	 to	a	histidine	 residue	 identified	 to	be	 the	 likely	 catalytic	
residue	for	DNA	hydrolysis	(His277).			





























Figure	 6.19	 Purification	 of	 His6.TanBH,	 His6.TanBH.CTD	 and	 His6.TanBH	 G276D	 by	 IMAC.	
His6.TanBH	and	His6.TanBH.CTD	were	purified	in	complex	with	TaaB1H	by	native	IMAC	then	
treated	 with	 6	 M	 GuHCl	 and	 subjected	 to	 IMAC	 under	 denaturing	 conditions.	 Eluted	
samples	were	then	pooled	and	dialysed	overnight	against	50	mM	Tris-HCl	(pH	7.5)	using	a	
3000	 MWCO	 dialysis	 membrane.	 Resulting	 dialysate	 was	 concentrated	 using	 a	 10000	
MWCO	centrifugal	concentrator	and	protein	purity	assessed	by	SDS-PAGE.	The	His6.TanBH	






































TanBH	 contains	 a	 predicted	 non-specific	 endonuclease	 domain	
(Endonuclease_NS_2,	 pfam13930)	 at	 the	 C-terminus	 of	 the	 protein,	 so	 following	
purification	 of	 both	 the	 full-length	 protein	 and	 the	 CTD	 alone,	 it	 was	 decided	 to	
investigate	whether	these	proteins	possessed	non-specific	DNase	activity.	
	
6.4.1 Analysis	 of	 DNase	 activity	 of	 purified	 TanBH	 and	 TanBH.CTD	 by	
DNA	zymography		
DNase	activity	can	be	analysed	by	the	use	of	DNA	substrate	polyacrylamide	
gels,	 also	 known	 as	 DNA	 zymography.	 Here,	 DNase	 activity	 results	 in	 the	
















present	 at	 the	 locations	 corresponding	 to	 proteins	 migrating	 with	 the	 expected	
molecular	masses	for	both	His6.TanBH	and	His6.TanBH.CTD.	Non-	fluorescent	regions	
corresponding	 to	 proteins	 of	 lower	 molecular	 masses	 were	 also	 present	 in	 the	









































































































7.5,	 5	 mM	 MgCl2,	 and	 20%	 2-propanol).	 DNase	 activity	 was	 assessed	 by	 incubation	 in	
reaction	buffer	(50	mM	Tris-HCl,	pH	7.5,	5	mM	MgCl2,	2	mM	CaCl2,	and	0.1%	Triton	X-100)	
for	 37°C	 for	 2	 hours,	 and	 then	 visualised	 by	 staining	 of	 the	 gel	 with	 ethidium	 bromide	
solution	and	 imaged	by	UV	 illumination.	Non-fluorescent	bands	 in	 the	gel	 indicate	DNase	
activity.	 (A)	 DNase	 activity	 of	 induced	 whole	 cell	 lysates	 of	 BL21(DE3)/pLysS	 containing	
expression	plasmid	pHLS3,	pHLS4	and	pHLS1,	as	 indicated	 (top).	Duplicated	SDS-PA	gel	of	




with	 Coomassie	 blue	 (bottom).	 Arrows	 indicate	 proteins	 migrating	 at	 the	 expected	
molecular	 mass	 for	 each	 protein	 and	 equivalent	 non-fluorescent	 regions	 in	 the	 DNA-
substrate	 gel.	 Blue	 arrows	 indicate	 non-fluorescent	 regions	 migrating	 at	 the	 molecular	
mass	 equivalent	 to	 dimers	 complexes.	 Samples	 as	 indicated	 above	 the	 lanes.	 Purified	
DNase	I,	bovine	pancreatic	(31	kDa)	was	used	as	a	positive	control	for	DNase	activity,	and	






























































Note,	 non-fluorescent	 regions	 corresponding	 to	 proteins	 migrating	 at	 a	 higher	
molecular	 mass	 in	 both	 His6.TanBH	 and	 His6.TanBH.CTD	 samples	 were	 observed,	




kDa	 and	 86	 kDa,	 the	 latter	 being	 similar	 to	 the	 theoretical	 molecular	 mass	 of	 a	
dimeric	 His6.TanBH	 structure.	 As	 the	 samples	 were	 electrophoresed	 in	 system	
containing	SDS	in	the	gel	and	in	the	running	buffer	one	would	not	expected	dimer	







The	ability	of	 TanBH	and	TanBH.CTD	 to	degrade	 linearised	double	 stranded	
DNA	 (dsDNA)	 in	 solution	was	analysed	 (Section	2.8.2).	pBluescript	 II	 plasmid	DNA	
was	linearised	by	digestion	with	BamHI,	purified	and	then	used	to	evaluate	dsDNA	
degradation	 by	 TanBH.	 Evaluation	 of	 the	 integrity	 of	 the	 dsDNA	 after	 incubation	
with	His6.TanBH	 and	His6.TanBH.CTD	 indicated	 that	 both	were	 able	 to	 successfully	
degrade	 dsDNA	 irrespective	 of	 the	 presence	 of	 additional	MgCl2	 or	 CaCl2	 (Figure	
6.21).		
EDTA	 is	 a	 known	 inhibitor	 of	 nuclease	 activity	 due	 to	 its	 ability	 to	 chelate	
divalent	 cations.	 To	 determine	whether	 the	 DNase	 activity	 of	 TanBH	 (via	 its	 CTD)	
required	 divalent	 cations,	 20	mM	EDTA	was	 included	 in	 samples	with	 or	without	
























Figure	 6.21	 In-solution	 degradation	 of	 dsDNA	 by	 TanBH	 and	 TanBH.CTD.	 100	 ng	 dsDNA	
(pBluescript	 II	 (2961bp)	 linearised	by	BamHI	 restriction	digestion)	was	 incubated	with	2.8	
µg	purified	enzyme	in	a	reaction	buffer	containing	10	mM	Tris-HCl	(pH	8.0),	with	or	without	
2.5	 mM	MgCl2,	 0.5	 mM	 CaCl2	 or	 20	 mM	 EDTA	 in	 a	 total	 reaction	 volume	 of	 10	 µL	 and	
incubated	at	37°C	for	2	hours.	DNase	 I	was	used	as	positive	control.	 	The	 integrity	of	 the	
dsDNA	was	then	determined	by	DNA	gel	electrophoresis	in	a	0.8%	agarose	DNA	and	stained	
with	ethidium	bromide,	after	incubation	with	(A)	His6.TanBH	and	(B)	His6.TanBH.CTD.	Arrows	
indicate	 undigested	dsDNA,	 and	black	 lines	 indicate	 slower	migrating	DNA	 that	 has	 been	



































































































































may	 be	 due	 to	 the	 association	 of	 the	 nuclease	 with	 the	 DNA,	 retarding	 the	
migration	of	the	DNA	in	the	agarose	gel.	A	greater	shift	in	migration	was	observed	
when	 dsDNA	 was	 incubated	 with	 full	 length	 TanBH	 containing	 EDTA	 than	 when	
incubated	the	CTD	and	EDTA.	This	may	indicate	that	the	migration	of	dsDNA	(due	to	
complex	formation	between	TanBH	and	the	DNA)	is	perhaps	being	further	retarded	
by	 the	 formation	 of	 multimers	 between	 TanBH.	 Together,	 this	 indicates	 that	 the	





6.4.3 Analysis	 of	 the	 ability	 of	 TanBH	 and	 TanBH.CTD	 to	 degrade	
supercoiled	DNA	in	solution	
	 The	 ability	 of	 TanBH	 and	 TanBH.CTD	 to	 degrade	 supercoiled	 pBluescriptII	
plasmid	 DNA	 in-solution	 was	 ascertained.	 2.8	 µg	 of	 purified	 His6.TanBH	 or	
His6.TanBH.CTD	 was	 combined	 with	 pBluescript	 II	 in	 10	 mM	 Tris-HCl	 (pH	 7.5)	
reaction	buffer	with	or	without	potential	co-factors	MgCl2	and	CaCl2,	and	incubated	
for	2	hours	at	37°C.	The	integrity	of	plasmid	DNA	after	incubation	was	analysed	by	
agarose	 gel	 electrophoresis	 (Figure	 6.22).	 Results	 showed	 that	 both	 TanBH	 and	
TanBH.CTD	 were	 able	 to	 degrade	 supercoiled	 plasmid	 DNA	 irrespective	 of	 buffer	
































enzyme	 in	a	 reaction	buffer	containing	10	mM	Tris-HCl	 (pH	8.0),	with	or	without	2.5	mM	
MgCl2,	0.5	mM	CaCl2	or	20	mM	EDTA	in	a	total	reaction	volume	of	10	µL	and	incubated	at	
37°C	for	2	hours.	DNase	 I	was	used	as	positive	control.	 	The	 integrity	of	the	plasmid	DNA	
was	 then	 determined	 by	 electrophoresis	 in	 a	 0.8%	 agarose	 gel	 after	 incubation	with	 (A)	
His6.TanBH	 and	 (B)	 His6.TanB.CTD.	 Arrows	 indicate	 intact	 plasmid	 DNA,	 and	 black	 lines	
























































































































both	 purified	 TanBH	 and	 TanBH.CTD	 were	 able	 to	 degrade	 ssDNA	 irrespective	 of	
additional	MgCl2	and	CaCl2.	The	presence	of	20	mM	EDTA	was	unable	to	inhibit	the	
DNase	 activity	 of	 TanBH	 and	 TanBH.CTD	 when	 additional	 divalent	 cations	 were	













decolourisation	 began	 to	 appear	 around	 wells	 containing	 both	 TanBH	 and	
TanBH.CTD	but	not	around	the	negative	control	well	containing	only	Tris-HCl	buffer	

























250	 ng	 of	M13mp18	 single-stranded	 DNA	was	 incubated	with	 2.8	µg	 of	 either	 TanBH	 or	
TanBH.CTD	in	reaction	buffer	containing	10	mM	Tris-HCl	with	or	without	2.5	mM	MgCl2,	0.5	
mM	CaCl2	and	20	mM	EDTA	 in	a	 total	 reaction	volume	of	10	µL	 for	2	hours	at	37°C.	DNA	
integrity	 was	 analysed	 by	 electrophoresis	 in	 a	 0.8%	 agarose	 gel.	 Reaction	 buffer	 only	
control,	and	untreated	ssDNA	were	also	included,	as	well	as	DNase	I	positive	control.	Upper	



















































































applied	 to	wells	bored	 into	DNase	 test	agar	plates	containing	0.005%	 (w/v)	methyl	green	
and	 incubated	 at	 37°C	 for	 36	 hours.	 Appearance	 of	 zones	 of	 decolourisation	 indicating	
DNase	 activity	was	monitored	 and	 imaged	 at	 (A)	 2	 hours,	 (B)	 16	 hours	 and	 (C)	 36	 hours	
post-incubation.	 10	 mM	 Tris-HCl	 buffer	 containing	 no	 enzyme	 was	 used	 as	 a	 negative	
control	 (1).	Note,	 for	better	clarity	of	zones	of	decolourisation	at	2	hours	post	 incubation	













Most	 proteins	 are	 susceptible	 to	 heat	 inactivation	 at	 56°C	 or	 above.		
However,	 thermo-stable	 enzymes	 have	 been	 described,	 including	 the	 S.	 aureus	
nuclease,	Nuc,	which	retains	DNase	activity	after	heating	up	to	97°C	for	10	minutes	
(Lachica	 et	 al.,	 1972),	 as	 well	 as	 a	 glucose	 dehydrogenase	 from	 a	 Burkholderia	
cepacia	 complex	 spp.	 that	 is	 activate	 up	 to	 70°C	 (Sode	 et	 al.,	 1996;	 Inose	 et	 al.,	









in	 non-reducing	 (without	 β-mercaptoethanol)	 and	 reducing	 (with	 β-
mercaptoethanol)	 SDS-PAGE	 sample	 buffer	 and	 the	 enzyme	 activity	 compared	 to	
unheated	 samples	by	DNA	 zymogram	analysis	 (Section	2.8.1).	Visualisation	of	 the	
DNA-substrate	gel	after	ethidium	bromide	staining	indicated	non-fluorescent	zones	
at	 the	 expected	molecular	mass	 for	 TanBH	 (40	 kDa)	 in	 all	 samples	 irrespective	 of	
heat	treatment	or	presence	of	β-mercaptoethanol	(Figure	6.25B).		However,	several	
non-fluorescent	 zones	 corresponding	 to	 the	 migration	 of	 lower	 molecular	 mass	
proteins	 (16-18	 kDa)	 were	 more	 prominent	 in	 the	 heated	 TanBH	 samples,	





























Figure	 6.25	 Analysis	 of	 the	DNase	 activity	 of	 TanBH	 following	 heat	 treatment.	10	µL	of	
purified	 enzyme	 was	 boiled	 for	 10	 minutes	 in	 50	 mM	 Tris-HCl	 (pH	 7.5)	 and	 the	 DNase	
activity	determined.	(A)	Resulting	plasmid	degradation	from	in-solution	degradation	assay	
using	 unheated	 (-H)	 and	 heated	 (+H)	 samples	 of	 His6.TanBH	 and	 His6.TanBH.CTD.	 M,	
Supercoiled	 DNA	 ladder.	 (B)	 DNA-zymogram	 analysis	 (top)	 of	 the	 effect	 of	 boiling	
His6.TanBH	 in	 SDS-PAGE	 sample	 buffer	 with	 (+βMSH)	 and	 without	 (-βMSH)	 β-
mercaptoethanol	as	a	reducing	agent.	BSA	(right)	is	used	a	DNase	negative	control.	Bottom	
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It	 is	 known	 that	 in	 other	 T6SS-containing	 bacteria	 immunity	 proteins	 are	








presence	 of	 6	M	GuHCl	 and	 5	mM	DTT,	 followed	 by	 subtractive	 IMAC.	Here,	 un-
complexed	 His6.TanBH.CTD	 was	 sequestered	 by	 passing	 the	 solution	 through	 a	
HisTrap	 nickel	 column,	 followed	 by	 further	 washes	 with	 denaturing	 buffer	
containing	6	M	GuHCl,	5	mM	DTT,	50	mM	Tris-HCl	(pH	7.5),	200	mM	NaCl,	and	20	
mM	 imidazole	 to	 remove	 residual	 TaaB1H,	 and	 then	 immobilised	 proteins	 eluted.	





using	 a	 10000	 MWCO	 concentrator.	 TaaB1H	 purity	 was	 analysed	 by	 SDS-PAGE	
(Figure	6.26A)	and	observed	to	be	>95%	pure.		
	
6.5.2 Analysis	of	 the	 inhibitory	effect	of	TaaB1H	on	the	DNase	activity	of	
TanBH	and	TanBH.CTD	
To	 determine	 whether	 TaaB1H	 was	 able	 to	 inhibit	 the	 DNase	 activity	 of	
TanBH	 and	 TanBH.CTD,	 the	 in-solution	 DNA	 degradation	 assay	 was	 employed	
(Section	 2.8.2).	 Addition	 of	 a	 2-fold	 excess	 of	 TaaB1H	 to	 pBluescript	 II	 samples	
containing	purified	TanBH	or	TanBH.CTD	 resulted	 in	 inhibition	of	DNase	activity	 as	





















Figure	 6.26	 Inhibition	 of	 DNase	 activity	 of	 TanBH	 and	 TanBH.CTD	 by	 purified	 TaaB1H.	
Affinity	 purified	 His.TanBH.CTD-TaaB1H	 complex	 was	 denatured	 using	 6	 M	 GuHCl.	 Free	
His6.TanBH.CTD	was	removed	from	the	dissociated	complex	by	binding	to	a	HisTrap	column	
and	 washing	 with	 6	 M	 GuHCl-containing	 buffer.	 The	 flow	 through	 and	 wash	 fractions	




arrows	 indicate	 presence	 of	 purified	 proteins.	 Lanes	 as	 indicated.	M,	 EZ-Run	Rec	 protein	
ladder.	(B)	The	inhibition	of	pBluescript	II	plasmid	DNA	degradation	by	addition	of	a	2-fold	


























































whereas	control	 reactions	 that	contained	only	TanBH	and	TanBH.CTD	were	able	 to	
fully	 degraded	 plasmid	 DNA	 (Figure	 6.26B).	 	 The	 inhibitory	 effect	 of	 TaaB1H	 was	























 Investigation	 of	 the	 interaction	 between	 TanBH,	 and	6.6
TaaB1H	 by	 the	 bacterial	 adenylate	 cyclase	 two-hybrid	
system	
TaaB1H	was	co-purified	during	the	purification	of	both	TanBH	and	TanBH.CTD	
(Section	 6.3.3),	 which	 indicated	 a	 direct	 physical	 interaction	 between	 the	 two	




The	 BACTH	 system	was	 developed	 to	 investigate	 interactions	 between	 two	
proteins	of	 interest	 (Karimova	et	al.,	1998),	Figure	6.27	 illustrates	 the	principle	of	




the	 two	 fragments	 can	 be	 monitored	 by	 the	 activation	 of	 reporter	 genes	 that	





vectors	pKT25	and	pKNT25	and	 the	 compatible	high	 copy-number	BACTH	vectors	
pUT18C	and	pUT18.	Gene	fusions	constructed	in	pKT25	or	pKTN25	and	pUT18C	or	
pUT18	are	then	co-expressed	 in	a	Δcya	mutant	of	E.	coli.	 	 If	 the	X	and	Y	moieties	




promoters	 of	 many	 resident	 operons	 in	 E.	 coli	 resulting	 in	 gene	 activation.	 This	




































utilisation.	 CRP.cAMP	 complex	 can	 specifically	 activate	 transcription	 of	malT	 that	
encodes	the	maltose	regulon	activator	protein,	 thus	 leading	to	activation	of	other	
mal	genes	 in	 the	mal	 regulon	such	as	malEFG,	malK	 lamB	and	malM	 required	 for	




which	 results	 in	 a	 colour	 change	of	 the	 colonies	 from	pale	pink	 to	deep	purple	 if	
there	is	a	decrease	in	the	pH.	It	has	been	noticed	that	the	strength	of	the	Cya+/Mal+	
phenotype	resulting	from	protein-proteins	 interactions	using	this	system	can	vary.	





Due	 to	 the	difficulties	encountered	cloning	 the	 coding	 sequences	of	 tanBH	
and	 tanBH.CTD	 into	 the	 pETDuet-1	 expression	 vector	 (Section	 6.2.1),	 is	 was	
hypothesised	 that	 it	would	 not	 be	 possible	 to	 clone	wild-type	 copies	 of	 tanBH	 or	
tanBH.CTD	 into	 the	 BACTH	 vectors	 without	 the	 presence	 of	 the	 taaB1H	 gene	
encoding	its	putative	immunity	protein.	To	circumvent	this,	it	was	decided	to	utilise	
a	variant	of	tanBH	that	encoded	a	non-toxic	TanBH	G276D	mutant	(Section	6.2.1).	
The	 pHLS7	 plasmid	 was	 used	 as	 template	 DNA	 for	 the	 amplification	 of	
coding	 sequences	 of	 tanBH	 and	 tanBH.CTD	 for	 insertion	 into	 the	 BACTH	 vectors.	
Primer	 pairs	 BCAL1298ForNtermHisBamHI	and	 BCAL1298Rev2Acc65I,	 and	
BCAL1298ForNtermHisBamHI	and	BCAL1298RevAcc65I,	were	used	to	amplify	tanBH	
for	generation	of	in-frame	N-	and	C-terminal	fusions	to	the	T25	and	T18	fragments,	
respectively.	 Primer	 pairs	 BCAL198CTDNtermHisForBamHI	 and	
BCAL1298Rev2Acc65I,	 and	 BCAL1298CTDNtermHisForBamHI	 and	
BCAL1298RevAcc65I	were	used	to	amplify	tanBH.CTD	for	generation	of	in-frame	N-	
and	 C-terminal	 fusions	 to	 the	 T25	 and	 T18	 fragments,	 respectively.	 Primer	 pairs	






reverse	 primer,	 allowing	 read-through	 of	 the	 amplicon	 coding	 sequence	 into	 the	




between	 the	 corresponding	 restriction	 sites	 of	 the	 four	 BACTH	 vectors.	
Transformants	 harbouring	 pKT25	 and	 pKTN25	 plasmids	 were	 selected	 for	 using	
kanamycin	and	those	containing	pUT18C	and	pUT18	derivatives	were	selected	for	
using	ampicillin.	Plasmids	encoding	both	N-	and	C-terminal	fusions	of	TanBH	G276D,	
TanBH.CTD	G276D	and	TaaB1H	with	both	 the	T25	 fragment	and	 the	T18	 fragment	
were	successfully	generated.		
	
6.6.3 Investigation	of	 the	 interaction	between	TanBH	and	TaaB1H	by	the	
BACTH	system	
To	determine	whether	TaaB1H	was	able	to	 interact	with	TanBH	and	 its	CTD	
using	 the	 BACTH	 system,	 pairwise	 combinations	 of	 plasmids	 encoding	 N-	 and	 C-
terminal	 fusions	 of	 T25	 and	 T18	 to	 TanBH	 G276D,	 TanBH.CTD	 G276D	 and	 TaaB1H	
were	 introduced	 into	 E.	 coli	 BTH101	 and	 the	 maltose	 phenotype	 monitored.	











































using	 BACTH	 assay.	 Pairwise	 combinations	 of	 plasmids	 encoding	 compatible	 T25/T18	
fusions	 of	 (A)	 TanBH	 G276D	 with	 TaaB1H	 and	 (B)	 TanBH.CTD	 G276D	 with	 TaaB1H	 were	
introduced	into	BTH101	and	grown	on	MacConkey	maltose	agar	containing	the	antibiotics	
ampicillin	and	kanamycin	at	30°C,	 for	up	to	7	nights.	Mal+	phenotype	was	monitored	and	
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pUT18C	or	pUT18	plasmids,	 encoding	 TanBH	G276D,	 TanBH.CTD	G276D	or	 TaaB1H	
T25	 and	 T18	 fusions,	 were	 co-expressed	 in	 BTH101	 and	 maltose	 phenotype	
monitored	 by	 use	 of	MacConkey-maltose	media.	 Figure	 6.29	 shows	 the	 resulting	
Mal	 phenotype	 for	 each	 plasmid	 combination	 tested.	 All	 plasmid	 combinations	
tested	gave	rise	to	a	Mal-	phenotype,	except	one,	T25-TaaB1H	C-terminal	fusion	in	
combination	with	a	N-terminal	TaaB1H-T18	fusion	gave	rise	to	a	weak	Mal+	patchy	




























































Figure	 6.29	 Analysis	 of	 TanBH,	 TanBH.CTD	 and	 TaaB1H	 self-interaction	 by	 BACTH	 assay.	
Pairwise	 combinations	 of	 compatible	 plasmids	 encoding	 T25/T18	 fusions	 of	 (A)	 TanBH	
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Co-purification	 of	 TaaB1H	 with	 His-tagged	 TanBH	 and	 TanBH.CTD	 (Section	
6.3.3)	and	positive	Mal	phenotypes	in	a	two-hybrid	analysis	(Section	6.6)	indicated	
that	TanBH	was	able	to	directly	 interact	with	TaaB1H	to	form	a	complex.	However,	





A	 C-terminal	 FLAG	 tag	 (DYKDDDDK) was	 added	 to	 TaaB1H	 by	 way	 of	
incorporating	the	FLAG	epitope	coding	sequencing	into	the	reverse	primer	used	to	
amplify	 the	 coding	 sequence	 of	 taaB1H.	 This	 primer,	 termed	
BCAL1299RevFLAGAcc65I,	 was	 used	 in	 combination	 with	 BCAL1299ForNdeI	 to	
amplify	the	taaB1H.FLAG	coding	sequence	from	B.	cenocepacia	H111.	taaB1H.FLAG	
was	 inserted	 into	 the	 expression	 vector	 pETDuet-1	 between	 the	 restriction	 sites	
NdeI	and	Acc65I	as	described	in	Section	6.2.3,	generating	the	plasmid	pHLS8.	tanBH	
and	 tanBH.CTD	 where	 subsequently	 amplified	 and	 cloned	 into	 pHLS8	 as	 BamHI-
HindIII	 restriction	 digestion	 fragments	 as	 previously	 described	 (Section	 6.2.1),	
generating	the	co-expression	plasmids	pHLS9	and	pHLS10,	respectively.		
	
6.7.2 Analysis	 of	 the	 interaction	 between	 TanBH	 and	 TaaB1H	 by	 a	 pull-
down	assay	
pHLS8,	 pHLS9	 and	 pHLS10	 were	 introduced	 separately	 into	 the	 E.	 coli	
expression	 strain	 BL21(DE3)/pLysS	 for	 protein	 over-production.	 Similar	 to	 the	
results	 presented	 in	 Section	 6.3.1-6.3.2,	 His6.TanBH,	 His6.TanBH.CTD	 and	
TaaB1H.FLAG	were	all	overproduced	as	soluble	proteins	 following	 induction	of	 the	
T7	 promoter	 (results	 not	 shown).	 To	 determine	whether	 the	 two	 epitope	 tagged	
proteins	 directly	 interacted,	 the	 soluble	 lysates	 from	 induced	 cultures	 of	







were	 co-expressed	and	most	of	 the	excess	 TaaB1H.FLAG	was	present	 in	 the	 flow-
through	 and	wash	 fractions	 of	 these	 samples.	 Both	 His6.TanBH	 or	 His6.TanBH.CTD	
and	TaaB1H.FLAG	were	detected	in	the	imidazole-eluted	fraction.	TaaB1H.FLAG	was	
unable	 to	 bind	 non-specifically	 to	 the	 nickel	 resin.	 Therefore	 TanBH	 and	 TaaB1H	
must	 physically	 interact	 in	 order	 for	 TaaB1H	 to	 be	 retained	 on	 the	 resin	 and	 this	
interaction	occurs	through	the	C-terminal	domain	of	TanBH.		
	






lysate	of	 induced	BL21(DE3)/pLysS	 cells	 habouring	pHLS7	 (His6.TanBH	G276D)	was	
loaded	 onto	 nickel	 affinity	 resin	 to	 allow	 immobilisation	 of	 the	 His-tagged	 ‘bait’	
protein.	 The	 cleared	 lysate	 of	 induced	 BL21(DE3)pLysS	 cells	 harbouring	 pHLS1	
(overproducing	 un-tagged	 TaaB1H)	 was	 then	 applied	 to	 the	 resin	 containing	 the	
anchored	TanBH	G276D	‘bait’	protein.	After	washing,	the	column	bait:prey	complex	




























His6.TanBH	 or	 His6.TanBH.CTD	 and	 TaaB1H.FLAG	 were	 overproduced	 together	 in	
BL21(DE3)/pLysS	cells	from	pETDuet-1	co-expression	derivatives.	The	resulting	lysates	from	
induced	 cultures	 were	 bound	 to	 nickel	 affinity	 resin,	 washed	 and	 the	 bound	 material	
specifically	 eluted	 with	 150	mM	 imidazole.	 Load,	 flow-through	 (FT),	 wash	 and	 imidazole	
eluate	 samples	 from	 each	 stage	 were	 subjected	 to	 SDS-PAGE	 and	 electro-blotted	 onto	
PVDF	membrane.	Membranes	were	probed	with	anti-His	and	anti-FLAG	antibodies.	Images	
showing	 resulting	blots	 from	 (A)	His6.TanBH	 and	TaaB1H.FLAG	and	 (B)	His6.TanBH.CTD	and	
TaaB1H.FLAG	 co-expression	 pull	 downs	 and	 (C)	 TaaB1H	 only	 control.	 Estimated	molecular	



















































































































down	 assay.	 His6.TanBH	 G276D	 mutant	 and	 un-tagged	 TaaB1H	 were	 overproduced	
separately	 in	 BL21(DE3)/pLysS	 harbouring	 pHLS7	 and	 pHLS1,	 respectively.	 The	 cleared	
lysate	 from	 induced	 cultures	 of	 overproduced	 His6.TanBH	 G276D	 was	 bound	 to	 nickel	
affinity	 resin,	 and	 washed.	 Following	 this	 the	 induced	 cell	 lysate	 containing	 TaaB1H	 was	
added	 to	 the	 resin	containing	 the	 immobilised	His6.TanBH	G27D,	washed	and	 then	bound	
proteins	were	eluted	with	a	high	imidazole	buffer.	Immobilisation	of	His6.TanBH	and	TaaB1H	
only	 controls	were	 included.	 Load	 flow-through	 (FT),	wash	 and	 imidazole	 eluate	 samples	
from	each	stage	were	subjected	to	SDS-PAGE.	(A)	Coomassie	stain	of	His6.BCA1298	G276D	
and	 TaaB1H	 pull	 down.	 (B)	 Coomassie	 stain	 of	 control	 TanBH	 immobilisation	 (left)	 and	


























































































































 Analysis	 of	 the	 oligomeric	 status	 of	 the	 TanBH-TaaB1H	6.8
complex	
To	 further	 characterise	 the	 TanBH-TaaB1H	complex,	 the	 oligomeric	 status	 of	
TanBH	 and	 its	 CTD	 in	 complex	 with	 TaaB1H	 was	 investigated	 by	 the	 use	 of	 size	
exclusion	chromatography	(SEC).		
	





and	estimation	of	 the	oligomeric	 status	of	 the	 complex.	 	As	a	1:1	or	2:1	 complex	
would	have	an	estimated	molecular	mass	of	60	kDa	or	95	kDa,	it	was	decided	that	a	
Superose	12	10/300	column	should	allow	sufficient	resolution	of	the	TanBH-TaaB1H	
complex.	 First,	 the	 Superose	 12	 10/300	 column	 was	 calibrated	 with	 molecular	
standards	 to	 generate	 a	 standard	 curve	 (Figure	 6.32A).	 100	 µL	 of	 concentrated	
nickel	 affinity	 purified	 TanBH-TaaB1H	 complex	 (prepared	 as	 described	 in	 Section	
6.3.3)	was	then	subjected	to	gel	filtration	(Section	2.3.7).	It	was	observed	that	the	
TanBH-TaaB1H	 complex	 eluted	 as	 seven	 protein	 peaks,	 with	 the	 majority	 of	 the	
protein	present	in	the	third	and	fourth	peaks	to	be	eluted,	at	9.5	mL	and	10.8	mL,	




the	 column.	 The	 smaller	 peaks	 that	 eluted	 later	 corresponded	 to	 proteins	 of	 an	
approximate	molecular	mass	 of	 37.3	 kDa,	 8.2	 kDa	 and	7.0	 kDa,	 the	 former	being	
similar	 to	 the	 estimated	 molecular	 mass	 of	 monomeric	 TanBH.	 The	 skew	 of	 the	
calibration	 curve	 to	 higher	 molecular	 weight	 proteins	 may	 underestimate	 the	
molecular	weight	of	 the	sixth	and	seventh	peak,	so	either	may	still	 correspond	to	
monomeric	 TaaB1H.	 Together	 this	 data	 indicated	 that	 the	 TanBH-TaaB1H	 complex	



























(A)	 Calibration	 curve	 for	 the	 Superose	 12	 column	 using	 proteins	 of	 a	 known	 molecular	
weight,	 where	 the	 experimentally	 defined	 Kav	 value	 (x	 axis)	 is	 plotted	 against	 molecular	
weight	for	each	standard	(y	axis)	on	a	log	scale	and	fitted	with	a	semi-log	regression	curve,	
with	the	equation	as	 indicated.	100	µL	of	affinity-purified	His6.TanBH-TaaB1H	complex	was	
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but	 also	 as	 a	 precautionary	measure	 due	 to	 the	 higher	 than	 expected	molecular	
mass	values	obtained	for	full	length	TanBH	in	complex	with	TaaB1H	using	a	Superose	
12	column	(Section	6.8.1).		A	calibration	curve	was	generated	by	calibration	of	the	





second	peak	 and	 corresponded	 to	 a	protein	 complex	of	 93.9	 ±	 0	 kDa	 (SD).	 Three	
subsequent	peaks	corresponded	to	an	estimated	molecular	mass	of	72.1	±	2.5	kDa	
(SD),	52.4	±	1.2	kDa	(SD)	and	32.6	±	0	kDa	(SD).	All	of	which	lay	within	the	limits	of	





in	 all	 four	 samples	 (Figure	 6.33C).	 Taken	 together,	 this	 data	 suggested	 that	 the	
TanBH.CTD-TaaB1H	 complex	 may	 occur	 in	 three	 different	 stoichiometries,	 the	
smallest	 and	most	abundant	of	 the	 three,	 approximately	 corresponding	 to	an	1:1	




































using	 proteins	 of	 a	 known	molecular	 weight,	 depicted	 as	 the	 experimentally	 defined	 Kav	
value	(x	axis)	plotted	against	the	molecular	weight	for	each	standard	(y	axis)	on	a	log	scale,	
and	 fitted	with	 a	 semi-log	 regression	 curve,	with	 the	equation	as	 indicated.	 (B)	A280	nm	
trace	 following	 elution	 of	 the	 His6.TanBH.CTD-TaaB1H	 complex,	 where	 fractions	 (A1-A9)	
were	then	analysed	by	SDS-PAGE	(C).	Labelled	arrows	at	expected	molecular	mass	indicate	
the	 identity	 of	 the	 eluted	 proteins.	 Labels	 1-4	 corresponded	 to	 the	 elution	 peaks	 in	 (B),	
which	also	corresponds	to	the	numbered	‘unknowns’	in	(A).	M,	EZ-Run	Rec	protein	ladder.	
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6.8.3 Estimation	 of	 the	 oligomeric	 size	 of	 TanBH.CTD	 by	 size	 exclusion	
chromatography	
To	 evaluate	whether	 the	 CTD	 of	 TanBH	 contained	 an	 oligomerisation	 site,	
allowing	multimerisation	of	the	protein,	 it	was	decided	to	estimate	the	oligomeric	





was	 observed	 eluting	 at	 an	 average	 volume	 of	 14	 ±	 0.07	mL	 (SD)	 (Figure	 6.34B),	
which	corresponded	to	a	molecular	mass	of	19.5	±	0.7	kDa.	This	value	was	within	
the	 limits	of	 the	 calibration	 curve	as	 indicated	 in	 Figure	6.34A.	As	 the	 theoretical	






































subjected	 to	 SEC	 using	 a	 Superose	 12	 10/300	 column	 coupled	 to	 an	 ÄKTA	 purifier	 FPLC	
system	with	a	flow	rate	of	0.5	mL/min.	(A)	Calibration	curve	generated	from	the	elution	of	
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Recent	 findings,	 described	 in	 detail	 in	 Section	 1.5,	 suggest	 different	 T6SS-
dependent	effectors	can	be	secreted	by	different	mechanisms.		Some	effectors	may	
directly	 interact	with	 the	 secreted	 spike-like	 TssI	 subunit,	 facilitating	 secretion	 of	
the	effector	 (Dong	et	al.,	2013;	Whitney	et	al.,	2014).	Others	may	utilise	separate	
adaptor	 or	 chaperone	 proteins	 to	 enable	 secretion	 of	 the	 effector	 by	 the	 T6SS.	
Current	models	suggest	that	T6SS	chaperone	proteins	act	as	a	platform	to	facilitate	
the	 loading	 of	 an	 effector	 protein	 onto	 a	 cognate	 TssI	 protein	 (Koskiniemi	 et	 al.,	
2013;	Shneider	et	al.,	2013;	Liang	et	al.,	2015;	Unterweger	et	al.,	2015).	Therefore	it	
was	decided	to	 investigate	 interactions	between	the	putative	T6SS-effector	TanBH	
and	other	proteins	within	 its	 gene	 cluster	 that	may	 facilitate	 the	 secretion	of	 the	
effector	by	 the	T6SS.	This	 included	a	TssI	protein	encoded	by	BCAL1294	 (TssI1294),	
and	the	product	of	a	T6SS	accessory	gene,	tagA,	that	contains	a	DUF2169	domain.	
Proteins	 homologous	 to	 tagA	 are	 also	 found	 upstream	 of	 other	 candidate	 T6SS	
effectors	 in	T6SS-containing	bacteria.	 Some	of	 these	effectors	have	an	N-terminal	
region	homologous	to	the	NTD	of	TanBH	and	TanAJ	(discussed	in	Section	6.1).	
	
6.9.1 Investigation	 of	 interactions	 between	 TanBH	 and	 TssI1294	 protein	
using	the	BACTH	system	
Combinations	 of	 compatible	 BACTH	 plasmids	 encoding	 N-	 and	 C-terminal	






































Pairwise	 combinations	 of	 compatible	 plasmids	 encoding	 T25/T18	 fusions	 to	 TanBH	 and	
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6.9.2 Investigation	 of	 interactions	 between	 TanBH	 and	 TagA	 using	 the	
BACTH	system	
Combinations	of	compatible	BACTH	constructs	encoding	N-	and	C-terminal	
fusions	 of	 T25	 and	 T18	 to	 TanBH	 (Section	 6.6.2)	 and	 TagA	 (Jones,	 2012)	 were	
introduced	 into	 E.	 coli	 BTH101	 and	 the	 Mal	 phenotype	 scored	 as	 described	 in	
Section	 2.7.2.	 Figure	 6.36	 illustrates	 the	 resulting	 Mal	 phenotypes	 for	 each	
combination	 tested.	 Two	 out	 of	 eight	 possible	 combinations	 gave	 rise	 to	 a	Mal+	
phenotype	after	72	hours	incubation:	the	presence	of	T25-TagA	C-terminal	fusion	in	
combination	 with	 the	 T18-TanBH	 C-terminal	 fusion	 resulted	 in	 a	 weak	 Mal+	
phenotype	and	 the	TagA-T25	N-terminal	 fusion	 in	combination	with	T18-TanBH	C-
terminal	 fusion	 gave	 rise	 to	 a	 stronger	 but	 patchy	 Mal+	 phenotype.	 This	 result	
strongly	suggests	that	TanBH	is	able	to	interact	with	TagA.	
This	result	 led	to	further	 investigations	 into	the	interaction	between	TanBH	
and	TagA,	whereby	plasmids	encoding	T25/T18	fusions	to	the	C-terminal	domain	of	
TanBH	 (TanBH.CTD)	 were	 tested	 in	 pairwise	 combination	 with	 the	 TagA	 BACTH	
constructs.	All	 combinations	gave	rise	 to	a	Mal-	phenotypes,	 suggesting	 that	TagA	
may	interact	with	the	N-terminal	region	of	the	TanBH	rather	than	the	CTD.		
	
6.9.3 Investigation	 of	 interactions	 between	 TagA	 and	 DUF2345-
containing	TssI,	TssI0148	
BACTH	results	 from	a	previous	study	 (Jones,	2012)	suggested	that	TagA	was	
able	 to	 weakly	 interact	 with	 a	 DUF2345-containing	 TssI,	 in	 TssI0148,	 encoded	 by	
BCAM0148.	This	led	to	the	hypothesis	that	TagA	may	act	as	a	T6SS	adaptor	protein	
for	the	secretion	of	putative	effector	TanBH	by	a	TssI	protein.	Pairwise	combinations	




































Figure	 6.36	 Analysis	 of	 interactions	 between	 TanBH	 and	 TagA	 by	 the	 BACTH	 system.	
Pairwise	 combinations	 of	 compatible	 plasmids	 encoding	 T25/T18	 fusions	 to	 TanBH	 and	
BCAL1295	 (TagA)	 were	 introduced	 into	 BTH101	 and	 grown	 on	MacConkey	maltose	 agar	
containing	ampicillin	and	kanamycin	at	30°C,	 for	up	to	7	nights.	The	Mal+	phenotype	was	
monitored	 and	 scored	72-84	hours	 after	 initial	 plating.	Mal	 phenotype	 scored	here	 as:	 -,	
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To	 investigate	 the	 function	 of	 the	 putative	 T6SS	 effector	 TanBH	 and	 its	
cognate	 immunity	 protein	 TaaB1H	 in	 vivo	 it	 was	 decided	 to	 introduce	 in-frame	
deletions	 into	 the	 tanBH	 open	 reading	 frames	 in	 the	 genome	 of	 B.	 cenocepacia	
H111.	 Although	 it	 seemed	 likely	 that	 a	 taaB1H	 null	 mutant	 would	 be	 non-viable	
(based	on	the	inability	to	clone	the	intact	tanBH	coding	sequence	in	the	absence	of	
taaB1H),	an	equivalent	mutant	has	been	attained	in	B.	cenocepacia	strain	K56-2	as	
part	 of	 a	 random	 screen	 looking	 to	 identify	 essential	 genes	 in	 B.	 cenocepacia	
(Bloodworth	 et	 al.,	 2013).	 Therefore,	 it	 was	 also	 decided	 to	 attempt	 to	 delete	
taaB1H,	as	a	single	ΔtaaB1H	mutant	and	together	with	the	deletion	of	tanBH.	Upon	
deletion	of	this	putative	effector-immunity	pair	the	affect	on	particular	phenotypic	
characteristics	of	B.	cenocepacia	 in	comparison	 to	 the	wild-type	strain	could	 then	
be	investigated,	in	particular	the	bacterial	competition	ability	of	the	mutants.			
	
6.10.1 Construction	 of	 allelic	 replacement	 vectors	 for	 construction	 of	 B.	
cenocepacia	ΔtanBH,	ΔtaaB1H	and	ΔtanBH-taaB1H	mutants	
DNA	 fragments	 containing	 in-frame	 deletions	 (Δ)	 of	 tanBH,	 taaB1H	 and	
tanBH-ΔtaaB1H	 were	 generated	 by	 SOE-PCR.	 To	 generate	 the	 ΔtanBH	 allele,	




fused	 to	 codons	 354-365	 of	 the	 same	 gene	 followed	 by	 576	 bp	 of	 flanking	 DNA	
downstream	of	 tanBH.	Primers	BCAL1298ForA	and	BCAL1298revIP-B	were	used	 to	
generate	 the	 amplicon	 ΔtanBH-AB,	 and	 primers	 BCAL1298ForIP-C	 and	
BCAL1298revD	 for	 amplicon	 ΔtanBH-CD	 (Figure	 6.37A).	 The	 amplified	 DNA	
fragments	were	purified,	quantified	and	then	combined	in	1:1	ratio.	A	subsequent	
round	of	PCR	was	performed	using	the	two	amplicons	as	a	template	with	primers	
BCAL1298ForA	 and	 BCAL1298revD	 to	 generate	 a	 1244	 bp	ΔtanBH	 DNA	 fragment,	


















bp	of	 genome	DNA	surrounding	 tanBH	was	generated	by	SOE-PCR.	 Fragments	AB	and	CD	
were	amplified	from	H111	genomic	DNA	in	the	first	round	PCR,	as	visualised	on	a	1.0%	DNA	
agarose	 gel	 shown	 in	 (A).	 Fragments	were	 then	 combined	 in	 an	 equal	 ratio	 and	 used	 as	
template	 DNA	 for	 the	 second	 PCR	 step	 using	 primers	 annealing	 to	 the	 upstream	 end	 of	
fragment	AB	and	downstream	end	of	fragment	CD	(primers	A	and	D),	to	generate	a	1244	bp	
spliced	fragment,	AD	(ΔtanBH),	as	visualised	on	a	1.0%	DNA	agarose	gel	shown	in	(B).	The	
ΔtanBH	 fragment	was	 then	 cloned	between	XbaI	 and	HindIII	 restriction	 sites	 in	 the	allelic	
replacement	 vector	 pEX18TpTer-pheS,	 generating	 a	 5425	 bp	 plasmid.	 Plasmid	
minipreparations	 of	 a	 candidate	 pEX18TpTer-pheS-ΔtanBH	 clone	 was	 analysed	 by	
electroporation	 and	 subjected	 to	 diagnostic	 restriction	 digestion	 using	 a	 unique	 ZraI	













































(Figure	 6.37B).	 ΔtanBH	 was	 digested	 with	 XbaI	 and	 HindIII,	 and	 then	 ligated	
between	corresponding	 restriction	 sites	 in	a	modified	version	of	 the	Burkholderia	
allelic	 replacement	 vector	 pEX18Tp-pheS,	 pEX18TpTer-pheS	 (Section	 4.3.1),	 to	
generate	 a	 5425	 bp	 plasmid,	 pEX18TpTer-pheS-ΔtanBH.	 Blue	white	 screening	was	
possible	 for	 this	 vector,	 whereby	 recombinant	 clones	 were	 identified	 following	
growth	at	30°C	on	M9	agar	 containing	 trimethoprim	and	additional	 supplements.	
Candidate	 clones	were	 screened	 by	 colony	 PCR	 using	 vector	 primers	M13for	 and	
M13revBACTH.	 Selected	 positive	 clones	 were	 verified	 by	 diagnostic	 restriction	
digestion	using	ZraI,	which	cuts	once	within	the	region	located	upstream	of	tanBH,	
thereby	 linearizing	 the	 vector	 (Figure	 6.37C),	 and	 further	 verification	 by	 DNA	
sequencing.			
The	 ΔtanBH-taaB1H	 allelic	 replacement	 vector,	 pEX18TpTer-pheS-ΔtanBH-
taaB1H,	 was	 constructed	 in	 an	 analogous	manner.	 First	 round	 amplicons	ΔtanBH-
taaB1H-AB	 and	ΔtanBH-taaB1H-CD	were	 generated	 by	 primer	 pairs	 BCAL1298ForA	
and	 BCAL1298-99revIP-B	 and	 BCAL1298-99ForIP-C	 and	 BCAL1299RevD,	





The	 construction	 of	 a	 vector	 to	 delete	 taaB1H	 was	 attempted,	 whereby	
primer	 pairs	 BCAL1299ForA	 and	 BCAL1299RevIP-B	 and	 BCAL1299ForIP-C	
BCAL1299RevD	were	used	to	amplify	the	DNA	fragments	ΔtaaB1H-AB	and	ΔtaaB1H-
CD.	The	ΔtaaB1H	DNA	fragment	was	successfully	amplified	using	BCAL1299ForA	and	
BCAL1299RevD	 in	 the	 second	 SOE-PCR	 step.	However,	 subsequent	 cloning	of	 this	
fragment	 into	pEX18TpTer-pheS	proved	difficult.	Several	attempts	were	made	but	
the	 limited	number	of	 candidate	clones	 identified	all	proved	 to	be	 incorrect	after	






PCR	 fragment	 itself	 was	 checked	 by	 diagnostic	 restriction	 digestion	 using	 EcoRI	
(Figure	 6.38).	 The	 ΔtaaB1H	 amplicon	 was	 successfully	 digested,	 generating	 the	
expected	 fragment	 sizes	 of	 1016	 bp	 and	 161	 bp,	 but	 some	 smearing	 occurred,	
indicating	 the	 PCR-amplified	 product	 may	 have	 contained	 small	 amounts	 of	
incorrect	 fragments	 caused	 by	 non-specific	 primer	 annealing.	 This	 indicated	 that	




6.10.2 Generation	 of	 tanBH	 and	 tanBH-taaB1H	 deletion	 mutants	 in	 B.	
cenocepacia	H111	by	allelic	replacement	
To	 construct	ΔtanBH	 and	ΔtanBH-taaB1H	mutants	 in	B.	 cenocepacia,	 allelic	
replacement	 constructs	 pEX18TpTer-pheS-ΔtanBH	 and	 pEX18TpTer-pheS-ΔtanBH-
taaB1H	 were	 each	 introduced	 into	 the	 E.	 coli	 donor	 strain,	 SM10.	 These	 donors	
where	 then	 used	 to	 transfer	 in	 the	 pEX18TpTer-derivatives	 into	 B.	 cenocepacia	
H111	 by	 conjugation.	 This	 allowed	 homologous	 single	 crossover	 recombination	
between	 the	 deletion	 allele	 within	 the	 vector	 and	 the	 wild-type	 allele	 on	 the	
chromosome.	 Trimethoprim-resistant	 pEX18TpTer-pheS-ΔtanBH	 and	 pEX18TpTer-
pheS-ΔtanBH-taaB1H	 co-integrate	 strains	 were	 selected	 on	 M9-glucose	 agar	
containing	trimethoprim.	Co-integrate	strains	where	purified	by	streaking	onto	the	
same	 selection	medium	and	 checked	 for	 plasmid	 integration	by	 PCR	using	 vector	
specific	primers,	pEX18Tpfor	and	pEX18Tprev.	Verified	recombinants	containing	an	
integrated	plasmid	were	then	streaked	onto	M9-glucose	containing	0.1%	(w/v)	DL-
4-chlorophenylalanine	 (cPhe),	 for	 counter-selection	 of	 the	 pheS	 marker.	 This	
allowed	 selection	 of	 a	 second	 recombination	 event	 between	 the	 sequence	























Figure	 6.38	 Diagnostic	 restriction	 digestion	 of	 ΔtaaB1H	 DNA	 fragment	 using	 EcoRI.	
ΔtaaB1H	AD	 amplicon	was	 digested	with	 EcoRI	 to	 determine	whether	 the	 DNA	 fragment	
contained	 the	 correct	 flanking	 sequence	 upstream	 of	 taaB1H.	 Products	 were	 analysis	 by	































H111-ΔtanBH	 and	 H111-ΔtanBH-taaB1H	 double	 crossover	 recombinants	 were	
screened	 using	 primers	 BCAL1298ForOP	 and	 BCAL1299RevOP	 that	 annealed	 to	
flanking	 regions	 of	 both	 deleted	 alleles.	 After	 screening	 50-100	 cPhe-resistant	
recombinants	 for	 each	mutant,	 several	 candidate	mutants	 were	 identified	 which	




candidate	 H111-ΔtanBH	 and	 H111-ΔtanBH-taaB1H	 deletion	 mutants	 were	 PCR	
screened	again	using	the	above	primers	to	verify	gene	deletion	(Figure	6.39A).	The	
candidate	mutants	were	also	checked	for	trimethoprim	sensitivity	and	subjected	to	
a	 further	 PCR	 screen	 with	 vector	 primers	 pEX18Tpfor	 and	 pEX18Tprev	 (which	
produced	 a	 fragment	 size	 of	 397	 bp	 if	 the	 vector	 backbone	 was	 present).	 This	






the	 growth	 rate	 of	 the	 strain,	 wild-type	 H111,	 H111-ΔtanBH	 and	 H111-ΔtanBH-
taaB1H	 were	 grown	 in	 BHI	 broth	 at	 37°C	 and	 the	 culture	 optical	 densities	 were	
monitored	 over	 time.	 The	 resulting	 growth	 curves	 are	 shown	 in	 Figure	 6.40.	 No	
statistically	significant	difference	was	observed	between	the	growth	rate	of	H111-




























cenocepacia	 H111	 derivatives	 containing	 allelic	 replacement	 vectors	 pEX18TpTer-pheS-
ΔtanBH	and	pEX18TpTer-pheS-ΔtanBH-taaB1H	integrated	at	the	tanBH-taaB1H	genetic	locus,	
by	 single	 cross	 over	 recombination,	 were	 subjected	 to	 counter-selection	 using	 medium	
containing	 0.1%	 cPhe.	 (A)	 Resultant	 cPhe-resistant	 recombinants	 were	 screened	 by	 PCR	
amplification	 using	 primers	 that	 annealed	 to	 genomic	 DNA	 just	 outside	 of	 the	 flanking	
regions	 of	 tanBH	 and	 taaB1H.	 (B)	 PCR	 screening	 for	 loss	 of	 integrated	 pEX18TpTer-pheS-
ΔtanBH	 and	 pEX18TpTer-pheS-ΔtanBH-taaB1H	 vectors	 from	 candidate	 H111-ΔtanBH	 and	
ΔtanBH-taaB1H	mutants	 using	 vector	 specific	 primers	 pEX18Tpfor	 and	 pEX18Tprev.	 These	
primers	yielded	a	397	bp	fragment	if	the	vector	was	present.		Samples	as	indicated	above	
the	 lanes.	M,	GeneRuler	DNA	 ladder	mix;	 s.c,	 pEX18TpTer-pheS-ΔtanBH	or	ΔtanBH-taaB1H	
co-integrate	control;	WT,	wild-type	control;	-ve,	no	DNA	control.	
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ΔtanBH	and	H111-ΔtanBH-taaB1H	were	 grown	 in	 BHI-broth	 at	 37°C	with	 shaking,	 and	 the	

































H111	 and	 a	 T6SS	 mutant	 (ΔtssM)	 indicated	 the	 presence	 of	 similar	 levels	 of	
secreted	TssD	from	H111	wild-type,	H111-ΔtanBH	and	H111-ΔtanBH-taaB1H	strains,	
but	 an	 absence	 of	 this	 protein	 in	 the	 culture	 supernatants	 of	 H111-ΔtssM,	 as	
detected	by	a	western	blot	probed	with	anti-TssD	(Figure	6.41).	Extracellular	levels	
of	 the	 intracellular	 RNA	 polymerase	 β-subunit	 were	 determined	 by	 western	





6.10.5 Effect	 of	 ΔtanBH	 null	 allele	 on	 inter-bacterial	 competition	 in	 B.	
cenocepacia	H111	
To	 understand	 whether	 TanBH	 plays	 a	 role	 in	 the	 T6SS-dependent	
competitive	 advantage	B.	 cenocepacia	 H111	 has	 over	 some	 bacterial	 strains,	 the	
H111-ΔtanBH	mutant	strain	was	employed	in	a	bacterial	competition	assay	with	P.	
putida	 (Section	2.9.1).	Control	co-cultures	using	H111	wild-type	and	a	H111	T6SS-
deficient	mutant	 (H111-ΔtssM)	 in	 combination	with	P.	putida	were	also	 included.		
Results	 presented	 here	 confirm	 the	 previous	 observation	 that	 B.	 cenocepacia	
results	 in	a	decreased	titre	of	viable	P.	putida	 following	co-culture	 for	 four	hours,	
and	 this	 competition	 edge	 is	 T6SS-dependent	 (Figure	 6.42).	 However,	 results	
obtained	 following	 co-culture	 of	 the	 H111-ΔtanBH	 mutant	 with	 P.	 putida	 were	
















Figure	 6.41	 Analysis	 of	 the	 effect	 of	 tanBH	and	 tanBH-taaB1H	 deletion	 on	 T6SS	 activity.	
Western	blot	analysis	of	secreted	and	cell	associated	TssD	(upper)	and	β-RNAP	(lower)	of	














Figure	6.42	Analysis	of	 the	 competitive	ability	of	H111-ΔtanBH	 against	P.	putida.	H111-
ΔtanBH	 was	 co-cultured	 with	 P.	 putida	 for	 4	 hours	 at	 30°C	 on	 LB	 agar.	 The	 number	 of	
surviving	P.	putida	was	enumerated	by	 growth	on	appropriate	 selection	plates.	 P.	 putida	
























































































including	 in-solution	 DNase	 hydrolysis	 assays	 and	 DNA	 substrate	 gels,	 which	
attributed	 the	 DNase	 activity	 of	 the	 protein	 to	 its	 C-terminal	 domain.	 Results	
indicated	 that	 the	DNase	 activity	 of	 the	 protein	was	 likely	 to	 be	 dependent	 on	 a	
common	DNase	co-factor	Mg2+.	TanBH	was	able	to	degrade	both	single	and	double-
stranded	linear	and	supercoiled	DNA.	These	findings	are	in-line	with	the	predicted	
endonuclease	 motif	 of	 TanBH	 belonging	 to	 the	 endonucleases	 of	 the	 ββα-Metal	
finger	 clan.	 Similarly,	 the	 experimentally	 characterised	 endonuclease	 Spd1	 in	 S.	
pyogenes	 and	 the	S.	marcescens	 endonuclease	both	 require	 a	Mg2+	metal	 ion	 for	









glycine	 residue	 amongst	 Endonuclease	 NS_2	 family	 proteins	 may	 be	 important.	
However,	 rather	 than	 be	 involved	 in	 catalysis	 or	 metal	 ion	 coordination,	 its	
important	 feature	may	be	the	fact	 that	 it	 is	a	small	neutral	amino	acid,	 thus	does	
not	 interfere	with	 the	predicted	catalytic	histidine	 residue	 (His277)	next	 to	 it.	Gly	
was	substituted	for	an	aspartate	residue	in	the	spontaneous	G276D	mutant,	which	
contains	 a	 larger,	 negatively	 charged	 side	 chain,	which	 could	potentially	 interfere	
with	the	negatively	charged	histidine	residue,	meaning	it	can	no	longer	function	as	
a	base	to	deprotonate	water	for	the	hydrolysis	reaction.		Further	mutagenic	studies	














DNA	encoding	 the	 putative	 nuclease	without	 its	 immunity	 protein	 is	 perhaps	 not	
surprising.	Being	a	predicted	non-specific	endonuclease,	TanBH	may	be	expected	to	
degrade	 most	 forms	 of	 DNA	 and	 RNA.	 Hence,	 even	 tiny	 amounts	 of	 expression	
could	 result	 in	 host	 cell	 toxicity	 due	 to	 genomic	 DNA	 and	 RNA	 degradation.	 This	
problem	 is	 not	 exclusive	 to	 TanBH;	 it	 has	 been	 encountered	with	 other	 nuclease	




Direct	 inhibition	 of	 the	 enzymatic	 activity	 of	 TanBH	 caused	 by	 TaaB1H	was	
demonstrated	by	prevention	of	DNA	degradation	in	vitro,	illustrated	in	Figure	6.43.	
This	neutralising	quality	of	 immunity	proteins	 is	 in	agreement	with	other	effector-
immunity	 pairs,	 including	 the	 T6SS	 DNase	 effector-immunity	 pair	 Tde1-Tdi1	
(Atu4350-Atu4351)	 in	A.	 tumefaciens	 (Ma	et	al.,	2014).	Here	co-expression	of	 the	
immunity	protein	Tdi1	restored	the	viability	of	A.	tumefaciens	cells	overexpressing	
the	 toxic	 Tde1	 DNase	 effector.	 It	 is	 also	 in	 line	 with	 other	 ββα-Metal	
endonucleases,	 including	 the	Anabaena	 spp.	NucA,	which	has	an	 inhibitor	protein	
NuiA	(Muro-Pastor	et	al.,	1997).	NuiA	is	similar	to	TaaB1H	in	the	respect	that	it	is	a	
small	protein,	encoded	by	a	gene	directly	downstream	from	the	gene	encoding	the	


























the	 NucA	 active	 site	 through	 a	 polar	 amino	 acid	 of	 NuiA,	 which	 coordinates	 the	
metal	 ion.	 It	 is,	 however,	 unknown	 whether	 TaaB1H	 acts	 as	 an	 active	 site	 or	
allosteric	inhibitor.	Further	characterisation	of	the	binding	and	inhibitory	properties	
of	 TaaB1H	 would	 be	 beneficial,	 particularly	 if	 TaaB1H	 possesses	 novel	 binding	
properties	that	could	be	exploited	and	translated	into	wider	applications.		
A	 direct	 interaction	 between	 TanBH	 (or	 its	 CTD)	 and	 TaaB1H	 was	
demonstrated	 by	 use	 of	 the	 BACTH	 system	 and	 by	 pull-down	 assays.	 Neither	 of	
these	 methods	 allow	 for	 a	 quantitative	 measurement	 of	 the	 binding	 affinities.	
Nevertheless,	 the	 interaction	between	TanBH	 and	TaaB1H	 can	be	 inferred	 to	be	 a	
strong	 one	 due	 to	 the	 strong	 denaturing	 conditions	 required	 to	 dissociate	 the	
His6.TanBH(CTD)-TaaB1H	complex.	The	use	of	8	M	urea	as	a	strong	denaturant,	along	
with	 extremes	of	 pH	 and	NaCl	 concentration,	were	 ineffective	 at	 dissociating	 the	





patch	 of	 residues	 on	 Tsi2	 (Li	 et	 al.,	 2012).	 This	 general	model	 of	 acidic	 immunity	
proteins	 and	 basic	 effector	 proteins	 was	 also	 proposed	 for	 Ssp-Rap	 complex	
formation	 in	 S.	 marcescens	 (English	 et	 al.,	 2012).	 However,	 those	 authors	
considered	complementary	shape	and	protein	orientation	to	be	just	as	significant.	
The	theoretical	pI	value	of	the	immunity	protein	TaaB1H	is	highly	acidic,	with	a	pI	of	
4.5,	 whereas	 the	 nuclease	 CTD	 of	 TanBH	 is	 basic,	 with	 a	 pI	 of	 9.1.	 Therefore	
electrostatic	 interactions	 between	 regions	 of	 acidic	 and	 basic	 residue	 on	 TaaB1H	





a	 conformational	 change	 that	means	 TaaB1H	 is	 dissociated	 from	 TanBH.	Or,	 upon	
secretion	 into	 the	 periplasm	of	 a	 target	 bacteria	 or	 exposure	 to	 the	 extracellular	
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surroundings,	 a	 similar	 conformational	 change	 and	 complex	 dissociation	 occurs.	
Alternatively,	TanBH	may	never	be	given	 the	chance	 to	 target	host	 cell	DNA/RNA,	
where	upon	translation	it	is	immediately	loaded	onto	the	apparatus,	or	the	effector	
is	 attached	 to	 the	 apparatus	 whilst	 still	 being	 translated	 by	 the	 ribosome,	 in	
something	reminiscent	to	co-translation	translocation.		
For	 TaaB1H	 to	 be	 classed	 as	 a	 bona	 fide	 immunity	 protein,	 it	 would	 have	
been	 ideal	 to	 determine	whether	 TaaB1H	was	 able	 to	 provide	 protection	 against	
TanBH	 in	 vivo,	 if	 in-fact	 TanBH	 was	 injected	 in	 a	 T6SS-dependent	 manner	 into	
surrounding	bacterial	cells.	To	address	this	it	was	intended	to	use	the	H111-ΔtanBH-
taaB1H	 mutant	 as	 the	 target	 strain	 in	 an	 intra-species	 competition	 experiment,	





Estimation	 of	 the	 oligomeric	 status	 of	 both	 the	 TanBH-TaaB1H	 and	
TanBH.CTD-TaaB1H	 complex	 by	 SEC	 indicated	 that	 both	 complexes	 potentially	
existed	 in	 at	 least	 three	 oligomeric	 states.	 For	 the	 TanBH.CTD-TaaB1H	 complex	
stoichiometries	 of	 at	 least	 1:1	 and	 other	 higher	 order	 state	 were	 detected.	
Structural	 insights	 into	other	T6SS	effector-immunity	pairs	have	highlighted	that	a	
variety	 of	 stoichiometric	 arrangements	 are	 possible	 between	 different	 classes	 of	
effector	and	their	cognate	immunity	proteins.		
The	 P.	 aeruginosa	 muramidase	 T6SS-effector	 Tse3	 (Russell	 et	 al.,	 2011)	
appears	 to	 bind	 in	 a	 1:1	 complex	with	 its	 immunity	 protein	 Tsi1	 (Li	 et	 al.,	 2013;	

















on	 the	 level	 of	 Kid	 available,	 where	 different	 stoichiometric	 complexes	 have	




It	 important	 to	 note,	 however,	 that	 as	 SEC	 measures	 the	 hydrodynamic	
volume	of	 proteins	 through	a	medium	and	as	 a	 perfect	 sphere,	 proteins	 that	 are	
asymmetrical	will	deviate	from	this	relationship	between	size	and	elution	volume.	






genomic	 location	 downstream	 of	 genes	 encoding	 TssI1294	 and	 two	 tag	 genes.	
Current	 models	 of	 T6SS-effector	 secretion	 suggest	 that	 particular	 T6SS-effectors	
directly	or	 indirectly	 interact	with	TssI	proteins	 to	allow	 their	export	 (Dong	et	al.,	
2013;	Koskiniemi	et	al.,	2013;	Shneider	et	al.,	2013;	Whitney	et	al.,	2014;	Liang	et	
al.,	 2015;	 Unterweger	 et	 al.,	 2015).	 Experimental	 evidence	 in	 P.	 aeruginosa	
strengthened	this	notion	by	demonstrating	toxin	proteins	encoded	downstream	of	
three	 tssI	 genes	 of	 the	 H1-T6SS	 were	 required	 to	 facilitate	 TssI-dependent	 anti-
bacterial	killing	 (Hachani	et	al.,	2014).	 Interestingly,	 it	was	 found	that	a	 toxin	 that	
required	 VgrG1b	 to	 exert	 is	 anti-bacterial,	 PA0099,	 contained	 a	 HNH/Endo	 VII	
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superfamily	 nuclease	 domain	 at	 its	 C-terminus.	 This	 study	 was	 unable	 to	
demonstrate	the	direct	secretion	of	the	putative	nuclease	effector	by	the	H1-T6SS,	
but	it	was	implied	due	to	the	contribution	of	PA0099	to	VgrG1b-dependent	killing.		
It	 was	 intended	 to	 try	 to	 detect	 secretion	 of	 TanBH	 by	 tandem	 mass	
spectroscopy	and	generate	a	custom	anti-TanBH	antibody	to	be	used	for	 immuno-
detection.	However,	due	to	time	constraints	neither	experiment	were	undertaken.	
Although,	 ectopic	 expression	 of	 a	 N-terminally	 His-tagged	 TanBH	 in	 wild-type	 B.	
cenocepacia	and	a	T6SS	mutant	was	performed	as	an	alternative	strategy	to	try	to	
detect	 secretion	 of	 TanBH	 (data	 not	 shown).	 However,	 only	 small	 His-tagged	
degradation	 products	 appeared	 to	 be	 presented	 in	 the	 cell	 culture	 supernatants	
after	 induction	 in	both	the	wild-type	and	a	T6SS	mutant.	 It	 is	possible	that	the	N-
terminal	His-tag	was	interfering	with	secretion	of	the	effector	due	to	disruption	of	
protein-protein	 interactions	 between	 TanBH.NTD	 and	 a	 T6SS	 adaptor/chaperone	
crucial	for	secretion	of	the	effector,	if	the	NTD	functions	in	this	role.	
It	 was	 intended	 to	 exploit	 the	 observation	 that	 bacteria	 possessing	




intraspecies	 competition	 experiment	 against	 wild-type	 B.	 cenocepacia	 H111,	 a	
T6SS-deficient	mutant	and	H111-ΔtanBH.	 If	the	action	of	TanBH	was	dependent	on	
the	 T6SS	 then	 co-culturing	 of	 the	 H111-ΔtanBH-taaB1H	 mutant	 as	 ‘prey’	 bacteria	
with	a	T6SS-deficient	H111	or	a	ΔtanBH	mutant	as	the	‘attacker’	strain	should	result	
in	 a	 greater	 number	 of	 recovered	 prey	 bacteria,	 than	when	 co-cultured	with	 the	
T6SS-proficient	wild-type	 attacker	 strain.	However,	 this	would	 also	 be	 dependent	





6.11.5 Interaction	 of	 TanBH	 with	 other	 T6SS	 associated	 proteins	 for	
secretion	
Investigations	into	interactions	between	TanBH	and	other	proteins	encoded	









cenocepacia	 J2315	 and	 other	 related	 proteins	 discussed	 in	 Section	 5.1.	 It	 can	 be	
speculated	 that	 the	 CTD	 nuclease	 domain	may	 be	 released	 from	 the	 rest	 of	 the	
protein	by	proteolytic	cleavage	of	the	linker	domain.		This	defines	the	Tan	proteins	
as	a	modular	polymorphic	toxin	family	(Jamet	and	Nassif,	2015).		
In	 polymorphic	 toxin	 families	 the	 conserved	 N-terminal	 regions	 are	 often	
related	 to	 secretion	 of	 the	 toxin	 (Jamet	 and	 Nassif,	 2015).	 So,	 as	 an	 interaction	
between	TagA	and	the	NTD	of	TanBH	was	observed,	it	may	suggest	that	TagA	acts	as	
a	 T6SS-adaptor	 protein	 (depicted	 in	 Figure	 6.44).	 TagA	may	 interact	 with	 the	 N-
terminal	region	of	TanBH	to	facilitate	the	binding	of	TanBH	onto	a	core	T6SS	subunit	
such	as	TssI	 (model	A	 in	 Figure	6.44).	 This	 general	model	has	been	 suggested	 for	
secretion	of	Tle1VC	in	V.	cholerae,	where	Tle1VC	interacts	with	a	chaperone	protein	
(TEC/Tap-1)	 that	 facilitates	 its	 secretion	 by	 a	 TssI	 protein,	 but	 the	 adaptor	 is	 not	
secreted.		
An	alternative	model	for	TanBH	secretion	is	the	attachment	of	TanBH	onto	an	

























protein	 TagA.	 Using	 the	 BACTH	 system,	 an	 interaction	 between	 TanBH	 and	 TagA	 was	
detected.	 Based	 on	 this	 observation	 and	 the	 general	 model	 for	 TssI-mediate	 effector	
secretion,	two	models	for	secretion	of	TanBH	can	be	proposed:	(A)	depicts	a	model	where	









However,	 this	 study	 could	 not	 repeat	 these	 previous	 findings.	 Therefore,	 the	
identification	of	the	T6SS	core	component	with	which	TagA	interacts	with	remains	
unclear.	 It	 must	 be	 noted,	 however,	 that	 this	 TagA	 facilitated	 TanBH	 secretion	






transverse	 the	 inner	 cell	membrane	 of	 the	 target	 Gram-negative	 bacterial	 cell	 to	




which	 contained	 conserved	 motifs	 identifying	 them	 as	 putative	 T6SS-dependent	




cytotoxic	 P.	 aeruginosa	 T6SS	 nuclease	 effector,	 Tse2,	 is	 transported	 into	 the	
cytoplasm	(Hood	et	al.,	2010;	Li	et	al.,	2012).	With	what	little	is	known	concerning	




by	 self-promoted	uptake,	 in	 a	 similar	manner	 to	 colicin	DNase	 translocation.	 This	
involves	 self-propulsion	 across	 the	 cytoplasmic	 membrane	 by	 electrostatic	
interactions	with	the	phospholipid	bilayer	(Mosbahi	et	al.,	2004).	Alternatively,	the	
effector	 may	 be	 transported	 from	 the	 periplasm	 through	 an	 inner	 membrane	




dependent	 inhibition	 system	 (CDI)	 in	 B.	 pseudomallei	 (Koskiniemi	 et	 al.,	 2015).	 If	
this	were	the	case	for	TanBH	then	the	CTD	domain	may	be	proteolytically	cleaved	in	
the	 periplasm	 releasing	 the	 small	 nuclease	 domain	 from	 the	 remainder	 of	 the	
protein.	Concurrently,	CdiA	proteins	in	CDI	systems	have	shown	to	translocate	only	
the	C-terminal	 toxin	domain	of	 the	protein	 into	 the	 cytoplasm	of	 target	bacteria,	
whilst	the	N-terminal	region	remains	associated	on	the	cell	surface	of	the	target	cell	





J2315	 had	 been	 identified	 as	 being	 required	 for	 the	 normal	 growth	 of	 B.	
cenocepacia	K56-2	in	a	screen	of	a	conditional	growth	mutant	library,	which	looked	
to	 identify	 essential	 genes	 in	 B.	 cenocepacia	 K56-2	 (Bloodworth	 et	 al.,	 2013).	
Insertions	of	a	rhamnose	inducible	promoter	in	this	gene	(and	a	orthologue	of	the	
BCAL1300	 gene	 locus	 (taaA2J)	 in	 J2315)	 led	 to	 a	 slow	 growth	 phenotype	 in	 the	






proteins	 in	 K56-2	 and	 H111,	 may	 act	 as	 immunity	 proteins	 for	 their	 cognate	
nucleases	in	vivo,	and	that	these	putative	nucleases	have	anti-bacterial	properties.		
Other	 T6SS-dependent	 effectors	 with	 a	 nuclease	 domain	 have	 been	
demonstrated	to	exhibit	anti-bacterial	activity	and	are	involved	in	T6SS-dependent	
inter-	and	intra-species	competition	(Hachani	et	al.,	2014;	Ma	et	al.,	2014;	Diniz	and	
Coulthurst,	 2015).	 In	 this	 study,	 however,	 the	 H111-ΔtanBH	 mutant	 did	 not	











DNase	activity	 for	 this	protein	via	a	non-specific	endonuclease	domain	at	 its	CTD,	
which	is	both	metal-ion	dependent	and	thermostable,	has	been	demonstrated.	 Its	
ability	 to	 form	 a	 complex	 with	 its	 putative	 immunity	 protein	 TaaB1H	 was	 also	





































































































T6SS	 gene	 cluster.	 BCAS0667,	 located	 on	 the	 third	 chromosome,	 is	 predicted	 to	
encode	one	such	protein,	termed	TssI0667.	The	orthologous	gene	of	BCAS0667	in	the	
B.	 cenocepacia	 H111	 strain	 is	 at	 the	 I35_7843	 gene	 loci.	 The	 protein	 product	 of	
I35_7843	 is	near	 identical	 to	 that	of	 the	product	of	BCAS0667,	bar	 several	 amino	
acid	 changes.	 Bioinformatic	 analysis	 of	 the	 large	 TssI0667	 protein	 from	 both	
BCAS0667	 and	 I35_7843	 identified	 a	 core	 gp27gp5-like	 region	 located	 at	 the	 N-
terminus	 of	 the	 polypeptide	 that	 is	 homologous	 to	 other	 TssI	 proteins	 (Jones,	
2012).	Examples	of	 this	 type	of	specialised	TssI,	containing	a	C-terminal	extension	
with	 effector-like	 function,	 have	 been	 identified	 and	 characterised	 in	 other	 T6SS	
systems	 and	 given	 the	 term	 ‘evolved	 TssI’	 (Section	 1.5.1).	 The	 secretion	 of	 these	
effector	 domains	 have	 been	 shown	 to	 be	 T6SS-dependent	 but	 they	 are	 not	 an	
essential	 component	 of	 the	 T6SS	 complex	 itself	 (Pukatzki	 et	 al.,	 2007;	Ma	 et	 al.,	
2009a;	Brooks	et	al.,	2013).	
Interestingly,	 bioinformatic	 analysis	 of	 TssI0667	 identified	 a	 C-terminal	
extension,	 predicted	 to	 contain	 a	 phospholipase	 A1	 (PLA1)	 domain,	 which	 is	
connected	 to	 the	 core	 TssI	 region	 via	 a	 linker-like	 region	 rich	 in	 proline	 residues	
(Jones,	2012).	Figure	7.1	depicts	the	predicted	domain	arrangement	of	TssI0667.	The	
PLA1	domain	of	TssI0667	was	found	to	contain	a	lipase	specific	motif,	GxSxG,	which	is	
also	 found	 in	 an	 experimentally	 characterised	 superfamily	 of	 T6SS-dependent	
phospholipase	 effectors,	 Tle	 (Section	 1.5.3	 and	 3.3.5).	 This	 superfamily	 is	 further	
split	into	five	subfamilies,	Tle1-Tle5,	based	on	sequence	homology	of	the	GxSxG	or	




















a	 core	 TssI	 region	 that	 displays	 sequence	 homology	 to	 other	 TssI	 subunits	 and	 to	 the	
gp27gp5	tail-spike	complex	of	bacteriophage	T4.	This	is	followed	by	a	C-terminal	extension	



























other	 homologous	 phospholipases	 such	 as	 the	 protein	 encoded	 by	 BCAL1296,	
identified	as	a	further	putative	T6SS-dependent	effector	located	within	a	tssI	cluster	
(Section	3.4.2).		
	 Previous	 work	 on	 the	 BCAS0667-encoded	 product	 has	 focused	 on	 the	
enzymatic	 properties	 of	 the	 phospholipase	 domain	 (Jones,	 2012).	 Its	 activity	 as	 a	
phospholipase	A1	was	verified	and	the	catalytic	residues	identified.	Intriguingly,	the	
enzyme	 displayed	 psychrophilic	 characteristics	 in	 vitro,	 with	 a	 temperature	
optimum	 for	 fatty	 acyl	 esterase	 activity	 at	 10°C.	 However,	 verification	 of	 the	
protein	as	a	T6SS-dependent	effector	and	an	analysis	of	its	role	in	the	lifestyle	of	B.	
cenocepacia	were	not	carried	out.	Therefore,	the	study	presented	here	specifically	
addresses	 the	 hypothesis	 that	 TssI0667	 is	 a	 T6SS-dependent	 secreted	 effector	 and	
investigates	its	possible	role	as	an	effector	that	can	target	other	bacteria.		
	 Studies	carried	out	on	the	role	of	the	T6SS	in	other	organisms	(Hood	et	al.,	
2010;	MacIntyre	 et	 al.,	 2010)	 has	 suggested	 the	 T6SS	mainly	 functions	 to	 target	
other	 bacteria.	 For	 this	 reason	 T6SS-effectors	 have	 evolved	 cognate	 immunity	
proteins	 or	 antitoxins	 to	 neutralise	 anti-bacterial	 effectors	 within	 the	 producing	
bacterium	and	its	siblings	or	closely	related	strains.	Therefore,	it	was	also	sought	to	
identify	 the	 immunity	 protein	 for	 TssI0667	 and	 its	 Tle6	 phospholipase	A1	extension	
domain	 and	 to	 investigate	 the	 complex	 formed	 between	 them.	 The	 most	 likely	
candidate	 for	 the	 TssI0667	 immunity	 protein	 was	 a	 Sec-dependent	 periplasmic	
protein	 encoded	 directly	 downstream	 of	 BCAS0667,	 by	 BCAS0666.	 Bioinformatic	
analysis	of	the	protein	encoded	by	BCAS0666	indicated	the	presence	of	four	ankyrin	
repeat	motifs	 (Section	3.3.6,	 Figure	3.9).	 This	motif	 is	 thought	 to	 form	helix-turn-
helix	 structural	 units,	 where	 each	 repeat	 unit	 comes	 together	 to	 form	 a	 super	
helical	bundle,	 shown	to	be	 important	 for	 facilitating	protein-protein	 interactions.	
The	homologous	gene	 to	BCAS0666	 in	B.	 cenocepacia	H111	 is	 represented	at	 the	
I35_	7842	loci.	This	loci	is	misannotated	in	the	H111	genome,	the	gene	is	indicated	
as	starting	further	downstream	than	its	BCAS0666	orthologue.	But	inspection	of	the	






BCAS0666	and	 its	protein	product.	Further	 indication	of	 the	product	of	BCAS0666	
(and	I35_	7842)	being	an	immunity	protein	is	its	homology	to	a	protein	encoded	by	
a	 gene	 located	 immediately	 downstream	of	 BCAL1296,	 the	 product	 of	which	 is	 a	
predicted	phospholipase	A1	of	the	newly	created	Tle6	family.	It	was	proposed	to	call	
this	 putative	 immunity	 protein	 Tli6,	 to	 coincide	 with	 the	 naming	 of	 the	 CTD	
phospholipase	A1	region	of	TssI0667	as	a	Tle6	extension	domain.		
For	simplicity,	from	hereon	the	gene	corresponding	to	the	coding	sequence	
of	 both	 BCAS0667	 and	 I35_7843	 loci	 from	 J2315	 and	 H111,	 respectively,	 will	 be	
preferred	to	as	BCAS0667,	and	DNA	encoding	 just	 the	CTD	will	be	preferred	to	as	
BCAS0667.CTD.	 The	 encoded	 protein	 will	 be	 referred	 to	 as	 TssI0667	 and	 the	
phospholipase	 C-terminal	 extension	 of	 TssI0667	 will	 be	 preferred	 to	 as	 a	 Tle6	
extension.	 A	 numerical	 subscript	will	 also	 be	 used	where	 appropriate	 to	 indicate	
which	amino	acids	are	encoded	relative	to	C-terminal	of	the	protein,	 i.e.	Tle6258	 is	
the	last	C-terminal	258	amino	acids	of	TssI0667	corresponding	to	the	phospholipase	



















by	 the	 secretion	 of	 TssD	 into	 the	 culture	 supernatant	 of	 liquid	 grown	 cultures,	
(Section	 4.5).	 Hence,	 liquid	 grown	 cultures	 of	 H111	 and	 a	 T6SS-deficient	 mutant	
were	 subjected	 to	 secreted	protein	extraction	 (Section	2.4.1)	and	assayed	 for	 the	
presence	 of	 TssI0667	 by	 western	 blotting,	 using	 a	 custom	 polyclonal	 rat	 antibody	
raised	 against	 the	 C-terminal	 domain	 of	 TssI0667	 (R.A.	 Jones	 and	 M.S.	 Thomas,	
unpublished	 results).	 As	 controls	 the	 secreted	 T6SS	 subunit,	 TssD,	 and	 the	
cytoplasmic	 β-subunit	 of	 the	 enzyme	 RNAP	 were	 also	 analysed.	 TssI0667	 was	
detected	as	a	120	kDa	protein	present	 in	the	secreted	samples	of	H111	wild-type,	
but	 not	 in	 the	 secreted	 proteins	 from	 all	 of	 the	 T6SS-deficient	 mutants	 tested,	
including	 H111-tssA::Tp,	 H111-tssK::Tp,	 H111-tssM::Tp	 and	 H111-ΔtssM	 mutants,	
the	latter	is	shown	in	Figure	7.2.	This	result	strongly	suggests	that	TssI0667	is	a	T6SS-
dependent	 secreted	 protein.	 Cell-associated	 TssI0667	 was	 detected	 in	 all	 strains	
tested,	 indicating	 that	 TssI0667	was	 being	 produced	 in	 the	 cytoplasm	 of	 the	 T6SS-
deficient	mutants	but	not	secreted.		Accumulation	of	a	possible	intracellular	TssI0667	
degradation	product	was	also	detected	 in	all	cell	associated	samples,	migrating	at	
approximately	 26	 kDa,	 which	 was	 more	 abundant	 in	 the	 T6SS-deficient	 mutants	
that	the	wild-type	strain	(data	not	shown).		
	 To	 determine	 whether	 secretion	 of	 TssI0667	 could	 be	 restored	 in	 a	 T6SS-
deficient	 mutant.	 Using	 the	 tssA::Tp	 mutant	 as	 an	 example,	 a	 broad-host	 range	
plasmid	encoding	tssA	was	introduced	into	the	corresponding	mutant	and	secreted	
proteins	 extracted	 and	 analysed	 by	 western	 blotting.	 Proteins	 were	 probed	 with	
anti-TssI0667.CTD	antibody,	and	an	anti-TssD	control	antibody.	Figure	7.3	shows	the	
restoration	 of	 TssI0667	 secreted	 by	 complementation	 of	 the	H111-tssA::Tp	mutant	
with	pBBR1-tssA.	 The	secretion	of	TssD	was	also	 restored	by	complementation	of	
this	 mutant.	 Cell	 associated	 TssI0667	 was	 difficult	 to	 detect	 in	 wild-type	 and	 the	









Figure	 7.2	 Analysis	 of	 T6SS-dependent	 secretion	 of	 putative	 effector	 TssI0667	 by	 B.	
cenocepacia	 H111.	 Spent	 liquid	 culture	 supernatants	 of	H111	WT	 and	H111-ΔtssM	were	
subjected	 to	 DOC-TCA	 precipitation.	 The	 resulting	 secreted	 protein	 samples	 and	 cell	
associated	proteins	were	 separated	by	 SDS-PAGE	 and	 transferred	onto	 PVDF	membrane.	
Blots	were	probed	with	custom	polyclonal	antibody	raised	against	the	CTD	region	of	TssI0667		
(top	 panel),	 custom	 polyclonal	 anti-TssD	 antibody	 (middle	 panel)	 and	 commercially	
available	anti-β-RNAP	antibody	as	a	 lysis	control	 (bottom	panel).	Samples	were	 loaded	as	
indicated	above	the	lanes.		Molecular	masses	of	the	detected	proteins	are	indicated	on	the	











Spent	 culture	 supernatants	 of	 H111	WT	 and	 tssA::Tp	mutant	 containing	 pBBR1MCS-1	 or	
pBBR1-tssA	were	subjected	to	DOC-TCA	precipitation.	Resulting	sample	were	separated	by	
SDS-PAGE	and	transferred	onto	PVDF	membrane.	Blots	were	probed	with	anti-TssI0667.CTD	
antibody	 (top	 panel)	 and	 anti-TssD	 antibody	 (middle	 panel).	 Samples	 were	 loaded	 as	
indicated	above	the	lanes.		Molecular	masses	of	the	detected	proteins	are	indicated	on	left,	









































































	 To	 allow	 further	 verification	 of	 the	 secretion	 of	 TssI0667	 and	 investigation	
into	 its	 role	 in	B.	 cenocepacia	H111	 it	was	decided	 to	 generate	 in-frame	deletion	
H111	 mutants	 containing	 an	 in-frame	 deletion	 of	 BCAS0667,	 either	 alone	 or	
together	 with	 a	 deletion	 of	 BCAS0666,	 encoding	 its	 putative	 immunity	 protein.	
Upon	deletion	of	 this	putative	effector-immunity	pair,	 the	mutants	 could	 then	be	
assessed	 for	 phenotypic	 differences,	 in	 particular	 the	 ability	 of	 the	 mutants	 to	
compete	against	other	bacterial	strains.		
	
7.3.1 Construction	 of	 allelic	 replacement	 vectors	 for	 deletion	 of	
BCAS0667	and	BCAS0667-0666	in	B.	cenocepacia	H111	
	 SOE-PCR	was	used	 to	generate	 in-frame	deletion	alleles	of	both	BCAS0667	
and	 BCAS0667-BCAS0666,	 whereby	 fragments	 either	 side	 of	 each	 region	 were	
amplified	 and	 splice	 together	 to	 omit	 the	 intervening	 regions,	 as	 explained	 in	
Section	5.4.1,	Figure	5.20.	To	generate	the	ΔBCAS0667	allele,	DNA	fragments	either	
side	 of	 BCAS0667	were	 amplified	 by	 PCR	 from	H111	 genomic	DNA	 using	 primers	
0667ΔforA	and	0667ΔIPrevB	to	generate	a	ΔBCAS0667-AB	fragment	of	672	bp	and	
primers	0667ΔIPforC	and	0667ΔrevD	to	generate	a	ΔBCAS0667-CD	fragment	of	635	
bp.	 Each	 fragment	 contained	 overlapping	 regions	 complementary	 to	 the	 other	
fragment	to	allow	splicing	of	the	fragments	together	by	a	second	PCR	step.	To	do	
this,	 ΔBCAS0677-AB	 and	 ΔBCAS0667-CD	 fragments	 were	 combined	 in	 an	 equal	




intervening	region.	Primers	used	 in	 this	amplification	step	contained	5’	 restriction	
sites,	 BamHI	 and	 HindIII,	 allowing	 directional	 cloning	 of	 the	 ΔBCAS0667	 DNA	
fragment	 into	the	Burkholderia	allelic	replacement	vector	pEX18TpTer-pheS	at	the	
corresponding	 restriction	 sites	 in	 the	MCS	 of	 the	 vector,	 generating	 pEX18TpTer-
pheS-ΔBCAS0667	 of	 5440	 bp.	 Clones	 were	 selected	 for	 trimethoprim-resistance	





positive	 in	 the	 PCR	 screen	 and	 subjected	 to	 size	 analysis	 by	 agarose	 gel	
electrophoresis	 (Figure	7.4).	Correct	sized	clones	 (8,	9	and	10)	were	confirmed	by	
DNA	sequencing.		
	 The	ΔBCAS0667-BCAS0666	 allele	 was	 generated	 as	 described	 above	 using	
primer	 pairs	 0667ΔforA	 and	 0667-0666ΔIPRevB	 and	 0667-0666ΔIPforC	 and	 0667-
0666ΔrevD,	to	generate	a	fragment	of	672	bp	for	ΔBCAS0667-BCAS0666	AB,	and	a	
fragment	 of	 665	 bp	 for	 ΔBCAS0667-BCAS0666	 CD.	 Primers	 0667ΔforA	 and	
0666revD	were	 used	 in	 the	 second	 PCR	 step,	 generating	 the	 spliced	 fragment	 of	
1295	 bp,	 ΔBCAS0667-BCAS0666,	 in	 which	 the	 first	 18	 codons	 of	 the	 coding	
sequence	 of	 BCAS0667	 were	 fused	 to	 last	 39	 codons	 of	 the	 coding	 sequence	 of	
BCAS0666,	deleting	1231	codons	in	the	intervening	region,	generating	a	BCAS0667-
BCAS0666	 in-frame	 fusion. This	 was	 subsequently	 cloned	 as	 a	 BamHI-HindIII	




	 To	 create	 an	 in-frame	markerless	 deletion	 of	 BCAS0667	 in	B.	 cenocepacia	
H111,	the	allelic	replacement	vector	pEX18TpTer-pheS-ΔBCAS0667	was	introduced	
into	 the	 strain	 H111	 by	 conjugation.	 This	 allowed	 recombination	 events	 to	 occur	
between	 the	 ΔBCAS0667	 allele	 on	 the	 vector	 and	 the	 complementary	 region	 in	
H111	genomic	DNA.	Single	crossover	recombinants	(co-integrates)	were	selected	by	
virtue	 of	 their	 trimethoprim-resistance	 on	 M9-glucose	 agar	 containing	
trimethoprim.	Verified	co-integrated	were	 then	re-streaked	onto	M9-glucose	agar	
containing	 0.1%	 cPhe	 to	 select	 for	 a	 second	 recombinant	 event	 that	 resulted	 in	
excision	of	 the	plasmid,	 leaving	behind	either	 the	wild-type	 copy	of	BCAS0667	or	
the	ΔBCAS0667	 allele.	 Several	 candidates	 were	 PCR	 screened	 using	 primers	 that	
annealed	 upstream	 of	 the	 regions	 flanking	 the	 deleted	 allele	 introduced	 by	 the	














































bp	 compared	 to	 4373	 bp,	 were	 considered	 as	 H111-ΔBCAS0667	mutants	 (Figure	
7.5).		
	 Note	 however,	 a	 non-specific	 band	 was	 also	 generated	 in	 the	 wild-type	
strain	that	corresponded	to	the	expected	size	of	the	DNA	fragment	amplified	from	
the	ΔBCAS0667	mutants,	which	was	in	a	greater	yield	that	the	wild-type	fragment	
size.	 This	 could	 have	 given	 rise	 to	 false	 positive	 mutants	 being	 identified	 in	 this	
initial	screen.	Candidates	2,	3,	5,	7,	8,	13,	16	and	22	were	colony	purification	by	two	
rounds	 of	 re-streaking	 on	 the	 same	 medium	 and	 then	 final	 re-streak	 onto	 M9-
glucose	 agar.	 After	 this,	 the	 candidates	 were	 re-screened	 by	 PCR,	 again	 using	
0667for-OP	 and	 0667rev-OP	 outside	 primers,	 and	 also	 using	 the	 0667ΔForA	 and	
0667ΔRevD	inside	primers	(Figure	7.6A).	Excision	of	the	pEX18TpTer-pheS	plasmid	
was	verified	by	trimethoprim-sensitivity	and	by	PCR	screening	using	vector	specific	
primers	 pEX18Tpfor	 and	 pEX18Tprev.	 All	 candidates	 were	 trimethoprim-sensitive	
and	did	not	amplify	the	397	bp	vector	fragment	(Figure	7.6B).	Only	candidates	2,	3,	
5,	8	and	22	gave	rise	to	a	DNA	fragment	corresponding	in	size	to	that	expected	for	
the	 presence	 of	 the	ΔBCAS0667	 allele	 when	 amplified	 with	 the	 outside	 primers.	
Candidate	2	was	selected	for	phenotype	studies.	
	 An	 analogous	 approach	 to	 that	 described	 above	 was	 undertaken	 for	
generation	of	a	H111	mutant	 that	contain	a	deleted	 in-frame	 fusion	of	BCAS0667	
with	 BCAS0006	 (Section	 7.3.1).	 However,	 problems	 were	 encountered	 with	 cPhe	
counter-selection,	 it	 appeared	 to	 be	 inefficient.	 Over	 100	 cPhe-resistant	 colonies	
isolated	 after	 the	 first	 round	 of	 cPhe	 counter-selection	 were	 screened	 for	
trimethoprim	sensitivity	 to	help	 identify	 strains	 that	had	excised	 the	pEX18TpTer-
pheS	plasmid.	Over	90%	of	the	patched	colonies	were	still	 trimethoprim-resistant,	
indicating	 they	 still	 contained	 the	 allelic	 replacement	 vector	 integrated	 into	 the	
genome.	Several	 trimethoprim	sensitive	colonies	were	eventually	 found,	but	after	




















Figure	 7.5	 Initial	 PCR	 screen	 to	 identify	 candidate	 H111-ΔBCAS0667	 mutants.	 Co-
integrates	 of	 H111	 containing	 pEX18TpTer-pheS-ΔBCAS0667	 integrated	 at	 the	 genomic	
BCAS0667	 loci	 were	 subjected	 to	 counter-selection	 on	 M9	 agar	 containing	 0.1%	 cPhe.	
Selected	cPhe-resistant	colonies	were	PCR	screened	using	primers	annealing	outside	of	the	
deleted	 region	 to	 identify	 recombinants	 where	 plasmid	 excision	 had	 resulted	 in	
replacement	of	the	wild-type	BCAS0667	gene	by	the	ΔBCAS0667	allele.	Resulting	fragments	
were	 visualised	 following	 electrophoresis	 in	 a	 0.8%	 DNA	 agarose	 gel.	 Mutants	 were	
expected	to	give	rise	to	a	fragment	smaller	than	that	derived	from	the	wild-type	(WT),	1360	















































ΔBCAS0667	mutants	were	PCR	 screened	using	pairs	 of	 primers	 that	 anneal	 to	 sequences	
outside	the	homologous	region	of	the	ΔBCAS0667	allele	 introduced	on	pEX18TpTer-pheS-
ΔBCAS0667,	 inside	primers	 that	 anneal	 to	 the	 inserted	deletion	allele	 and	vector	 specific	
primers.	 (A)	DNA	agarose	 gel	 of	 fragments	 amplified	 using	 outside	 and	 inside	primers	 as	
indicated,	following	DNA	electrophoresis	in	a	0.8%	agarose	gel.	The	upper	arrow	indicates	















































































































wild-type	 genomic	 DNA,	 resulted	 in	 non-specific	 amplification	 of	 a	 fragment	 of	 a	
similar	size	to	that	of	the	expected	size	for	a	ΔBCAS0667-0666	mutant	(along	with	
the	 wild-type	 fragment).	 Therefore	 it	 was	 sometimes	 difficult	 to	 distinguish	
between	 potential	mutants	 and	 colonies	 that	 had	 reverted	 back	 to	wild-type.	 To	
overcome	 this	 problem,	 primers	 BCAS0667PLAForNcoI	 and	 BCAS0667PLARevXbaI,	
which	annealed	to	DNA	located	within	the	BCAS0667	coding	sequence,	were	used	
to	screen	potential	mutants.	Candidate	ΔBCA0667-0666	mutants	were	revisited	and	
screened	using	 the	BCAS0667PLA	primers.	However,	 all	 candidates	 gave	 rise	 to	 a	
segment	 of	 DNA	 within	 the	 region	 targeted	 for	 deletion,	 indicating	 the	
recombinants	were	not	ΔBCAS0667-0666	mutants	(data	not	shown).		
	
7.3.3 Effect	of	 the	deletion	of	BCAS0667	on	the	activity	of	 the	T6SS	 in	B.	
cenocepacia	H111	
	 Ten	 tssI	 clusters	 are	 found	within	 the	 genome	of	B.	 cenocepacia,	 but	 it	 is	
unknown	which,	 if	 any,	 of	 these	 encoded	 TssI	 subunits	 are	 strictly	 required	 for	 a	
functional	 T6SS	 in	 this	 bacterium.	 To	 determine	 whether	 deletion	 of	 BCAS0667	
affected	T6SS	activity,	TssD	secretion	into	the	supernatants	of	cultures	of	wild-type	
H111,	 H111-ΔBCAS0667	 and	 a	 H111	 T6SS-deficient	 mutant,	 H111-ΔtssM,	 were	
analysed	by	western	blotting	using	a	custom	polyclonal	anti-TssD	antibody	(Figure	
7.7).	 The	 level	 of	 cell	 associated	 TssD	 in	 each	 strain	 was	 also	 determined.	 The	
results	indicated	the	presence	of	similar	levels	of	secreted	TssD	in	the	wild-type	and	
ΔBCAS0667	 strains,	 but	 absence	 of	 secreted	 TssD	 in	 the	 ΔtssM	 mutant.	 Cell-
associated	 TssD	was	detected	 in	 all	 strains.	 	 These	observations	 indicate	 that	 the	
H111-ΔBCAS0667	 mutant	 possessed	 a	 functional	 T6SS	 system,	 and	 therefore	
BCAS0667	did	not	encode	a	core	T6SS	subunit.		
Secreted	 samples	were	 also	 probed	with	 the	 anti-TssI0667.CTD	 antibody	 to	





















Figure	 7.7	 Analysis	 of	 the	 effect	 of	 deletion	 of	 BCAS0667	 on	 T6SS	 activity	 in	 B.	
cenocepacia	H111.	Secreted	proteins	were	precipitated	from	liquid	grown	cultures	of	wild-
type	H111,	H111-ΔtssM	and	H111-ΔBCAS0667	mutants,	concentrated	1000-fold,	separated	
by	 SDS-PAGE	 and	 analysed	 by	 western	 blotting.	 Image	 shows	 resulting	 western	 blots	











































the	 custom	 anti-TssI0667.CTD	 antibody	 was	 indeed	 detecting	 TssI0667,	 and	 not	 an	
unrelated	cross-reacting	protein.		
An	anti-β-RNAP	subunit	antibody	was	used	as	a	lysis	control	to	indicate	the	
level	 of	 lysis	 occurring	 in	 the	 cultures	 during	 growth.	 Figure	 7.7	 shows	 that	 this	





Results	 presented	 in	 chapter	 4	 suggested	 that	 the	 T6SS	 in	B.	 cenocepacia	
provides	 this	species	with	a	 fitness	advantage	over	other	bacterial	 strains	 in	a	co-
culture,	 including	 P.	 putida	 and	 E.	 coli,	 a	 phenomenon	 observed	 in	 other	 T6SS-
containing	 bacteria.	 Therefore	 it	 was	 decided	 to	 determine	 whether	 the	 T6SS-





the	 ‘attacker’	 strains.	 Figure	 7.8A	 shows	 the	 resulting	 number	 of	 recovered	 P.	
putida	 from	 each	 co-culture	 condition,	 demonstrating	 that	 in	 co-culture	with	 the	




by	 a	 factor	 of	 58.	 Levels	 of	 recovered	 B.	 cenocepacia	 attacker	 strains	 were	 also	
monitored,	and	as	shown	in	Figure	7.8B,	no	significant	difference	been	strains	was	
observed.	Together	this	data	suggests	that	TssI0667	makes	a	partial	contribution	to	
























Figure	 7.8	 Analysis	 of	 the	 contribution	 of	 TssI0667	 to	 the	 T6SS-dependent	 competitive	
advantage	of	B.	cenocepacia	H111	against	P.	putida.	Wild-type	B.	cenocepacia	H111,	and	
corresponding	 ΔBCAS0667	 and	 ΔtssM	mutants	were	 co-cultured	 in	 a	 5:1	 ratio	 against	P.	
putida	KT2440	and	incubated	on	nitrocellulose	membranes	on	LB	agar	for	4	hours	at	30°C.	
Surviving	bacteria	were	recovered	and	enumerated	on	selection	plates.	(A)	The	number	of	
recovered	 P.	 putida	 resulting	 from	 each	 co-culture	 with	 different	 B.	 cenocepacia	 H111	
attacker	 strains,	 and	 P.	 putida	 cultured	 on	 its	 own.	 (B)	 The	 number	 of	 recovered	 B.	































































































	 To	 confirm	 that	 the	 effect	 of	 ablation	 of	 BCAS0667	 on	 inter-bacterial	
competition	 was	 not	 due	 to	 polar	 effects	 of	 the	 lesion	 or	 an	 unrelated	 genetic	
alteration,	 a	 complementation	 plasmid	 was	 constructed.	 To	 do	 this,	 the	 coding	
sequence	 of	 BCAS0667	 along	 with	 a	 35	 bp	 sequence	 directly	 upstream,	
encompassing	 the	 putative	 Shine-Dalgarno	 sequence,	 was	 amplified	 from	 H111	
genomic	DNA	using	the	primers	BCAS0667ForATG1Acc65I	and	BCAS0667RevXbaI	to	
generate	a	DNA	fragment	of	3088	bp	(Figure	7.9A).	This	fragment	was	gel	purified,	
and	 together	 with	 the	 vector	 pBBR1MCS-2	 (named	 pBBR2	 from	 hereon),	 were	
subjected	 to	 restriction	 digest	with	 Acc65I	 and	 XbaI	 (Figure	 7.9B).	 Following	 this,	
the	 two	 fragments	 were	 ligated	 together,	 introduced	 into	 E.	 coli	 JM83,	 and	
transformants	selected	for	kanamycin-resistance.	Positive	clones	were	identified	by	
colony	 PCR	 screening	 using	 vector	 primers	 M13for	 and	 M13rev	 (Figure	 7.9C).	
Clones	1,	2,	4,	7,	11,	and	12	gave	rise	to	the	correct	sized	insert	of	3224	bp	in	this	
screen.	 Clones	 1	 and	 2	 were	 selected	 for	 plasmid	 isolation	 and	 size	 analysis	
following	 electrophoresis	 (Figure	 7.9D).	 The	 expected	 plasmid	 size	 for	 pBBR2-
BCAS0667	was	8138	bp,	therefore	both	clones	gave	rise	to	plasmids	of	the	desired	
size.	Clone	1	was	confirmed	by	DNA	sequencing.		
	 Unfortunately,	 due	 to	 time	 constraints	 the	 effectiveness	 of	 pBBR2-
BCAS0667	 to	 complement	 the	H111-ΔBCAS0667	mutant	was	 unable	 to	 be	 tested	
fully.	 An	 initial	 conjugation	 experiment	 undertaken	 to	 transfer	 pBBR2-BCAS0667	
into	wild-type	H111	and	the	ΔBCAS0667	mutant	showed	that	this	plasmid	exerted	a	
negative	 effect	 on	 the	 colony	 growth	 and	 morphology.	 Thus,	 H111/pBBR2-
BCAS0667	 colonies	 were	 of	 non-uniform	 size,	 some	 with	 slightly	 translucent	
crateriform	 morphology	 when	 compared	 to	 H111/pBBR2.	 H111-
ΔBCAS0667/pBBR2-BCAS0667	 colonies	 had	 a	 small,	 irregular	 and	 translucent	
morphology	compared	to	H111-ΔBCAS0667/pBBR2.	Restoration	of	TssI0667	secretion	

















































































Figure	 7.9	 Construction	 of	 the	 BCAS0667	 complementation	 vector,	 pBBR2-BCAS0667.	




(B)	 BCAS0667	 and	 pBBR2	 DNA	 fragments	 resulting	 from	 XbaI	 and	 Acc65I	 restriction	
digestion,	 as	 indicated.	 (C)	 Analysis	 of	 PCR	 colony	 screen	 of	 transformants	 containing	
potential	 pBBR2-BCAS0667	 plasmids	 using	 vector	 specific	 primers,	 positive	 clones	 were	
expected	to	amplify	a	 fragment	of	3224	bp,	as	 indicated	by	arrow,	and	the	empty	pBBR2	
vector	was	expected	to	amplify	a	fragment	of	230	bp.	(D)	Size	analysis	of	candidate	pBBR2-























to	 the	 competitive	 advantage	 the	 T6SS	 confers	 upon	 B.	 cenocepacia	 when	 co-
cultured	 with	 competing	 bacterial	 strains,	 suggesting	 that	 TssI0667	 is	 an	 anti-
bacterial	effector.	Therefore	it	was	decided	to	further	investigate	the	anti-bacterial	
properties	of	TssI0667	to	determine	which	subcellular	location	it	targeted.		
As	 discussed	 previously,	 TssI0667	 contains	 a	 C-terminal	 extension	 that	 was	
demonstrated	 in	a	previous	study	to	have	phospholipase	A1	activity,	and	could	be	
defined	 as	 a	 founding	 member	 of	 a	 new	 subfamily	 of	 the	 Tle	 T6SS-dependent	
phospholipase	effector	superfamily,	Tle6.	Therefore,	it	was	postulated	that	the	anti-
bacterial	 properties	 associated	 with	 this	 protein	 might	 be	 occurring	 via	 the	
phospholipase	 activity	 of	 the	 C-terminal	 extension	 region,	 specifically	 through	
degradation	 of	 the	 phospholipids	 in	 cellular	 membranes.	 This	 should	 be	
demonstrable	by	ectopic	expression	of	DNA	encoding	the	Tle6	domain	of	TssI0667.	
	
7.4.1 Construction	 of	 plasmids	 for	 periplasmic	 targeting	 of	 the	 TssI0667	
Tle6	domain	in	E.	coli	
To	 determine	 whether	 periplasmic	 expression	 of	 the	 Tle6	 phospholipase	
domain	of	TssI0667	had	an	adverse	effect	on	bacterial	cell	viability,	the	coding	region	
was	 cloned	 in-frame	 into	 a	 pET	 expression	 vector	 that	 fused	 a	 periplasmic	
localisation	 signal,	 the	 PelB	 signal	 sequence,	 to	 the	 N-terminus	 of	 the	 protein	 in	
question	(Figure	7.10).	A	previous	investigation	found	that	the	shortest	C-terminal	
region	 of	 TssI0667	 that	 retained	 catalytic	 activity	 and	 was	 produced	 as	 a	 soluble	





























Figure	 7.10	 Diagrammatic	 representation	 of	 the	 periplasmic-expression	 construct	 pET-
22b(+).	 Image	 showing	 a	 plasmid	 map	 of	 the	 T7lac	 periplasmic	 expression	 vector	 pET-
22b(+),	illustrating	the	restriction	sites	in	the	MCS	and	the	location	of	the	T7	promoter	and	
pelB	 coding	 sequence	 (top).	 The	expression	 region	of	 the	plasmid	 (bottom)	 indicates	 the	
presence	of	the	coding	sequencing	for	the	PelB	signal	sequence.	This	sequence	allows	Sec-
dependent	 targeting	 of	 the	 overproduced	 protein	 into	 the	 periplasm	 of	 host	 cells	 if	 the	





BCAS0667PLAForNcoI	 and	 BCAS0667PLARevXhoI,	 and	 BCAS0667PLAFor2NcoI	 and	
BCAS0667PLARevXhoI,	 generating	 DNA	 fragments	 of	 848	 bp	 and	 824	 bp,	
respectively	 (the	 latter	 shown	 in	 Figure	 7.11A).	 DNA	 fragments	 BCAS0667.CTD265	





Rev.	 Clones	 that	 gave	 rise	 to	 the	 expected	DNA	 fragment	 size	were	 subjected	 to	
plasmid	isolation	and	size	analysis	following	electrophoresis	(pHLS13	clones	shown	
in	Figure	7.11B),	and	then	confirmed	by	DNA	sequencing.		
A	 pET-22b(+)	 derivative	 specifying	 a	 catalytically	 inactive	 version	 of	 the	
Tle6258	domain	 of	 TssI0667	was	 also	 generated	 to	 act	 a	 negative	 control	 in	 toxicity	
experiments.	A	previous	study	identified	three	residues	in	the	Tle6	region	essential	
for	 catalysis,	 including	 S879	 (numbered	 from	 the	 N-terminus	 of	 TssI0667)	 (Jones,	
2012).	 A	 previously	 generated	 plasmid	 encoding	 a	 S879A	 substitution	 mutant	 of	
Tle6258	was	used	as	template	DNA	in	a	PCR	reaction	using	the	primer	pair	specified	
from	the	coding	region	of	BCAS0667.CTD258	described	above,	to	generate	the	DNA	
fragment	 BCAS0667.CTD258	 S879A	 (Figure	 7.11A).	 This	 fragment	 was	 then	 cloned	
into	 pET-22b(+)	 as	 above,	 to	 generate	 the	 plasmid	 pHLS14	 (Figure	 7.11B).	 The	
plasmid	was	 confirmed	by	DNA	 sequencing.	 It	 is	 important	 to	note	here	 that	 the	
resulting	 DNA	 fragments	 derived	 from	 the	 B.	 cenocepacia	 Pc715j-based	




7.4.2 Effect	 of	 periplasmic	 production	 of	 the	TssI0667	 Tle6	domain	 on	E.	
coli	
To	 understand	 whether	 presence	 of	 the	 Tle6	 domain	 of	 TssI0667	 in	 the	




















Figure	 7.11	 Construction	 of	 pET-22b(+)	 plasmids	 specifying	 overproduction	 of	
periplasmically	 located	 TssI0667	 Tle6	domain	derivatives.	DNA	fragments	encoding	 the	C-
terminal	258	amino	acid	of	TssI0667	were	amplified	from	H111	genomic	DNA	and	a	plasmid	
containing	a	S789	mutant	copy	of	BCAS0667.CTD258	and	ligated	between	the	NcoI	and	XhoI	





























cells	 BL21(DE3)/pLysS.	 Liquid	 cultures	 were	 grown	 to	 mid-log	 phase	 and	
recombinant	proteins	induced	by	addition	of	IPTG.	The	optical	densities	(at	600nm)	
of	 the	 cultures	were	monitored	at	 specific	 time-points	pre-	 and	post-induction	 to	
infer	 the	 level	of	 lysis	occurring	 in	 the	 cultures	 (Section	2.9.2).	 Figure	7.12	 shows	
the	 resulting	optical	densities	 recorded	after	 induction	of	periplasmically	 targeted	








cultures	 were	 subjected	 to	 SDS-PAGE	 and	 western	 blot	 analysis.	 The	 resulting	
Coomassie	blue	stained	gel	revealed	that	no	obvious	protein	corresponding	to	the	
Tle6	 domains	 was	 present	 in	 the	 induced	 cultures	 (Figure	 7.13A).	 However,	 the	
presence	 of	 the	 correct	 sized	 product	 in	 the	 appropriate	 induced	 samples	 was	
apparent	 on	 an	 anti-TssI0667.CTD	 western	 blot	 (Figure	 7.13B).	 The	 expected	
molecular	 mass	 of	 each	 protein	 was	 approximately	 27	 kDa	 without	 the	 signal	
sequence	 and	 29	 kDa	with	 the	 signal	 sequence.	 Proteins	were	 detected	 at	 these	
two	expected	sizes	 in	the	 induced	cultures,	as	well	as	a	slightly	smaller	protein	at	




Furthermore,	 samples	 of	 spent	 culture	 supernatant	were	 taken	 at	 regular	
intervals	 from	 uninduced	 and	 induced	 cultures	 containing	 the	 periplasmic	
expression	 plasmids	 described	 above	 and	 subjected	 to	 DOC-TCA	 precipitation.	

























E.	 coli.	 pET22b(+)	 derivatives	 specifying	 overproduction	 of	 periplasmically	 located	 Tle6	
domains	of	TssI0667	were	introduced	into	BL21(DE3)/pLysS,	grown	in	BHI-broth	to	an	OD600	
of	 0.8	 and	 then	 induced	 with	 1	 mM	 IPTG	 (final	 conc.)	 or	 left	 uninduced.	 	 Following	
induction	 culture	 optical	 densities	 were	 measured	 at	 30-minute	 intervals	 over	 a	 3-hour	
period.	 (A)	 The	 results	 of	 periplasmic	 targeting	 of	 Tle6265,	 Tle6258	 and	 Tle6258	 S879A	 or	
empty	pET-22b(+)	vector,	as	 indicated.	 (B)	The	optical	densities	of	corresponding	cultures	
from	 (A)	 without	 the	 inducer	 added,	 as	 indicated.	 Points	 represent	 average	 OD600	 value	
where	n≥3	and	error	bars	=	±SD.	
A	















































TssI0667.	 pET22b(+)	 derivatives	 specifying	 overproduction	 of	 periplasmically	 located	 Tle6	
domains	 of	 TssI0667	 were	 introduced	 into	 BL21(DE3)/pLysS	 and	 resulting	 cultures	 were	
induced	with	1	mM	IPTG.	 (A)	SDS-PAGE	analysis	of	uninduced	(-)	and	induced	(+)	cultures	
containing	 pHLS12,	 encoding	 Tle6265,	 pHLS13,	 encoding	 Tle6258	 and	 pHLS14,	 encoding	
Tle6258	 S879A	and	empty	pET-22b(+)	 vector	 control,	 as	 indicated	above	 the	 lanes.	M,	 EZ-
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following	 induction	 of	 periplasmically	 targeted	 Tle6	 domain	 of	 TssI0667	 than	what	
was	detected	in	uninduced	and	vector	controls,	which	increased	over	the	induction	
period	 (Figure	7.14).	 	 This	 implied	 that	 a	 significant	 amount	of	 host	 cell	 lysis	was	
occurring,	mirroring	the	observed	decreasing	culture	optical	densities.		
	
7.4.3 Effect	of	 intracellular	production	of	 the	TssI0667	Tle6	domain	on	E.	
coli	
To	 investigate	 whether	 cytoplasmic	 targeting	 of	 the	 Tle6	 phospholipase	
domain	 of	 TssI0667	 exerted	 an	 effect	 on	 the	 viability	 of	 bacterial	 cells,	 previously	
generated	pET-28a-derivatives	encoding	wild-type	and	S879A	versions	of	 the	Tle6	
domain	of	TssI0667	 (Jones,	2012)	were	 introduced	 into	 the	E.	coli	expression	strain	
BL21(DE3)/pLysS.	 Cultures	 containing	 the	 expression	 plasmids	 were	 induced	 and	
the	 culture	 optical	 densities	 monitored	 (Section	 2.9.2).	 The	 results	 indicate	 that	
intracellular	targeting	of	either	the	wild-type	or	S879	mutant	versions	of	Tle6258	had	
no	effect	of	the	growth	of	E.	coli	cells	(Figure	7.15).		
Uninduced	and	 induced	whole	cells	 lysates	of	 cultures	containing	 the	pET-
28a-derived	expression	vectors	encoding	wild-type	and	S879A	versions	of	the	Tle6	
domain	of	 TssI0667	 described	 above	were	 also	 analysed	by	 SDS-PAGE	and	by	 anti-
TssI0667.CTD	western	blotting	to	determine	whether	the	desired	protein	was	being	
produced	 in	 the	 induced	 cultures.	 The	 resulting	 Coomassie	 blue	 stained	 gel	 and	
corresponding	western	blot	shows	clear	accumulation	of	a	27	kDa	protein	 in	cells	
containing	 plasmids	 specifying	 both	 wild-type	 and	 S879A	 versions	 of	 the	 Tle6	
domains	 of	 TssI0667	 following	 induction	 (Figure	 7.16).	 Therefore,	 even	 though	 a	
significantly	greater	amount	of	TssI0667	Tle6	accumulated	in	the	cell	than	that	what	
occurred	 following	 periplasmic	 targeting,	 intracellular	 expression	 was	 still	 not	



























periplasmically	 targeted	 TssI0667	 Tle6	 domain.	 The	 spent	 culture	 supernatants	 from	
BL21(DE)pLysS	 cells	 harbouring	 an	 expression	 vector	 specifying	 periplasmically	 targeted	
TssI0667	 Tle6265	 domain,	 pHLS12,	 and	empty	pET-22b(+)	 vector,	were	 taken	at	 30,	 90,	 160	
and	200	minutes	post-induction,	subjected	to	DOC-TCA	precipitation	and	concentrated	50-
fold.	 Samples	 were	 then	 separated	 by	 SDS-PAGE	 and	 gels	 were	 stained	 with	 Coomassie	
blue.	 (A)	 The	 resulting	 protein	 samples	 from	uninduced	 and	 induced	 cultures	 harbouring	
pHLS12,	encoding	Tle6265,	as	 indicated.	Black	underline	bracket	 indicates	 induced	samples	



























































E.	 coli.	 pET-28a(+)	 derivatives	 specifying	 overproduction	 of	 cytoplasmically	 located	 Tle6	
domains	of	TssI0667	were	introduced	into	BL21(DE3)/pLysS,	grown	in	BHI-broth	to	an	OD600	
of	0.8	and	then	induced	with	1	mM	IPTG	(final	conc.)	or	left	uninduced.	Following	induction	
culture	 optical	 densities	were	measured	 at	 30-minute	 intervals	 over	 a	 3-hour	 period.	 (A)	
The	 results	 of	 cytoplasmic	 targeting	 of	 Tle6258	 and	 Tle6258	 S879A	 domains	 of	 TssI0667	 or	
empty	pET-28a(+)	vector,	as	 indicated.	 (B)	The	optical	densities	of	corresponding	cultures	



























































TssI0667.	 pET-28a(+)	 derivatives	 specifying	 overproduction	 of	 cytoplasmically	 located	 Tle6	
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 Analysis	 of	 Tli6	 as	 a	 potential	 immunity	 protein	 to	 the	7.5
T6SS-dependent	effector	TssI0667	
	 Many	 T6SS	 effector	 have	 cognate	 immunity	 proteins/antitoxins,	 as	
discussed	in	Section	1.5.	They	are	thought	to	inhibit	the	toxic	activity	of	the	effector	
protein	 to	 prevent	 self-killing	 from	 within	 and	 prevent	 killing	 of	 surrounding	
bacteria	of	the	same	species	by	the	toxic	effector.		
	 It	was	hypothesised	that	BCAS0666	encoded	the	cognate	immunity	protein	
for	 TssI0667,	 as	 the	 gene	 is	 situated	 adjacent	 to	 BCAS0667	 in	 the	 B.	 cenocepacia	
genome	and	the	protein	product,	termed	Tli6,	was	predicted	to	be	periplasmically	
localised	due	 to	 the	presence	of	 an	N-terminal	 Sec-dependent	 signal	peptide	and	
contain	 ankyrin	 repeat	 motifs,	 known	 to	 be	 important	 for	 protein-protein	
interactions.	 Therefore	 it	 was	 decided	 to	 investigate	 whether	 Tli6	 was	 able	 to	
inhibit	the	toxic	effect	of	targeting	TssI0667	to	the	periplasmic	compartment.	
	
7.5.1 Construction	 of	 ColE1-compatible	 expression	 plasmid	 for	
production	of	Tli6	in	E.	coli	
	 To	 facilitate	 expression	 of	 the	 gene	 encoding	 Tli6	 with	 it	 corresponding	
effector	 encoding	 gene	 BCAS0667,	 BCAS0666	 was	 cloned	 into	 pSCrhaB2,	 a	
rhamnose-inducible	 pBBR1-based	 replicon	 that	 is	 compatible	 with	 the	 ColE1-like	
origin	 of	 replication	 of	 pET-22b(+).	 The	 coding	 region	 of	 BCAS0666	 (including	 the	
signal	peptide	coding	sequence)	was	amplified	from	H111	genomic	DNA	using	the	
primers	 BCAS0666ForNdeI	 and	 BCAS0666RevXbaI,	 generating	 a	 DNA	 fragment	 of	
944	 bp	 (Figure	 7.17A).	 The	 product	 was	 then	 digested	 with	 NdeI	 and	 XbaI	 and	
ligated	 between	 the	 corresponding	 restriction	 sites	 of	 pSCrhaB2	 to	 generate	 the	
plasmid	 termed	pHLS15,	with	 an	 expected	 size	 of	 8423	 bp.	 Clones	were	 selected	
























Figure	 7.17	 Construction	 of	 a	 ColE1-compatible	 expression	 vector	 encoding	 Tli6.	 The	
BCAS0666	 coding	 sequence	was	 amplified	 from	H111	 genomic	 DNA	 and	 cloned	 into	 the	































effect	 of	 periplasmically	 targeted	 Tle6	 domain	 of	 TssI0667	 in	 E.	 coli.	 To	 do	 this,	
plasmids	 pHLS15,	 encoding	 Tli6,	 and	 pHLS13,	 encoding	 periplasmically	 targeted	
Tle6258	 domain	 of	 TssI0667	 were	 co-introduced	 into	 the	 expression	 strain	
BL21(DE3)/pLysS.	 pHLS13	 and	 the	 empty	 pSCrhaB2	 vector,	 and	 pHLS15	 and	 the	
empty	pET-22b(+)	vector	were	also	co-introduced	as	controls.	Liquid	cultures	were	
simultaneously	induced	with	IPTG	and	0.1%	rhamnose	and	the	optical	density	was	
monitored	 (Section	 7.4.2).	 Figure	 7.18A	 demonstrates	 that	 co-production	 of	 Tli6	
with	 the	periplasmically	 located	TssI0667	 Tle6	domain	prevented	a	decrease	 in	 the	
optical	 density	 of	 the	 culture,	 unlike	 the	 situation	 when	 Tle6	 is	 targeted	 to	 the	
periplasmic	 alone,	 which	 occurs	 following	 induction	 of	 BL21(DE3)/pLysS	 cells	
containing	 pHLS13	 and	 the	 empty	 pSCrhaB2	 vector.	 The	 growths	 of	 uninduced	
cultures	harbouring	the	expression	plasmids	were	similar	(Figure	7.18B).	
	 Production	of	Tli6	was	verified	by	SDS-PAGE	analysis	of	whole	cell	lysates	of	
cultures	 described	 above	 following	 induction	 (Figure	 7.18C).	 The	 theoretical	
molecular	mass	 of	 Tli6	 is	 31.3	 kDa	 including	 the	 Sec-dependent	 signal	 sequence,	
and	28.4	kDa	without	 it.	A	30	kDa	protein	was	observed	 in	strains	 that	contained	
pHLS15	 following	 induction,	 whereas	 it	 was	 absent	 from	 the	 strain	 harbouring	
pSCrhaB2,	 indicating	 specific	 induction	 of	 Tli6	 synthesis.	 Intriguingly,	 there	was	 a	
faint	 presence	 of	 a	 protein	 at	 approximately	 27	 kDa	 in	 the	 strain	 harbouring	
plasmids	 encoding	 both	 Tli6	 and	 periplasmically	 target	 Tli6	 domain	 of	 TssI0667	
following	 induction.	 This	 27	 kDa	was	 confirmed	 to	 the	 Tle6	 domain	of	 TssI0667	 by	




formation	between	 the	 two	proteins	 inhibits	 the	 toxic	action	of	 the	Tle6	domain.	









































































domain	 in	 E.	 coli.	 pET-22b(+)	 and	 pSCrhaB2	 derivatives	 specifying	 production	 of	
periplasmically	 located	 Tle6	 domain	 of	 TssI0667	 and	 Tli6	 were	 introduced	 into	
BL21(DE3)/pLysS	cells,	grown	in	BHI-broth	to	an	OD600	of	0.8	and	then	induced	with	1	mM	
IPTG	 and	 0.1%	 rhamnose	 (final	 conc.)	 or	 left	 uninduced.	 pHLS13	 encodes	 periplasmically	
targeted	 TssI0667	 Tl6	 domain,	 and	 pHLS15	 encodes	 Tli6.	 Following	 induction,	 the	 culture	
optical	 densities	were	measured	 at	 30-minute	 intervals	 over	 a	 3-hour	 period.	Uninduced	
and	 induced	 samples	 were	 taken	 as	 whole	 cell	 lysates	 and	 analysed	 by	 SDS-PAGE	 and	
western	 blotting.	 	 (A)	 The	 resulting	 culture	 optical	 densities	 following	 induction	 of	





























































































phospholipase	 domain	 of	 the	 latter.	 It	 was	 decided	 to	 investigate	 this	 potential	
interaction	by	pull-down	analysis.	
	
7.6.1 Construction	 of	 plasmids	 for	 overproduction	 of	 epitope-tagged	
TssI0667	Tle6	domain	and	Tli6	
	 For	 immuno-detection	 of	 potentially	 interacting	 proteins	 TssI0667	 Tle6	
domain	 and	 Tli6	 antibodies	 should	 be	 available	 for	 both	 proteins.	 To	 facilitate	
detection	 of	 Tli6	 it	 was	 decided	 to	 append	 a	 C-terminal	 triple-FLAG	 tag	 to	 the	
protein	 lacking	 its	 signal	 sequence.	 Although	 an	 antibody	 that	 specifically	
recognised	the	TssI0667.CTD	(Tle6	domain)	was	available,	it	was	necessary	to	append	
an	 affinity	 tag	 to	 the	 N-terminus	 of	 this	 protein	 for	 purification.	 This	 could	 also	
serve	as	an	epitope	 tag.	To	do	 this,	 the	coding	 sequence	of	BCAS0667.CTD	which	
encoded	 the	 C-terminal	 258	 amino	 acids	 of	 TssI0667	 was	 PCR	 amplified	 from	 the	
plasmid	 pHLS13	 using	 the	 primers	 BCAS0667PLAForBamHI	 and	
BCAS0667PLARevXhoI,	generating	a	DNA	fragment	of	824	bp.	The	coding	sequence	
of	 BCAS0666	 encoding	 mature	 (i.e.	 processed)	 Tli6	 was	 PCR	 amplified	 from	 the	
plasmid	 pHLS15	 using	 the	 forward	 primer	 BCAS0666For2NdeI	 and	 a	 long	 reverse	
primer	 that	 included	 a	 66	 bp	 coding	 sequence	 encoding	 the	 3xFLAG	 peptide	
sequence,	 BCAS0666Rev3xFLAGAcc65I,	 to	 generate	 a	 DNA	 fragment	 of	 864	 bp	
(Figure	7.19A).	The	BCAS0667.CTD	amplicon	was	digested	with	BamHI	and	XhoI	and	
successfully	 ligated	 between	 the	 BamHI	 and	 SalI	 restriction	 sites	 of	 the	 T7lac	
expression	vector	pETDuet-1,	giving	rise	to	a	6199	bp	plasmid	termed	pHLS16.	The	
BCAS0666.3xFLAG	 amplicon	 was	 digested	 with	 NdeI	 and	 Acc65I	 and	 successfully	




















tagged	 Tle6	 domain	 of	 TssI0667	 and	 Tli6.	 The	 coding	 sequence	 of	 BCAS0667.CTD	 was	
amplified	from	H111	genomic	DNA	and	cloned	between	the	BamHI-SalI	restriction	sites	of	
pETDuet-1,	 incorporating	 an	N-terminal	 His-tag	 coding	 sequence	 provided	 by	 the	 vector.	
BCAS0666	was	amplified	from	H111	genomic	DNA	using	a	reverse	primer	containing	a	DNA	
sequence	encoding	a	3xFLAG	epitope	tag,	and	cloned	between	the	NdeI-Acc65I	restriction	
sites	 of	 pETDuet-1.	 (A)	 Successful	 PCR	 amplification	 of	 BCAS0667.CTD	 and	
BCAS0666.3xFLAG	 DNA	 fragments	 using	 the	 stated	 annealing	 temperature,	 as	 indicated,	
visualised	following	electrophoresis	in	a	0.8%	agarose	gel.	Upper	arrow	indicates	expected	
DNA	 fragment	 size	 of	 BCAS0667.3xFLAG,	 and	 lower	 arrow	 indicates	 BCAS0667.CTD	 DNA	
fragment.	–ve,	no	DNA	negative	control;	M,	GeneRuler	DNA	ladder	mix.	(B)	Size	analysis	of	
































































A	 dual	 expression	 plasmid	 was	 then	 constructed	 to	 direct	 high-level	
synthesis	 of	 N-terminally	 His-tagged	 Tle6	 domain	 of	 TssI0667	 and	 C-terminally	
3xFLAG	 tagged	 Tli6	 from	 the	 same	 plasmid.	 This	was	 successfully	 constructed	 by	
digesting	pHLS16	with	NdeI	and	Acc65I,	and	ligating	in	to	the	BCAS0666.3xFLAG	PCR	
amplified	 DNA	 fragment	 cut	 with	 the	 same	 restriction	 enzymes,	 giving	 rise	 to	 a	
7006	bp	plasmid,	pHLS18.			
	
7.6.2 Overproduction	 and	 solubility	 of	His6.Tle6	 domain	 of	 TssI0667	 and	
Tli6.3xFLAG	
	 It	 was	 first	 required	 to	 determine	 whether	 the	 plasmids	 described	 above	
provided	sufficient	expression	for	overproduction	of	soluble	protein	to	be	used	in	a	
pull-down	 assay.	 Therefore	 constructs	 pHLS16,	 pHLS17	 and	 pHLS18	 were	
introduced	separately	 into	E.	coli	BL21(DE3)/pLysS,	and	subjected	 to	a	 small	 scale	
test	induction.	Strains	where	induced	with	1	mM	IPTG	at	37°C	for	3	hours	(Section	
2.3.1).	 Whole	 cell	 lysates	 where	 then	 analysed	 by	 SDS-PAGE.	 The	 expected	
molecular	masses	of	the	His6.Tle6	domain	of	TssI0667	and	Tli6.3xFLAG	are	27.8	kDa	
and	 31.2	 kDa,	 respectively.	 Figure	 7.20	 shows	 the	 resulting	 SDS-PA	 gel.	 The	
presence	 of	 proteins	 of	 the	 expected	 size	 can	 be	 clearly	 observed	 in	 all	 induced	




7.6.3 Analysis	 of	 the	 interaction	between	TssI0667	His6.Tle6	domain	 and	
Tli6.3xFLAG	by	a	pull-down	assay	
	 For	 detection	 of	 interactions	 between	 the	 Tle6	 phospholipase	 domain	 of	
TssI0667	 and	 its	 putative	 immunity	 protein	 Tli6	 a	 pull-down	 assay	 was	 performed	
(Section	2.7.1).	A	cleared	lysate	containing	soluble	His6.Tle6	domain	of	TssI0667	was	
obtained	and	this	His-tagged	bait	protein	was	immobilised	onto	nickel	affinity	resin.	
After	 subsequent	wash	 steps,	 a	 cleared	 lysate	 containing	 soluble	Tli6.3xFLAG	was	



















Figure	 7.20	 Analysis	 of	 overproduction	 of	 His6.Tle6	 domain	 of	 TssI0667	 and	 Tli6.3xFLAG	
from	 pETDuet-1	 based	 constructs.	 Expression	 plasmids	 pHLS18,	 specifying	 the	
overproduction	 of	 both	 His6.Tle6	 domain	 of	 TssI0667	 and	 Tli6.3xFLAG,	 pHLS16,	 specifying	
His6.Tle6	 domain	 of	 TssI0667	 alone	 and	 pHLS17,	 specifying	 Tli6.3xFLAG	 alone	 were	
introduced	 into	 BL21(DE3)/pLysS	 cells	 separately.	 Liquid	 cultures	 were	 grown	 to	mid-log	
phase	 and	 induced	 with	 1	 mM	 IPTG	 for	 3	 hours	 at	 37°C.	 Samples	 of	 uninduced	 (-)	 and	
induced	cells	 (+)	were	analysed	by	SDS-PAGE	on	a	12%	SDS-PA	gel.	The	 resulting	gel	was	
visualised	 by	 Coomassie	 blue	 staining,	 samples	were	 loaded	 as	 indicated.	M,	 EZ-Run	Rec	
protein	ladder,	labelled	arrows	indicate	the	identity	of	induced	proteins.	
	
















addition	of	a	high	 concentration	of	 imidazole.	 Samples	were	 fractionated	by	SDS-
PAGE,	and	analysed	by	both	Coomassie	blue	staining	and	western	blotting	followed	
by	 probing	 with	 anti-His	 and	 anti-FLAG	 antibodies	 (Figure	 7.21).	 It	 was	 observed	
that	His6.Tle6	domain	of	TssI0667	was	able	to	bind	to	the	nickel	resin	and	was	eluted	
by	 the	 addition	 of	 500	 mM	 imidazole.	 In	 agreement	 with	 the	 hypothesis,	
Tli6.3xFLAG	 was	 retained	 on	 the	 nickel	 resin	 that	 was	 pre-loaded	 with	 His6.Tle6	
domain	of	 TssI0667	 but	 did	 not	 bind	 to	 the	 resin	 in	 the	 absence	of	 the	His-tagged	
Tle6	domain.	Upon	elution	of	bound	His6.Tle6	 that	had	 retained	Tli6.3xFLAG	with	
500	mM	imidazole	Tli6.3xFLAG	was	also	co-eluted.		
	 A	 pull-down	 of	 Tli6.3xFLAG	with	 the	 His6.Tle6	 domain	 of	 TssI0667	 was	 also	
performed	using	a	 cleared	 lysate	 that	 contained	both	His6.Tle6	domain	of	TssI0667	
and	 Tli6.3xFLAG	 that	 was	 obtained	 following	 induction	 of	 BL21(DE)/pLysS	 cells	
containing	 the	 co-expression	 vector	 pHLS18.	Here,	 the	 lysate	was	 incubated	with	
nickel	affinity	resin	to	allow	binding	of	the	His6.Tle6-Tli6.3xFLAG	complex	directly	to	
the	 resin,	 and	 then	 subsequently	 eluted	 with	 500	 mM	 imidazole.	 The	 resulting	
samples	 were	 fractionated	 by	 SDS-PAGE	 and	 then	 analysed	 following	 Coomassie	
blue	 staining	 (Figure	 7.21C)	 and	 western	 blotting	 (Figure	 7.21D),	 as	 described	

























































































































































































down	 assays.	 His6.Tle6	 domain	 of	 TssI0667	 and	 Tli6.3xFLAG	 were	 overproduced	 in	
BL21(DE3)/pLysS	cells	harbouring	pHLS16	and	pHLS17,	respectively.	The	cleared	lysate	from	
induced	cultures	of	overproduced	His6.Tle6	was	bound	to	nickel	affinity	resin,	and	washed.	
Following	 this	 the	 induced	 cell	 lysate	 containing	 Tli6.3xFLAG	 was	 added	 to	 the	 resin	
containing	 the	 immobilised	His6.Tle6,	washed	 and	 then	bound	proteins	were	 eluted	with	
500	mM	 imidazole	buffer.	 Immobilisation	of	His6.Tle6	and	Tli6.3xFLAG	only	controls	were	
included.	Load	flow-through	(FT),	wash	and	imidazole	eluate	samples	from	each	stage	were	
separated	 by	 SDS-PAGE	 and	 visualised	 by	 Coomassie	 blue	 staining	 and	 by	 anti-His6	 and	
anti-FLAG	 western	 blotting.	 (A)	 Resulting	 Coomassie	 blue	 stain	 of	 His6.Tle6	 and	 Tli6	 pull	
down	 (left)	 and	 His6.Tle6	 and	 Tli6	 only	 controls	 (right),	 as	 indicated.	 (B)	Western	 blot	 of	
samples	 in	 (A)	 following	 probing	with	 anti-FLAG	 and	 anti-His	 antibodies	 as	 indicated.	 (C)	
Resulting	 Coomassie	 blue	 stain	 of	 samples	 from	 pull-down	 assay	 that	 used	 a	 lysate	
containing	 both	 His6.Tle6	 domain	 of	 TssI0667	 and	 Tli6.3xFLAG	 produced	 from	 pHLS18.	
Samples	loaded	as	indicated	above	the	lanes.	(D)	Western	blot	of	samples	in	(C)	following	
probing	 with	 anti-FLAG	 and	 anti-His	 antibodies	 as	 indicated.	 Labelled	 arrows	 indicate	






























































 Analysis	 of	 the	 oligomeric	 status	 of	 the	 TssI0667	 Tle6–Tli6	7.7
complex	
	 The	 pull	 down	 assay	 results	 described	 in	 Section	 7.6	 indicated	 a	 direct	
complex	 was	 formed	 between	 TssI0667	 Tle6	 domain	 and	 the	 putative	 immunity	




	 Larger	 and	 purer	 quantities	 of	 the	 complex	 formed	 between	 the	 Tle6	
domain	of	 TssI0667	 and	 Tli6	were	 required	 for	 downstream	 investigations	 into	 the	
characteristics	of	 the	complex.	To	do	 this,	a	previously	generated	dual	expression	
plasmid	 (Hedayat	 and	 Thomas,	 unpublished)	 encoding	 the	 C-terminal	 267	 amino	
acids	 of	 TssI0667	 with	 a	 hexa-histidine	 tag	 located	 at	 the	 N-terminus,	 and	 an	
untagged	version	of	Tli6	without	 its	 signal	 sequence	was	used,	 termed	pSH1.	This	
plasmid	 was	 introduced	 into	 BL21(DE3)/pLysS	 cells,	 and	 protein	 synthesis	 was	
induced	with	1	mM	IPTG	for	3	hours	at	37°C.	Protein	overproduction	and	protein	
solubility	 of	 the	 overproduced	 proteins	were	 determined	 following	 separation	 by	




not	 impossible,	 to	 resolve	 the	 two	 proteins	 by	 SDS-PAGE.	 Confirming	 previous	





eluted	 at	 a	 concentration	 of	 75	 mM	 imidazole	 (data	 not	 shown).	 Fractions	
containing	 eluted	 proteins	 were	 analysed	 by	 SDS-PAGE	 to	 determine	 protein	




















Figure	 7.22	 Overproduction	 and	 purification	 of	 His6.Tle6-Tli6	 complex	 by	 IMAC.	 pSH1,	
encoding	 His6.Tle6	 domain	 of	 TssI0667	 and	 untagged	 Tli6,	 was	 introduced	 into	
BL21(DE3)/pLysS	 cells.	 The	 strain	 was	 grown	 to	mid-log	 phase	 in	 BHI-broth	 and	 plasmid	
encoded	 protein	 synthesis	 was	 induced	 with	 1	 mM	 IPTG	 at	 37°C	 for	 3	 hours,	 following	
which	 cultures	 were	 lysed	 and	 sonicated	 as	 standard	 procedure.	 The	 lysate	 was	 then	
loaded	on	a	1	mL	His-trap	column	(load),	washed	(wash)	and	then	bound	material	eluted	by	
addition	 of	 a	 10-500	mM	 imidazole	 gradient	 using	 an	 ÄKTA	 FPLC	 system.	 (A)	 Coomassie	
blue	stained	12%	SDS-PA	gel	of	cell	extracts	from	uninduced	(-)	and	induced	(+)	cultures	of	
BL21(DE3)pLysS/pSH1	 cells,	 and	 the	 resulting	 total	 (T)	 and	 soluble	 protein	 fractions	 (S)	
following	 lysis.	 (B)	Coomassie	blue	stained	SDS-PA	gel	of	eluted	His6.Tl6-Tli6	samples	 (A3-














































concentrated	 and	 the	 buffer	 exchanged	 to	 50	mM	Tris-HCl	 pH	 7.5	 using	 a	 10000	





	 A	 sample	 of	 the	 TssI0667	 His6.Tle6-Tli6	 complex,	 purified	 as	 described	 in	
Section	 7.7.1	 was	 subjected	 to	 size	 exclusion	 chromatography	 to	 estimate	 the	
oligomeric	size	of	 the	complex.	Using	a	Superose	12	10/300	GL	column	calibrated	
with	standards	of	a	known	molecular	weight	(Figure	7.23A),	100	µL	of	the	sample	





the	 standards	 used,	 indicated	 by	 red	 data	 point	 in	 Figure	 7.23A.	 The	 theoretical	
molecular	mass	of	a	1:1	complex	of	the	His6.Tle6	domain	of	TssI0667	to	Tli6	 is	57.3	




































Figure	 7.23	Analysis	 of	 TssI0667	His6.Tle6-Tle6	 complex	 by	 SEC.	100	µL	of	purified	TssI0667	
His6.Tle6-Tle6	 complex	 was	 subjected	 to	 SEC	 using	 a	 Superose	 12	 10/300	 GL	 column	
coupled	to	an	ÄKTA	purifier	FPLC	system	with	a	flow	rate	of	0.5	mL/min.	(A)	A	calibration	
curve	 generated	 from	 the	 elution	 of	 protein	 standards,	 presented	 as	 experimentally	
determined	Kav	values	(x	axis)	against	the	known	molecular	weight	(y	axis)	of	each	standard,	
fit	with	a	semi-log	regression	curve,	with	the	equation	as	indicated.	(B)	Representative	A280	






























 Characterisation	 of	 a	 putative	 T6SS-dependent	7.8
peptidoglycan	hydrolase	effector	encoded	by	I35_5786	
Bioinformatic	analysis	of	genes	located	downstream	of	tssI	orthologues	in	B.	
cenocepacia	 J2315	 suggested	 that	 BCAL1166	 encoded	 a	 T6SS-dependent	 effector	
(Section	 3.4.1).	 This	 putative	 effector	 gene	 is	 located	 downstream	 of	 a	 tssI	
orthologue	 BCAL1165,	 which	 encodes	 TssI1165.	 The	 corresponding	 gene	 in	 B.	





proteins	 are	 predicted	 to	 contain	 an	 N-terminal	 region	 containing	 an	 M23-like	
metallo-peptidase	domain,	which	is	dispersed	in	the	BCAL1166-encoded	product,	a	
conserved	 domain	 of	 unknown	 function	 that	 is	 shared	 by	 both	 proteins	 and	 a	 C-
terminal	 region	 containing	 a	 lysozyme-like	 superfamily	 (cl00222)	 domain	 (Figure	
7.24).	The	product	of	I35_5786	contained	a	conserved	HxH	motif	found	in	the	M23	
family	of	metallo-peptidases.	The	first	histidine	of	this	motif	is	the	thought	to	be	the	
active	 site	 residue	 and	 the	 latter	 histidine	 is	 required	 for	 metal	 ion	
binding/coordination,	 as	 experimentally	 defined	by	 the	M23	peptidase-containing	
autolysin	 protein	 LytM	 in	 S.	 aureus	 (Odintsov	 et	 al.,	 2004;	 Firczuk	 et	 al.,	 2005).	
Additional	 conserved	 histidine	 and	 aspartate	 residues	 in	 the	 M23	 peptidase-like	
domain	may	be	also	be	involved	in	metal	ion	co-ordination	(Odintsov	et	al.,	2004).	
The	 product	 of	 BCAL1166	 is	 predicated	 to	 contain	 an	 additional	 SH3	 domain,	
thought	 to	 be	 important	 for	 protein-protein	 interactions,	 and	 the	 I35_5787	
encoded	protein	contains	an	additional	DUF	domain	that	is	not	present	in	the	other	
protein.	 Interestingly,	 the	 dual	 feature	 of	 a	M23	 family	metallopeptidase	 domain	
and	 a	 lysozyme-like	 domain	 has	 also	 been	 observed	 in	 the	 cell-wall	 degrading	
enzyme	of	bacteriophage	φ29,	the	tail	protein	Gp13	(Xiang	et	al.,	2008).	







































Bcc	member	B.	ambifaria,	 but	 it	 also	 included	 several	Yersinia	 species,	 such	as	Y.	
pestis	 (not	shown).	 Intriguingly,	alignment	of	 these	homologous	proteins	with	 the	
proteins	encoded	by	I35_5786	and	BCAL1166	indicated	that	whilst	regions	of	the	N-
terminus	showed	some	sequence	identity,	the	C-terminal	domains	were	divergent	
even	 though	 all	 proteins	 were	 predicted	 to	 contain	 a	 lysozyme-like	 superfamily	
domain	at	the	C-terminus.	Furthermore,	it	was	noted	that	many	of	the	genes	that	





confer	 glycoside	 hydrolase/muramidase	 activity	 at	 their	 C-terminus	 via	 the	
lysozyme-like	 domain.	 This	 is	 due	 to	 the	 known	 substrate	 specificity	 of	 other	
lysozyme-like	 proteins,	 including	 the	 Tge	 effector	 superfamily	 (Whitney	 et	 al.,	
2013),	 which	 hydrolyse	 the	 β-(1,4)-glycosidic	 bond	 between	N-acetylglucosamine	
and	N-acetylmuramic	acid	in	the	glycan	backbone	(Figure	1.8,	Section	1.5).		Second,	
they	 may	 also	 specify	 amidase/peptidase	 activity	 through	 their	 N-terminal	 M23	
peptidase	domain,	which	has	been	shown	to	cleave	amide	bonds	in	peptidoglycan	
at	peptide	cross-links	 (Firczuk	et	al.,	2005).	Due	to	the	predicted	muramidase	and	
amidase	 features	 of	 these	 effectors	 these	 proteins	 shall	 be	 designated	 Tpe1	 and	
Tpe2	 (type	 VI	 peptidoglycan	 hydrolase	 effector)	 for	 the	 protein	 products	 of	
I35_5786	and	BCAL1166,	respectively.	Thus	from	herein	the	I35_5786	gene	will	be	
referred	to	as	tpe1,	and	subsequently,	DNA	fragments	encoding	the	N-terminus	of	
tpe1	 will	 be	 referred	 to	 as	 tpe1.NTD	 and	 the	 C-terminus	 as	 tpe1.CTD.	Note	 the	
putative	 effectors	 cannot	 be	 assigned	 to	 either	 of	 the	 current	 T6SS-dependent	
superfamilies	 of	 peptidoglycan	 hydrolase	 effectors,	 the	 glycoside	 hydrolase	 (Tge)	







the	 individual	N-	 and	 C-terminal	 regions,	 specifying	 the	 predicted	M23	 peptidase	
region	and	the	lysozyme-like	region,	respectively.		
	
7.8.1 Construction	 of	 plasmids	 for	 overproduction	 of	 epitope-tagged	
Tpe1	derivatives	
The	coding	sequences	of	full-length	tpe1,	and	the	N-	and	C-terminal	coding	
regions	of	 the	gene	were	cloned	 into	 the	T7lac	expression	vector	pETDuet.	To	do	
this,	 full-length	 tpe1	 was	 amplified	 from	 H111	 genomic	 DNA	 using	 primers	
BCAL1166ForNtermHisNcoI	and	BCAL1166CTDRevXhoI,	generating	a	DNA	fragment	
of	 2493	 bp.	 The	 forward	 primer	 for	 this	 amplification	 contained	 the	 coding	
sequence	of	 a	hexa-histidine	 tag	 (encoding	 the	peptide	MGSSHHHHHHS)	allowing	
incorporation	of	this	coding	sequence	into	the	N-terminus	of	the	coding	sequence	
of	tpe1.	The	N-terminal	coding	sequence,	specifying	the	N-terminal	239	codons	of	
tpe1,	 was	 amplified	 using	 primers	 BCAL1166NTDForNtermHisBglII	and	
BCAL1166NTDRevHindIII,	 giving	 rise	 to	a	DNA	 fragment	of	741	bp.	The	C-terminal	









product	 of	 the	 coding	 sequence	 of	 tpe1.CTD	 was	 digested	with	 BamHI	 and	 XhoI,	
where	 it	 was	 then	 ligated	 into	 pETDuet-1	 cut	 with	 BamHI	 and	 SalI,	 generating	 a	
6114	bp	plasmid,	termed	pHLS21.	Transformants	containing	recombinant	plasmids	
of	 the	 desired	 size	were	 identified	 by	 PCR	 colony	 screening	 using	 vector	 specific	






















Figure	 7.25	 Size	 analysis	 of	 pETDuet-1	 derivative	 encoding	 epitope-tagged	 Tpe1,	
Tpe1.NTD	 and	 Tpe1.CTD.	 Transformants	 containing	 pHLS19,	 pHLS20	 and	 pHLS21	 were	
selected	 for	 plasmid	 isolation	 by	 mini-preparation,	 and	 the	 resulting	 plasmids	 were	
electrophoresis	 in	0.8%	agarose	gel,	 as	 indicated.	Upper	arrow	 indicates	expected	 size	of	

















































derivatives	 are	 produced	 as	 soluble	 proteins,	 induced	 cultures	 of	 BL21(DE3)	 cells	
harbouring	pHLS19,	pHLS20	and	pHLS21	were	 lysed	as	described	 in	Section	2.3.2,	
and	 the	 total,	 soluble	and	 insoluble	protein	 fractions	were	 then	analysed	by	SDS-
PAGE.	 The	 results	 shown	 in	 Figure	 7.27	 indicated	 that	 for	 cultures	 grown	 and	
induced	at	37°C	all	three	overproduced	proteins	were	insoluble,	as	they	were	only	
present	in	the	total	and	insoluble	fractions.	To	try	to	improve	protein	solubility	the	
induction	 was	 performed	 at	 a	 lower	 temperature	 (30°C)	 and	 with	 a	 reduced	
concentration	of	 inducer	 (100	µM	IPTG).	However,	all	 three	recombinant	proteins	
remained	in	the	insoluble	fraction	(data	not	shown).				
As	Tpe1	contains	nine	cysteine	residues,	and	it	likely	to	be	delivered	to	the	
periplasmic	 compartment	 of	 a	 target	 cell,	 it	 may	 contain	 disulphide	 bonds	 in	 its	
tertiary	 structure.	 	 Therefore,	 another	 strategy	was	 undertaken	 in	 an	 attempt	 to	
improve	protein	solubility.	This	involved	the	use	of	a	commercially	available	E.	coli	

























were	 grown	 to	 mid-log	 growth	 phase	 in	 BHI	 broth	 and	 then	 plasmid-encoded	 protein	
synthesis	was	induced	with	1	mM	IPTG	at	30°C	or	37°C	for	3	hours.	Image	shows	SDS-PAGE	
analysis	 of	 lysates	 from	 uninduced	 (-)	 and	 induced	 (+)	 cultures,	 as	 indicated.	 Labelled	
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Figure	 7.27	 Analysis	 of	 His6.Tpe1,	 His6.Tpe1.NTD	 and	 His6.Tpe1.CTD	 solubility	 following	
overproduction	 in	 BL21(DE3).	 Cultures	 of	 BL21(DE3)	 cells	 containing	 plasmids	 pHLS19,	
pHLS20	 and	 pHLS21,	 specifying	 overproduction	 of	 His6.Tpe1,	 His6.Tpe1.NTD	 and	
His6.Tpe1.CTD,	 respectively,	were	 induced	with	 1	mM	 IPTG	 at	 37°C	 for	 3	 hours.	 Cultures	
were	lysed	as	standard	protocol,	and	the	resulting	whole	cell	extracts,	total	(T),	soluble	(S)	
and	 insoluble	 (P)	 protein	 fractions	 from	 uninduced	 (-)	 and	 induced	 (+)	 cultures	 were	










































cells.	 This	 E.	 coli	 strain	 carries	 nulls	 mutations	 in	 two	 genes	 encoding	 reductase	
enzymes,	 trxB	 and	 gor,	 a	 gene	 for	 the	 cytoplasmic	 targeting	 of	 disulphide	 bond	
isomerase	DsbC,	and	a	gene	 that	encodes	a	 suppressor	mutant	of	 the	peroxidase	
AhpC	 that	 reinstates	 the	 viability	 of	 the	 cells	 (Derman	 et	 al.,	 1993;	 Ritz,	 2001;	
Lobstein	et	al.,	2012).	This	set	of	conditions	 favours	redox	enzymes	(thioredoxins)	
to	 be	 in	 an	 oxidized	 stated,	 meaning	 they	 confer	 oxidation	 activity	 rather	 than	
reductase	 activity	 (Stewart	 et	 al.,	 1998),	which	 in	 turn	promotes	 the	oxidation	of	
sulfhydryl	 groups,	 generating	 stable	 disulphide	 bonds	 in	 the	 cytoplasm.	
Unfortunately,	use	of	this	expression	strain	did	not	improve	the	solubility	of	any	of	
the	Tpe1	recombinant	proteins	(Figure	7.28).	Other	strategies	for	producing	soluble	
Tpe1	 were	 not	 tested	 due	 to	 more	 fruitful	 areas	 of	 this	 study	 taking	 priority.	
























Figure	 7.28	 Analysis	 of	 His6.Tpe1,	 His6.Tpe1.NTD	 and	 His6.Tpe1.CTD	 solubility	 following	




(T),	 soluble	 (S)	 and	 insoluble	 (P)	 protein	 fractions	 from	 uninduced	 (-)	 and	 induced	 (+)	
cultures	were	 separated	 by	 SDS-PAGE	 and	 the	 gels	 stained	with	 Coomassie	 blue.	 Images	











































bacteria	 is	 well	 documented.	 Examples	 include	 VgrG-5	 in	 the	 T6SS-5	 of	 B.	
thailandensis	and	B.	pseudomallei,	which	was	shown	to	contained	a	CTD	essential	






putative	 evolved	 TssI	 protein	 encoded	 by	 BCAS0667	 in	 B.	 cenocepacia	 discussed	
here	 has	 previously	 been	 demonstrated	 to	 have	 a	 C-terminal	 extension	 with	
phospholipase	 A1	 activity	 (Jones,	 2012).	 So,	 consistent	 with	 other	 evolved	 TssI	
proteins,	 T6SS-dependent	 secretion	 of	 TssI0667	 by	 B.	 cenocepacia	 H111	 has	 now	
been	confirmed	using	immuno-detection.	Thus,	it	is	the	first	confirmed	evolved	TssI	
to	be	characterised	with	phospholipase	activity	at	its	C-terminus.		
	 Unlike	 some	 characterised	 evolved	 TssI	 proteins,	 such	 as	 VgrG-1	 in	 V.	
cholerae	(Pukatzki	et	al.,	2007),	this	study	found	that	TssI0667	was	not	essential	for	
T6SS	activity	as	determined	by	the	secretion	of	TssD	in	a	H111-ΔBCAS0667	mutant.	
This	 finding	 was	 not	 surprising,	 as	 B.	 cenocepacia	 encodes	 ten	 different	 TssI	
subunits	encoded	within	its	genome	and	it	is	unlikely	that	all	ten	are	core	structural	
subunits	of	 the	 system.	Furthermore,	a	very	 recent	observation	made	by	another	
group,	that	was	published	whilst	writing	this	thesis,	found	that	deletion	of	the	ten	
tssI	genes	 in	B.	cenocepacia	K56-2	did	not	have	an	effect	on	TssD	secretion	when	
deleted	 individually,	 but	 deletion	 of	 all	 ten	 in	 the	 same	 strain	 abolished	 TssD	
secretion	 (Aubert	 et	 al.,	 2015).	 This	 validates	 the	 observation	made	 in	 this	 study	









If	 the	 latter	were	 the	 case	 then	 this	 could	 involve	 the	 core	 TssI	 region	 remaining	
embedded/associated	with	the	outer	membrane	of	the	target	cell.	The	presence	of	
a	long	linker-like	region	preceding	the	CTD	also	suggests	this.	It	is	possible	that	this	
linker	 is	 cleaved	 to	 release	 the	 phospholipase-specifying	 CTD	 of	 TssI0667	 into	 the	
periplasm.	 Evidence	 to	 support	 a	 proteolytically	 susceptible	 linker	 region	 comes	
from	the	presence	a	smaller	anti-TssI0667.CTD	reactive	protein	of	~26	kDa	(similar	in	
size	to	the	free	Tle6	domain)	that	was	present	 in	the	cell-associated	fraction	of	B.	
cenocepacia	 by	 western	 blotting	 (data	 not	 shown).	 This	 fragment	 was	 more	
prevalent	than	the	full-length	TssI0667	 in	the	cell	associated	fraction,	particularly	 in	
B.	cenocepacia	T6SS-deficient	mutants	(data	not	shown).		
	 Evidence	 of	 a	 similar	 phenomenon	 of	 proteolytic	 cleavage	 has	 been	
suggested	 for	 the	 cytoplasmic	 delivery	 of	 the	 C-terminal	 toxin	 domains	 of	 CdiA	
proteins	in	the	contact	dependent	inhibition	system.	It	was	observed	that	the	entire	
CdiA	 protein	 is	 first	 transferred	 on	 to	 the	 surface	 of	 a	 target	 cell,	 where	 the	 N-
terminal	 region	 of	 CdiA	 remains	 associated	 with	 the	 cell	 surface	 whilst	 the	 C-




	 Over	 recent	 years	 there	 has	 been	 overwhelming	 evidence	 to	 suggest	 that	
the	 T6SS	 plays	 an	 anti-bacterial	 role.	 Superfamilies	 of	 T6SS-dependent	 effectors	
have	 been	 described	 that	 are	 thought	 to	 target	 bacterial	 cells	 by	 a	 variety	 of	
mechanisms,	 including	 peptidoglycan	 hydrolases,	 such	 as	 Tse1	 (Tae1)	 and	 Tse3	
(Tge1)	(Hood	et	al.,	2010;	Russell	et	al.,	2012),	DNases	such	as	Tde1	(Koskiniemi	et	
al.,	 2013;	Ma	 et	 al.,	 2014)	 as	well	 as	 phospholipases	 such	 as	 Tle1	 (Russell	 et	 al.,	





that	 it	 is	not	known	whether	TssI0667	 is	 causing	direct	 killing	of	 its	 target	or	has	a	
bacteriostatic	effect.		
	 The	anti-bacterial	 nature	of	 TssI0667	was	 further	 validated	by	 the	observed	
toxic	 effect	 of	 directing	 its	 phospholipase	 domain	 (Tle6)	 to	 the	 E.	 coli	 periplasm,	
which	 was	 specifically	 related	 to	 the	 phospholipase	 activity	 of	 the	 protein.	
Interestingly,	 intracellular	 expression	 of	 the	 TssI0667	 Tle6	 domain	 was	 not	 toxic,	
suggesting	 that	 the	protein	was	only	 able	 to	 target	 the	 inner	 leaflet	 of	 the	outer	
membrane	and/or	the	outer	leaflet	of	the	cytoplasmic	membrane	of	the	E.	coli	cell	
envelope.	 These	 findings	 are	 consistent	 with	 the	 trans-kingdom	 phospholipase	 D	
effector	of	 the	P.	aeruginosa	H3-T6SS,	PldB,	as	 this	was	also	observed	to	be	 toxic	
when	targeted	to	the	periplasm	in	E.	coli	but	not	when	directed	to	the	cytoplasm	
(Jiang	et	 al.,	 2014).	 For	 further	evidence	of	 the	 lytic	 ability	of	 TssI0667	 it	would	be	
useful	 to	 monitor	 cell	 viability	 by	 additional	 means,	 such	 as	 monitoring	 cell	
membrane	integrity	or	redox	potential.			
	 One	cannot	 rule	out	an	additional	 role	 for	TssI0667	as	a	 facilitator	 for	 the	
delivery	 of	 other	 T6SS	 effectors,	 as	 observed	 for	 VgrG1a,	 -b,	 and	 -c	 mediate	
bacterial	killing	in	P.	aeruginosa.	The	killing	by	each	of	those	VgrG	subunits	requires	
a	 toxin	 protein	 encode	 downstream	 of	 the	 vgrG	 gene	 (Hachani	 et	 al.,	 2014).	
Furthermore,	 VgrG-1	 in	 V.	 cholerae	 mediates	 killing	 by	 the	 Tle1VC	 phospholipase	
effector	 (Liang	et	al.,	2015;	Unterweger	et	al.,	2015).	 So,	 there	may	be	additional	
effectors	that	can	attach	onto	TssI0667	either	directly	or	indirectly	to	be	translocated	
into	a	target	cell.		
	 Alternatively,	 by	 delivery	 of	 TssI0667	 into	 the	 periplasm	 of	 competing	
bacterial	 cells,	 this	 may	 causes	 perturbations	 in	 either	 the	 outer	 or	 inner	 cell	
membrane	that	allows	the	movement	of	other	effectors	into	to	their	periplasmic	or	
cytoplasmic	target	sites.		Therefore,	the	reduction	in	the	competitive	ability	of	the	
ΔBCAS0667	 could	 well	 be	 due	 to	 prevention	 of	 other	 unknown	 anti-bacterial	
effectors	being	transported	into	the	bacteria,	rather	than	standalone	effects	of	the	
phospholipase	 domain	 of	 TssI0667.	 In	 this	 regard,	 it	 is	 interesting	 that	 predicted	
T6SS-dependent	 nuclease	 effectors,	 such	 as	 that	 encoded	 by	 BCAL1298	 and	
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of	 a	 fatty	 acyl	 ester	 substrate,	 4-nitrophenyl	 palmitate,	 of	 10°C	 (Jones,	 2012).	
However,	evidence	presented	 in	 this	current	study	demonstrated	a	 toxic	effect	of	
the	 Tle6	 domain	 at	 temperatures	 far	 above	 this	 in	 vitro	 optimum.	 For	 example,	
periplasmically	targeted	synthesis	of	the	TssI0667	Tle6	domain	in	E.	coli	was	carried	
out	 at	 30°C.	 Furthermore,	 a	 phenotypic	 effect	 on	 bacterial	 competition	with	 the	
ΔBCAS0667	mutant	was	observed	 at	 30°C.	 Thus	 it	 is	 difficult	 to	 imagine	how	 the	
psychrophilic	characteristics	of	 the	Tle6	domain	 link	 in	with	 these	new	findings.	 It	
could	 be	 argued	 that	 the	 distinct	 conditions	 of	 the	 periplasm,	 i.e.	 an	 oxidising	
environment,	 or	 presence	 of	 unknown	 additional	 chaperones	 or	 co-factors,	 may	
facilitate	 proper	 folding	 of	 the	 phospholipase	 domain	 of	 TssI0667	 to	 allow	 its	 full	
phospholipase	activity	to	be	demonstrated,	which	is	not	achieved	when	the	TssI0667	
Tle6	domain	is	overproduced	and	purified	from	the	cytoplasm.		
	 It	 would	 be	 interesting	 to	 determine	 if	 a	 more	 profound	 effect	 on	 the	
bacterial	 competition	 ability	 of	 the	 ΔBCAS0667	 mutant	 and/or	 lysis	 caused	 by	
periplasmic	targeting	of	the	Tle6	domain	of	TssI0667	in	E.	coli	is	observed	when	lower	




	 Several	 characteristics	 of	 the	 protein	 encoded	 by	 BCAS0666,	 termed	 Tli6,	
suggested	 it	 might	 be	 an	 immunity	 protein	 against	 TssI0667,	 which	 have	 been	
observed	 with	 other	 T6SS-dependent	 effectors	 and	 their	 cognate	 immunity	
proteins.	This	 included	 the	genomic	 location	of	BCAS0666	directly	downstream	of	
BCAS0667,	 the	 predicted	 periplasmic	 location	 of	 its	 protein	 product	 and	 the	
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presence	 of	 ankyrin-like	 repeats	 throughout	 the	 protein	 that	may	 be	 involved	 in	
protein-protein	 interactions.	 This	 study	 found	 that	presence	of	 Tli6	 in	E.	 coli	 cells	
prevented	the	toxic	 lytic	effect	of	 the	periplasmically	 targeted	Tle6	phospholipase	
domain	 of	 TssI0667	 when	 co-produced,	 and	 that	 the	 two	 proteins	 were	 able	 to	
directly	 interact	 to	 form	 a	 stable	 complex.	 The	 latter	 was	 demonstrated	 by	 pull-
down	analysis	and	size	exclusion	chromatography.	These	results	mirror	those	that	
demonstrated	TsaB	as	 the	antitoxin	 to	 the	evolved	VgrG-3,	VgrG-3	 (Brooks	et	 al.,	
2013;	Zhang	et	al.,	2014).			
	 It	 is	 likely	 that	Tli6	acts	as	an	 inhibitor	by	directly	sequestering	 the	TssI0667	
Tle6	domain,	and	thereby	preventing	it	from	binding	to	its	target	substrate,	either	
by	 masking	 the	 catalytic	 domain	 or	 sterically	 occluding	 it.	 By	 analogy	 with	 the	
charged	 interaction	surface	between	Tse2	and	 its	 immunity	protein	Tsi2	 (Li	et	al.,	
2012),	one	might	predict	 that	a	difference	 in	 surface	charge	between	TssI0667	and	
Tli6	 is	 important	 for	 their	 interaction.	 The	 theoretical	 pI	 of	 the	 Tle6	 domain	 of	
TssI0667	 is	 acidic	 (5.1),	 whereas	 Tli6	 has	 a	 slightly	 basic	 theoretical	 pI	 (8.75).	
However,	further	investigations	are	needed	to	support	this	idea.		
Furthermore,	 it	 is	 also	 required	 to	 confirm	 the	 loss	 of	 Tle6	 phospholipase	
activity	by	complex	formation	with	Tli6,	which	could	be	achieved	by	demonstrating	
direct	 inhibition	 of	 the	 fatty	 acyl	 esterase	 activity	 of	 TssI0667	Tle6	 domain	 by	 the	
addition	of	Tli6	in	vitro.			
	 It	 is	 interesting	 to	 consider	 how	 the	 immunity	 function	 of	 Tli6	 fits	 in	with	
secretion	of	TssI0667.	Does	Tli6	prevent	self-toxicity	of	the	TssI0667	Tl6	domain	during	
transport	through	the	cell	envelope?	Or	is	it	just	required	for	preventing	toxicity	to	
surrounding	 cells	 of	 the	 same	 species?	 Or	 is	 it	 a	 combination	 of	 the	 two?	 The	
former	would	imply	that	TssI0667	is	in	complex	with	Tli6	during	secretion.	If	this	were	
so,	 the	 complex	 would	 need	 to	 dissociate	 before	 injection	 into	 the	 surrounding	
target	 bacteria.	 Recent	 evidence	 has	 demonstrated	 the	 structure	 of	 the	 purified	
TssJLM	 sub-complex.	 It	 forms	 a	 chamber-like	 structure	 that	 is	 embedded	 in	 the	
cytoplasmic	membrane,	transverses	the	periplasm	and	is	associated	with	the	outer	
membrane,	 with	 a	 base,	 arches	 and	 tip	 complex	 (Durand	 et	 al.,	 2015).	 This	may	








evaluated.	 This	 would	 require	 the	 intra-species	 competition	 ability	 of	 wild-type,	
ΔBCAS0667	 and	 ΔBCAS0667-BCAS0666	 mutants	 to	 be	 assessed.	 	 A	 ΔBCAS0667	
mutant	 was	 successfully	 constructed	 using	 the	 pEX18TpTer-pheS	 allelic	
replacement	vector,	but	unfortunately	a	ΔBCAS0667-BCAS0666	mutant	was	unable	
to	 be	 generated	 using	 the	 same	 system.	 It	 appeared	 that	 either	 there	 was	 a	
problem	with	cPhe	counter-selection	of	single	recombinants	that	was	unable	to	be	
rectified	before	submission	of	this	work.		
Alternatively,	 deletion	 of	 BCAS0666	 may	 be	 lethal	 for	 some	 unforeseen	
reason,	even	though	it	was	being	deleted	in	combination	with	the	cognate	effector	
gene	 BCAS0667.	 If	 the	 latter	 was	 true	 then	 cross-immunity	 of	 Tli6	 with	 other	
potential	phospholipases	could	account	for	this.	There	is	evidence	to	suggest	some	
cross-immunity	 can	 be	 provided	 between	 different	 effector-immunity	 pairs	 in	 a	
peptidoglycan	hydrolase	effector	superfamily,	within	and	between	subfamilies	and	
bacterial	 species	 (Russell	 et	 al.,	 2012).	 However,	 this	 idea	 must	 be	 taken	 with	
caution	 as	 cross-immunity	 does	 not	 hold	 true	 for	 all	 T6SS-effector-immunity	
modules.	
To	 summarise,	 the	 results	 presented	 here	 allow	 future	 development	 of	 a	





able	to	prevent	toxicity	of	periplasmically	 located	TssI0667	 if	 it	 is	 injected	 into	 it	by	







Figure	 7.29	Model	 for	 shielding	 of	 TssI0667	 in	 the	 T6SS	 chamber.	 	 The	 TssI	 subunit	may	
reside	 in	a	 chamber	 structure	created	by	 the	TssJLM	sub-complex.	This	would	mean	 that	
the	phospholipase	domain	of	TssI0667	would	not	‘see’	the	periplasm	of	the	T6SS-containing	
producer	cell.	Subunits	as	 indicated	by	 the	 labels.	 Individual	baseplate	and	phage-like	 tail	
























Figure	7.30	Proposed	mode	of	action	 for	 the	T6SS-dependent	evolved	TssI,	TssI0667	 in	B.	
cenocepacia.	 Image	 depicts	 the	 trimeric	 TssI0667	 subunit	 with	 a	 C-terminal	 extension	
domain	that	specify	phospholipase	A1	activity.	This	subunit	is	affixed	to	the	tip	of	a	tubular	
structure	in	the	T6SS	complex.	It	 is	anticipated	that	either	the	core	gp27gp5-like	region	in	
TssI	 trimerises	 with	 itself	 or	 with	 other	 TssI	 subunits.	 (A)	 In	 a	 co-culture,	 TssI0667	 is	
transported	 by	 the	 T6SS-proficent	 producer,	 B.	 cenocepacia,	 into	 the	 periplasm	 of	
surrounding	target	bacteria	of	a	different	species.	The	C-terminal	phospholipase	domain	is	
able	 to	 target	 cellular	 membranes	 facing	 the	 periplasmic	 space,	 where	 it	 hydrolyses	
phospholipids.	 This	 compromises	 the	 integrity	 the	 cell	 membrane,	 resulting	 in	 death	 or	
bacteriostasis.	 (B)	 Protection	 from	 the	 toxic	 effect	 of	 TssI0667	 is	 inhibited	 by	 complex	
formation	with	periplasmic	immunity	protein	Tli6,	produced	in	surrounding	sibling	cells	of	



















Characterisation	 of	 another	 candidate	 T6SS-effector	 was	 pursued	 in	 this	
study,	Tpe1.	This	was	predicted	to	contain	a	M23	peptidase-like	domain	specifying	
amidase	 activity	 at	 its	 N-terminus,	 and	 a	 lysozyme-like	 domain	 conferring	




The	 insoluble	 nature	 of	 recombinant	 Tpe1	 is	 in	 contrast	 to	 several	 T6SS	
peptidoglycan	 degrading	 effectors	 that	 have	 been	 overproduced	 and	 purified,	
including	the	amidase	effectors	Tse1	(Tae1)	and	Tae2	(Russell	et	al.,	2011;	Russell	et	
al.,	 2012;	 Ding	 et	 al.,	 2012),	 further	 Tae	 effectors	 Ssp1	 and	 Ssp2	 (Tae4)	 in	 S.	
marcescens	 (English	et	al.,	2012),	and	muramidase	effectors	Tse3	(Tge1)	and	Tge2	
(Russell	et	al.,	2011;	Li	et	al.,	2013;	Whitney	et	al.,	2013;	Wang	et	al.,	2013).		
Tpe1	 contains	 several	 cysteine	 residues	 so	 it	 is	 possible	 that	 for	 correct	
folding	in	the	target	cell	periplasm	the	polypeptide	requires	formation	of	disulphide	
bridges,	which	are	difficult	 to	achieve	 in	 the	 cytoplasm.	This	may	account	 for	 the	
insolubility	of	the	protein.	However,	many	if	not	all	of	characterised	peptidoglycan	
hydrolases	 stated	 above	 also	 contain	 cysteine	 residues	 thus	 are	 also	 likely	 to	
require	 disulphide	 bond	 formation	 for	 proper	 folding.	 To	 overcome	 this	many	 of	









The	 method	 described	 in	 Whitney	 et	 al.	 (2013),	 which	 used	 Shuffle®	 T7	
Express	lysY	cells	as	the	expression	host,	states	induction	of	protein	synthesis	from	
pET	expression	 series-derivatives	was	performed	with	1	mM	 IPTG	 for	18	hours	at	




and	 duration	 used	 for	 Tpe1	 overproduction	 in	 both	 expression	 hosts	 tested	may	
have	 been	 too	 short	 and	 performed	 at	 a	 too	 high	 temperature.	 Therefore,	 any	





















































	 The	 overall	 aim	of	 this	 study	was	 to	 identify	 and	 characterise	 novel	 T6SS-
dependent	effectors	in	a	Burkholderia	cepacia	complex	species,	B.	cenocepacia,	to	
help	 understand	 what	 role	 the	 ancestral	 T6SS	 plays	 in	 this	 organism	 and	 other	
members	of	the	Bcc.	As	observed	in	a	related	but	non-Bcc	Burkholderia	species,	B.	
thailandensis	 (Schwarz	 et	 al.,	 2010),	 it	 was	 shown	 that	 selected	 B.	 cenocepacia	
strains	 had	 a	 constitutively	 active	 T6SS-1	which	 it	 used	 to	 compete	 against	 other	
bacterial	species,	including	P.	putida	and	E.	coli.	This	is	the	first	demonstration	that	
T6SS-1	in	a	Bcc	member	plays	a	role	in	inter-bacterial	competition.	This	observation	
also	 further	 adds	 to	 the	 catalogue	 of	 Gram-negative	 bacteria	 that	 use	 a	 specific	
T6SS	 for	 bacterial	 interactions,	 including	 but	 not	 exclusively,	 the	 H1-T6SS	 in	 P.	
aeruginosa	 and	 the	single	T6SSs	 in	V.	cholerae,	A.	 tumefaciens	 and	S.	marcescens	
(Hood	et	al.,	2010;	MacIntyre	et	al.,	2010;	Murdoch	et	al.,	2011;	Ma	et	al.,	2014).	
The	 natural	 reservoir	 of	B.	 cenocepacia	 is	within	 the	 environment,	 particularly	 in	
soil	around	plant	root	systems	(the	rhizosphere),	where	many	other	bacteria	vie	for	
a	foothold.	Hence,	 it	 is	unsurprising	that	B.	cenocepacia	has	evolved	a	mechanism	
for	 competitive	 fitness	 against	 other	 bacteria,	 particular	 if	 it	 has	 to	 survive	 in	 an	
environment	where	 other	microorganisms	 are	 competing	 for	 the	 same	 biological	
niches.	
This	study	attributed	some	of	the	competition	advantage	the	T6SS	provides	
to	 B.	 cenocepacia	 on	 a	 T6SS-dependent	 evolved	 TssI	 protein,	 TssI0667,	 with	 a	 C-
terminal	extension	that	possesses	enzymatic	activity	similar	to	the	anti-bacterial	Tle	
phospholipase	 superfamily	 of	 effectors	 (Russell	 et	 al.,	 2013).	 In	 contrast,	 this	
investigation	could	not	assign	an	anti-bacterial	 role	 to	a	putative	T6SS-dependent	
nuclease	effector,	TanBH,	even-though	T6SS-dependent	nucleases	used	for	inter-	or	




in	 interactions	 with	 eukaryotes.	 This	 includes	 a	 T6SS	 cluster	 encoded	 in	 a	 more	
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pathogenic	Burkholderia	 species	B.	 pseudomallei	 that	 is	 required	 for	 intracellular	
survival	 of	 the	 bacteria	 within	 a	 host	 cell,	 typically	 in	 phagocytes	 (Shalom	 et	 al.,	
2007;	 Burtnick	 et	 al.,	 2011).	 This	 occurs	 specifically	 via	 the	 T6SS-5,	 which	 is	 not	
encoded	in	Bcc	bacteria.	Despite	this,	B.	cenocepacia	and	other	Bcc	bacteria	are	still	
able	 to	 survival	 intracellularly	 within	 membrane-bound	 vacuoles	 (BcCVs)	 in	 both	
professional	 phagocytes	 such	 as	 macrophages	 (Saini	 et	 al.,	 1999)	 and	 non-
professional	 phagocytes	 such	 as	 epithelial	 cells	 (Burns	 et	 al.,	 1996;	 Sajjan	 et	 al.,	
2006).		
The	detection	of	intracellular	B.	cenocepacia	is	sensed	by	the	cytosolic	pyrin	
inflammasome,	 which	 leads	 to	 the	 secretion	 of	 pro-inflammatory	 cytokines	
following	caspase-1	activation,	 including	 IL-1β,	 and	 thus	 leads	 to	an	 inflammatory	
response.	 Chronic	 inflammation	 in	 the	 lungs	 of	 CF-patients	 infected	 with	 B.	
cenocepacia	 is	 common.	 Interestingly,	 it	 was	 shown	 that	 an	 active	 T6SS-1	 is	
required	for	pyrin	inflammasome	activation	and	thus	IL-1β	secretion	in	response	to	
intracellular	B.	cenocepacia	(Gavrilin	et	al.,	2012).	The	T6SS-1	induces	this	response	
by	 increasing	 the	 amount	 of	 active	 (i.e.	 GTP-bound)	 RhoA	 (Rosales-Reyes	 et	 al.,	
2012b)	through	deamination	of	residue	Asn21	in	the	protein	(Xu	et	al.,	2014).		
There	 is	 evidence	 to	 suggest	 that	 the	T6SS-1	 is	 able	 to	puncture	 the	BcCV	
membrane	 to	 release	 T2SS-dependent	 effectors	 from	 the	 extracellular	 milieu	 of	
BcCVs	 into	 the	 cytosol,	 and	 this	 event	 contributes	 to	 the	 activate	 of	 the	 pyrin	
inflammasome	 as	 inferred	 by	 IL-β	 secretion	 (Rosales-Reyes	 et	 al.,	 2012a).	 It	 is	
currently	unknown	whether	inactivation	of	the	T2SS	in	B.	cenocepacia	has	a	direct	
effect	on	pyrin	activation	through	deamination	of	RhoA,	but	 it	has	been	shown	to	
decrease	 IL-1β	 secretion	 similar	 to	 that	 observed	 upon	 inactivation	 of	 the	 T6SS	
(Rosales-Reyes	et	al.,	2012a).	If	inactivation	of	the	B.	cenocepacia	T2SS	did	prove	to	
directly	 affect	 the	 deamination	 of	 RhoA	 and	 in	 turn	 affect	 pyrin	 inflammasome	
activation,	 this	would	suggest	 that	 rather	 than	an	effector	being	secreted	directly	
into	the	cytosol	by	the	T6SS,	T6SS-faciliated	leakage	of	the	BcCV	contents,	including	




Although	 T6SS-1	has	 been	 implicated	 in	 subverting	 eukaryotic	 cells,	 either	
directly	or	indirectly,	the	results	of	this	study	did	not	demonstrate	an	obvious	role	
for	 this	 system	 in	 pathogenicity	 towards	 eukaryotic	 organisms.	 T6SS-defective	
mutants	all	showed	a	similar	overall	virulence	as	the	wild-type	strain	in	a	zebrafish	
embryo	infection	model	and	a	G.	mellonella	larvae	model.	Both	of	these	organisms	
are	 used	 to	model	 innate	 immune	 responses	 to	 infection,	 as	 they	 have	 primitive	
phagocytic	 cells	 and	 other	 anti-microbial	 defences.	 Taking	 into	 consideration	 the	
observations	 regarding	 T6SS-dependent	 inflammasome	 activation	 and	 T2SS-
dependent	IL-1β	secretion	in	phagocytic	cells	(Rosales-Reyes	et	al.,	2012a;	Gavrilin	
et	al.,	2012;	Xu	et	al.,	2014),	one	could	argue	that	inactivation	of	the	T6SS	may	not	
affect	 the	 overall	 virulence	 of	 the	 bacterium	 in	 vivo,	 but	 the	 host	 may	 show	 a	
delayed	inflammatory	response	to	strains	 lacking	T6SS-1.	 	A	T6SS	mutant	may	still	
eventually	activate	the	pyrin	inflammasome	if	the	toxin	that	causes	this	activation	is	
not	T6SS-dependent	but	 is	able	 to	escape	 into	 the	cytosol	of	host	cells	 in	a	T6SS-
independent	manner,	e.g.	T2SS	substrate	 (Rosales-Reyes	et	al.,	2012a).	This	study	
















This	 study	 has	 opened	 up	 several	 avenues	 of	 investigations	 that	 can	 be	
further	 explored	 in	 relation	 to	 the	 role	 of	 T6SS-1	 in	 Bcc	 bacteria.	 First,	 for	 firm	
evidence	 for	 the	 role	of	 the	T6SS-1	 in	bacterial	 competitive	 in	B.	 cenocepacia	 the	
T6SS	 mutants	 need	 to	 be	 genetically	 complemented.	 The	 same	 applies	 to	 the	
observations	 in	the	G.	mellonella	 larvae	 infection	assays.	For	further	evaluation	of	
the	 function	of	 T6SS-1	 in	B.	 cenocepacia	 it	would	be	 interesting	 to	determine	 	 (i)	
whether	 there	 are	 other	 bacterial	 species	 that	 are	more	 susceptible	 to	 the	 anti-
bacterial	 activity	 of	 B.	 cenocepacia;	 (ii)	 whether	 there	 is	 a	 target	 cell	 or	
experimental	conditions	that	can	induce	T6SS	activity	in	B.	cenocepacia	strains	that	
do	not	show	a	constitutively	active	T6SS-1,	 such	as	Pc715j;	and	 (iii)	whether	T6SS	
mutants	 show	 any	 difference	 in	 their	 pathogenicity	 in	 other	 innate	 immune	
response	infection	models,	such	as	C.	elegans	or	D.	discoideum,		and	plant	infection	
models	 such	 as	 A.	 thaliana	 or	 alfalfa	 seedlings.	 This	 may	 shed	 light	 on	 the	
observation	 of	 T6SS-dependent	 pyrin	 inflammasome	 activation	 by	 intracellular	B.	
cenocepacia	 in	 eukaryotic	 host	 cells.	 It	 would	 also	 be	 fascinating	 to	 investigate	
whether	 effectors	 secreted	 by	 other	 secretion	 system,	 such	 as	 the	 T2SS,	 co-
ordinate	with	 the	 T6SS	 to	 leak	 effectors	 from	 BcCVs	 into	 the	 cytosol	 of	 infected	
cells.	
It	 is	 also	 intriguing	 that	 the	 B.	 cenocepacia	 H111	 strain	 shows	 greater	
constitutive	 levels	 of	 T6SS	 expression	 than	 other	B.	 cenocepacia	 strains	 tested	 in	
this	 study	 and	 it	 would	 be	 interesting	 to	 elucidate	 the	 reasons	 for	 this	
phenomenon.	One	possible	reason	could	be	the	lack	of	the	CciIR	quorum	regulatory	
system	in	H111,	thought	to	be	a	negative	regulator	of	T6SS	cluster	expression.	Also	
in	 regards	 to	 regulation,	 as	 this	 study	 demonstrated	 that	 deletion	 of	 tagF	had	 a	
positive	effect	on	T6SS	activity	in	some	cases,	this	could	be	an	additional	avenue	to	
explore,	particularly	because	TagF	 is	also	 found	 in	T6SS	gene	clusters	 that	do	not	






the	 verification	 of	 both	 Tli6	 and	 TaaB1H	 as	 bona	 fide	 immunity	 proteins	 to	 their	




detection	 of	 the	 protein	 by	 immuno-blotting	 or	 mass	 spectrometry	 methods,	 or	
inferred	 by	 intraspecies	 competition	 assays.	 Confirmation	 of	 the	 interaction	
between	putative	chaperone	protein	TagA	and	TanBH	would	also	be	beneficial,	as	
well	 as	 further	 exploration	 of	 the	 putative	 role	 of	 TagA	 as	 a	 chaperone	 by	
ascertaining	whether	or	not	it	is	able	to	interact	with	other	core	T6SS	components.	
	Overall,	 it	 is	 clear	 there	 is	 significant	 work	 still	 to	 be	 carried	 out	 to	 fully	
understand	 the	 role	 played	 by	 the	 T6SS-1	 in	 B.	 cenocepacia	 and	 the	 effectors	 it	
secretes.	Nevertheless,	 this	work,	 and	 the	work	of	others	have	begun	 to	uncover	
potential	roles	for	this	secretion	system	in	B.	cenocepacia	and	other	Bcc	bacteria,	as	
well	 as	 providing	 insights	 into	 the	 potential	 effectors	 its	 secretes.	 A	 better	



























































Reference	 DNA	 ladders	 used	 in	 this	 study.	 	 Images	 of	 DNA	 ladders	 supplied	 by	 the	
manufacturer,	indicating	the	fragment	sizes	in	bp	or	kbp	and	relative	DNA	concentration	in	











Reference	protein	 ladders	used	 in	 this	 study.	 	 Images	of	protein	 ladders	supplied	by	the	
manufacturer,	 indicating	 the	 estimated	 molecular	 mass	 of	 each	 protein	 in	 the	 ladder	
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